10-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended March 29, 2013

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No.: 1-4850

	COMPUTER SCIENCES CORPORATION
	(Exact name of Registrant as specified in its charter)

Nevada	95-2043126
(State of incorporation or organization)	(I.R.S. Employer Identification No.)
3170 Fairview Park Drive
Falls Church, Virginia	22042
(Address of principal executive offices)	(zip code)
Registrant's telephone number, including area code: (703) 876-1000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:	Name of each exchange on which registered
Common Stock, $1.00 par value per share	New York Stock Exchange
Preferred Stock Purchase Rights
Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     x Yes  o No  

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.      o Yes  x   No  

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x Yes  o   No  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes  o   No     

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller reporting company.

Large accelerated filerx Accelerated filer o Non-accelerated filer o Smaller reporting companyo

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    o Yes  x   No

As of September 28, 2012, the aggregate market value of stock held by non-affiliates of the Registrant was approximately $4,956,615,996.

There were 150,228,623 shares of the Registrant’s common stock outstanding as of May 3, 2013.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s definitive Proxy Statement for its 2013 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission within 120 days after March 29, 2013, are incorporated by reference into Part III hereof.

TABLE OF CONTENTS

Item		Page
	PART I
1.	Business	1
1A.	Risk Factors	5
1B.	Unresolved Staff Comments	13
2.	Properties	14
3.	Legal Proceedings	15
4.	Mine Safety Disclosures	15
	Executive Officers of the Registrant	16
	PART II
5.	Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	17
6.	Selected Financial Data	20
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
7A.	Quantitative and Qualitative Disclosures about Market Risk	57
8.	Financial Statements and Supplementary Data	58
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	139
9A.	Controls and Procedures	139
9B.	Other Information	143
	PART III
10.	Directors, Executive Officers and Corporate Governance	143
11.	Executive Compensation	143
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	143
13.	Certain Relationships and Related Transactions, and Director Independence	145
14.	Principal Accountant Fees and Services	145
	PART IV
15.	Exhibits, Financial Statement Schedules	145

i

PART I

Item 1. Business

INTRODUCTION AND HISTORY

General

Computer Sciences Corporation (CSC or the Company), is a global leader of information technology (IT) and professional services and solutions. Since the Company was founded in 1959, CSC has helped develop and integrate IT assets in support of operational efficiency, new growth initiatives and other business objectives. The Company’s 90,000 employees serve approximately 2,500 clients in more than 70 countries. Clients include commercial enterprises and the U.S. federal government, as well as state, local and non-U.S. government agencies. The Company is incorporated in the state of Nevada.

The Company's mission is to enable superior returns on our client's technology investments through best-in-class industry solutions, domain expertise and global scale. CSC generally does not operate through exclusive agreements with hardware or software providers and believes this vendor neutrality enables the Company to better identify and manage solutions specifically tailored to each client’s needs.

CSC's management team has strived to create shareholder value by aligning its assets with its strategy, executing its $1.0 - $1.2 billion cost takeout program, and prudent capital deployment. The Company completed four divestitures in fiscal 2013 in order to better align our assets with its strategy of leading the next generation of IT services and solutions. The Company's cost takeout program is focused on four areas: 1) supply chain and procurement savings, 2) workforce optimization, 3) enterprise overhead reduction, and 4) contract management discipline. The cost takeout program was initiated in fiscal 2012 and extends through fiscal 2014. CSC's priorities for capital deployment include 1) reinvesting in the core business, 2) pursuing strategic acquisitions, 3) ensuring a strong financial position with ample access to liquidity, and 4) returning cash to shareholders.

Services and Sectors

The Company delivers IT services and solutions through three broad service lines or sectors: North American Public Sector (NPS), Managed Services Sector (MSS), and Business Solutions and Services (BSS). Geographically, CSC has major operations throughout North America, Europe, Asia and Australia. Segment and geographic information are included in Note 16 to the Consolidated Financial Statements for the year ended March 29, 2013. For a discussion of risks associated with our foreign operations, see Item 1A "Risk Factors".

NPS

NPS provides IT-related and mission/operations-related services to the U.S. federal government. NPS's customer base includes most branches of the military and many civil departments, as well as the Department of Homeland Security and NASA. The Company provides systems integration and outsourcing to complex project management and technical services. Key offerings include enterprise modernization, telecommunications and networking, managed services, base and range operations, and training and simulation.

MSS

MSS provides information systems outsourcing services to clients in a broad array of industries, including financial services, healthcare, manufacturing, and other diversified industries. IT outsourcing involves operating all or a portion of a customer's technology infrastructure, including systems analysis, applications development, network operations, end-user computing and data center management. In addition, MSS provides an array of emerging services in the areas of Infrastructure as a Service (IaaS), Software as a Service (SaaS), Business Process as a Service (BPaaS), Platform as a Service (PaaS), Cyber Security Managed Services and other emerging technologies and associated service delivery models. CSC's services are delivered through allocation of resources located both on a client's premises and through CSC's service centers around the world.

1

BSS

BSS serves a broad array of industries, providing industry-specific solutions in areas such as consulting and systems integration, business process outsourcing, and intellectual property-based software to chemical, energy and natural resources, financial services, technology and consumer, manufacturing, healthcare, and public sector organizations. Consulting and professional services include advising clients on the strategic acquisition and utilization of IT and on business strategy, security, modeling, simulation, engineering, operations, change management and business process reengineering. Systems integration encompasses designing, developing, implementing and integrating complete information systems. In prior periods, BSS provided professional technology staffing services in Australia, computer equipment repair and maintenance services in Asia, and credit reporting services in the United States. These businesses were divested in fiscal 2013.

During the last three fiscal years, the Company’s revenue mix by line of business was as follows:

	2013		2012		2011
North American Public Sector	36	%	37	%	39	%
Managed Services Sector	43		43		42
Business Solutions and Services	22		21		20
Subtotal	101		101		101
Corporate and Eliminations	(1	)	(1	)	(1	)
Total Revenues	100	%	100	%	100	%

Fiscal 2013 Overview

During fiscal 2013, CSC announced contract awards, or bookings, with a total contract value (TCV) of approximately $13.8 billion, consisting of $3.5 billion of NPS awards, $6.9 billion of MSS awards, and $3.4 billion of BSS awards. The total commercial awards represented through MSS and BSS of $10.3 billion was lower than the $12.8 billion of awards during fiscal 2012. Additionally, fiscal 2013 NPS awards of $3.5 billion compare with fiscal 2012 awards of $6.0 billion, reflecting softness in demand among public sector clients. These amounts have been adjusted for discontinued operations.

New business contributed $8.5 billion and $12.4 billion to the TCV of fiscal 2013 and 2012 contract awards, respectively. The TCV of renewals and recompetes was $5.3 billion and $6.4 billion, during fiscal 2013 and fiscal 2012, respectively.

For NPS, announced values for indefinite delivery and indefinite quantity (IDIQ) awards represent the expected contract value at the time a task order is awarded under the contract. The bookings value of MSS announced awards is estimated at the time of contract signing and includes optional contract years. New contract bookings are recorded using then-existing projections of service volumes and then-existing currency exchange rates, and are not subsequently adjusted for volume or currency fluctuations. The announced values for BSS line of business awards are based on firm commitments.

Although commercial demand for IT services and solutions grew modestly during the year, CSC did not benefit materially from this trend because the Company embarked on a concerted program to review, rationalize, and modernize its portfolio of service offerings. As part of the broader transformation of CSC's business operations, its go-to-market organizations, programs, and offerings were thoroughly assessed relative to competitive position, profitability, and scalable delivery. The effect of these reviews and realignments impacted the Company's lead generation activities. Win rates on the business opportunities pursued by the Company's sales force were sustained at historical levels, but the absolute volume of new business proposals submitted declined year-over-year. Fiscal 2013 was a year focused on rebuilding both the portfolio of service offerings and the organizations, processes, and channels through which those offerings are taken to market.

Many of our government customers continue to experience uncertainty about their fiscal budgets due to the Budget Control Act of 2011 and sequestration. As a result, large program awards are delayed and government customers are shifting to smaller and shorter term contracts.

2

In future periods, CSC’s results of operations and financial condition may be negatively affected by conditions in the various global markets in which the Company operates or client budget constraints. Economic conditions could impact the credit quality of CSC's receivables portfolio and, therefore, the level of provision for bad debts. CSC continues to review credit policies and collection efforts in both the origination of new business and the evaluation of existing projects.

Contract terminations, cancellations or delays could result from our performance or factors that are beyond our control, including the business or financial condition of the client, changes in client ownership or management, and changes in client strategies, the economy or markets generally. When contracts are terminated, we lose the anticipated revenues and might not be able to eliminate associated costs simultaneously with contract termination, and the contract assets may become impaired. Consequently, our profit margins in subsequent periods could be lower than expected.

Currency fluctuations will continue to have an effect on both revenue and profit. The Company’s foreign currency risk management program, however, attempts to mitigate some of the economic and margin risk.

Acquisitions and Divestitures

Acquisitions

During fiscal 2013,CSC acquired 42Six Solutions, LLC (42Six) for $35 million in an all cash transaction. 42Six, a software development company specializing in providing analytics and applications software products and services for the U.S. government intelligence community and the Department of Defense, was acquired primarily to enhance CSC's strategy of offering customers greater value through data expertise and intellectual property. This acquisition is related to the Company's NPS segment.

During fiscal 2012, CSC acquired iSOFT Group Limited (iSOFT), a publicly-held company listed on the Australian Securities Exchange, for cash consideration of $200 million, and the assumption of debt of $315 million, of which $298 million was repaid immediately after the acquisition, in the Company's BSS segment. The acquisition complements and strengthens CSC's software products, healthcare integration and services portfolio, and its healthcare research and development capabilities, as iSOFT provides advanced application solutions across both the public and private sectors.

In addition, CSC acquired three privately-held companies for an aggregate purchase price of $201 million during fiscal 2012, the largest being the acquisition of AppLabs for $171 million in CSC's MSS segment, and the other two acquisitions in the NPS and BSS segments. The AppLabs acquisition enhances the Company's capabilities in application testing services and complements CSC's expertise in financial services, healthcare, manufacturing, chemical, energy, and natural resources and technology and consumer markets. The acquisitions in the NPS and BSS segments enhance the Company's offerings in the healthcare IT and financial services industries.

During fiscal 2011, CSC acquired four privately-held companies for an aggregate purchase price of $156 million; two of the acquisitions are included in CSC’s NPS segment and two were included in the BSS segment.

The NPS segment acquisitions enhanced the Company’s offerings and position in the key areas of cybersecurity and intelligence, surveillance and reconnaissance solutions, sensor integration, and in-theater analysis and exploitation.

The BSS segment acquisitions expanded CSC’s presence in the life sciences sector by enhancing its service offerings to include integrated, end-to-end business solutions for electronic regulatory submissions, integrating other acquired expertise with CSC’s established Cloud/SaaS capabilities, and expanding CSC’s presence and offerings in the chemical, energy and natural resources markets.

Divestitures

As described below, during fiscal 2013 CSC divested three businesses that qualified for discontinued operations presentation. As a result, CSC's results from continuing operations, for all periods presented, have been recast to exclude the results of the divested businesses.

3

During the third quarter of fiscal 2013, CSC completed the divestiture of its U.S. based credit services business for cash proceeds of approximately $1.0 billion and its Italian consulting and system integration business for a cash payment of $35 million. During the fourth quarter of fiscal 2013, CSC completed the divestiture of one of its enterprise systems integration businesses based in Singapore and Malaysia for consideration of approximately $104 million. This business was primarily involved in the reselling of enterprise hardware and software and providing the related maintenance services. All of these businesses were primarily a part of the Company's BSS segment and the divestitures reflect the Company's ongoing initiative to focus on next-generation technology services.

Additionally, during the fourth quarter of fiscal 2013, the Company divested its Australian information technology staffing unit, Paxus, for cash consideration of approximately $79 million. Due to CSC's ongoing business involvement with Paxus, this divestiture did not qualify to be presented as discontinued operations, and therefore its results are included in continuing operations.

During fiscal 2011, CSC completed the divestiture of two immaterial businesses within its NPS segment whose ultimate customer is the U.S. federal government, one during the second quarter for consideration of approximately $56 million and another during the fourth quarter for consideration of approximately $65 million. Both of these divestitures were driven by governmental Organizational Conflict of Interest concerns. These divestitures have been reflected as discontinued operations in our financial statements.

For further discussion of these acquisitions and divestitures, see Notes 3 and 4 to the Consolidated Financial Statements.

Competition

The IT and professional services markets in which CSC competes are not dominated by a single company or a small number of companies. A substantial number of companies offer services that overlap and are competitive with those offered by the Company. Some of these are large industrial firms, including computer manufacturers and major aerospace firms that may have greater financial resources than CSC and, in some cases, may have greater capacity to perform services similar to those provided by the Company. In addition, the increased importance of offshore labor centers has brought a number of foreign-based firms into competition with CSC. Offshore IT outsourcers selling directly to end-users have captured an increasing share of awards as they compete directly with U.S. domestic suppliers of these services. The Company continues to increase resources in offshore locations to mitigate somewhat this market development.

More recently, the accelerating demand for multi-tenant infrastructure services, commonly referred to as Cloud Computing offerings, is continuing to alter the landscape of competition. New entrants to our markets are offering service models that change the decision criteria and contracting expectations of our target market. The Company has responded to these changing market conditions with new offerings that are intended to position CSC favorably.

CSC’s ability to obtain business is dependent upon its ability to offer better strategic concepts and technical solutions, better value, a quicker response, more flexibility, better quality, a higher level of experience, or a combination of these factors. In the opinion of the Company’s management, CSC’s lines of business are positioned to compete effectively in the BSS, MSS and NPS markets based on its technology and systems expertise and large project management skills. It is also management’s opinion that CSC’s competitive position is enhanced by the full spectrum of IT and professional services it provides, including consulting and software and systems design, implementation and integration, IT and business process outsourcing and technical services, delivered to a broad commercial and government customer base.

4

EMPLOYEES

The Company has offices worldwide, and as of March 29, 2013, had approximately 90,000 employees. The services provided by CSC require proficiency in many fields, such as computer sciences, programming, telecommunications networks, mathematics, physics, engineering, astronomy, geology, operations, research, finance, economics, statistics and business administration.

U.S. SECURITIES AND EXCHANGE COMMISSION REPORTS

All of the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to those reports, and other materials required to be filed with or furnished to the U.S. Securities and Exchange Commission (SEC) on or after January 19, 1995, are available free of charge through the Company’s Internet website, www.csc.com, or through the CSC Investor Relations Office at 1-800-542-3070. The content on any website referred to in this Annual Report on Form 10-K is not incorporated by reference into this report, unless expressly noted otherwise. As soon as reasonably practical after the Company has electronically filed such material with or furnished it to the SEC, these items can be read and copied at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. Periodic reports, proxy statements, information statements, and other information filed with or furnished by the Company to the SEC are available on the SEC’s website, www.sec.gov, or by calling the SEC at 1-800-SEC-0330 (1-800-732-0330).

FORWARD-LOOKING AND CAUTIONARY STATEMENTS

All statements and assumptions contained in this Annual Report and in the documents attached or incorporated by reference that do not directly and exclusively relate to historical facts constitute “forward-looking statements” within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements represent current expectations and beliefs of CSC, and no assurance can be given that the results described in such statements will be achieved.

Forward-looking information contained in these statements include, among other things, statements with respect to CSC’s financial condition, results of operations, cash flows, business strategies, operating efficiencies or synergies, competitive position, growth opportunities, plans and objectives of management, and other matters. Such statements are subject to numerous assumptions, risks, uncertainties and other factors, many of which are outside of CSC’s control, which could cause actual results to differ materially from the results described in such statements. These factors include without limitation those listed below under Item 1A. "Risk Factors."

Forward-looking statements in this Annual Report speak only as of the date of this Annual Report, and forward-looking statements in documents attached or incorporated by reference speak only as to the date of those documents. CSC does not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Annual Report or to reflect the occurrence of unanticipated events, except as required by law.

Item 1A. Risk Factors

Past performance may not be a reliable indicator of future financial performance. Future performance and historical trends may be adversely affected by the following factors, as well as other variables, and should not be relied upon to project future period results.

1. Our business may be adversely impacted as a result of changes in demand, both globally and in individual market segments, for IT outsourcing, business process outsourcing and consulting and systems integration services. In addition, worldwide economic weakness and uncertainty could adversely affect our revenue and expenses.

Current weakness in worldwide economic conditions and political uncertainty may adversely impact our customers' demand for our services in the markets in which we compete, including our customers' demand for consulting, systems integration and other IT services. Our government customers' demand may also be affected by budgetary and political uncertainties, changing priorities, military conflicts and other events.

5

2. We are the subject of an ongoing SEC investigation and an SEC comment letter process, which could divert management's focus, result in substantial investigation expenses and have an adverse impact on our reputation and financial condition and results of operations.

On May 2, 2011, the Audit Committee commenced its investigation into certain accounting errors and irregularities, primarily in our Nordic region and in our operations in Australia. This investigation also reviewed certain aspects of our accounting practices within our Americas Outsourcing operation and certain of our contracts that involve the percentage-of-completion accounting method, including our contract with the U.K. National Health Service (NHS). As a result of this investigation, we have recorded certain out of period adjustments to our historical financial statements and taken certain remedial measures.

The SEC is conducting its own investigation into the foregoing areas as well as certain related disclosure matters.

The Audit Committee determined in August 2012 that its independent investigation was complete. The Audit Committee instructed its independent counsel to cooperate with the SEC's Division of Enforcement by completing production of documents and providing any further information requested by the SEC's Division of Enforcement.

In addition to the matters noted above, the SEC's Division of Enforcement is continuing its investigation involving its concerns with certain of the Company's prior disclosure and accounting determinations with respect to the Company's contract with the NHS and the possible impact of such matters on the Company's financial statements for years prior to the Company's current fiscal year. The Company and the Audit Committee and its independent counsel are investigating these matters and are continuing to cooperate with the SEC's Division of Enforcement in its investigation.

In addition, the SEC's Division of Corporation Finance has issued comment letters to the Company requesting, among other things, additional information regarding the Company's previously disclosed accounting adjustments, the Company's conclusions regarding the materiality of such adjustments and the Company's analysis of the effectiveness of its disclosure controls and procedures and its internal control over financial reporting. The SEC's Division of Corporation Finance's comment letter process is ongoing, and the Company is continuing to cooperate with that process.

The investigation being conducted by the SEC's Division of Enforcement and the review of our financial disclosures by the SEC's Division of Corporation Finance are continuing and could identify other accounting errors, irregularities and other areas of review. As a result, we have incurred and may continue to incur significant legal and accounting expenditures. We are unable to predict how long the SEC's Division of Enforcement's investigation will continue or whether, at the conclusion of its investigation, the SEC will seek to impose fines or take other actions against us. In addition, we are unable to predict the timing of the completion of the SEC's Division of Corporation Finance's review of our financial disclosures or the outcome of such review. Publicity surrounding the foregoing or any enforcement action as a result of the SEC's investigation, even if ultimately resolved favorably for us, could have an adverse impact on our reputation, business, financial condition, results of operations or cash flows.

See Note 2 to the Consolidated Financial Statements for a discussion of these investigations and adjustments.

3. On August 31, 2012, we entered into a binding interim agreement contract change note (IACCN) with the NHS, which amends the terms of the then current contract with the NHS and forms the basis on which we will finalize a full restatement of the current contract. Under the IACCN, the NHS will not be subject to any trust volume commitment for Lorenzo products and the Company has agreed to non-exclusive deployment rights for all products and services in those regions in which it previously enjoyed exclusivity.

CSC and the NHS are parties to a contract under which the Company is developing and deploying an integrated electronic patient records system. On August 31, 2012, after a series of negotiations, CSC and NHS entered into the IACCN, which has been approved by all required U.K. government officials, and which amended the terms of the parties' then current contract. Under the IACCN, the parties have agreed to a mutual release of all past or

6

future disputed amounts under the contract through the date of the IACCN. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain financial terms of the IACCN. The IACCN will form the basis of an amendment and restatement of the existing NHS contract which the parties are in the process of negotiating.

Under the IACCN, the NHS will not be subject to any trust volume commitment for Lorenzo (there are no changes in quantities for non-Lorenzo deployments), and the Company has agreed to non-exclusive deployment rights for all products and services in those regions in which it previously enjoyed exclusivity. As a result, the individual trusts can choose third-party software vendors other than CSC to provide a software solution. CSC and the NHS have also agreed to a streamlined approach for trusts which wish to take the Lorenzo products within the NME regions to obtain central funding from the U.K. Department of Health for implementation of the Lorenzo products. In addition, CSC may offer the Lorenzo solution throughout the rest of England where trusts select CSC's solutions through a separate competitive process.

See Note 18 to the Consolidated Financial Statements for further discussion concerning the foregoing matters.

4. Contracts with the U.S. federal government and related agencies account for a significant portion of our revenue and earnings.

Our NPS segment generated approximately 36.0% of our revenue for fiscal 2013. The U.S. government fiscal issues, and continued uncertainty regarding the timing and magnitude of U.S. government budget reductions, may reduce the U.S. federal government's demand and available funds for IT projects, which would have a material adverse impact on our NPS segment and our business.

We closely monitor federal budget, legislative and contracting trends and activities and continually examine our strategies to take these into consideration. The Budget Control Act of 2011 (“BCA”) commits the U.S. government to reduce the federal deficit over ten years through caps on discretionary spending. The BCA established a Congressional Joint Select Committee on Deficit Reduction responsible for identifying an additional $1.2 trillion in deficit reductions by November 23, 2011. However, the failure to produce a deficit reduction proposal by this deadline triggered sequestration, which calls for automatic spending cuts split between defense and non-defense programs beginning in 2013 and continuing over a ten-year period. Sequestration was to have gone into effect on January 2, 2013, but The American Taxpayer Relief Act of 2012 that was signed into law on January 2, 2013 contained provisions that delayed sequestration provisions of the BCA for two months and reduced the mandatory reduction to $85 billion. The sequestration order was approved by the President on March 1, 2013. As a result of sequestration, we have already begun to see our federal government customers becoming more cautious with contract awards and spending, resulting in shorter contract durations, smaller award values and an inclination towards extension of existing customers, and we expect this behavior to continue until the uncertainties are resolved. We are continuously reviewing our operations in an attempt to identify those programs that could be at risk so that we can make appropriate contingency plans. While we are already experiencing reduced funding on some of our programs, and may see further reductions, we do not expect the cancellation of any of our major programs.

In addition, if the existing statutory limit on the amount of permissible federal debt is not raised by May 19, 2013, we may be required to continue to perform for some period of time on certain of our U.S. government contracts even if the U.S. government is unable to make timely payments. Furthermore, such limits could also potentially delay program/contract start dates in an effort to curb obligations until all debt negotiations are complete or the U.S. government may issue a stop work order and later order the work to resume or may terminate the contract altogether. Any of these events would likely result in a material adverse effect on our financial position, results of operations and cash flows.

5. Our contracts with the U.S. federal government contain provisions giving government customers certain rights that are unfavorable to us. Such provisions may materially and adversely affect our business and profitability.

Federal government contracts contain provisions and are subject to laws and regulations that give the federal government rights and remedies not typically found in commercial contracts. Our exposure to the risks inherent in the government contracting process is material. These risks include government audits of billable contract costs

7

and reimbursable expenses, project funding and requests for equitable adjustment, and compliance with government reporting requirements as well as the consequences if improper or illegal activities are discovered.

If any of these should occur, our reputation may be adversely impacted and our relationship with the government agencies we work with may be damaged, resulting in a material and adverse effect on our profitability.

6. Our ability to continue to develop and expand our service offerings to address emerging business demands and technological trends will impact our future growth. If we are not successful in meeting these business challenges, our results of operations and cash flows will be materially and adversely affected.

Our ability to implement solutions for our customers incorporating new developments and improvements in technology which translate into productivity improvements for our customers and to develop service offerings that meet current and prospective customers' needs are critical to our success. The markets we serve are highly competitive. Our competitors may develop solutions or services that make our offerings obsolete. Our ability to develop and implement up to date solutions utilizing new technologies which meet evolving customer needs in consulting and systems integration and technology outsourcing markets will impact our future revenue growth and earnings.

7. Our primary markets, technology outsourcing and consulting and systems integration, are highly competitive markets. If we are unable to compete in these highly competitive markets, our results of operations will be materially and adversely affected.

Our competitors include large, technically competent and well capitalized companies, some of which have emerged as a result of industry consolidation, as well as “pure play” companies that have a single product focus. The competition created by these companies may place downward pressure on operating margins in our industry, particularly for technology outsourcing contract extensions or renewals. As a result, we may not be able to maintain our current operating margins, or achieve favorable operating margins, for technology outsourcing contracts extended or renewed in the future.

Any reductions in margins will require that we effectively manage our cost structure. If we fail to effectively manage our cost structure during periods with declining margins, our results of operations will be adversely affected.

8. Our ability to raise additional capital for future needs will impact our ability to compete in the markets we serve.

In fiscal 2012, Standard and Poor's Rating Services ("S&P") downgraded the Company from A- to BBB+ with a negative credit watch. On May 17, 2012, Moody's Investors Service, Inc. downgraded the Company's senior unsecured rating to Baa2 from Baa1 with a stable outlook and confirmed its short term rating at Prime-2. On May 22, 2012, S&P and Fitch Ratings LTD ("Fitch") lowered the Company's credit rating to BBB with a negative outlook. On March 5, 2013 and March 8, 2013, S&P and Fitch, respectively, raised the Company's outlook to stable.

Our credit ratings are based upon information furnished by us or obtained by a rating agency from its own sources and are subject to revision, suspension or withdrawal by one or more rating agencies at any time. Rating agencies may review the ratings assigned to us due to developments that are beyond our control, including as a result of new standards requiring the agencies to reassess rating practices and methodologies.

If further downgrades in our credit ratings were to occur, it could result in higher interest costs under certain of our credit facilities. It would also cause our future borrowing costs to increase and limit our access to capital markets. Further downgrades could negatively impact the perception of the Company by lenders and other third parties. In addition, certain of the Company's major contracts provide customers with a right of termination in certain circumstances in the event of a rating downgrade below investment grade.

8

9. We may be unable to identify future attractive acquisitions, which may adversely affect our growth. In addition, our ability to consummate or integrate acquisitions we consummate may materially and adversely affect our profitability if we fail to achieve anticipated revenue improvements and cost reductions.

We intend to identify strategic acquisitions that will allow us to expand our operations. However, we may be unable to identify attractive candidates or complete acquisitions on terms favorable to us. In addition, our ability to successfully integrate the operations we acquire and leverage these operations to generate revenue and earnings growth will significantly impact future revenue and earnings as well as investor returns. Integrating acquired operations is a significant challenge and there is no assurance that the Company will be able to manage such integrations successfully. Failure to successfully integrate acquired operations may adversely affect our cost structure, thereby reducing our margins and return on investment.

10. We could suffer additional losses due to asset impairment charges.

We test our goodwill for impairment during the second quarter of every year, and on an interim date should events or changes in circumstances indicate the carrying value of goodwill may not be recoverable in accordance with ASC 350 "Goodwill and Other Intangible Assets". If the fair value of a reporting unit is revised downward due to declines in business performance or other factors, an impairment under ASC 350 could result and a non-cash charge could be required.

We also test certain equipment and deferred cost balances associated with contracts when the contract is materially underperforming or is expected to materially underperform in the future, as compared to the original bid model or budget. If the projected cash flows of a particular contract are not adequate to recover the unamortized cost balance of the asset group, the balance is adjusted in the tested period based on the contract's fair value. Either of these impairments could materially affect our reported net earnings.

11. If our customers experience financial difficulties or request out-of-scope work, we may not be able to collect our receivables, which would materially and adversely affect our profitability.

Over the course of a long-term contract, our customers' financial condition may change such that their ability to pay their obligations, and our ability to collect our fees for services rendered, is adversely affected. Additionally, we may perform work for the U.S. federal government, with respect to which we must file requests for equitable adjustment or claims with the proper agency to seek recovery in whole or in part, for out-of-scope work directed or caused by the government customer in support of its critical missions. While we may resort to other methods to pursue our claims or collect our receivables, these methods are expensive and time consuming and successful collection is not guaranteed. Failure to collect our receivables or prevail on our claims would have an adverse affect on our profitability.

12. If we are unable to accurately estimate the cost of services and the timeline for completion of contracts, the profitability of our contracts may be materially and adversely affected.

Our commercial and federal government contracts are typically awarded on a competitive basis. Our bids are based upon, among other items, the cost to provide the services. To generate an acceptable return on our investment in these contracts, we must be able to accurately estimate our costs to provide the services required by the contract and to complete the contracts in a timely manner. In addition, revenues from some of our contracts are recognized using the percentage-of-completion method, which requires estimates of total costs at completion, fees earned on the contract, or both. This estimation process, particularly due to the technical nature of the services being performed and the long-term nature of certain contracts, is complex and involves significant judgment. Adjustments to original estimates are often required as work progresses, experience is gained and additional information becomes known, even though the scope of the work required under the contract may not change. If we fail to accurately estimate our costs or the time required to complete a contract, the profitability of our contracts may be materially and adversely affected.

9

13. We are defendants in pending litigation that may have a material and adverse impact on our profitability.

As noted in Part I, Item 3, "Legal Proceedings" and Note 20 to the Consolidated Financial Statements, we are currently party to a number of disputes which involve or may involve litigation. We are not able to predict the ultimate outcome of these disputes or the actual impact of these matters on our profitability. If we agree to settle these matters or judgments are secured against us, we may incur liabilities which may have a material and adverse impact on our liquidity and earnings.

14. Our contracts with U.S. governmental agencies are subject to regulations, audits and cost adjustments by the U.S. government, which could materially and adversely affect our operations.

We are engaged in providing services under contracts with U.S. government agencies. These contracts are subject to extensive legal and regulatory requirements and, from time to time, such agencies investigate whether our operations are being conducted in accordance with these requirements. These investigations may include a review of our performance on contracts, pricing practices, cost structure and compliance with applicable laws and regulations. U.S. government investigations of us, whether related to the Company's federal government contracts or conducted for other reasons, could result in administrative, civil or criminal liabilities, including repayments, fines or penalties being imposed upon us, or could lead to suspension or debarment from future U.S. government contracting. In addition, we could suffer serious reputational harm.

15. Our ability to provide our customers with competitive services is dependent on our ability to attract and retain qualified personnel.

Our ability to grow and provide our customers with competitive services is partially dependent on our ability to attract and retain highly motivated people with the skills necessary to serve our customers. As noted above, the markets we serve are highly competitive and competition for skilled employees in the technology outsourcing and consulting and systems integration markets is intense for both on-shore and offshore locales. The loss of personnel could impair our ability to perform under certain of our contracts, which could have a material adverse effect on our consolidated financial position, results of operations and cash flows.

16. Our ability to perform services for certain of our government clients is dependent on our ability to maintain necessary security clearances.

Select U.S. and non-U.S. government clients require CSC to maintain security clearances for certain of our facilities used in the performance of classified contracts. Employees who perform under certain government contracts are required to possess appropriate personnel security clearances for access to classified information granted by the respective government. The competition for qualified personnel who possess security clearance is very strong in certain public sector markets. In the event that a government customer were to revoke the facility and/or personnel clearances of all or substantially all of the employees performing work under a classified contract, such revocation could be grounds for termination of the contract by the government customer. Similarly, if the Company is unable to hire sufficient qualified and cleared personnel to meet contractual commitments, a contract could be terminated for non-performance. Under either circumstance, such termination, depending on the contract value, could have a material adverse effect on our consolidated financial position, results of operations and cash flows.

17. Our international operations are exposed to risks, including fluctuations in exchange rates, which may be beyond our control.

For fiscal 2013, approximately 38% of our recognized revenues were denominated in currencies other than the U.S. dollar. The exposure to currencies other than the U.S. dollar may impact our results as they are expressed in U.S. dollars. In particular, the uncertainty with respect to the ability of certain European countries to continue to service their sovereign debt obligations and the related European financial restructuring efforts may cause the value of the euro to fluctuate. Currency variations also contribute to variations in sales of products and services in impacted jurisdictions. For example, in the event that one or more European countries were to replace the euro with another currency, sales in that country or in Europe generally may be adversely affected until stable exchange rates are established. While currency risk, including exposure to fluctuations in currency exchange rates, is partially mitigated largely by matching costs with revenues in a given currency, our exposure to

10

fluctuations in other currencies against the U.S. dollar increases as revenue in currencies other than the U.S. dollar increase and as more of the services we provide are shifted to lower cost regions of the world. We believe that the percentage of our revenue denominated in currencies other than the U.S. dollar will continue to represent a significant portion of our revenue. Also, we believe that our ability to match revenue and expenses in a given currency will decrease as more work is performed at offshore locations.

We operate in approximately seventy countries and our operations in these countries are subject to the local legal and political environments. Our operations are subject to, among other things, employment, tax, statutory reporting, trade restriction and other regulations. Notwithstanding our best efforts, we may not be in compliance with all regulations in the countries in which we operate and may be subject to penalties and/or fines as a result. These penalties or fines may materially and adversely impact our profitability.

18. We may be exposed to negative publicity and other potential risks if we are unable to maintain effective internal controls over financial reporting.

We are required under the Sarbanes-Oxley Act of 2002 to include a report of management on the Company's internal controls that contains an assessment by management of the effectiveness of our internal control over financial reporting. In addition, the public accounting firm auditing our financial statements must report on the effectiveness of our internal control over financial reporting. If we are unable to conclude that we have effective internal control over financial reporting or, if our independent registered public accounting firm is unable to provide us with an unqualified report as to the effectiveness of our internal control over financial reporting as of each fiscal year end, we may be exposed to negative publicity. The resulting negative publicity may materially and adversely affect our business and stock price.

19. In the course of providing services to customers, we may inadvertently infringe on the intellectual property rights of others and be exposed to claims for damages.

The solutions we provide to our customers may inadvertently infringe on the intellectual property rights of third parties resulting in claims for damages against us or our customers. Our contracts generally indemnify our clients from claims for intellectual property infringement for the services and equipment we provide under our contracts. The expense and time of defending against these claims may have a material and adverse impact on our profitability. Additionally, the publicity we may receive as a result of infringing intellectual property rights may damage our reputation and adversely impact our ability to develop new business.

20. Our contracts generally contain provisions under which a customer may terminate the contract prior to completion. Early contract terminations may materially and adversely affect our revenues and profitability.

Our contracts typically contain provisions by which customers may terminate the contract prior to completion of the term of the contract. These contracts generally allow the customer to terminate the contract for convenience upon providing written notice. If a contract is terminated for convenience, we seek, either by defined contract schedules or through negotiations, recovery of our property, plant, equipment, outsourcing costs, investments, and other intangibles. However, there is no assurance we will be able to fully recover our investments.

We may not be able to replace the revenue and earnings from these contracts in the short-term. In the long-term, our reputation may be harmed by the publicity generated from contract terminations.

21. Our ability to compete in certain markets we serve is dependent on our ability to continue to expand our capacity in certain offshore locations. However, as our presence in these locations increases, we are exposed to risks inherent to these locations which may adversely impact our revenue and profitability.

A significant portion of our application outsourcing and software development activities have been shifted to India, and we plan to continue to expand our presence there and in other lower cost locations. As such, we are exposed to the risks inherent to operating in India including (1) a highly competitive labor market for skilled workers which may result in significant increases in labor costs as well as shortages of qualified workers in the future, and (2) the possibility that the U.S. federal government or the European Union may enact legislation that provides significant disincentives for customers to locate certain of their operations offshore which would reduce the demand for the services we provide in India and may adversely impact our cost structure and profitability. In

11

addition, India has recently experienced civil unrest and acts of terrorism and has been involved in confrontations with Pakistan. If India continues to experience this civil unrest or if its conflicts with Pakistan escalate, our operations in India could be adversely affected.

22. Our performance on contracts, including those on which we have partnered with third parties, may be adversely affected if we or the third parties fail to deliver on commitments.

Our contracts are increasingly complex and, in some instances, require that we partner with other parties, including software and hardware vendors, to provide the complex solutions required by our customers. Our ability to deliver the solutions and provide the services required by our customers is dependent on our and our partners' ability to meet our customers' delivery schedules. If we or our partners fail to deliver services or products on time, our ability to complete the contract may be adversely affected, which may have a material and adverse impact on our revenue and profitability.

23. Security breaches or service interruptions could expose us to liability or impair our reputation, which could cause significant financial loss.

As a U.S. government contractor and a provider of information technology services operating in a number of regulated industries and countries, we handle sensitive data of our clients, including personal information and information relating to sensitive government functions. In the ordinary course of our business, we develop, install and maintain systems and networks that manage and store this data. The security and privacy of information stored or managed by our systems is subject to numerous international, U.S. federal and state laws. While we maintain information security policies and procedures designed to comply with relevant privacy and security laws and restrictions, if a system or network that we develop, install or maintain were to fail or experience a security breach or service interruption, we may be subject to significant legal and financial exposure, damage to our reputation, and loss of confidence in the security of our products and services.

24. Changes in the Company's tax rates could affect our future results.

Our future effective tax rates could be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, or by changes in tax laws or their interpretation. We are subject to the continuous examination of its income tax returns by the U.S. Internal Revenue Service and other tax authorities. We regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for taxes. There can be no assurance that the outcomes from these examinations will not have a material adverse effect on our financial condition and operating results.

25. We may be adversely affected by disruptions in the credit markets, including disruptions that reduce our customers' access to credit and increase the costs to our customers of obtaining credit.

The credit markets have historically been volatile and therefore it is not possible for the Company to predict the ability of our clients and customers to access short-term financing and other forms of capital. If a disruption in the credit markets were to occur, it could also pose a risk to our business if customers and suppliers are unable to obtain financing to meet payment or delivery obligations to the Company. In addition, customers may decide to downsize, defer or cancel contracts which could negatively affect our revenue.

26. Our foreign currency hedging program is subject to counterparty default risk.

We enter into foreign currency forward contracts and options with a number of counterparties. As of March 29, 2013, we had outstanding foreign currency forward contracts with a notional value of $993 million and outstanding option contracts with a notional value of $744 million. As a result, we are subject to the risk that the counterparty to one or more of these contracts defaults on its performance under the contract. During an economic downturn, the counterparty's financial condition may deteriorate rapidly and with little notice and we may be unable to take action to protect our exposure. In the event of a counterparty default, we could incur significant losses, which may harm our business and financial condition. In the event that one or more of our counterparties becomes insolvent or files for bankruptcy, our ability to eventually recover any losses suffered as a result of that counterparty's default may be limited by the liquidity of the counterparty.

12

27. We derive significant revenue and profit from contracts awarded through competitive bidding processes, which can impose substantial costs on us, and we will not achieve revenue and profit objectives if we fail to bid on such projects effectively.

We derive significant revenue and profit from contracts that are awarded through competitive bidding processes. We expect that most of the government business we seek in the foreseeable future will be awarded through competitive bidding. Competitive bidding imposes substantial costs and presents a number of risks, including:

• the substantial cost and managerial time and effort that we spend to prepare bids and proposals for contracts that may or may not be awarded to us;

• the need to estimate accurately the resources and costs that will be required to service any contracts we are awarded, sometimes in advance of the final determination of their full scope and design; 

• the expense and delay that may arise if our competitors protest or challenge awards made to us pursuant to competitive bidding, and the risk that such protests or challenges could result in the requirement to resubmit bids, and in the termination, reduction, or modification of the awarded contracts; and

• the opportunity cost of not bidding on and winning other contracts we might otherwise pursue.

28. Catastrophic events or climate conditions may disrupt our business.

The Company and its customers are subject to various federal, state, local and foreign government requirements relating to the protection of the environment. Our revenues and results of operations may be adversely affected by the passage of climate change and other environmental legislation and regulations. For example, new legislation or regulations may result in increased costs directly relating to our compliance or indirectly to the extent that such requirements increase prices charged to us by vendors because of increased compliance costs. At this point, we are unable to determine the impact that climate change and other environmental legislation and regulations could have on our overall business.

Item 1B. Unresolved Staff Comments

On February 11, 2011, the Company received a letter from the Staff of the SEC's Division of Corporation Finance as part of its review of the Company's Form 10-Q for the fiscal quarter ended October 1, 2010 and Form 10-Q for the fiscal quarter ended December 31, 2010. The Company responded to that letter, which has been followed by a series of new letters with additional comments from the Staff on subsequent filings. The Company has responded to each of these letters with supplemental information and analyses to address the comments from the Staff. The Staff's comments have focused on a number of issues and have requested, among other things, additional information regarding the Company's previously disclosed accounting adjustments, the Company's conclusions regarding the materiality of such adjustments and the Company's analysis of the effectiveness of its disclosure controls and procedures and its internal control over financial reporting. As of the date of this annual report, the Company has not received confirmation from the Staff that its review process is complete. The Company intends to continue to work with the Staff and respond to any remaining comments. See Risk Factor number 2 under Item 1A. "Risk Factors" in this Annual Report.

On August 23, 2012, the Company received a letter from the Staff of the SEC's Division of Corporation Finance as part of its review of the Company's Form 10-K for the fiscal year ended March 30, 2012. The Staff requested additional information and provided comments related to our acquisition of iSOFT Group Limited, revenue recognition policies and litigation matters. The Company responded to that letter and believes that it has addressed the Staff's comments. As of the date of this annual report, the Company has not received confirmation from the Staff that its review process is complete. The Company intends to continue to work with the Staff and respond to any remaining comments.

13

Item 2. Properties

Following is a summary of properties owned and leased by CSC or its subsidiaries as of March 29, 2013:

Properties Owned	Approximate Square Footage	General Usage
Blythewood, South Carolina	456,000	Computer and General Office
Falls Church, Virginia	401,000	General Office
Copenhagen, Denmark	368,000	Computer and General Office
Aldershot, United Kingdom	211,000	General Office
Newark, Delaware	176,000	Computer and General Office
Chennai, India	159,000	General Office
Daleville, Alabama	150,000	General Office
Norwich, Connecticut	144,000	Computer and General Office
Petaling Jaya, Malaysia	126,000	Computer and General Office
Meriden, Connecticut	118,000	Computer and General Office
Berkeley Heights, New Jersey	95,000	Computer and General Office
Maidstone, United Kingdom	79,000	Computer and General Office
Jacksonville, Illinois	60,000	General Office
Chesterfield, United Kingdom	51,000	General Office
Vadodara, India	47,000	General Office
Singapore, Singapore	46,000	General Office
Tunbridge Wells, United Kingdom	43,000	Computer and General Office
Sterling, Virginia	41,000	General Office
Various other U.S. and foreign locations	62,000	General Office

14

Properties Leased	Approximate Square Footage	General Usage
Washington, D.C. area	2,525,000	Computer and General Office
India	1,880,000	General Office
Australia & other Pacific Rim locations	613,000	Computer and General Office
Germany	605,000	General Office
New Jersey	549,000	General Office
California	514,000	General Office
United Kingdom	464,000	Computer and General Office
Texas	421,000	Computer and General Office
Florida	356,000	General Office
Denmark	350,000	General Office
North Carolina	261,000	General Office
Pennsylvania	242,000	General Office
France	240,000	General Office
New York	229,000	General Office
Michigan	228,000	General Office
Illinois	215,000	General Office
Wisconsin	208,000	General Office
Canada	195,000	General Office
Connecticut	175,000	Computer and General Office
Minnesota	172,000	General Office
Iowa	157,000	General Office
Delaware	154,000	General Office
Ohio	153,000	General Office
Alabama	148,000	General Office
Spain	146,000	General Office
Sweden	140,000	General Office
China	125,000	General Office
Kansas	102,000	General Office
Bulgaria	101,000	General Office
Various other U.S. and foreign locations	1,089,000	Computer and General Office

Upon expiration of its leases, the Company expects to obtain renewals or to lease alternative space. Lease expiration dates range from fiscal 2014 through 2029. We believe that all of the properties are well-maintained, suitable and adequate to meet current and anticipated requirements.

Item 3. Legal Proceedings

The information required by this Item is set forth in Note 20, Commitments & Contingencies of the Notes to the Consolidated Financial Statements under the caption “Contingencies”, contained in Part II - Item 8 of this filing. Such information is incorporated herein by reference and made a part hereof.

Item 4. Mine Safety Disclosures

Not applicable.

15

Executive Officers of the Registrant

Name	Age	Year First Elected as an Officer	Term as an Officer	Position Held With the Registrant as of the filing date	Family Relationship
J. Michael Lawrie	59	2012	Indefinite	President and Chief Executive Officer	None
Paul N. Saleh	56	2012	Indefinite	Executive Vice President and Chief Financial Officer	None
Gary M. Budzinski	56	2012	Indefinite	Executive Vice President and General Manager, Global Infrastructure Services	None
Thomas R. Colan	57	2012	Indefinite	Vice President and Controller	None
James D. Cook	60	2009	Indefinite	Executive Vice President and General Manager, Global Industries	None
William L. Deckelman, Jr.	55	2008	Indefinite	Executive Vice President and General Counsel	None
Thomas E. Hogan	53	2012	Indefinite	Executive Vice President and General Manager, Global Business Services	None
Sunita Holzer	52	2012	Indefinite	Executive Vice President and Chief Human Resources Officer	None
John P. Maguire	52	2013	Indefinite	Executive Vice President and General Manager for Global Sales and Marketing and Regional Operations	None
David W. Zolet	53	2012	Indefinite	Executive Vice President and General Manager, North American Public Sector	None

Business Experience of Executive Officers

J. Michael Lawrie joined CSC as President and Chief Executive Officer on March 19, 2012 and as a member of its Board of Directors in February 2012. Prior to joining CSC, he served as the Chief Executive Officer of UK-based Misys plc, a leading global IT solutions provider to the financial services industry, from November 2006 to March 2012. Mr. Lawrie also served as the Executive Chairman of Allscripts-Misys Healthcare Solutions, Inc., from October 2008 to August 2010. From 2005 to 2006, Mr. Lawrie was a general partner with ValueAct Capital, a San Francisco-based private investment firm. He also served as Chief Executive Officer of Siebel Systems, Inc., an international software and solutions company, from 2004 to 2005. Mr. Lawrie also spent 27 years with IBM where he rose to Senior Vice President and Group Executive, responsible for sales and distribution of all IBM products and services worldwide. From 1998 to 2001, Mr. Lawrie was General Manager for IBM's business in Europe, the Middle East and Africa, which included operations in 124 countries and 90,000 employees. Prior to that, Mr. Lawrie served as General Manager of Industries for IBM's business operations in Asia Pacific, based in Tokyo. Mr. Lawrie is currently the lead independent, non-executive Director of Juniper Networks, Inc. and is also a Trustee of Drexel University, Philadelphia.

Paul N. Saleh joined CSC as Vice President and Chief Financial Officer on May 23, 2012. His current CSC job title is Executive Vice President and Chief Financial Officer. Prior to joining the Company, Mr. Saleh served as the Chief Financial Officer of Gannett Co. from 2010 to 2012. Prior to his tenure at Gannett Co., from 2008 to 2010, Mr. Saleh was a Managing Partner at Menza Partners, an operational and financial advisory group focusing on media, telecommunications, and technology industries.  Prior to that, he served as Chief Financial Officer of Nextel Communications from 2001 to 2007 and as Interim Chief Executive Officer of Sprint Nextel until 2008.  He served as Senior Vice President and Chief Financial Officer of Walt Disney International where he also held various other senior positions from 1997 to 2001. 

Gary M. Budzinski was appointed Executive Vice President and General Manager, Managed Services Sector in June 2012 and currently is the Executive Vice President and General Manager, Global Infrastructure Services. Prior to joining CSC, Mr. Budzinski was CEO and Founder of Integrity Innovation International, LLC, a private IT consulting firm from 2011 to 2012. Prior to that, he was Senior Vice President and General Manager at Hewlett Packard's Technology Services business unit from 2005 to 2011.

Thomas R. Colan was appointed Vice President, Controller and Principal Accounting Officer in August, 2012. Prior to joining the Company, Mr. Colan served as Executive Vice President and Chief Accounting Officer at Discovery Communications from 2008 to 2012. Prior to his tenure at Discovery Communications, Mr. Colan served as Senior Vice President, Controller and Treasurer at AOL Online/Time Warner. Prior to that, he held various financial leadership positions at GTE, Planning Research Corporation and Coopers & Lybrand.

16

James D. Cook is currently the Executive Vice President and General Manager, Global Industries. He served as President, Business Solutions and Services Sector from 2009 to 2012. Mr. Cook is currently the Executive Vice President and General Manager, Global Industries and has previously served as CSC's President, Financial Services Sector from 2001 to 2009. Prior to joining CSC in 1995, Mr. Cook held a wide range of executive positions at Philip Morris, Kraft Foods, General Electric, and Chase Manhattan Bank.

William L. Deckelman, Jr. is Executive Vice President and General Counsel. Mr. Deckelman joined CSC in January 2008 and served as Vice President, General Counsel and Secretary from 2008 to 2012. Prior to joining CSC, Mr. Deckelman served as Executive Vice President and General Counsel of Affiliated Computer Services Inc., since March 2000, and served as a director from 2000 to 2003, holding various executive positions there since 1989.

Thomas E. Hogan was appointed Executive Vice President and General Manager, Business Solutions and Services Sector in June 2012 and is currently the Executive Vice President and General Manager, Global Business Services. Prior to joining the Company, Mr. Hogan held senior positions at Hewlett Packard from 2006 to 2011 and served as Executive Vice President of Sales & Marketing from 2006 to 2011. Prior to that, he was CEO of Vignette, a publicly held software company that specializes in enterprise content management.

Sunita Holzer joined CSC as Vice President and Chief Human Resources Officer in June 2012. Her current job title is Executive Vice President and Chief Human Resources Officer. Prior to joining the Company, Ms. Holzer served as Executive Vice President, Human Resources at Chubb Insurance from 2003 to 2012. Prior to her tenure at Chubb Insurance, she was Vice President of Human Resources for GE Capital Corporate and also held positions at American Express and AIG.

John P. Maguire was appointed Executive Vice President and General Manager, Global Sales & Marketing and Regional Operations in May 2013. Prior to joining the Company, Mr. Maguire served as Senior Vice President at Hewlett-Packard from 2011 to 2013. Prior to that, he served as Managing Partner at Accenture from 2002 to 2011. Prior to that he served as Vice President at IBM from 1984 to 2002.

David W. Zolet is Executive Vice President and General Manager, North American Public Sector in June 2012. Mr. Zolet joined CSC as Vice President of Business Development in the North American Public Sector in July 2010 and was promoted to President, North American Public Sector in June 2012. Prior to his tenure at the Company, from 2009 to 2012, Mr. Zolet was a Vice President of Public Sector Systems Integration at IBM. Prior to that, he held various senior positions at Northrop Grumman Corporation.

PART II

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

(a) Holders

Common stock of Computer Sciences Corporation is listed and traded on the New York Stock Exchange under the ticker symbol “CSC.”

As of April 29, 2013, the number of registered shareholders of Computer Sciences Corporation’s common stock was 6,315. The table shows the high and low sales prices of the Company’s common stock as reported on the composite tape of the New York Stock Exchange for each quarter during the last two fiscal years.

	2013				2012
Fiscal Quarter	High		Low		High		Low
1st	$	30.28	$	23.10	$	51.43	$	36.30
2nd	34.74		22.19		38.41		25.60
3rd	40.63		30.15		33.12		22.80
4th	50.59		39.02		33.80		23.27

17

Cash dividends declared on our common stock for each quarter of fiscal 2013 and fiscal 2012 are included in Selected Quarterly Financial Data (Unaudited) of this Annual Report on Form 10-K. We expect to return excess cash flow to our stockholders from time to time through our common stock repurchase program described below or the payment of dividends. However, there can be no assurance that share repurchases will occur or future dividends will be declared or paid. Our share repurchase program and the declaration and payment of future dividends, the amount of any such share repurchases or dividends, and the establishment of record and payment dates for dividends, if any, are subject to final determination by our Board of Directors after review of our current strategy and financial performance and position, among other things.

(b) Purchases of Equity Securities

The following table provides information on a monthly basis for the fourth quarter ended March 29, 2013 with respect to the Company’s purchase of equity securities:

Period	Total Number of Shares Purchased (1)	Average Price Paid Per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (2)
December 29, 2012 to January 25, 2013	192,942	$40.01	150,000	$852,089,072
January 26, 2013 to February 22, 2013	1,201,341	$47.91	1,200,000	$794,971,697
February 23, 2013 to March 29, 2013	3,469,734	$48.76	3,386,452	$629,875,583

⁽¹⁾  The Company accepted 49,458 shares of common stock in the quarter ended March 29, 2013 tendered by employees in lieu of cash due to the Company in connection with the exercise of stock options. The Company accepted 78,107 shares of its common stock in the quarter ended March 29, 2013 from employees in lieu of cash due to the Company in connection with the issuance of shares of common stock related to vested RSUs. Such shares of common stock are stated at cost and held as treasury shares.

⁽²⁾  On December 13, 2010, the Company publicly announced that its Board of Directors approved a share repurchase program authorizing up to $1 billion in repurchases of shares of the Company’s outstanding common stock. CSC is implementing the program through purchases made in open market transactions in compliance with SEC Rule 10b-18, subject to market conditions, and applicable state and federal legal requirements. Share repurchases will be funded with available cash. The timing, volume, and nature of share repurchases will be at the discretion of management, and may be suspended or discontinued at any time. CSC’s Board of Directors has not established an end date for the new repurchase program. The Company repurchased 4,736,452 shares of its common stock in the fiscal quarter ended March 29, 2013 under the share repurchase program.

18

(c) Performance Graph

The following graph compares the cumulative total return on CSC common stock during the last five fiscal years with the cumulative total return on the Standard & Poor’s 500 Stock Index and the S&P North American Technology Services Index, formerly the Goldman Sachs Technology Services Index.

CSC Total Shareholder Return

(Period Ended March 29, 2013)

Indexed Return Chart (2008 = 100)
	Return 2009		Return 2010		Return 2011		Return 2012		Return 2013		CAGR
CSC common stock	-1.59	%	35.12	%	-7.61	%	-37.74	%	68.31	%	5.18	%
S&P 500 Index	-34.23	%	42.85	%	15.36	%	8.00	%	13.96	%	5.93	%
S&P North American Technology Services Index	-16.96	%	37.63	%	18.49	%	15.36	%	18.02	%	13.02	%

Assumes $100 invested on March 28, 2008, in CSC common ctock, the S&P 500 Index, and the S&P North American Technology Services Index, formerly the Goldman Sachs Technology Services Index. Indexed amounts and return percentages follow CSC fiscal years.

(d) Equity Compensation Plans

See Item 12 of this Annual Report on Form 10-K for information regarding our equity compensation plans.

19

Item 6. Selected Financial Data

COMPUTER SCIENCES CORPORATION

	Five Year Review
Amounts in millions, except per share amounts	March 29, 2013			March 30, 2012			April 1, 2011			April 2, 2010			April 3, 2009
Total assets	$	11,251		$	11,189		$	16,120		$	16,455		$	15,619
Debt
Long-term, net of current maturities	2,498			1,486			2,409			3,669			4,173
Short-term	—			43			29			21			32
Current maturities	234			1,211			141			54			30
Total	2,732			2,740			2,579			3,744			4,235
Stockholders’ equity	3,160			2,834			7,560			6,508			5,618
Debt to total capitalization	46.4		%	49.2		%	25.4		%	36.5		%	43.0		%

	Five Year Review
	Fiscal Year
Amounts in millions, except per-share amount	2013(5)			2012(1)(5)			2011(1)(5)		2010(1)(5)		2009(5)
Revenues	$	14,993		$	15,364		$	15,582	$	15,505	$	16,006
Costs of services (excludes depreciation and amortization, contract charge, settlement charge and restructuring costs of $137 (2012))	11,851			13,019			12,578		12,303		12,684
Costs of services – specified contract charge (excludes amount charged to revenue of $204)(2)	—			1,281			—		—		—
Costs of services – settlement charge (excludes amount charged to revenue of $42)(3)	—			227			—		—		—
Restructuring costs	264			140			—		—		—
Goodwill impairment(4)(7)	—			2,745			—				4
Income (loss) from continuing operations before taxes	480			(4,454		)	878		939		859
Taxes on income (benefit)	(35		)	(84		)	202		156		(213		)
Income (loss) from continuing operations, net of taxes	515			(4,370		)	676		783		1,072
Income (loss) from discontinued operations, net of taxes	464			145			83		51		51
Net income (loss) attributable to CSC common shareholders	$	961		(4,242		)	740		$	817	$	1,115
Earnings (loss) per common share:
Basic:
Continuing operations	$	3.22		$	(28.31	)	$	4.25	$	5.05	$	7.03
Discontinued operations	3.00			0.94			0.54		.31		0.34
	$	6.22		$	(27.37	)	$	4.79	$	5.36	$	7.37
Diluted:
Continuing operations	$	3.20		(28.31		)	4.20		$	4.97	$	6.98
Discontinued operations	2.98			0.94			0.53		.31		0.33
	$	6.18		(27.37		)	4.73		$	5.28	$	7.31
Cash dividend per common share(6)	$	0.80		$	0.80		$	0.70	$	—	$	—

⁽¹⁾  Fiscal 2012 and prior year amounts have been recast to present discontinued operations for divestments of three BSS businesses in fiscal 2013.

⁽²⁾  Fiscal 2012 specified contract charge related to the Company’s contract with the U.K. National Health Service. See Note 18 of the Consolidated Financial Statements.

⁽³⁾  Fiscal 2012 settlement charge related to the contract settlement with the federal government. See Note 19 of the Consolidated Financial Statements.

⁽⁴⁾  Fiscal 2012 goodwill impairment charge related to MSS segment and two of the reporting units in the BSS segment. See Note 9 of the Consolidated Financial Statements.

⁽⁵⁾  The Company recorded various out of period adjustments in fiscal 2013, 2012, 2011 and 2010 that should have been recorded in prior fiscal years. See Note 2 of the Consolidated Financial Statements.

⁽⁶⁾  In Fiscal 2011, the Company implemented a regular quarterly dividend.

⁽⁷⁾  Fiscal 2009 goodwill impairment charge related to an Asian reporting unit in the BSS segment.

20

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

General

The following discussion and analysis provides information management believes is relevant to an assessment and understanding of the consolidated results of operations and financial condition of the Company. This discussion should be read in conjunction with the Company's consolidated financial statements and associated notes as of and for the year ended March 29, 2013.

There are three primary objectives of this discussion:

1. Provide a narrative on the consolidated financial statements, as presented through the eyes of management;

2. Enhance the disclosures in the consolidated financial statements and footnotes by providing context within which the consolidated financial statements should be analyzed; and

3. Provide information to assist the reader in ascertaining the predictive value of the reported financial results.

To achieve these objectives, the management discussion and analysis is presented in the following sections:

Overview - includes a description of the Company's business, how it earns revenue and generates cash, as well as a discussion of economic and industry factors, key business drivers, key performance indicators and fiscal 2013

highlights.

Results of Operations - discusses year-over-year changes to operating results for fiscal 2011 through fiscal 2013, describing the factors affecting revenue on a consolidated and reportable segment basis, including new contracts, acquisitions and divestitures and currency impacts, and also describing the factors affecting changes in the the Company's major cost and expense categories.

Financial Condition - discusses causes of changes in cash flows and describes the Company's liquidity and available capital resources.

Critical Accounting Estimates - discusses the significant accounting policies that require critical judgments and estimates.

Overview

CSC provides IT and business process outsourcing, consulting, systems integration and other IT services to its customers. The Company targets the delivery of these services within three broad lines of business or sectors: North American Public Sector (NPS), Managed Services Sector (MSS), and Business Solutions and Services (BSS).

The Company's reportable segments are as follows:

• The NPS segment provides services to the U.S. federal government and its agencies, civil departments and branches of the military, and operates principally within a regulatory environment subject to governmental contracting and accounting requirements, including Federal Acquisition Regulations, Cost Accounting Standards and audits by various U.S. federal agencies.

• The MSS segment provides large-scale infrastructure and application outsourcing solutions offerings as well as mid-size services delivery to customers globally.

• The BSS segment provides industry-specific consulting and systems integration services, business process outsourcing, and intellectual property-based software solutions.

For additional information regarding our business segments, see Note 16 of the Consolidated Financial Statements.

During fiscal 2013, the Company was in the process of changing its operating model and realigning executive management accordingly. In the first quarter of fiscal 2014, the Company expects that it will commence operating under the new model and its operating and reportable segments will change to align with this new model.

21

Economic and Industry Factors

The Company's results of operations are impacted by economic conditions generally, including macroeconomic conditions. We are monitoring current macroeconomic and credit market conditions and levels of business confidence and their potential effect on our clients and on us. A severe and/or prolonged economic downturn could adversely affect our clients' financial condition and the levels of business activities in the industries and geographies in which we operate. This may reduce demand for our services or depress pricing of those services and have a material adverse effect on our new contract bookings and results of operations. Particularly in light of recent economic uncertainty, we continue to monitor our costs closely in order to respond to changing conditions and to manage any impact to our results of operations.

Our results of operations are also affected by levels of business activity and rates of change in the industries we serve, as well as by the pace of technological change and the type and level of technology spending by our clients. The ability to identify and capitalize on these markets and technological changes early in their cycles is a key driver of our performance.

Revenues are driven by our ability to secure new contracts and to deliver solutions and services that add value to our clients. Our ability to add value to clients, and therefore generate revenues, depends in part on our ability to deliver market-leading service offerings and to deploy skilled teams of professionals quickly and on a global basis.

The BSS and MSS segment markets are affected by various economic and industry factors. The economic environment in the regions CSC serves will impact customers' decisions for discretionary spending on IT projects. CSC is in a highly competitive industry which exerts downward pressure on pricing and requires companies to continually seek ways to differentiate themselves through several factors, including service offerings and flexibility. Management monitors industry factors including relative market shares, growth rates, billing rates, staff utilization rates and margins as well as macroeconomic indicators such as interest rates, inflation rates and foreign currency rates.

Outsourcing contracts are typically long-term relationships. Long-term, complex outsourcing contracts, including their consulting components, require ongoing review of the terms and scope of work in order to meet clients' evolving business needs and performance expectations.

More recently, the Company has rationalized its service offerings and implemented a strategy of selling defined solutions that require less customization and benefit from leveraged delivery at scale. Such solutions include our portfolio of Cloud-based Infrastructure-as-a-Service offerings, managed applications services and a range of discrete offerings for computing, storage, mobility and networking services.

The NPS segment market is also highly competitive and has unique characteristics. All U.S. government contracts and subcontracts may be modified, curtailed or terminated at the convenience of the government if program requirements or budgetary constraints change. In the event that a contract is terminated for convenience, the Company generally is reimbursed for its allowable costs through the date of termination and is paid a proportionate amount of the stipulated profit or fee attributable to the work performed. Shifting priorities of the U.S. government can also impact the future of projects. Management monitors government priorities and industry factors through numerous industry and government publications and forecasts, legislative activity, budgeting and appropriation processes and by participating in industry professional associations.

Business Drivers

Revenue in all three lines of business is generated by providing services on a variety of contract types lasting from less than six months to ten years or more. Factors affecting revenue include the Company's ability to successfully:

• bid on and win new contract awards,

• satisfy existing customers and obtain add-on business and win contract recompetes,

• compete on services offered, delivery models offered, technical ability and innovation, quality, flexibility, global reach, experience, and results created, and

• identify and integrate acquisitions and leverage them to generate new revenues.

Earnings are impacted by the above revenue factors and, in addition, the Company's ability to:

22

• control costs, particularly labor costs, subcontractor expenses and overhead costs including healthcare, pension and general and administrative costs,

• anticipate talent needs to avoid staff shortages or excesses,

• accurately estimate various factors incorporated in contract bids and proposals,

• develop offshore capabilities and migrate compatible service offerings offshore, and

• manage foreign currency fluctuations related to international operations.

Cash flows are affected by the above earnings factors and, in addition, by the following factors:

• timely management of receivables and payables,

• investment opportunities available, particularly related to business acquisitions, dispositions and large outsourcing contracts,

• tax obligations, and

• the ability to efficiently manage capital deployed for outsourcing contracts, software, and property, plant and equipment.

Key Performance Indicators

The Company manages and assesses the performance of its business through various means, with the primary financial measures including new contract wins, revenue, operating margins, and free cash flow.

New contract wins: In addition to being a primary driver of future revenue, new contract wins also provide management an assessment of the Company's ability to compete. The total level of wins tends to fluctuate from year to year depending on the timing of new or recompeted contracts, as well as numerous external factors.

Revenue: Revenue is a product of contracts won in prior periods, known as backlog, and work secured in the current year. Year-over-year revenues tend to vary less than new contract wins, and reflect performance on both new and existing contracts. Foreign currency fluctuations also impact revenue.

Operating margins: Operating margins reflect the Company's performance on contracts and ability to control costs. While the ratios of various cost elements as a percentage of revenue can shift as a result of changes in the mix of businesses with different cost profiles, a focus on maintaining and improving overall margins leads to improved efficiencies and profitability. Although the majority of the Company's costs are denominated in the same currency as revenues, increased use of offshore support also exposes CSC to additional margin fluctuations.

Free cash flow: Primary drivers of the Company's free cash flow are earnings provided by the Company's operations and the use of capital to generate those earnings. Also contributing to short-term cash flow results are movements in current asset and liability balances.

23

Fiscal 2013 Highlights

The key operating results for fiscal 2013 include:

• Revenues decreased $371 million, or 2.4%, to $14,993 million compared to fiscal 2012. On a constant currency basis⁽¹⁾, revenues decreased $164 million or 1.1%.

• Operating income⁽²⁾ increased to $900 million as compared to an operating loss of $1,359 million in fiscal 2012. The operating income margins increased to 6.0% from (8.8)% in fiscal 2012.

• Earnings before interest and taxes⁽³⁾ (EBIT) increased to $641 million as compared to a loss before interest and taxes of $(4,317) million in fiscal 2012. The EBIT margin increased to 4.3% from (28.1)% in fiscal 2012.

• Income from continuing operations before taxes was $480 million, compared to a loss from continuing operations before taxes of $(4,454) million in fiscal 2012.

• Income from discontinued operations, net of taxes was $464 million, compared to $145 million in fiscal 2012.

• Net income attributable to CSC common shareholders was $961 million, an increase from $(4,242) million in the prior year.

• Diluted earnings (loss) per share (EPS) from continuing operations was $3.20 as compared to $(28.31) in the prior year.

• Diluted EPS from discontinued operations was $2.98 as compared to $0.94 in the prior year.

• In fiscal 2013, the Company recorded restructuring costs of $264 million, of which $190 million related to MSS, $39 million to BSS, $13 million to NPS and $22 million to Corporate. In fiscal 2012, the Company recorded restructuring costs of $140 million, of which $108 million was related to MSS, $31 million to BSS, $1 million to NPS and none to Corporate.

• The Company announced contract awards of $13.8 billion, including MSS segment awards of $6.9 billion, NPS segment awards of $3.5 billion, and BSS segment awards of $3.4 billion.

• Total backlog⁽⁴⁾ at the end of fiscal 2013 was $34.4 billion, a decrease of $2.0 billion as compared to the backlog at the end of fiscal 2012 of $36.4 billion. Of the total $34.4 billion backlog, $10.5 billion is expected to be realized as revenue in fiscal 2014, and $11.4 billion is not yet funded.

• Days Sales Outstanding (DSO)⁽⁵⁾ was 73 days at March 29, 2013, a change from 72 days at March 30, 2012.

• Debt-to-total capitalization ratio⁽⁶⁾ was 46.4% at the end of fiscal 2013, a decrease of 2.8 percentage points from 49.2% at the end of fiscal 2012.

• Cash provided by operating activities was $1,119 million, as compared to $1,176 million during fiscal 2012.

• Cash provided by investing activities was $456 million, as compared to cash used of $1,308 million during fiscal 2012.

• Cash used in financing activities was $589 million, as compared to $581 million during fiscal 2012.

• Free cash flow⁽⁷⁾ was $264 million, as compared to $59 million in fiscal 2012.

⁽¹⁾  Selected references are made on a “constant currency basis” so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby providing comparisons of operating performance from period to period. Financial results on a “constant currency basis” are calculated by translating current period activity into U.S. dollars using the comparable prior period’s currency conversion rates. This approach is used for all results where the functional currency is not the U.S. dollar.

24

⁽²⁾  Operating income is a non-U.S. Generally Accepted Accounting Principle (GAAP) measure used by management to assess performance of the Company's segments and on a consolidated basis. The Company’s definition of such measure may differ from other companies. We define operating income as revenue less costs of services, depreciation and amortization expense, and segment general and administrative (G&A) expense, excluding corporate G&A. Management compensates for the limitations of this non-GAAP measure by also reviewing income (loss) from continuing operations before taxes, which includes costs excluded from the operating income definition such as goodwill impairment, corporate G&A, interest and other income. A reconciliation of consolidated operating (loss) income to (loss) income from continuing operations before taxes is as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Operating (loss) income	$	900		$	(1,359	)	$	1,125
Corporate G&A	(293		)	(219		)	(138		)
Interest expense	(183		)	(175		)	(167		)
Interest Income	22			38			37
Goodwill impairment	—			(2,745		)	—
Other income, net	34			6			21
Income (loss) from continuing operations before taxes	$	480		$	(4,454	)	$	878

⁽³⁾  EBIT is a non-U.S. GAAP measure that provides useful information to investors regarding the Company's results of operations as it provides another measure of the Company's profitability, and is considered an important measure by financial analysts covering CSC and its peers. The Company’s definition of such measure may differ from other companies. We define EBIT as revenue less costs of services, selling, general and administrative expenses, depreciation and amortization, goodwill impairment, restructuring costs, and other income (expense). EBIT margin is defined as EBIT as a percentage of revenue. A reconciliation of EBIT to net income from continuing operations is as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Earnings (loss) before interest and taxes	$	641		$	(4,317	)	$	1,008
Interest expense	(183		)	(175		)	(167		)
Interest income	22			38			37
Taxes on income	35			84			(202		)
Income (loss) from continuing operations	$	515		$	(4,370	)	$	676

⁽⁴⁾  Backlog represents total estimated contract value of predominantly long-term contracts, based on customer commitments that the Company believes to be firm. Backlog value is based on contract commitments, management’s judgment and assumptions about volume of services, availability of customer funding and other factors. Backlog estimates for government contracts include both the funded and unfunded portions and all of the option periods. Backlog estimates are subject to change and may be affected by factors including modifications of contracts and foreign currency movements. CSC's backlog, for all periods presented, have been recast to exclude the backlog relating to discontinued operations.

For NPS, announced award values for competitive indefinite delivery and indefinite quantity (IDIQ) awards represent the expected contract value at the time a task order is awarded under the contract. Announced values for non-competitive IDIQ awards represent management’s estimate at the award date. Business awards for MSS are estimated at the time of contract signing based on then existing projections of service volumes and currency exchange rates, and include option years. BSS award values are based on firm commitments, with the exception of deals greater than $20 million and contract terms greater than two years. In those instances, BSS estimates are based on projections of service volumes and currency exchange rates at the time of contract signing and include option years. CSC's business awards, for all periods presented, have been recast to exclude the awards relating to discontinued operations.

⁽⁵⁾  DSO is calculated as total receivables at the fiscal period end divided by revenue-per-day. Revenue-per-day equals total revenues divided by the number of days in the fiscal period. Total receivables includes unbilled receivables but excludes tax receivables and long-term receivables.

⁽⁶⁾  Debt-to-total capitalization ratio is defined as total current and long-term debt divided by total debt and equity, including noncontrolling interest.

⁽⁷⁾  Free cash flow is a non-GAAP measure and the Company's definition of such measure may differ from that used by other companies. We define free cash flow as equal to the sum of (1) operating cash flows, (2) investing cash flows, excluding business acquisitions, dispositions and investments (including short-term investments and purchase or sale of available for sale securities) and (3) payments on capital leases and other long-term asset financings.

CSC’s free cash flow measure does not distinguish operating cash flows from investing cash flows as they are required to be presented in accordance with GAAP, and should not be considered a substitute for operating and investing cash flows as determined in accordance with GAAP. Free cash flow is one of the factors CSC management uses in reviewing the overall performance of the business. Management compensates for the limitations of this non-GAAP measure by also reviewing the GAAP measures of operating, investing and financing cash flows as well as debt levels measured by the debt-to-total capitalization ratio.

25

A reconciliation of free cash flow to the most directly comparable GAAP financial measure is presented below:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Free cash flow	$	264		$	59		$	678
Net cash used in investing activities	(456		)	1,308			892
Acquisitions, net of cash acquired	(34		)	(374		)	(158		)
Business dispositions	1,108			2			119
Short-term investments	—			4			—
Payments on capital leases and other long-term asset financings	237			177			33
Net cash provided by operating activities	$	1,119		$	1,176		$	1,564
Net cash provided by (used in) investing activities	$	456		$	(1,308	)	$	(892	)
Net cash used in financing activities	$	(589	)	$	(581	)	$	(1,676	)

Results of Operations

Revenues

Revenues for the NPS, MSS, and BSS segments for fiscal 2013, 2012, and 2011 are as follows:

	Twelve Months Ended
	March 29, 2013					March 30, 2012					April 1, 2011
(Amounts in millions)	Amount			Percent Change		Amount			Percent Change		Amount
NPS	$	5,391		(5.5	)%	$	5,703		(5.0	)%	$	6,002
MSS	6,457			(2.2	)	6,602			0.3		6,583
BSS	3,272			2.9		3,180			2.3		3,110
Corporate	13					13					14
Subtotal	15,133			(2.4	)	15,498			(1.3	)	15,709
Eliminations	(140		)			(134		)			(127		)
Total Revenue	$	14,993		(2.4	)%	$	15,364		(1.4	)%	$	15,582

The major factors affecting the percent change in revenues are presented as follows:

Twelve Months Ended March 29, 2013 vs. March 30, 2012	Acquisitions		Approximate Impact of Currency Fluctuations		Net Internal Growth (Decline)		Total
NPS	0.5	%	—		(6.0	)%	(5.5	)%
MSS	0.7		(1.9	)%	(1.0	)	(2.2	)
BSS	2.1		(2.6	)	3.4		2.9
Cumulative Net Percentage	0.9	%	(1.3	)%	(2.0	)%	(2.4	)%
Twelve Months Ended March 30, 2012 vs. April 1, 2011	Acquisitions		Approximate Impact of Currency Fluctuations		Net Internal Growth (Decline)		Total
NPS	0.6	%	—		(5.6	)%	(5.0	)%
MSS	0.9		2.7	%	(3.3	)	0.3
BSS	5.5		3.6		(6.8	)	2.3
Cumulative Net Percentage	1.7	%	1.8	%	(4.9	)%	(1.4	)%

26

The Company's fiscal 2013 revenue decreased $371 million as compared to fiscal 2012. This decrease was primarily due to reduction in net internal revenue of $299 million and the adverse impact of foreign currency movement of $207 million, partially offset by $141 million of revenue from acquisitions.

The Company's fiscal 2012 revenue decreased $218 million as compared to fiscal 2011. This decrease was primarily due to reduction in net internal revenue of $762 million, partially offset by favorable impact of foreign currency movement of $284 million and $268 million of revenue from acquisitions.

North American Public Sector

The Company’s NPS Sector segment revenues were derived from the following sources:

	Twelve Months Ended
	March 29, 2013				March 30, 2012				April 1, 2011
Dollars in millions	Amount		Percent Change		Amount		Percent Change		Amount
Department of Defense	$	3,687	(4.6	)%	$	3,863	(10.0	)%	$	4,290
Civil agencies	1,473		(9.0	)	1,618		7.3		1,508
Other (1)	231		4.1		222		8.8		204
Total	$	5,391	(5.5	)%	$	5,703	(5.0	)%	$	6,002

⁽¹⁾  Other revenues consist of foreign, state and local government work as well as commercial contracts performed by the NPS segment.

Fiscal 2013

NPS segment revenue decreased $312 million, or 5.5%, as compared to fiscal 2012. This decline was due to decreases on both Department of Defense (DOD) and Civil Agencies (Civil) contracts, of $176 million, or 4.6%, and $145 million, or 9.0%, respectively.

The revenue decrease on DOD contracts was comprised of reduced revenue of $96 million on certain contracts with the U.S. Air Force and other DOD agencies that either had concluded or were winding down, and reduced revenue of $140 million due to a net reduction in tasking on existing contracts, primarily with the U.S. Army and the U.S. Navy. The year-over-year revenue trend, however, benefited from the fiscal 2012 adverse adjustment to revenue of $42 million resulting from the settlement on a contract with the U.S. Army, which did not recur, and an increase in revenue of $19 million from a wage determination settlement on a contract with the U.S. Air Force, which occurred in the third quarter of fiscal 2013.

The revenue decrease on contracts with Civil was primarily due to a net reduction in scope and tasking on existing contracts of $138 million, primarily on contracts with NASA and the U.S. Postal Service, and reduced revenue of $92 million due to the programs winding down or ending with the Department of State, Department of Commerce, Department of Labor and the Environmental Protection Agency (EPA), along with reduced revenue due to timing of certain contractual milestones of $12 million. These revenue decreases were partially offset by increased revenue of $97 million on contracts with the Department of State and Department of Homeland Security (DHS), which fully ramped up in fiscal 2013.

NPS revenue trend benefited $34 million from adjustments recorded on contracts accounted for under the percentage-of-completion method. Fiscal 2013 had net favorable adjustments of $5 million as compared to $29 million of net adverse adjustments in fiscal 2012.

NPS won contracts of $3.5 billion during fiscal 2013 compared to $6.0 billion during fiscal 2012. These amounts included $1.1 billion and $1.3 billion of recompetes, respectively. The decrease was due to two large awards that occurred in fiscal 2012.

As previously reported, and reinforced by sequestration, NPS' federal government customers are becoming more cautious with contract awards and spending, resulting in shorter contract durations, smaller award values and an inclination towards extension of existing contracts. We expect this trend to continue for the foreseeable future.

27

Fiscal 2012

NPS segment revenue for fiscal 2012 decreased $299 million, or 5.0%, as compared to fiscal 2011. This decrease was due to its DOD contracts, which had a $427 million, or 10.0%, decrease. Partially offsetting the decline in revenue on DOD contracts were increases in revenue from contracts with Civil , which had a $110 million, or 7.3%, increase, and increases in revenue from Other contracts, which had a $18 million, or 8.8%, increase. Fiscal 2012 NPS revenue was adversely impacted by net $29 million of adjustments on certain long-term contracts accounted for under the percentage-of-completion method. Of such adjustments, $39 million reduced revenue and $10 million increased revenue.

The decreases in revenue on DOD contracts, primarily with the U.S. Army and the U.S. Air Force, were due to a combination of completion of existing task orders, a contract termination and net reduction in scope and tasking on other existing contracts. In addition, revenue was adversely impacted by the contract claims settlement with the U.S. federal government in the second quarter of $42 million (see Note 19 to the Consolidated Financial Statements) and by a $14 million adjustment on a contract with the U.S. Air Force accounted for under the percentage-of-completion method due to a stop work order.

The increase in revenue from Civil was primarily due to contracts with the DHS, the Department of Human and Health Services (DHHS) and the Social Security Administration that commenced during the second half of fiscal 2011. These increases were partially offset by revenue that did not recur due to contract completions, primarily the U.S. Census support contract, as well as reduced scope on certain other contracts, primarily with the EPA, Department of Transportation, Department of Energy and the Internal Revenue Service.

The increase in revenue from Other contracts was primarily due to higher revenue on a contract with a state agency for the development of a healthcare administration system. The higher revenue on this contract was partially offset by a $25 million adverse adjustment resulting from revised estimates under the percentage-of-completion accounting method. Of the $25 million revenue reduction, $16 million was recorded in the fourth quarter of fiscal 2012.

During fiscal 2012, many of our government customers continued to experience uncertainty about their fiscal budgets due to the Budget Control Act of 2011. As a result, large program awards were delayed and customers shifted to smaller and shorter term contracts.

NPS won new contracts of $6.0 billion during fiscal 2012 as compared to $5.5 billion during fiscal 2011.

Managed Services Sector

Fiscal 2013

MSS segment revenue decreased $145 million, or 2.2%, as compared to fiscal 2012. In constant currency, revenue decreased $22 million, or 0.3%. The unfavorable foreign currency impact was primarily due to the movement in the U.S. dollar against the euro, the Danish kroner, and the British pound. MSS' fiscal 2012 acquisition of AppLabs resulted in an increase of revenue for the year of $48 million, or 0.7% of the revenue growth for fiscal 2013. Excluding the impact of foreign currency and the acquisition, net internal revenue decreased $70 million, or 1.0%, as compared to the same period of fiscal 2012.

The decrease in MSS' net internal revenue for fiscal 2013 of $70 million was primarily due to reduced revenue of $267 million from contracts that terminated or concluded and reduced revenue of $276 million from existing contracts primarily due to price-downs, contract modifications and lower pass-through revenue. Partially offsetting these decreases was increased revenue from new client engagements acquired in late in fiscal 2012 and fiscal 2013 of $391 million, favorable impact of a year-over-year change in revenue adjustments of $54 million related to adjustments on contracts accounted for under the percentage-of-completion method, and $28 million of other fiscal 2013 favorable revenue adjustments relating primarily to contract settlements with certain customers.

Included in the MSS revenue change described above is a $5 million year-over-year favorable impact of out of period adjustments. MSS' fiscal 2013 revenue was adversely impacted by $1 million of out of period adjustments where as the fiscal 2012 revenue was adversely impacted by $6 million of out of period adjustments (see Notes 2 and 16 to the Consolidated Financial Statements).

28

During fiscal 2013, the MSS had contract awards with a total value of $6.9 billion compared to $9.5 billion during fiscal 2012. These amounts included $4 billion and $5.1 billion of recompetes, respectively. Additionally, the decrease in awards was mainly due to the Company being more selective in its bid and proposal activity, and the awards that were bid on being of shorter duration and, thus, lower total contract value. Prospectively, the Company plans to focus on securing new business through greater cross selling between segments and targeting a greater number of market renewals.

Fiscal 2012

MSS segment revenue increased $19 million, or 0.3%, as compared to fiscal 2012. In constant currency, revenue decreased $156 million, or 2.4%. The foreign currency impact was primarily due to the movement in the U.S. dollar against the Australian dollar, the British pound, the euro and the Swiss franc. MSS' second quarter acquisition of AppLabs (see Note 4 to the Consolidated Financial Statements) provided revenue of $60 million, or 0.9% of the revenue growth.

Excluding the impact of foreign currency effects and the acquisition, fiscal 2012 net internal revenue decreased $216 million, or 3.3%, as compared to the prior year. This decrease was primarily due to net volume and scope reductions of approximately $140 million and contract conclusions and terminations of approximately $200 million, partially offset by revenue from new contracts of approximately $270 million. In addition, revenue was impacted by certain one-time adjustments, including adverse adjustments on long-term contracts accounted for under the percentage-of-completion method of $48 million and missed service level metrics of $10 million due to delays on certain outsourcing contracts, partially offset by a favorable adjustment on termination of a contract of $15 million. The MSS year-over-year revenue trend was also adversely impacted by out of period adjustments. The out of period revenue decreases recorded in fiscal 2012 and fiscal 2011 were $7 million and $33 million, respectively (see Notes 2 and 15 to the Consolidated Financial Statements).

During fiscal 2012, MSS had contract awards with a total value of $9.5 billion as compared to $5 billion during fiscal 2011.

Business Solutions & Services

Fiscal 2013

BSS segment revenue increased $92 million, or 2.9%, as compared to fiscal 2012. In constant currency, revenue increased $176 million or 5.5%. The twelve-month revenue growth was unfavorably impacted by foreign currency movement in the U.S. dollar of $84 million, or 2.6%, primarily against the euro, the Brazilian real, the British pound and the Australian dollar.

The acquisition of iSOFT and the other fiscal 2012 acquisitions provided $67 million, or 2.1% of the year-over-year revenue increase. Excluding the effect of foreign currency movements and acquisitions, BSS fiscal 2013 revenue increased $109 million, or 3.4%, over the prior year. The increase in BSS net internal revenue includes the impact of the fiscal 2012 adverse revenue adjustment of $204 million associated with the NHS contract charge, which did not recur in fiscal 2013. Excluding the adverse NHS contract revenue charge, BSS fiscal 2013 net internal revenue decreased $95 million, or 2.8%.

The decrease in BSS net internal revenue for fiscal 2013, excluding the impact of the adverse fiscal 2012 NHS revenue adjustment, was due to revenue decreases primarily in its professional technology staffing business in Australia, in its financial services group, and in its healthcare group. These revenue decreases were partially offset by revenue increases on contracts with the NHS.

The year-over-year revenue decrease from the Australian staffing business was $90 million. This was due to a combination of a slowdown in its business, prior to its sale, from reduced demand from certain of its key customers, and its sale on January 25, 2013_. The revenue decrease of $37 million in the financial services group was due to lower license sales and services revenue in European markets. The revenue decrease in the health services of $35 million was due to a combination of lower revenue in the Nordic and U.S. markets. The revenue increase relating to the NHS contract, excluding the fiscal 2012 write-off, was primarily due to recording revenue from achieving a key milestone associated with the Lorenzo Care Management software, deployment of the software at three NHS trust sites, and revenue indexation for fiscal 2013.

29

BSS revenue increase included $17 million of favorable adjustments on contracts accounted for under the percentage-of-completion method. Fiscal 2013 revenue included favorable adjustments of $11 million as compared to fiscal 2012 revenue that included adverse adjustments of $6 million.

BSS year-over-year revenue trend was also favorably impacted by $32 million of out of period adjustments. Fiscal 2013 revenue included $13 million of adverse out of period adjustments, whereas fiscal 2012 included $45 million of adverse adjustments. (see Notes 2 and 16 to the Consolidated Financial Statements).

During fiscal 2013, BSS had contract awards of $3.4 billion compared to $3.3 billion in fiscal 2012. The fiscal 2013 amount included $0.2 billion of recompetes. There were no recompete awards in fiscal 2012.

Fiscal 2012

BSS segment revenue increased $70 million, or 2.3%, as compared to fiscal 2011. In constant currency, revenue decreased $40 million, or 1.3%. The foreign currency impact was primarily due to the movement in the U.S. dollar against the Australian dollar, the British pound and the euro. The acquisition of iSOFT and the other fiscal 2012 and fiscal 2011 acquisitions provided $171 million, or 5.5%, of the year-over-year revenue increase. Excluding the effect of foreign currency movements and acquisitions, BSS fiscal 2012 revenue decreased $211 million, or 6.8%, compared to the prior year.

The lower net internal fiscal 2012 revenue was primarily due to a decrease in revenue on the NHS contract of $233 million, which was adversely impacted by the third quarter $204 million revenue write-down (see Note 18 to the Consolidated Financial Statements) and by fiscal 2011 milestone revenue of $23 million that did not recur in fiscal 2012. BSS' health vertical also had reduced revenue due to continuing softness in the life sciences market and certain project completions in North America. Both of these revenue decreases were partially offset by revenue increases in the other verticals of BSS' consulting group. The consulting group's growth was primarily in North America, which offset revenue shortfalls in other regions. The BSS year-over-year revenue trend was also adversely impacted by out of period adjustments. The out of period revenue adjustments recorded in fiscal 2012 and fiscal 2011 were revenue decreases of $15 million and revenue increases of $15 million, respectively (see Notes 2 and 16 to the Consolidated Financial Statements).

During fiscal 2012, BSS had contract awards of $3.3 billioncompared to $3.8 billion in fiscal 2011.

Costs and Expenses

The Company’s total costs and expenses were as follows:

	Twelve Months Ended									Percentage of Revenue
Dollars in millions	March 29, 2013			March 30, 2012			April 1, 2011			2013		2012		2011
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs of $238 (2013) and $137 (2012))	$	11,851		$	13,019		$	12,578		78.9	%	84.7	%	80.7	%
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	—			1,281			—			—		8.3		—
Cost of services – settlement charge (excludes amount charged to revenue of $42)	—			227			—			—		1.5		—
Selling, general and administrative (excludes restructuring costs of $26 (2013) and $3 (2012))	1,195			1,128			949			8.0		7.3		6.1
Depreciation and amortization	1,076			1,147			1,068			7.2		7.5		6.9
Restructuring costs	264			140			—			1.8		0.9		—
Goodwill impairment	—			2,745			—			—		17.9		—
Interest expense, net	161			137			130			1.1		0.9		0.8
Other income, net	(34		)	(6		)	(21		)	(0.2	)	—		(0.1	)
Total	$	14,513		$	19,818		$	14,704		96.8	%	129.0	%	94.4	%

30

Costs of Services

Fiscal 2013

Costs of services (COS), excluding the specified contract charge, the settlement charge, and the restructuring charges noted above, as a percentage of revenue decreased to 78.9% for fiscal 2013 from 84.7% for fiscal 2012. The year-over-year COS trend was favorably impacted by out of period adjustments of $33 million, which was comprised of $6 million of favorable fiscal 2013 out of period adjustments and $27 million of adverse fiscal 2012 out of period adjustments which did not repeat in fiscal 2013 (see Note 2 to the Consolidated Financial Statements).

The fiscal 2013 NPS COS ratio decreased primarily due to a net favorable year-over-year adjustment to COS of $98 million on contracts accounted for under the percentage-of-completion method. Fiscal 2013 revenue included $55 million of favorable adjustments as compared to fiscal 2012, which had $43 million of adverse adjustments. Of the $98 million, $94 million related to three contracts, one each with the Department of Labor, U.S. Air Force and the State of North Carolina. The NPS COS ratio also benefited from a $42 million adverse fiscal 2012 revenue adjustment resulting from a contract settlement with the U.S. government that did not recur, and $34 million year-over-year net favorable revenue adjustment on contracts accounted for under the percentage-of-completion method.

The lower MSS COS ratio for fiscal 2013 was primarily due to year-over-year operational improvements on contracts which had performance issues in fiscal 2012. The operational improvements were a result of continued focus on troubled accounts, greater focus on cost take out by standardization of products and processes including diagnostics and re-engineering and greater focus on delivery. This year-over-year improvement was illustrated by reduced year-over-year adverse impact of asset impairments of $138 million, net favorable year-over-year adjustments to COS and revenue on contracts accounted for under the percentage-of-completion method of $32 million and $54 million, respectively, and reduced year-over-year impact of transition cost overruns of $16 million. The COS also benefited from operational efficiencies resulting from the implementation of the turnaround strategy, such as improved cost controls, headcount reductions through restructuring, centralized procurement, better discipline around contract management, rationalized organizational spans and layers, and reduced enterprise overhead. These efficiencies are partially offset by costs related to start-up issues on certain new contracts.

The lower BSS COS ratio for fiscal 2013 was primarily due to the fiscal 2012 adverse revenue adjustment of $204 million associated with a contract with the NHS. In addition, the BSS COS ratio was favorably impacted by lower costs within BSS' consulting services due to staff reductions, and adversely impacted by a higher COS ratio in the financial services group due to lower revenue. The twelve-month COS ratio was favorably impacted by a year-over-year change of $34 million related to adjustments on contracts accounted for under the percentage-of-completion method, including a year-over-year favorable adjustment to revenue of $17 million.

Fiscal 2012

COS, excluding the specified contract charge, the settlement charge, and the restructuring charges noted above, as a percentage of revenue increased to 84.7% for fiscal 2012 from 80.7% for fiscal 2011. Both fiscal 2012 and fiscal 2011 COS were adversely impacted by out of period adjustments recorded during these years but which were related to prior years. The amounts recorded in fiscal 2012 and fiscal 2011 were $25 million and $15 million, respectively, in MSS and $15 million and $4 million, respectively, in BSS. The fiscal 2012 increase in the COS ratio was primarily driven by adverse results in the MSS and BSS segments.

The MSS COS ratio was impacted by adverse adjustments on long-term contracts accounted for under the percentage-of-completion method of $142 million of which $48 million was recorded as a reduction of revenue, impairment of tangible and intangible assets of $144 million associated primarily with service delivery issues on certain outsourcing contracts, and start-up issues on certain outsourcing contracts, including transition cost overruns of $34 million. Of these specific charges of $320 million, $171 million were recorded in the fourth quarter of fiscal 2012.

BSS' COS ratio was adversely impacted primarily by the NHS contract and the financial services business. Subsequent to the $1.5 billion NHS adjustment recorded in the third quarter of fiscal 212, and pending the finalization of a contract amendment, the Company recorded $29 million of operating losses in the fourth quarter (see Note 18 to the Consolidated Financial Statements). In addition, a year-over-year shift in BSS' financial services revenue mix, caused by a decline in the proportion of the higher margin license revenue, adversely impacted the BSS COS ratio. BSS COS ratio was

31

impacted by adverse adjustments of $17 million on certain long-term contracts accounted for under the percentage-of-completion method, of which $6 million was recorded as reduction in revenue.

The NPS COS ratio increased primarily as a result of recording $72 million of net adverse adjustments on certain long-term contracts accounted for under the percentage-of-completion method. The net adjustments included adverse adjustments of $130 million, of which $40 million reduced revenue, and favorable adjustments of $58 million, of which $10 million increased revenue. Favorable adjustments included a $48 million COS benefit on a contract that had a similar adjustment in fiscal 2011. Of the total $72 million net adverse adjustments, $44 million was recorded in the fourth quarter of fiscal 2012.

Costs of Services – Settlement Charge

During the second quarter of fiscal 2012, the Company reached a settlement agreement with the U.S. government relating to its contract claims asserted under the Contract Disputes Act of 1978 (CDA). Under the terms of the settlement, the Company received $277 million in cash and a five-year extension (four base years plus one option year) with an estimated total contract value of $1 billion to continue to support and expand the capabilities of the systems covered by the original contract scheduled to expire in December 2011. In December 2011, the Company signed the contract modification based on the terms described above. As a result of the settlement, the Company recorded a pre-tax charge of $269 million during the second quarter of fiscal 2012 to write down its claim related assets (claim related unbilled receivables of $379 million and deferred costs of $227 million) to reflect the cash received of $277 million, the estimated fair value of the contract extension of $45 million, and previously unapplied payments of $15 million. Of the pre-tax charge of $269 million, $42 million was recorded as a reduction of revenue and $227 million as a separately itemized charge to cost of services. The fair value of the contract extension was recorded as a contract asset and will be amortized as a reduction of revenue over the four year fixed contract term in proportion to the expected revenues or a straight line basis, whichever is greater. The contract extension contained a Requirements portion and an Indefinite Quantity portion (and is not subject to any minimum values). See Note 19 to the Consolidated Financial Statements for further discussion.

Selling, General and Administrative

Fiscal 2013

Selling, general and administrative (SG&A) expense, excluding the restructuring charges, as a percentage of revenue increased to 8.0% for fiscal 2013 from 7.3% for fiscal 2012. The fiscal 2013 increase was primarily driven by an increase in corporate general & administrative (G&A) costs and a higher MSS ratio, partially offset by decreases in NPS and BSS ratios.

The higher MSS ratio was primarily due to the reclassification of $17 million of costs from COS to SG&A in fiscal 2013. In addition, there were higher costs in fiscal 2013 associated with the remediation efforts of investigation findings (see Note 2 of the Consolidated Financial Statements).

The lower NPS ratio was primarily due to the cost reduction initiatives and lower bid and proposal costs due to delays in government procurements, fewer opportunities and more selectivity in the bid process towards higher margin targets.

The lower BSS ratio was primarily due to the fiscal 2012 adverse revenue adjustment of $204 million associated with a contract with the NHS. The lower ratio was also attributable to a lower run rate within iSOFT due to cost take out activity, including back office integration, and fiscal 2012 acquisition and transition costs of $10 million, which did not repeat in fiscal 2013.

Corporate G&A for fiscal 2013 was $293 million and increased $74 million as compared to the prior year. The higher fiscal 2013 expense was primarily due to accrual of $97.5 million on account of the settlement of the consolidated shareholder securities class action lawsuit (see Note 20 to the Consolidated Financial Statements). This amount was partially offset by $45 million that was recoverable under the Company's corporate insurance policies. In addition, the fiscal 2013 increase was also due to higher professional fees of $20 million primarily associated with the Company's financial transformation, higher internal audit fees of $10 million, and higher stock-based compensation and bonus expense. Partially offsetting the increases in the Corporate G&A was net reduced legal fees associated with the SEC investigation and class action lawsuits due to $45 million of insurance claims that offset the fiscal 2013 legal expenses of $78 million.

32

Fiscal 2012

SG&A expense, excluding the restructuring charges, as a percentage of revenue increased to 7.3% for fiscal 2012 from 6.1% for fiscal 2011. The fiscal 2012 increase was primarily driven by an increase in corporate G&A costs and a higher BSS ratio.

The corporate G&A costs increased year-over-year primarily due to higher legal and other fees of $67 million incurred, mainly related to the ongoing SEC and Audit Committee investigations into the matters surrounding the out of period adjustments and additional legal and other professional fees in connection with consolidated securities class action lawsuits filed in federal court (see Note 20 to the Consolidated Financial Statements). Corporate G&A costs were also higher due to costs associated with the former CEO's severance of $7 million. These cost increases were partially offset by lower bonuses of $10 million and reduced stock compensation expense of $11 million, principally due to reduction in the probable outcome of performance-based restricted stock units for certain executives.

The BSS ratio increased primarily due to the acquisition of iSOFT. iSOFT's SG&A ratio was adversely impacted by $23 million of transaction and transition costs incurred related to its acquisition.

Goodwill Impairment

During the second quarter of fiscal 2013, the Company performed its annual impairment test of goodwill, proceeding directly to the first step of the impairment test, for all reporting units and concluded that no impairment had occurred.

Due to the divestiture of our credit services business in the third quarter of fiscal 2013, which caused the allocation of $241 million of goodwill from our BSS-Financial Services (BSS-FS) reporting unit to that disposed business, we assessed the goodwill remaining on BSS-FS' balance sheet for potential impairment. We performed the first step of the two-step goodwill impairment test and concluded that the goodwill remaining on BSS-FS' balance sheet, after the allocation of goodwill to the divested business, was not impaired.

During the fourth quarter of fiscal 2013, for reporting units with goodwill, we evaluated whether there were factors which would indicate a potential impairment of goodwill. The Company considered, among other factors, any significant changes in the Company's fiscal 2013 forecast since the annual impairment test was performed, the outlook for the Company's business and industry, the Company's market capitalization, and the current economic environment and outlook. Based on that evaluation, the Company determined that there have been no events or changes in circumstances that would more likely than not reduce the fair value of any of the reporting units below their carrying amounts, and, as a result, it was unnecessary to perform the first step of the two-step impairment testing process.

Based on the Company's fiscal 2012 annual goodwill impairment analysis performed during the second quarter, it was concluded that fair value was below carrying value for three reporting units: MSS, BSS Global Business Solutions (BSS-GBS) and the BSS Healthcare Group (BSS-Health). Management believed that the decline in the estimated fair values of these reporting units was a result of several factors, including uncertainty about the Company's overall value as reflected in CSC's stock price decline over the first half of fiscal 2012, overall decline in the broader stock market as indicated by reduced performance metric multiples at comparable public companies, and decline in forecasted operating performance of these reporting units. At that time, the Company recorded its best estimated goodwill impairment charge of $2,685 million, of which $2,074 million related to the MSS reporting unit, $453 million related to the BSS-GBS reporting unit, and $158 million related to the BSS-Health reporting unit. During the third quarter of fiscal 2012, based on the finalization of the annual test begun in the prior quarter, the Company recorded adjustments that reduced the impairment loss recorded in the second quarter by $3 million, to $2,682 million.

In the third quarter of fiscal 2012, the Company recorded an impairment charge of $63 million on the goodwill related to its reporting unit BSS-Health. After recording this impairment charge, the BSS-Health reporting unit had no remaining goodwill.

33

Depreciation and Amortization

Fiscal 2013

Depreciation and amortization (D&A) as a percentage of revenue decreased to 7.2% for fiscal 2013 from 7.5% for fiscal 2012. The decrease in the fiscal 2013 ratio was driven by decreases in the MSS and BSS segments.

The lower MSS ratio was due to reduced D&A expense as a result of significant impairments of fixed and intangible assets recorded in fiscal 2012, as well as a reduction in capital expenditures in fiscal 2013. The lower BSS ratio was due to the fiscal 2012 adverse revenue adjustment of $204 million associated with the NHS contract, as well due to lower depreciation expense due to certain data center assets associated with the NHS contract coming to the end of their useful lives.

Fiscal 2012

D&A as a percentage of revenue increased to 7.5% for fiscal 2012 from 6.9% for fiscal 2011. The increase in the fiscal 2012 ratio was driven by all three segments. The BSS ratio increased due to higher amortization expense associated with the acquired iSOFT intangible and tangible assets. The higher MSS ratio is due to higher capital expenditure on outsourcing contracts. The higher NPS ratio is due to higher fixed asset purchases on certain of its contracts, as well as amortization of acquired intangible assets from fiscal 2012 and 2011 acquisitions.

Restructuring Costs

During fiscal 2013, the Company continued its efforts to reduce its staffing and facility costs and engaged in additional restructuring actions that were first commenced in the fourth quarter of fiscal 2012. The fiscal 2013 actions (the "Fiscal 2013 Plan") related primarily to reducing headcount in order to align resources to support business needs, including assessment of management span of control and layers, and further increase the use of lower cost off-shore resources. In contrast, the fiscal 2012 restructuring efforts (the "Fiscal 2012 Plan") were designed primarily to address excess capacity issues and alignment of workforce with current business needs, primarily in Europe.

Total restructuring costs recorded during fiscal 2013 and 2012 were $264 million and $140 million, respectively. There were no restructuring costs for fiscal 2011. The amounts recorded in fiscal 2013 and 2012 included $22 million and $20 million, respectively, of pension benefit augmentations that were due to certain employees in accordance with legal or contractual obligations and which will be paid out over several years as part of normal pension distributions.

The total fiscal 2013 restructuring costs of $264 million comprised $233 million under the Fiscal 2013 Plan and $31 million under the Fiscal 2012 Plan, as compared to total fiscal 2012 restructuring costs of $140 million.

Of the total restructuring expense recorded for fiscal 2013 of $264 million, $13 million related to NPS, $190 million to MSS, $39 million to BSS, and $22 million to Corporate.

Income from Discontinued Operations

During fiscal 2013, CSC completed the divestiture of three businesses within its BSS segment, reflecting the Company's ongoing service portfolio optimization initiative to focus on next-generation technology services. These divestitures have been presented separately as discontinued operations in the Consolidated Statement of Operations and the prior years have been recast to reflect the divestitures.

The fiscal 2013 income from discontinued operations, net of taxes was $464 million, and included $47 million of net income from the operations of the divestitures and $417 million of gain on disposition, net of taxes from sale of the businesses.The fiscal 2012 income from discontinued operations, net of taxes was $145 million, and included $1 million gain on disposition, net of taxes (see Note 3 to the Consolidated Financial Statements).

During fiscal 2011, CSC completed the divestiture of two businesses within its NPS segment whose ultimate customer was the U.S. federal government. These divestitures resulted in total pre-tax gains of $59 million (after-tax gains of approximately $28 million).

34

Interest Expense and Interest Income

Fiscal 2013

Interest expense of $183 million in fiscal 2013 increased $8 million compared to fiscal 2012. The higher interest expense was primarily due to the loss of $19 million associated with the early redemption of the 5.50% and 5.00% Senior Notes due 2013, partially offset by lower interest expense associated with the issuances of new Senior Notes (see Note 11 of the Consolidated Financial Statements). Interest income decreased $16 million to $22 million in fiscal 2013 primarily due to reduced average cash balances outside the U.S., primarily in India, where both the rate of interest and average cash balances are typically higher than other non-U.S. jurisdictions.

Fiscal 2012

Interest expense of $175 million in fiscal 2012 increased $8 million compared to fiscal 2011 due to an increase in capital leases in MSS. Interest income increased $1 million to $38 million in fiscal 2012. Higher interest income was primarily due to higher interest earned on cash balances in India during the first two quarters of fiscal 2012.

Other (Income) Expense, Net

The components of other (income) expense, net for fiscal 2013, fiscal 2012, and fiscal 2011 are:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Foreign currency loss (gain)	$	17		$	4		$	(2	)
Equity in earnings of unconsolidated affiliates	(9		)	(10		)	(11		)
Other gains	(42		)	—			(8		)
Total	$	(34	)	$	(6	)	$	(21	)

Fiscal 2013

The foreign currency loss increased $13 million primarily due to movement in the U.S. dollar primarily versus the Indian Rupee, which caused a year-over-year increase in mark-to-market charge of $12 million. The other gains were primarily comprised of the $38 million gain on our sale of Paxus, the Australian staffing business.

Fiscal 2012

Foreign currency loss of $4 million for fiscal 2012 was due to the movements in foreign currency exchange rates, primarily between the U.S. dollar and the Indian rupee, which adversely impacted the Company's foreign currency options. Reduction in other gains is due to fiscal 2011 gains on sale of an investment and non-controlling interest in a business, both of which did not recur in fiscal 2012.

Taxes

The Company's effective tax rate (ETR) on (loss) income from continuing operations for fiscal years 2013, 2012, and 2011 was (7.3)%, (1.9)%, and 23%, respectively. As a global enterprise, our ETR is affected by many factors, including our global mix of earnings, the extent to which those global earnings are indefinitely reinvested outside the U.S., legislation, acquisitions, dispositions, and tax characteristics of our income. Our tax returns are routinely audited and settlements of issues raised in these audits sometimes affect our tax provisions. A reconciliation of the differences between the U.S. federal statutory rate and the ETR, as well as other information about our income tax provision, is provided in Note 10 to the Consolidated Financial Statements. For the tax impact of discontinued operations, see Note 3 to the Consolidated Financial Statements.

In fiscal 2013, the ETR was primarily driven by:

• The Company executed an internal restructuring whereby a significant operating subsidiary was recapitalized. Certain securities issued pursuant to the recapitalization were subsequently sold to a third party. The sale

35

resulted in the recognition of a capital loss of approximately $640 million, which reduced tax expense and the ETR by $248 million and 51.8%, respectively.

• A valuation allowance recorded for certain of the Company's German subsidiaries related to net operating losses and other net deferred tax assets. The impact to tax expense and the ETR was an increase of $77 million and 16%, respectively.

• An increase in the valuation allowance determined on a tax jurisdictional basis due to several factors including: (i) a shift in the global mix of income which increased tax expense and the ETR by $27.6 million and 5.8%, respectively (ii) capital gains from the sale of certain other assets which decreased tax expense and the ETR by $11.5 million and 2.4%, respectively and (iii) state capital losses and credits not expected to be fully utilized within the carryforward period which increased tax expense and the ETR by $29.6 million and 6.2%, respectively.

• Local losses on investment write-downs in Luxembourg (i) increased the valuation allowance and the ETR by $240.5 million and 50.2%, respectively, and (ii) decreased the foreign rate differential and ETR by $240.5 million and 50.2%, respectively.

In fiscal 2012, the ETR was primarily driven by:

• The Company recorded a $1,485 million charge related to the NHS contract. Following the write-down, a full valuation allowance was established against the net operating losses in the U.K., which resulted in the Company not recording a tax benefit for the NHS charges. This charge and subsequent valuation allowance had a significant impact on the tax expense and ETR of $508 million and 11.3%, respectively.

• The Company recorded a $2,745 million goodwill impairment charge, which was mostly not deductible for tax purposes. This charge resulted in an impact to the tax expense and ETR of $838 million and 18.8%, respectively.

• The Company settled various tax examinations and recognized income tax benefits related to audit settlements (and the expiration of statutes of limitations on audits) of approximately $111 million, which had a favorable impact on the ETR for the fiscal year of 2.5%.

• The Company elected to change the tax status of one of its foreign subsidiaries. This change in tax status resulted in a deemed liquidation for U.S. tax purposes and triggered various deductions, which resulted in an income tax benefit of approximately $32 million and had a favorable impact on the ETR for the fiscal year of 0.7%.

In fiscal 2011, the Company settled a portion of its U.S. federal income tax audit for the fiscal years 2005 through 2007 related specifically to research and development (R&D) credits. This favorable settlement of $68 million had a 7.7% impact on the ETR for the fiscal year ended 2011.

As of March 29, 2013, in accordance with ASC 740, "Income Taxes," the Company’s liability for uncertain tax positions was $262 million, including interest of $38 million, penalties of $17 million, and net of tax attributes of $32 million. During the year ended March 29, 2013, the Company accrued interest expense of $7 million ($5 million net of tax) and accrued penalties of $2 million.

The Finance Act of 2012 (the Finance Act) was signed into law in India on May 28th, 2012. The Act provides for the taxation of indirect foreign investment in India, including on a retroactive basis. The Finance Act overrides the recent Vodafone ruling by the Supreme Court of India which held that the Indian Tax Authorities cannot assess capital gains taxes on the sale of shares of non-Indian companies that indirectly own shares in an Indian company. The retroactive nature of these changes in law has been strongly criticized. The Finance Act has been challenged in the Indian courts. However, there is no assurance that such a challenge will be successful. CSC has engaged in the purchase of shares of foreign companies that indirectly own shares of an Indian company and internal reorganizations. The Indian tax authorities may seek to apply the provisions of the Finance Act to these prior transactions and seek to tax CSC directly or as a withholding agent or representative assessee of the sellers involved in prior acquisitions. The Company believes that the Finance Act does not apply to these prior acquisitions and that it has strong defenses against any claims that might be raised by the Indian tax authorities.

36

Earnings (Loss) Per Share and Share Base

Fiscal 2013

Earnings (loss) per share (EPS), on a diluted basis, increased $33.55 to $6.18 in fiscal 2013. This increase in total diluted EPS was comprised of increase in EPS from continuing operations of $31.51 and increase in EPS from discontinued operations of $2.04.

The increase in EPS from continuing operations was primarily due to the adverse fiscal 2012 charges not recurring in fiscal 2013. These fiscal 2012 charges included goodwill impairment of $2,745 million (see Note 9 to the Consolidated Financial Statements), the NHS contract related charge of $1,485 million (see Note 18 to the Consolidated Financial Statements), the settlement charge of $269 million resulting from settlement of claims with the federal government (see Note 19 to the Consolidated Financial Statements) and reduced impact of net adjustments on contracts accounted for under the percentage-of-completion method (see Note 1 to the Consolidated Financial Statements) and asset impairments (see Note 8 to the Consolidated Financial Statements).

The increase in EPS from discontinued operations was primarily due to the gain, net of taxes of $417 million on the disposition of the U.S. based credit services business and enterprise systems integration business in Malaysia and Singapore.

Fiscal 2012

Diluted EPS for fiscal 2012 decreased $32.10 to $(27.37) from $4.73 in fiscal 2011. The decrease in diluted EPS was due to the net loss attributable to CSC common shareholders in fiscal 2012 which was primarily due to the goodwill impairment charge of $2,745 million recorded during the second and third quarters of fiscal 2012 (see Note 9 to the Consolidated Financial Statements), the contract charge associated with the NHS contract of $1,485 million recorded during the third quarter of fiscal 2012 (see Note 18 to the Consolidated Financial Statements), the settlement charge of $269 million that resulted from the settlement of claims with the U.S. federal government during the second quarter of fiscal 2012 (see Note 19 to the Consolidated Financial Statements), and restructuring costs of $140 million recorded during the fourth quarter of fiscal 2012 (see Note 17 to the Consolidated Financial Statements). Delivery issues on certain MSS and NPS contracts resulted in recording forward losses on contracts accounted for under the percentage-of-completion method and asset impairments which also adversely impacted the EPS for fiscal 2012.

Investigations and Out of Period Adjustments

Summary of Audit Committee and SEC Investigations Related to the Out of Period Adjustments

As previously disclosed in fiscal 2012 and fiscal 2011, the Company initiated an investigation into out of period adjustments resulting from certain accounting errors in our Managed Services Sector (MSS) segment, primarily involving accounting irregularities in the Nordic region. Initially, the investigation was conducted by Company personnel, but outside Company counsel and forensic accountants retained by such counsel later assisted in the Company's investigation. On January 28, 2011, the Company was notified by the SEC's Division of Enforcement that it had commenced a formal civil investigation relating to these matters, which investigation has been expanded to other matters subsequently identified by the SEC, including matters specified in subpoenas issued to the Company from time to time by the SEC's Division of Enforcement as well as matters under investigation by the Audit Committee, as further described below. The Company is cooperating in the SEC's investigation.

On May 2, 2011, the Audit Committee commenced an independent investigation into the matters relating to the MSS segment and the Nordic region, matters identified by subpoenas issued by the SEC's Division of Enforcement, and certain other accounting matters identified by the Audit Committee and retained independent counsel to represent CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with such independent investigation. Independent counsel retained forensic accountants to assist with their work. Independent counsel also represents CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with the investigation by the SEC's Division of Enforcement.

The Audit Committee’s investigation was expanded to encompass (i) the Company’s operations in Australia, (ii) certain aspects of the Company’s accounting practices within its Americas Outsourcing operation, and (iii) certain of the

37

Company’s accounting practices that involve the percentage-of-completion accounting method, including the Company’s contract with the U.K. National Health Service (NHS). In the course of the Audit Committee's expanded investigation, accounting errors and irregularities were identified. As a result, certain personnel have been reprimanded, suspended, terminated and/or have resigned. The Audit Committee determined in August 2012 that its independent investigation was complete. The Audit Committee instructed its independent counsel to cooperate with the SEC's Division of Enforcement by completing production of documents and providing any further information requested by the SEC's Division of Enforcement.

In addition to the matters noted above, the SEC's Division of Enforcement is continuing its investigation involving its concerns with certain of the Company's prior disclosure and accounting determinations with respect to the Company's contract with the NHS and the possible impact of such matters on the Company's financial statements for years prior to the Company's current fiscal year. The Company and the Audit Committee and its independent counsel are investigating these matters and are continuing to cooperate with the SEC's Division of Enforcement in its investigation of prior disclosures of the Company's contract with the NHS. The SEC's investigative activities are ongoing.

In addition, the SEC's Division of Corporation Finance has issued comment letters to the Company requesting, among other things, additional information regarding its previously disclosed adjustments in connection with the above-referenced accounting errors, the Company's conclusions relating to the materiality of such adjustments, and the Company's analysis of the effectiveness of its disclosure controls and procedures and its internal control over financial reporting. The SEC's Division of Corporation Finance's comment letter process is ongoing, and the Company is continuing to cooperate with that process.

The investigation being conducted by the SEC's Division of Enforcement and the review of our financial disclosures by the SEC's Division of Corporation Finance are continuing and could identify other accounting errors, irregularities or other areas of review. As a result, we have incurred and may continue to incur significant legal and accounting expenditures. We are unable to predict how long the SEC's Division of Enforcement's investigation will continue or whether, at the conclusion of its investigation, the SEC will seek to impose fines or take other actions against the Company. In addition, we are unable to predict the timing of the completion of the SEC's Division of Corporation Finance's review of our financial disclosures or the outcome of such review. Publicity surrounding the foregoing or any enforcement action as a result of the SEC's investigation, even if ultimately resolved favorably for us, could have an adverse impact on the Company's reputation, business, financial condition, results of operations or cash flows. The Company is unable to estimate any possible loss or range of loss associated with these matters.

Out of Period Adjustments Financial Impact Summary

Cumulative Impact of Out of Period Adjustments

The rollover impact on income (loss) from continuing operations before taxes of the recorded out of period adjustments in fiscal 2013, 2012 and 2011 is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2011 Adjustments			Fiscal 2012 Adjustments			Fiscal 2013 Adjustments			Total Adjustments
Fiscal 2013	$	—		$	—		$	6		$	6
Fiscal 2012	—			79			7			86
Fiscal 2011	52			(29		)	(22		)	1
Fiscal 2010	(48		)	(9		)	14			(43		)
Prior fiscal years (unaudited)	(4		)	(41		)	(4		)	(49		)

See Note 16 for a summary of the effect of the pre-tax out of period adjustments on the Company's segment results for fiscal 2013, 2012 and 2011.

38

Fiscal 2013 Adjustments Financial Impact Summary

During fiscal 2013, the Company identified and recorded net adjustments decreasing income from continuing operations before taxes by $6 million that should have been recorded in prior fiscal years. This net impact on income from continuing operations before taxes for fiscal 2013 is comprised of the following:

• net adjustments decreasing fourth quarter pre-tax income by $9 million resulting primarily from the correction of inappropriately capitalized operating costs originating from MSS, a software revenue recognition correction originating from the Company's Business Solutions and Services (BSS) segment and the correction of understated payroll and related expenses at Corporate;

• net adjustments decreasing third quarter pre-tax income by $1 million primarily resulting from the correction of useful lives of property and equipment in service at a BSS contract that were inconsistent with established CSC accounting conventions;

• net adjustments increasing second quarter pre-tax income by $5 million primarily resulting from the correction of accounting errors identified by the Company related to costs incurred under the NHS contract (see below for more discussion of out of period adjustments related to the Company's NHS contract); and

• net adjustments decreasing first quarter pre-tax income by $1 million primarily resulting from the corrections of fiscal 2012 revenue recognized on a software contract in the Company's BSS segment, corrections of fiscal 2012 restructuring cost accruals originating primarily from the Company's BSS and MSS segments and corrections to record adjustments originating primarily from the Company's North American Public Sector (NPS) and MSS segments that were identified late in the close process but not included in the Company's consolidated fiscal 2012 financial statements.

Adjustments recorded during fiscal 2013 that should have been recorded in prior fiscal years increased income from continuing operations by $7 million. This increase is attributable to the tax effect of the adjustments described above and $5 million of discrete tax benefits that should have been recorded in prior fiscal years. The discrete tax benefits are primarily attributable to the adjustment of the deferred tax liability related to intellectual property assets.

NHS

As previously disclosed in fiscal 2012 and in the first quarter of fiscal 2013, the Company had identified certain additional items related to the investigation of the Company's use of the percentage-of-completion accounting method used on the NHS contract. During the second quarter of fiscal 2013, based on its analysis of these items, the Company recorded net credits of $9 million in pre-tax out of period adjustments impacting prior fiscal years. During the third quarter of fiscal 2013, the Company identified additional prior period errors. Such errors identified in the third quarter, which were self-correcting in the third quarter of fiscal 2012, have no impact on income from continuing operations before taxes for fiscal 2013. The accounting errors identified during fiscal 2013 are primarily related to either costs incurred under the contract or the estimation of contract revenues and costs at completion, which resulted in the overstatement of income from continuing operations before taxes. The Company has concluded that there is no cumulative impact of this overstatement as a result of the $1.5 billion specified contract charge recorded as of December 30, 2011 being overstated by the same amount.

The Company has concluded that the errors identified during fiscal 2013 do not appear to have any impact on amounts charged to the NHS. Based on information provided by independent counsel, the Company believes that a small portion of such adjustments should be characterized as intentional accounting irregularities. The impact on income (loss) from continuing operations before taxes of the out of period adjustments identified in fiscal 2013 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2013 Adjustments
Fiscal 2013	$	(9	)
Fiscal 2012	10
Fiscal 2011	(15		)
Fiscal 2010	18
Prior fiscal years (unaudited)	(4		)

39

The following table summarizes the cumulative effect on net income attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2013 under the rollover method. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2013 but had no net impact on the full year fiscal 2013 results:

	Fiscal 2013
	Quarter Ended
(Amounts in millions)	June 29, 2012			September 28, 2012			December 28, 2012			March 29, 2013			Total
NHS adjustments	$	—		$	(9	)	$	—		$	—		$	(9	)
Other adjustments	3			12			4			(4		)	15
Effect on income from continuing operations before taxes	3			3			4			(4		)	6
Taxes on income	(2		)	(1		)	(4		)	(1		)	(8		)
Other income tax adjustments	(2		)	—			(2		)	(1		)	(5		)
Effect on income from discontinued operations, net of taxes	—			—			(28		)	28			—
Effect on net income attributable to CSC common shareholders	$	(1	)	$	2		$	(30	)	$	22		$	(7	)

Out of period adjustments recorded in fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 29, 2013 under the rollover method:

	Twelve Months Ended March 29, 2013
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	14,993		14			$	15,007
Costs of services (excludes depreciation and amortization and restructuring costs)	11,851			6			11,857
Selling, general and administrative (excluding restructuring costs)	1,195			(1		)	1,194
Depreciation and amortization	1,076			(2		)	1,074
Restructuring costs	264			5			269
Interest expense	183			—			183
Other (income) expense	(34		)	—			(34		)
Income from continuing operations before taxes	480			6			486
Taxes on income	(35		)	13			(22		)
Income from continuing operations	515			(7		)	508
Income from discontinued operations, net of taxes	464			—			464
Net income attributable to CSC common shareholders	961			(7		)	954
EPS – Diluted
Continuing operations	$	3.20		$	(0.04	)	$	3.16
Discontinued operations	2.98			—			2.98
Total	$	6.18		$	(0.04	)	$	6.14

The out of period adjustments affecting income from continuing operations before taxes during the twelve months ended March 29, 2013 under the rollover method are related to the following consolidated balance sheet line items:

• Accounts receivable ($1 milliondecrease);

• Prepaid expenses and other current assets ($15 millionincrease);

• Outsourcing contract costs ($1 milliondecrease);

• Other assets ($6 milliondecrease);

• Property and equipment ($5 milliondecrease);

• Accrued payroll and related costs ($9 million increase);

• Accrued expenses and other current liabilities ($12 milliondecrease); and

• Deferred revenue ($13 millionincrease).

40

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2013 is immaterial to the consolidated results, financial position and cash flows for fiscal 2013 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2013.

Fiscal 2012 Adjustments Financial Impact Summary

As previously disclosed, during fiscal 2012, the Company recorded various pre-tax adjustments that should have been recorded in prior fiscal years. The aggregate fiscal 2012 adjustments increased the loss from continuing operations before taxes by $79 million ($63 million net of tax) and were comprised of $13 million of charges relating to operations in the Nordic region, $23 million of charges relating to the Company's operations in Australia, and $25 million of charges originating from the NHS contract in the Company's BSS segment. Additionally, $16 million and $2 million of charges were recorded in the NPS segment and other operations of the Company, respectively. The fiscal 2012 out of period adjustments primarily related to the Company’s MSS and BSS segments, with $37 million and $26 million of adjustments within MSS and BSS, respectively. Further adjustments were identified and recorded in fiscal 2013 related to fiscal 2012 that increased the net error by $7 million.

Nordic Region

The Company attributes the $13 million in pre-tax adjustments recorded in the Nordic region in fiscal 2012 to miscellaneous errors and not to any accounting irregularities or intentional misconduct other than a $1 million operating lease adjustment noted in the first quarter of fiscal 2012 which was a refinement of an error previously corrected and reported in fiscal 2011.

Australia

As previously disclosed, in the course of the Australia investigation initiated in fiscal 2012, accounting errors and irregularities were identified. As a result, certain personnel in Australia have been reprimanded, terminated and/or resigned. The Company attributes the $23 million of pre-tax adjustments recorded in fiscal 2012 to either intentional accounting irregularities (intentional irregularities) or other accounting errors (Other Errors). Other Errors include both unintentional errors and errors for which the categorization is unclear. The categorizations were provided to the Company through the independent investigation. The impact of the adjustments on income (loss) from continuing operations before taxes is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2008 & Prior (unaudited)			Fiscal 2009 (unaudited)			Fiscal 2010			Fiscal 2011			Total
Intentional irregularities	$	10		$	(7	)	$	(4	)	$	1		$	—
Other Errors	(7		)	(16		)	3			(3		)	(23		)
	$	3		$	(23	)	$	(1	)	$	(2	)	$	(23	)

NHS

As previously disclosed, in fiscal 2012, $25 million of out of period adjustments reducing income from continuing operations related to the Company's NHS contract were identified and recorded. During the course of the investigation in fiscal 2012 of the percentage-of-completion accounting method used on the Company's NHS contract, certain accounting errors were identified related to costs incurred under the contract, which resulted in errors in the recognition of income from continuing operations that would have reduced by approximately $24 million the $1.5 billion write-off recorded by the Company in the third quarter of fiscal 2012. Although the Company has concluded that these errors do not appear to have any impact on amounts charged to the NHS, the errors have impacted the operating income recognized on the NHS contract. The exclusion of certain costs incurred under the contract caused the estimated margin at completion, which determines the operating income that is booked when revenue milestones are achieved, to be overstated. Although the Company has concluded that there is no cumulative impact as a result of the $1.5 billion charge relating to the NHS contract recorded as of December 30, 2011, operating income from fiscal year 2007 through and including fiscal 2011 has been overstated by a total of approximately $24 million and, therefore, the charge taken by the Company as of December 30, 2011 was overstated by approximately the same amount.

41

Certain additional items had been identified related to the NHS contract that could have had an effect on the amount and the allocation of the out of period adjustments for fiscal 2012 and prior fiscal years. These additional items were subject to further investigation and therefore were not recorded in fiscal 2012. See our discussion of fiscal 2013 adjustments above for further information regarding the impact of such items.

Certain CSC finance employees based in the U. K. were aware prior to fiscal 2012 of the aforementioned errors, but those employees failed to appropriately correct the errors. Therefore, the Company has classified these errors as intentional. Such categorization was provided to the Company through the independent investigation. As a result, certain personnel have been suspended.

The impact on income (loss) from continuing operations before taxes of the $25 million of out of period adjustments identified in fiscal 2012 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2012 Adjustments
Fiscal 2012	$	25
Fiscal 2011	(7		)
Fiscal 2010	(4		)
Prior fiscal years (unaudited)	(14		)

NPS

As previously reported, in fiscal 2012 the Company identified and recorded pre-tax adjustments reducing income from continuing operations before taxes by $16 million. Such adjustments were identified by the Company and were primarily related to the percentage-of-completion accounting adjustments.

Americas Outsourcing

As previously disclosed, in the course of the independent investigation of Americas Outsourcing accounting practices, accounting conventions used by Americas Outsourcing relating to intraperiod cost allocations were determined to be unintentional accounting errors. The errors did not have an impact on a fiscal year basis. The Company also determined that other operating units employed similar practices and made necessary corrections.

The following table summarizes the cumulative effect on the fiscal 2012 net loss attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2012 and fiscal 2013 under the rollover method. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2012, but had no net impact on the full year fiscal 2012 results:

42

	Fiscal 2012
	Quarter Ended
(Amounts in millions)	July 1, 2011			September 30, 2011			December 30, 2011			March 30, 2012			Total
Operating costs inappropriately capitalized	$	1		$	—		$	—		$	—		$	1
Misapplication of US GAAP	1			(1		)	2			(1		)	1
Miscellaneous errors	2			7			—			2			11
Total Nordic adjustments	4			6			2			1			13
Operating costs inappropriately capitalized	—			11			—			—			11
Misapplication of US GAAP	—			8			—			1			9
Miscellaneous errors	—			2			2			(1		)	3
Total Australia adjustments	—			21			2			—			23
NHS adjustments	(2		)	(2		)	46			(7		)	35
NPS adjustments	3			1			(5		)	11			10
Other adjustments	2			(11		)	5			9			5
Effect on income (loss) from continuing operations before taxes	7			15			50			14			86
Taxes on income	(2		)	(3		)	(2		)	(4		)	(11		)
Other income tax adjustments	1			14			(10		)	(5		)	—
Effect on net income (loss) attributable to CSC common shareholders	$	6		$	26		$	38		$	5		$	75

Out of period adjustments recorded during fiscal 2012 and fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 30, 2012 under the rollover method:

	Twelve Months Ended March 30, 2012
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,364		$	56		$	15,420
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs)	13,019			(27		)	12,992
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	1,281			3			1,284
Selling, general and administrative (excludes restructuring costs)	1,128			2			1,130
Depreciation and amortization	1,147			(2		)	1,145
Restructuring costs	140			(5		)	135
Interest expense	175			(3		)	172
Other (income) expense	(6		)	2			(4		)
Loss from continuing operations before taxes	(4,454		)	86			(4,368		)
Taxes on income	(84		)	11			(73		)
Loss from continuing operations	(4,370		)	75			(4,295		)
Income from discontinued operations, net of taxes	145			—			145
Net loss attributable to CSC common shareholders	(4,242		)	75			(4,167		)
EPS – Diluted
Continuing operations	$	(28.31	)	$	0.48		$	(27.83	)
Discontinued operations	0.94						0.94
Total	$	(27.37	)	$	0.48		$	(26.89	)

43

The out of period adjustments affecting loss from continuing operations before taxes during the twelve months ended March 30, 2012 under the rollover method are related to the following consolidated balance sheet line items:

• Accounts receivable ($66 milliondecrease);

• Prepaid expenses and other current assets ($44 millionincrease);

• Other assets ($6 millionincrease);

• Property and equipment ($29 milliondecrease);

• Accrued payroll and related costs ($2 milliondecrease);

• Accrued expenses and other current liabilities ($46 millionincrease); and

• Deferred revenue ($3 milliondecrease).

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2012 and fiscal 2013 is immaterial to the consolidated results, financial position and cash flows for fiscal 2012 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2012 and fiscal 2013.

Fiscal 2011 Adjustments Financial Impact Summary

As previously reported, during fiscal 2011, the Company recorded $52 million of pre-tax adjustments that should have been recorded in prior fiscal years. The total out of period adjustments recorded in fiscal 2011 were comprised of $92 million of charges reducing income from continuing operations before taxes originating out of the Company’s MSS operations in the Nordic region, and $40 million of adjustments increasing income from continuing operations before taxes, with $36 million of the $40 million within MSS. Further adjustments were identified and recorded in fiscal 2012 and 2013 related to fiscal 2011 that reduced the net error by $29 million and $22 million, respectively.

Nordic Region

As noted above, during fiscal 2011, the Company commenced an investigation into accounting irregularities in the Nordic region. Based upon the Company's investigation, review of underlying documentation for certain transactions and balances, review of contract documentation and discussions with Nordic personnel, the Company attributes the majority of the $92 million of pre-tax adjustments recorded in the Nordic region in fiscal 2011 to accounting irregularities arising from suspected intentional misconduct by certain former employees in our Danish subsidiaries. These accounting irregularities included the inappropriate capitalization of operating costs, the misapplication of U.S. GAAP and miscellaneous errors.

The following table summarizes the cumulative effect on the fiscal 2011 net income attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2011, 2012 and 2013. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2011, but had no net impact on the full year fiscal 2011 results:

44

	Fiscal 2011
	Quarter Ended
(Amounts in millions)	July 2, 2010			October 1, 2010			December 31, 2010			April 1, 2011			Total
Operating costs inappropriately capitalized	$	15		$	38		$	8		$	6		$	67
Misapplication of US GAAP	4			3			6			(1		)	12
Miscellaneous errors	1			(1		)	9			(2		)	7
Total Nordic adjustments	20			40			23			3			86
Operating costs inappropriately capitalized	—			(1		)	(1		)	—			(2		)
Misapplication of US GAAP	—			1			3			(1		)	3
Miscellaneous errors	(4		)	5			(2		)	(3		)	(4		)
Total Australia adjustments	(4		)	5			—			(4		)	(3		)
NHS adjustments	(10		)	(2		)	(5		)	(5		)	(22		)
NPS adjustments	4			2			(10		)	(7		)	(11		)
Other adjustments	(9		)	(8		)	(18		)	(14		)	(49		)
Effect on income from continuing operations before taxes	1			37			(10		)	(27		)	1
Taxes on income	4			1			9			10			24
Other income tax adjustments	(1		)	(13		)	(6		)	18			(2		)
Effect on net income attributable to CSC common shareholders	$	4		$	25		$	(7	)	$	1		$	23

Out of period adjustments recorded during fiscal 2011, 2012 and 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended April 1, 2011 under the rollover method:

	Twelve Months Ended April 1, 2011
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,582		$	1		$	15,583
Costs of services (excludes depreciation and amortization)	12,578			(4		)	12,574
Selling, general and administrative	949			1			950
Depreciation and amortization	1,068			3			1,071
Interest expense	167			—			167
Other (income) expense	(21		)	—			(21		)
Income from continuing operations before taxes	878			1			879
Taxes on income	202			(22		)	180
Income from continuing operations	676			23			699
Income from discontinued operations, net of taxes	83			—			83
Net income attributable to CSC common shareholders	740			23			763
EPS – Diluted
Continuing operations	$	4.20		$	0.15		$	4.35
Discontinued operations	0.53			—			0.53
Total	$	4.73		$	0.15		$	4.88

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2013, 2012, and 2011 is immaterial to the consolidated results, financial position and cash flows for fiscal 2011 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2011.

Contract with the U.K. National Health Service

Reference is hereby made to CSC's Form 10-Q for the quarters ended September 28, 2012 and December 28, 2012 for previously disclosed information concerning CSC's contract with the NHS relating to an integrated electronic patient records system. Historical background is also presented below.

45

Interim Agreement Contract Change Note

On August 31, 2012, the Company and the NHS entered into a binding interim agreement which has been approved by all required U.K. government officials ("interim agreement contract change note" or "IACCN"). The IACCN, which is described in greater detail below, amended the terms of the parties' then current contract under which the Company has developed and deployed an integrated patient records system using the Company's Lorenzo Regional Care software product. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain financial terms of the IACCN. The IACCN, and such letter agreement, forms the basis on which the parties will subsequently finalize a full restatement of the contract through a revised project agreement. The revised project agreement will consolidate the three regional contracts which comprise the Company's NHS contract into a single agreement. CSC and the NHS are in the process of negotiating the revised project agreement.

Under the IACNN, the parties redefined the scope of the Lorenzo products and established deployment and ongoing service pricing. CSC will deliver additional Lorenzo implementations based on demand from individual NHS trusts. A more flexible arrangement than under the contract terms existing prior to the IACCN has been established for these trusts to combine additional clinical modules with the core care management functionality of the Lorenzo solution to meet their specific requirements. CSC and the NHS also agreed to a process for trusts which wish to take the Lorenzo products within the NHS-designated North, Midlands and East regions of England (NME) to obtain central funding from the U.K. Department of Health for implementation of the Lorenzo products. Separately, CSC may offer the Lorenzo solution throughout the rest of England where trusts select CSC's solutions through separate competitive processes. Under the IACCN, the NHS is no longer subject to trust volume commitments and CSC has agreed to non-exclusive deployment rights in its designated regions. New trusts taking deployments of the Lorenzo product will receive ongoing managed services from CSC for a period of five years from the date of Lorenzo deployment by such trust, provided deployment is complete or substantially complete by July 2016. Beyond its Lorenzo offerings, CSC continues to provide a wide range of other solutions and services to the NHS, including general practitioner, ambulance and community systems, digital imaging and other related services.

Pursuant to the letter agreement signed on March 28, 2013, the parties agreed to modify a small number of financial terms of the IACCN and the NHS confirmed it would make a change compensation payment in accordance with the terms of the IACCN. The NHS paid the change compensation payment of £10 million ($15 million) net of value added tax to CSC on March 28, 2013 in full and final satisfaction of all costs and claims by CSC arising from changes to Lorenzo that CSC delivered up to a certain version of the product, in addition to a small number of other changes.

Historical Background Concerning NHS Contract

The Company and the NHS are parties to a contract (originally having a value of £2.9 billion or approximately $5.4 billion at originally announced exchange rates) under which the Company has developed and deployed an integrated electronic patient records system. The NHS contract was amended in April 2009 and the parties entered into variation agreements subsequent to the 2009 amendment agreeing to various operational terms and conditions. The 2009 amendment included mutual releases of all claims existing at the time of the amendment.

In 2010, as part of the U.K. government's austerity program and to address delays in development and deployments, the Company and the NHS discussed modification of the contract scope in order to reduce the total contract value by £500 million. During the fourth quarter of fiscal year 2011, additional scope modification and total contract value reduction were discussed, bringing the combined total contract value reductions to £764 million, which would have reduced the total contract value to approximately £2.1 billion or $3.2 billion (at the March 29, 2013 exchange rate). Terms related to this scope modification and contract value reduction were included in a negotiated but unsigned non-binding memorandum of understanding (MOU), which MOU included a legally binding standstill agreement which provided that, while the parties were negotiating a contract amendment to implement the terms of the MOU, neither party would pursue any claims against the other party. Negotiation of the terms of the MOU was confirmed by the NHS to be substantially completed in May 2011, but CSC was subsequently informed by the NHS in December 2011 that neither the MOU nor the related contract amendment then under discussion would be approved by the U.K. government.

Based on subsequent discussions between CSC and the NHS regarding proposals advanced by both parties reflecting significant scope modifications, a reduced commitment by the NHS for deployment of the Lorenzo software product, revised delivery and payment terms, payments by the NHS for CSC-incurred costs and commitment and contract value reductions that differed materially from those contemplated by the MOU, on March 2, 2012, CSC and the NHS entered

46

into a non-binding letter of intent that included the statement of principles that would serve as the basis for an interim agreement between the parties. The letter of intent contemplated that under the interim agreement, the NHS would provide a commitment of a certain number of trusts to receive the Lorenzo software product, and the Lorenzo product was redefined into deployment units categorized as "Base Product" and "Additional Product" (in each case, as described below) for pricing purposes. The letter of intent also included a standstill agreement related to the Lorenzo product. While the parties originally intended to conclude a binding interim agreement by June 29, 2012, no agreement was reached by that date. On May 31, 2012, the standstill agreement was extended to August 31, 2012. On August 31, 2012, the parties entered into the IACCN. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain financial terms of the IACNN.

Principal Components of IACCN

The IACCN sets the terms relating to the delivery of the Lorenzo product and associated services as described below.

The key terms introduced by the IACCN are as follows:

1. Under contract terms existing prior to the IACCN, the NHS was committed to purchase the Lorenzo product for multiple trusts. In addition, the Company was the exclusive supplier of such software products and related services to two out of the three regions of the U.K. covered by the existing contract. Under the IACCN, the NHS is no longer subject to any trust volume commitment for the Lorenzo product (there were no changes in quantities for non-Lorenzo deployments), and the Company agreed to non-exclusive deployment rights for all products and services in those regions in which it previously enjoyed exclusivity. As a result, the individual trusts can choose third-party software vendors other than CSC to provide a software solution. CSC and the NHS have also agreed to a process for trusts which wish to take the Lorenzo products within the NME regions to obtain central funding from the U.K. Department of Health for implementation of the Lorenzo products. In addition, CSC may offer the Lorenzo solution throughout the rest of England where trusts select CSC's solutions through a separate competitive process.

2. The IACCN creates pricing and payment terms for the Lorenzo product and new terms under which trusts in the contract's NME region that choose the Lorenzo product can access central funds for its deployment, subject to business case justification. While the funding is provided by the NHS, there is a far greater degree of interaction with the trusts under the IACCN, as the Company works with each individual trust to build a business case and seek NHS approval and central funding to proceed.

3. The IACCN has not materially altered the terms relating to non-Lorenzo products. The Company will continue to provide non-Lorenzo deployment, hosting and maintenance services in accordance with contract terms in existence prior to the IACCN. The deployment of the non-Lorenzo products is expected to be completed or substantially completed by fiscal 2015.

4. Under the IACCN, the Lorenzo product is redefined for pricing purposes, with Lorenzo Regional Care comprising the "Base Product," consisting of seven deployment units (or modules) and the "Additional Product," consisting of three other modules. The parties agreed that six of the Base Product's modules had completed the necessary NHS assurances and were ready to deploy to further trusts as of August 31, 2012. The remaining module of the Base Product was similarly accepted by the NHS as complete and ready to deploy to further trusts in early September 2012. The Additional Product's three modules are expected to complete NHS assurance during 2013. Although the NHS assurance of the Base Product's seven modules is complete and the Company and the NHS are committed to complete the assurance of the Additional Product modules, neither the NHS nor any trust is obligated to purchase or deploy any of those modules.

5. New trusts taking deployments of the Lorenzo product will receive ongoing managed services from the Company for a period of five years from the date such deployment is complete, provided deployment is complete or substantially complete by July 7, 2016. The services include hosting of the software and trust data at the Company's data center as well as support and maintenance, including regulatory updates and other changes over the term of the contract. Under contract terms existing prior to the IACCN, all services were to expire upon the end of the contract term of July 7, 2016, subject to an optional one year extension and an exit transition period.

47

Accounting

Prior to the IACCN, the NHS contract has been accounted for using the percentage-of-completion method based on management's best estimates of total contract revenue and costs. Based on then existing circumstances, CSC revised its estimate of revenues and costs at completion during the third quarter of fiscal 2012 to include only those revenues reasonably assured of collection. As a result of that change, the Company recorded a $1.5 billion contract charge in that quarter, resulting in no material remaining net assets.

The terms of the IACCN represent a significant modification to the prior agreement, including a significant reduction in additional product development and elimination of any commitment by the NHS to future Lorenzo deployments and the Company's exclusivity rights in two of the three contract regions. The Company concluded that it will account for the IACCN as a new contract and will recognize revenue as a services arrangement. Revenue recognition for each trust deployment will begin at the start of the trust's hosting period. Payments from the NHS for deployment of systems will be deferred and recognized over the service period. Direct costs incurred for deployment activities will be deferred and amortized to expense over the service period as well. The total up-front consideration of £78 million ($126 million), including the £68 million ($110 million) net settlement payment and a £10 million ($16 million) escrow release, is primarily attributed to future Lorenzo deployments and will be deferred and recognized as revenue ratably over the term of the contract ending July 2016.

The £10 million ($15 million) payment received on March 28, 2013, as well as future consideration not noted above, when and if earned, will be deferred and amortized over the longer of the term of the contract or the estimated performance period.

Financial Condition

Cash Flows

Amounts in millions	Fiscal 2013			Fiscal 2012			Fiscal 2011
Net cash from operations	$	1,119		$	1,176		$	1,564
Net cash provided by (used in) investing	456			(1,308		)	(892		)
Net cash used in from financing	(589		)	(581		)	(1,676		)
Effect of exchange rate changes on cash and cash equivalents	(25		)	(31		)	57
Net increase (decrease) in cash and cash equivalents	961			(744		)	(947		)
Cash and cash equivalents at beginning of year	1,093			1,837			2,784
Cash and cash equivalents at end of year	$	2,054		$	1,093		$	1,837

Operating Cash Flow

Net cash provided by operating activities for fiscal 2013 of $1,119 million decreased $57 million as compared to fiscal 2012. The decrease was primarily due to higher pension plan funding of $500 million, restructuring payments of $166 million, and non-recurrence of cash inflow of $277 million received in the third quarter of fiscal 2012 in connection with settlement of claims with the U.S. government. These decreases were partially offset by a year-over-year favorable impact of $450 million associated with the NHS contract as described below, lower payroll-related payments of $340 million reflecting lower headcount, and higher cash collections from customers.

The year-over-year favorable cash impact associated with the NHS contract in fiscal 2013 was due to the second quarter receipt of $185 million, $110 million in relation to the settlement agreement (see Note 18 to the Consolidated Financial Statements) and $75 million primarily related to the achievement of a milestone during the first quarter, and non-recurrence of the fiscal 2012 repayment to the NHS of $265 million.

For fiscal 2012, net cash from operating activities of $1,176 million decreased $388 million as compared to fiscal 2011. The decrease is primarily due to higher payroll and related costs primarily due to the fiscal 2012 acquisitions and repayment of NHS advance contract payments (see Note 18 to the Consolidated Financial Statements), partially offset by receipt of cash upon settlement of claims with the U.S. government (see Note 19 to the Consolidated Financial Statements) and reduced cash taxes.

48

Investing Cash Flow

Net cash provided by investing activities for fiscal 2013 of $456 million increased $1,764 million compared to fiscal 2012. The increase is primarily due to net proceeds of $1,108 million from the fiscal 2013 divestitures (see Note 3 to the Consolidated Financial Statements), less net cash used for purchase of property and equipment and software and payment of outsourcing costs of $324 million, and less cash used for acquisitions of $340 million.

Net cash used in investing activities for fiscal 2012 of $1.3 billion increased $416 million compared to fiscal 2011. The increase is primarily due to an increase in payments for business acquisitions of $216 million, and higher expenditures on software of $63 million. These increases were partially offset by lower purchases of property and equipment of $94 million, lower proceeds from the sale of property and equipment of $94 million, and lower proceeds from two divestitures of $117 million in fiscal 2011, which did not recur in fiscal 2012.

Financing Cash Flow

Net cash used in financing activities in fiscal 2013 was $589 million, an increase of $8 million from fiscal 2012. The increase was primarily due to share repurchases of $283 million, higher payments to non-controlling interests of $12 million, and higher debt issuance costs of $8 million, partially offset by higher net proceeds from borrowings of $263 million and higher proceeds from stock options of $40 million. The higher net proceeds from borrowings comprised proceeds from the issuance of new long-term debt of $1,065 million, partially offset by net repayments on borrowings of $802 million.

Net cash used in financing activities in fiscal 2012 was $581 million, a decrease of $1,095 million from fiscal 2011. This decrease was primarily due to repayment of $1.5 billion related to a credit facility in the third quarter of fiscal 2011, partially offset by higher repayments on capital leases and other long-term debt.

Liquidity and Capital Resources

Cash and cash equivalents were $2,054 million at March 29, 2013 and $1,093 million at March 30, 2012. Of the total cash at March 29, 2013, $1,120 million was held outside of the U.S. It is generally management's intent to permanently reinvest earnings of its foreign operations. However, if these funds are needed for our U.S. operations, the Company can repatriate a substantial amount of cash to the U.S. through settlement of inter-company loans in a tax efficient manner. Should the Company determine to repatriate cash as dividends, it would be required to accrue and pay additional U.S. taxes. The cash held outside of the U.S. can be used to fund acquisitions, such as the fiscal 2012 acquisitions of iSOFT and AppLabs.

At the end of fiscal 2013, CSC’s ratio of debt to total capitalization was 46.4%, a decrease from 49.2% at the end of fiscal 2012. The decrease in the debt to total capitalization ratio was primarily the result of an increase in total equity associated with the fiscal 2013 net income of $979 million. The following table summarizes the Company’s debt to total capitalization ratios as of fiscal year end 2013 and 2012:

Amount in millions	March 29, 2013			March 30, 2012
Debt	$	2,732		$	2,740
Equity	3,160			2,834
Total capitalization	$	5,892		$	5,574
Debt to total capitalization	46.4		%	49.2		%

At March 29, 2013, the Company had $234 million of short-term borrowings and current maturities of long-term debt, and $2,498 million of long-term debt. There were no borrowings outstanding against the Company's commercial paper program and no amounts were drawn under the Company's committed revolving credit facility (see Note 11 to the Consolidated Financial Statements).

During the second quarter of fiscal 2013, the Company raised $700 million from the issuance of $350 million 2.50% Senior Notes and of $350 million 4.45% Senior Notes, and drew down $250 million against its new term loan credit facility. In the third quarter, the proceeds from new borrowings, plus available cash, were used to fund the early redemption of

49

$700 million 5.50% term notes due March 2013 and of $300 million 5.00% term notes due February 2013. The early redemption of $1 billion of term notes resulted in a $19 million loss that was charged to interest expense.

The Company's committed revolving line of credit of $1.5 billion serves as liquidity support for the Company's commercial paper program. Both the revolving credit facility and the term loan credit facility require the Company to maintain certain financial covenants and the Company was in compliance with these requirements as of March 29, 2013.

During the fourth quarter, the Company raised $125 million through a structured finance arrangement by selling its interest in the security instruments of a consolidated subsidiary. In this negotiated arrangement, the Company sold its interest in a British pound note receivable and mandatorily redeemable preferred stock of a consolidated subsidiary to a financial institution. The Company's interest in the note receivable due 2018 and its interest in the 3.48% mandatorily redeemable preferred stock due 2023, were sold for total cash consideration of £41 million ($62 million as of March 29, 2013) and $63 million, respectively.

During fiscal 2013, the Company divested four non-core businesses and received net proceeds of $1,108 million. The Company used the proceeds from these divestitures to incrementally fund its U.S. and Canadian pension plan trusts by $500 million, repurchase common shares as described below, and fund its restructuring program. Although the divestitures will cause a reduction of future cash flows, any shortfalls are expected to be partially offset by the benefits to be realized from the Company's ongoing restructuring program.

On December 13, 2010, CSC's Board of Directors approved a share repurchase program authorizing up to $1.0 billion in share repurchases of the Company's outstanding common stock (2011 Repurchase Program). The timing, volume, and nature of future share repurchases will be at the discretion of management, and may be suspended or discontinued at any time. CSC's Board of Directors has not established an end date for the 2011 Repurchase Program. During fiscal 2013, the Company repurchased 6.7 million shares of its common stock at an aggregate cost of $305 million in open market purchases, of which $283 million was paid in cash and the remainder accrued.

In fiscal 2013, the Company continued paying quarterly cash dividends to its common stockholders. During the year, cash dividends of $0.80 per share, or approximately $124 million, were paid out. The Company has sufficient liquidity and expects to continue paying quarterly cash dividends although such payments are subject to continued approval by the Board of Directors.

Liquidity Risk

The Company’s total liquidity comprises cash and cash equivalents plus borrowing available under its credit facility. As of March 29, 2013, the Company’s total liquidity was approximately $3.6 billion, consisting of $2.1 billion of cash and the full $1.5 billion available under the 2015 credit facility. In the opinion of management, CSC will be able to meet its liquidity and cash needs for the foreseeable future through the combination of cash flows from operating activities, available cash balances, and from available borrowings under the Company's undrawn credit facilities. If these resources need to be augmented, additional cash requirements would likely be financed by the issuance of debt and/or equity securities. However, there can be no assurances that the Company will be able to issue additional debt or equity with acceptable terms in the future.

As noted above, the Company holds $1,120 million of cash outside of the U.S. Should the Company repatriate any portion of this cash as dividends, it would be required to accrue and pay additional U.S. taxes.

The Company's exposure to operational liquidity is primarily from long-term contracts which require significant investment of cash flows from operating activities during the initial phases of the contracts. The recovery of these investments is over the life of the contract and is dependent upon the Company's performance as well as customer acceptance. Continued uncertainty in global economic conditions may also affect the Company's business as customers and suppliers may decide to downsize, defer or cancel contracts which could negatively affect operating cash flows.

The three major rating agencies that rate the Company's debt took ratings actions during the first quarter of fiscal 2013. On May 17, 2012, Moody's lowered the Company's long-term credit rating from Baa1 with a negative watch to Baa2 with a stable outlook. Moody's confirmed its short-term rating at P-2. On May 22, 2012, S&P and Fitch lowered the credit rating to BBB with a negative outlook and a short-term rating of A-2 and F-3 respectively. Each of S&P and Fitch subsequently

50

took rating actions during the fourth quarter of fiscal 2013, and raised the outlook assessment on the Company to “stable” without changing their underlying ratings, on March 5, 2013 and March 8, 2013, respectively.

The most recent ratings and outlooks issued by Moody's, S&P and Fitch are described in the table below:

Rating Agency	Rating	Outlook	Short Term Ratings
Fitch	BBB	Stable	F-3
Moody's	Baa2	Stable	P-2
S&P	BBB	Stable	A-2

Credit rating agencies review their ratings periodically and, therefore, the credit rating assigned to us by each agency may be subject to revision at any time. Accordingly, we are not able to predict whether our current credit ratings will remain as disclosed above. Factors that can affect our credit ratings include changes in our operating performance, our financial position, outcome of ongoing litigation as well as regulatory action, such as the SEC investigation, and changes in our business strategy. If further changes in our credit ratings were to occur, they could impact, among other things, our future borrowing costs and access to capital markets.

Off Balance Sheet Arrangements

As of March 29, 2013, the Company did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues, or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Contractual Obligations

The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of March 29, 2013:

(Amounts in millions)	Fiscal 2014		Fiscal 2015		Fiscal 2016 & thereafter		Total
Surety bonds	$	29	$	1	$	—	$	30
Letters of credit	58		1		33		92
Stand-by letters of credit	37		132		14		183
Total	$	124	$	134	$	47	$	305

The following table summarizes the Company’s future payments, excluding the effects of time value, on contractual obligations by period as of March 29, 2013:

(Amounts in millions)	1 year or less		1-3 years		3-5 years		More than 5 years		Total
Debt (1)	$	52	$	452	$	1,258	$	409	$	2,171
Interest and preferred dividend payments (2) (3)	102		195		174		81		552
Capitalized lease liabilities	221		310		111		97		739
Operating leases	250		299		135		68		752
Minimum purchase obligations	478		293		14		—		785
Total	$	1,103	$	1,549	$	1,692	$	655	$	4,999

⁽¹⁾Includes scheduled principal payments and mandatory redemption of preferred stock of consolidated subsidiary. Excludes capitalized lease liabilities.

⁽²⁾Includes scheduled interest payments on long-term debt and scheduled dividend payments associated with the mandatorily redeemable cumulative preferred stock outstanding.

⁽³⁾Excludes the contingent dividends associated with the participation and variable appreciation premium features on the mandatorily redeemable preferred stock outstanding.

51

The liability related to unrecognized tax benefits has been excluded from the table because a reasonable estimate of the timing and amount of cash outflows from future tax settlements cannot be determined.

Regarding minimum purchase obligations included above, the Company has signed long-term purchase agreements with certain software, hardware, telecommunication and other service providers to obtain favorable pricing, committed service levels and terms for services necessary for the operation of business activities. The Company is contractually committed to purchase specified service minimums over remaining periods ranging generally from one to five years. If the Company does not meet the specified service minimums, the Company may have an obligation to pay the service provider a portion or the entire shortfall.

During fiscal 2014, the Company expects to make contributions of approximately $123 million to pension and $9 million to postretirement benefit plans. The Company has not quantified expected contributions beyond fiscal 2014 because it is not possible to predict future timing or direction of the capital markets, which can have a significant impact on future minimum funding obligations. During fiscal 2013, pension and other pension benefits contributions amounted to $754 million, an increase of $492 million from $262 million in fiscal 2012. Refer to the Critical Accounting Estimates section later in this MD&A and to Note 12 to the Consolidated Financial Statements for further discussion.

Dividends

During fiscal 2013, quarterly dividends declared aggregated to $0.80 per share or $123 million. Of the total dividends declared, $30 million was declared but unpaid at March 29, 2013, and was paid on April 15, 2013.

CRITICAL ACCOUNTING ESTIMATES

Our Consolidated Financial Statements have been prepared in accordance with GAAP. Our significant accounting policies are described in Note 1 to the Consolidated Financial Statements under “Summary of Significant Accounting Policies.” The preparation of Consolidated Financial Statements in accordance with GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, as well as the disclosure of contingent assets and liabilities. We base our estimates and judgments on historical experience and other factors believed to be reasonable under the circumstances. Many of the estimates made are for contract-specific issues. Changes to estimates or assumptions on a specific contract could result in a material adjustment to the Consolidated Financial Statements.

We have identified several critical accounting estimates. An accounting estimate is considered critical if both: (a) the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment involved, and (b) the impact of changes in the estimates and assumptions would have a material effect on the Consolidated Financial Statements. Our critical accounting estimates relate to: revenue recognition, cost estimation and recoverability on long-term, fixed-price contracts; revenue recognition on software license sales that require significant customization; capitalization of outsourcing contract costs and software development costs; estimates used to determine deferred income taxes; assumptions related to purchase accounting and goodwill; assumptions to determine retirement benefits costs and liabilities; and assumptions and estimates used to analyze contingencies and litigation. For all of these estimates, we caution that future events rarely develop exactly as forecast, and the best estimates routinely require adjustment.

Revenue recognition

The majority of our revenue is recognized based on objective criteria and does not require significant estimates that may change over time. However, some arrangements are subject to specific accounting guidance that may require significant estimates, including contracts subject to percentage-of-completion accounting, contracts that include multiple-element deliverables, and contracts subject to software accounting guidance.

Percentage-of-completion method

Certain software development projects, all long-term construction-type contracts, and certain contracts with the U.S. federal government require the use of estimates at completion in the application of the percentage-of-completion

52

accounting method, whereby the determination of revenues and costs on a contract through its completion can require significant judgment and estimation. Under this method, and subject to the effects of changes in estimates, we recognize revenue using an estimated margin at completion as contract milestones or other input or output-based measures are achieved. This can result in costs being deferred as work in process until contractual billing milestones are achieved. Alternatively, this can result in revenue recognized in advance of billing milestones if output-based or input-based measures are achieved. Contracts that require estimates at completion using the percentage-of-completion method accounted for approximately 18% of the Company's revenues.

The percentage-of-completion method requires estimates of revenues, costs and profits over the entire term of the contract, including estimates of resources and costs necessary to complete performance. The cost estimation process is based upon the professional knowledge and experience of our software and systems engineers, program managers and financial professionals. The Company follows this method because reasonably dependable estimates of the revenue and costs applicable to various elements of a contract can be made; however, some estimates are particularly difficult for activities involving state-of-the-art technologies such as system development projects. Key factors that are considered in estimating the work to be completed and ultimate contract profitability include the availability and productivity of labor, the nature and complexity of the work to be performed, results of testing procedures, and progress toward completion. Management regularly reviews project profitability and the underlying estimates. A significant change in an estimate on one or more contracts could have a material effect on our results of operations. Revisions in profit estimates are reflected in the period in which the facts that give rise to the revision become evident.

Modifications to contract scope, schedule, and price may be required on contracts accounted for on a percentage-of-completion basis. Accounting for such changes prior to formal contract modification requires evaluation of the characteristics and circumstances of the effort completed and assessment of probability of recovery. If recovery is deemed probable, we may, as appropriate, either defer the costs until the parties have agreed on the contract change or recognize the costs and related revenue as current period contract performance. We periodically negotiate such contract modifications.

Multiple-element arrangements

Many of our contracts call for us to provide a range of services or elements to our customers, which may include any combination of services, products or both. As a result, significant contract interpretation is sometimes required to determine the appropriate accounting, including whether the elements specified in a multiple-element arrangement should be treated as separate units of accounting for revenue recognition purposes, and, if so, how the total estimated revenue should be allocated among the elements and when to recognize revenue for each element. Allocation of total contract consideration to each element requires estimating the fair value or selling price of each element based on, as required, vendor specific objective evidence (VSOE), third party evidence (TPE) or management's best estimate of selling price (BESP) for the deliverables when VSOE or TPE are not available. VSOE is established for an element based on the price charged when the element is sold separately. TPE is established by considering our competitors' prices for comparable product and service offerings in the market in which we operate. When we conclude that comparable products or services are sold by competitors to similarly situated customers, we consult available information sources to arrive at TPE such as published list prices, quoted market prices, and industry reports. We establish BESP consistent with our existing pricing practices involving a cost-plus-reasonable-margin methodology, and comparison of the margins to margins realized on recent contracts for similar products or services in that market. Once the total estimated revenue has been allocated to the various contract elements, revenue for each element is recognized based on the relevant revenue recognition method for the services performed or elements delivered if the revenue recognition criteria have been met. Estimates of total revenue at contract inception often differ materially from actual revenue due to volume differences, changes in technology or other factors which may not be foreseen at inception.

Software sales

If significant customization is required in the delivery of a proprietary software product, and VSOE is available to support accounting for the software as a separate unit of account, the software is determined to be delivered as the customization services are performed and revenue is recognized in accordance with the percentage-of-completion method described above. Thus, cost and profit estimates are required over the life of the project, and changes in such estimates can have a material effect on results. Additionally, the Company's ability to establish and maintain VSOE of fair value depends on sufficient transaction volumes and sufficient consistent separate pricing of the undelivered elements. Changes in judgments on these assumptions and estimates could materially impact the timing of revenue recognition.

53

Capitalization of outsourcing contract costs

Certain costs incurred upon initiation of an outsourcing contract are deferred and amortized over the contract life. These costs consist of contract acquisition and transition/set-up costs, costs associated with installation of systems and processes, and amounts paid to clients in excess of the fair market value of assets acquired (i.e., premiums). Finance staff, working with program management, review costs to determine appropriateness for deferral in accordance with relevant accounting guidance.

Key estimates and assumptions that we must make include assessing the fair value of assets acquired from a customer in order to calculate the premium and projecting future cash flows in order to assess the recoverability of deferred costs. We utilize the experience and knowledge of our professional staff in program management, operations, procurement and finance areas, as well as third parties on occasion, to determine fair values of assets acquired. To assess recoverability, undiscounted estimated cash flows of the contract are projected over its remaining life and compared to contract related assets, including the unamortized deferred cost balance. Such estimates require judgment and assumptions, which are based upon the professional knowledge and experience of our personnel. Key factors that are considered in estimating the undiscounted cash flows include projected labor costs and productivity efficiencies. A significant change in an estimate or assumption on one or more contracts could have a material effect on our results of operations. Amortization of such premiums is recorded as a reduction of revenue.

Capitalization of software development costs

We capitalize certain costs incurred to develop commercial software products and to develop or purchase internal-use software. Significant estimates and assumptions include: determining the appropriate period over which to amortize the capitalized costs based on estimated useful lives, estimating the marketability of the commercial software products and related future revenues, and assessing the unamortized cost balances for impairment. For commercial software products, determining the appropriate amortization period is based on estimates of future revenues from sales of the products. We consider various factors to project marketability and future revenues, including an assessment of alternative solutions or products, current and historical demand for the product, and anticipated changes in technology that may make the product obsolete. For internal-use software, the appropriate amortization period is based on estimates of our ability to utilize the software on an ongoing basis. To assess the recoverability of capitalized software costs, we must estimate future revenue, costs and cash flows. Such estimates require assumptions about future cash inflows and outflows, and are based on the experience and knowledge of professional staff. A significant change in an estimate related to one or more software products could result in a material change to our results of operations.

Estimates used to determine income tax expense

We make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which principally arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. We also must analyze income tax reserves, as well as determine the likelihood of recoverability of deferred tax assets, and adjust any valuation allowances accordingly. Considerations with respect to the recoverability of deferred tax assets include the period of expiration of the tax asset, planned use of the tax asset, and historical and projected taxable income as well as tax liabilities for the tax jurisdiction to which the tax asset relates. Valuation allowances are evaluated periodically and will be subject to change in each future reporting period as a result of changes in one or more of these factors. The calculation of our tax liabilities also involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes uncertain tax positions in the financial statements when it is more likely than not the tax position will be sustained under examination.

54

Assumptions related to purchase accounting and goodwill

We account for acquisitions using the acquisition method of accounting. This method requires estimates to determine the fair values of assets and liabilities acquired, including judgment in identifying acquired intangible assets, such as customer-related intangibles, as well as assessments of the fair value of acquired assets such as property and equipment. Liabilities acquired can include litigation and other contingency reserves existing at the time of acquisition, and require judgment in ascertaining the related fair values. Independent appraisals may be used to assist in the determination of the fair value of certain assets and liabilities. Such appraisals are based on significant estimates provided by the Company, such as forecasted revenues or profits utilized in determining the fair value of contract-related acquired intangible assets or liabilities. Purchase accounting assessments consider many factors which are analyzed by Company representatives in the legal, finance, human resources, information systems, program management and other areas, as appropriate. Additional information obtained during the allocation period related to the acquisition date fair value of acquired assets and liabilities may result in changes to the recorded values of acquired assets and liabilities, resulting in an offsetting adjustment to the goodwill balance associated with the business acquired. Significant changes in assumptions and estimates subsequent to completing the allocation of the purchase price to the assets and liabilities acquired, as well as differences in actual and estimated results, could result in material impacts to earnings.

Goodwill is reviewed for impairment annually and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable in accordance with ASC 350 “Goodwill and Other Intangible Assets.” A significant amount of judgment is involved in determining if an event representing an indicator of impairment has occurred between annual test dates. Such indicators may include, among others: a significant decline in expected future cash flows; a sustained, significant decline in stock price and market capitalization; a significant adverse change in legal factors or in the business climate; unanticipated competition; the testing for recoverability of a significant asset group within a reporting unit; and reductions in revenue or profitability growth rates. Any adverse change in these factors could have a significant impact on the recoverability of goodwill.

The goodwill impairment test initially involves the assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is not more likely than not, then the subsequent two-step process is not required, although the Company has the option to bypass the initial qualitative assessment stage and proceed directly to perform a step one analysis. If the Company determines that it is more likely than not, then it proceeds with the subsequent two-step goodwill impairment testing process. The first step is to compare each reporting unit’s fair value to its carrying value. If the reporting unit’s fair value exceeds its carrying value, no further procedures are required. However, if a reporting unit’s fair value is less than its carrying value, an impairment of goodwill may exist, requiring a second step to measure the amount of impairment loss.  In this step, the reporting unit’s fair value is determined and is allocated to all of the assets and liabilities of the reporting unit, including any unrecognized intangible assets, to calculate the implied fair value of goodwill in the same manner as if the reporting unit was being acquired in a business acquisition. If the implied fair value of goodwill is less than the recorded goodwill, an impairment charge is recorded for the difference.

The Company estimates the fair value of each reporting unit using a combination of the income approach and the market approach. The income approach incorporates the use of a discounted cash flow method in which the estimated future cash flows and terminal values for each reporting unit are discounted to a present value using a discount rate. Cash flow projections are based on management's estimates of economic and market conditions which drive key assumptions of revenue growth rates, operating margins, capital expenditures and working capital requirements. The discount rate in turn is based on the specific risk characteristics of each reporting unit, the weighted average cost of capital and its underlying forecast. The market approach estimates fair value by applying performance metric multiples to the reporting unit's prior and expected operating performance. The multiples are derived from comparable publicly traded companies with similar operating and investment characteristics as the reporting unit. If the fair value of the reporting unit derived using the income approach is significantly different from the fair value estimate using the market approach, the Company reevaluates its assumptions used in the two models. The fair values determined by the market approach and income approach, as described above, are weighted to determine the fair value for each reporting unit. The weighted values assigned to each reporting unit are primarily driven by two factors: 1) the number of comparable publicly traded companies used in the market approach, and 2) the similarity of the operating and investment characteristics of the reporting units to the comparable publicly traded companies used in the market approach. 

In order to assess the reasonableness of the calculated reporting unit fair values, the Company also compares the sum of the reporting units’ fair values to its market capitalization (per share stock price multiplied by shares outstanding) and

55

calculates an implied control premium (the excess of the sum of the reporting units’ fair values over the market capitalization).  The Company evaluates the control premium by comparing it to control premiums of recent comparable transactions. If the implied control premium is not reasonable in light of these recent transactions, the Company will reevaluate its fair value estimates of the reporting units by adjusting the discount rates and/or other assumptions. As a result, when the price for CSC’s common stock is low, this reevaluation can result in lower estimated fair values of the reporting units.

Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates, operating margins, terminal growth rates, and capital expenditures, as well as discount rates. Estimates involve the assessment of labor and other direct costs on existing contracts, estimates of overhead costs and other indirect costs, and assessments of new business prospects and projected win rates. In addition, judgments and assumptions are required for allocating shared assets and liabilities to determine the carrying values of each reporting unit. Although we have consistently used the same methods in developing the assumptions and estimates underlying the fair value calculations, such estimates are uncertain and can vary from actual results.

Assumptions to determine retirement benefits costs and liabilities

We offer a number of pension and postretirement benefit and life insurance benefit plans. CSC utilizes actuarial methods required by ASC 715 "Compensation – Retirement Benefits" to account for pension and postretirement benefit plans, respectively. The actuarial methods require numerous assumptions to calculate the net periodic pension benefit expense and the related pension benefit obligation for our defined benefit pension and postretirement plans. Two of the most significant assumptions are the expected long-term rate of return on plan assets and discount rates. We consider current market conditions such as changes in interest rates, in determining discount rates. Changes in the related net periodic pension costs may occur in the future due to changes in these and other assumptions.

The expected long-term rate of return on plan assets should, over time, approximate the actual long-term returns on pension and postretirement plan assets. The assumption for the expected long-term rate of return on plan assets is selected by taking into account the asset mix of the plan and other factors. Please see Note 12 to the Consolidated Financial Statements for more details. The weighted-average of the expected long-term rate of return, for all pension plans, on plan assets utilized for the fiscal 2013 and 2012 pension plan valuations was 6.2% and 6.8%, respectively. Holding all other assumptions constant, a one-half percentage increase or decrease in each of the assumed rates of return on plan assets would have decreased the fiscal 2013 net periodic pension cost by approximately $24 million, or increased it by approximately $22 million, respectively.

An assumed discount rate is required to be used in each pension and postretirement plan actuarial valuation. The discount rate assumption reflects the market rate for high-quality, fixed income debt instruments based on the expected duration of the benefit payments for our pension and postretirement plans as of the annual measurement date and is subject to change each year. The weighted-average of the discount rates utilized for the fiscal 2013 net periodic pension cost was 4.7% compared to 5.5% used for fiscal 2012. Holding all other assumptions constant, a one-half percent increase or decrease in each of the assumed discount rates would have decreased the fiscal 2013 net periodic pension cost by approximately $10 million, or increased it by approximately $12 million, respectively. Some portion of the increase or decrease would be moderated by cost-reimbursable contracts.

The accounting guidance includes mechanisms that serve to limit the volatility in earnings which would otherwise result from recording changes in the value of plan assets and benefit obligations in the Consolidated Financial Statements in the periods in which such changes occur. For example, while the expected long-term rate of return on plan assets should, over time, approximate the actual long-term returns, differences between the expected and actual returns may occur in any given year. Such differences contribute to the deferred actuarial gains or losses which are then amortized into earnings over time. During fiscal 2013, the actual return on assets exceeded the expected return on assets, producing an actuarial gain. Additionally, asset values increased due to the $500 million of discretionary employer contributions made to the U.S. and Canadian pension plans (see Note 12 to the Consolidated Financial Statements). However, partially offsetting this actuarial gain was an actuarial loss increasing the projected benefit obligation of the Company's pension plans primarily due to the decline in discount rates. As a result, pension assets as a percentage of projected benefit obligations increased during the fiscal year.

56

Assumptions and estimates used to analyze contingencies and litigation

We are subject to various claims and contingencies associated with lawsuits, insurance, tax and other issues arising in the normal course of business. The Consolidated Financial Statements reflect the treatment of claims and contingencies based on management's view of the expected outcome. CSC consults with legal counsel on issues related to litigation and seeks input from other experts and advisors with respect to matters in the ordinary course of business. If the likelihood of an adverse outcome is probable and the amount is estimable, we accrue a liability in accordance with ASC 450 “Contingencies.” Significant changes in the estimates or assumptions used in assessing the likelihood of an adverse outcome could have a material effect on the consolidated financial results.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Interest Rates

The Company utilizes fixed-rate long-term debt obligations, short-term commercial paper and other borrowings subject to market risk from changes in interest rates. Sensitivity analysis is one technique used to measure the impact of changes in interest rates on the value of market-risk sensitive financial instruments. For the year ended March 29, 2013, a hypothetical 10% movement in interest rates would not have had a material impact on the Company’s consolidated results of operations or financial condition.

Foreign Currency

As a large global organization, the Company faces exposure to adverse movements in foreign currency exchange rates. In the ordinary course of business, the Company enters into certain contracts denominated in foreign currency. Potential foreign currency exposures arising from these contracts are analyzed during the contract bidding process. The Company generally manages these contracts by incurring costs in the same currency in which revenue is received, and any related short-term contract financing requirements are met by borrowing in the same currency. Thus, by generally matching revenues, costs and borrowings to the same currency, the Company is able to mitigate a portion of the foreign currency risk to earnings. However, as the Company has increased its use of offshore support in recent years, it has become more exposed to currency fluctuations.

The Company has policies and procedures to manage the exposure to fluctuations in foreign currency by using foreign currency forwards to hedge intercompany loans denominated in non-functional currencies and certain foreign currency assets and liabilities. For accounting purposes, these contracts do not qualify for hedge accounting and thus all changes in fair value are reported in net earnings as part of other (income) expense. The Company also uses foreign currency options to manage its exposure to economic risk caused by exchange rate fluctuations. These financial instruments are generally short term in nature with typical maturities of less than one year. They are used to offset existing foreign currency positions or as economic hedges and not for speculative or trading purposes.

During fiscal 2013, approximately 38% of the Company’s revenue was generated outside of the U.S. The Company uses a sensitivity analysis to assess the impact of movement in foreign currency exchange rates on revenue and earnings. For the year ended March 29, 2013, a hypothetical 10% increase or decrease in the value of the U.S. dollar against all currencies would have impacted revenue by approximately 4%, or $571 million, while a hypothetical 10% decrease in the value of the U.S. dollar against all currencies would increase revenue by 4%^, or $571 million. In the opinion of management, a substantial portion of this fluctuation would be offset by expenses incurred in local currency. As a result, a hypothetical 10% movement of the value of the U.S. dollar against all currencies in either direction would impact the Company’s earnings before interest and taxes by approximately $27 million for the year ended March 29, 2013. This amount would be offset, in part, from the impacts of local income taxes and local currency interest expense.

As of March 29, 2013, the Company had approximately $1,120 million of cash and cash equivalents outside of the U.S. The Company had no borrowings outstanding under committed lines of credit with foreign banks as of March 29, 2013, compared with $43 million outstanding as of March 30, 2012.

57

Item 8. Financial Statements and Supplementary Data

Index to Consolidated Financial Statements and Financial Statement Schedule

	Page
Report of Independent Registered Public Accounting Firm	59
Consolidated Balance Sheets as of March 29, 2013 and March 30, 2012	60
Consolidated Statements of Operations for the Twelve Months Ended March 29, 2013, March 30, 2012, and April 1, 2011	62
Consolidated Statements of Comprehensive Income (Loss) for the Twelve Months Ended March 29, 2013, March 30, 2012, and April 1, 2011	63
Consolidated Statements of Cash Flows for the Twelve Months Ended March 29, 2013, March 30, 2012, and April 1, 2011	64
Consolidated Statements of Changes in Equity for the Twelve Months Ended March 29, 2013, March 30, 2012, and April 1, 2011	65
Notes to Consolidated Financial Statements
Note 1–Summary of Significant Accounting Policies	66
Note 2–Investigations and Out of Period Adjustments	76
Note 3–Divestitures	84
Note 4–Acquisitions	86
Note 5–Receivables	89
Note 6–Fair Value	89
Note 7–Foreign Currency Derivative Instruments	91
Note 8–Intangible Assets	92
Note 9–Goodwill	93
Note 10–Income Taxes	96
Note 11–Debt	101
Note 12–Pension and Other Benefit Plans	104
Note 13–Stockholders' Equity	117
Note 14–Stock Incentive Plans	118
Note 15–Other (Income) Expense, Net	121
Note 16–Segment and Geographic Information	122
Note 17-Restructuring Costs	125
Note 18-Contract with the U.K. National Health Service	127
Note 19-Settlement of Claims with U.S. Government	130
Note 20–Commitments and Contingencies	131
Note 21–Subsequent Events	135
Selected Quarterly Financial Data (Unaudited)	136
Schedule
Schedule II, Valuation and Qualifying Accounts for the years ended March 29, 2013, March 30, 2012, and April 1, 2011	138
Schedules other than that listed above have been omitted since they are either not required, are not applicable, or the required information is shown in the Consolidated Financial Statements or related notes.

58

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Computer Sciences Corporation

Falls Church, Virginia

We have audited the accompanying consolidated balance sheets of Computer Sciences Corporation and subsidiaries (the "Company") as of March 29, 2013 and March 30, 2012, and the related consolidated statements of operations, comprehensive income (loss), cash flows, and changes in equity for each of the three fiscal years in the period ended March 29, 2013. Our audits also included the financial statement schedule listed in the Index at Item 15. These financial statements and financial statement schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on the financial statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Computer Sciences Corporation and subsidiaries as of March 29, 2013 and March 30, 2012, and the results of their operations and their cash flows for each of the three fiscal years in the period ended March 29, 2013, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company's internal control over financial reporting as of March 29, 2013, based on the criteria established in Internal Control -Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated May 15, 2013 expressed an unqualified opinion on the Company's internal control over financial reporting.

/s/ DELOITTE & TOUCHE LLP

McLean, Virginia

May 15, 2013

59

COMPUTER SCIENCES CORPORATION
CONSOLIDATED BALANCE SHEETS

(Amounts in millions)	March 29, 2013		March 30, 2012
Current assets:
Cash and cash equivalents	$	2,054	$	1,093
Receivables, net of allowance for doubtful accounts of $48 (2013) and $51 (2012)	3,199		3,257
Prepaid expenses and other current assets	420		533
Total current assets	5,673		4,883
Intangible and other assets:
Software, net of accumulated amortization of $1,523 (2013) and $1,481 (2012)	611		649
Outsourcing contract costs, net of accumulated amortization of $968 (2013) and $1,240 (2012)	505		562
Goodwill	1,516		1,752
Other assets	762		902
Total intangible and other assets	3,394		3,865
Property and equipment—at cost:
Land, buildings and leasehold improvements	1,228		1,267
Computers and related equipment	3,989		4,357
Furniture and other equipment	392		464
Construction in progress	42		56
	5,651		6,144
Less: accumulated depreciation and amortization	3,467		3,703
Property and equipment, net	2,184		2,441
Total Assets	$	11,251	$	11,189

(See Notes to Consolidated Financial Statements.)

60

COMPUTER SCIENCES CORPORATION
CONSOLIDATED BALANCE SHEETS (CONTINUED)

(Amounts in millions, except shares)	March 29, 2013			March 30, 2012
Current liabilities:
Short-term debt and current maturities of long-term debt	$	234		$	1,254
Accounts payable	373			478
Accrued payroll and related costs	653			789
Accrued expenses and other current liabilities	1,425			1,339
Deferred revenue and advance contract payments	630			619
Income taxes payable and deferred income taxes	34			57
Total current liabilities	3,349			4,536
Long-term debt, net of current maturities	2,498			1,486
Income tax liabilities and deferred income taxes	501			357
Other long-term liabilities	1,743			1,976
Commitments and contingencies
CSC stockholders’ equity:
Preferred stock par value $1 per share; authorized 1,000,000 shares; none issued
Common stock, par value $1 per share; authorized 750,000,000 shares; issued 158,984,279 (2013) and 163,719,508 (2012)	159			164
Additional paid-in capital	2,167			2,168
Earnings retained for use in business	2,564			1,930
Accumulated other comprehensive loss	(1,354		)	(1,093		)
Less: common stock in treasury, at cost, 8,819,517 (2013) and 8,518,540 (2012)	(401		)	(390		)
Total CSC stockholders’ equity	3,135			2,779
Noncontrolling interest in subsidiaries	25			55
Total Equity	3,160			2,834
Total Liabilities and Equity	$	11,251		$	11,189

(See Notes to Consolidated Financial Statements.)

61

COMPUTER SCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS

	Twelve Months Ended
(Amounts in millions, except per-share amounts)	March 29, 2013			March 30, 2012			April 1, 2011
Revenues	$	14,993		$	15,364		$	15,582
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs of $238 (2013) and $137 (2012))	11,851			13,019			12,578
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	—			1,281			—
Cost of services – settlement charge (excludes amount charged to revenue of $42)	—			227			—
Selling, general and administrative (excludes restructuring costs of $26 (2013) and $3 (2012))	1,195			1,128			949
Depreciation and amortization	1,076			1,147			1,068
Goodwill impairment	—			2,745			—
Restructuring costs	264			140			—
Interest expense	183			175			167
Interest income	(22		)	(38		)	(37		)
Other income, net	(34		)	(6		)	(21		)
Total costs and expenses	14,513			19,818			14,704
Income (loss) from continuing operations before taxes	480			(4,454		)	878
Taxes on income	(35		)	(84		)	202
Income (loss) from continuing operations	515			(4,370		)	676
Income from discontinued operations, net of taxes	464			145			83
Net income (loss)	979			(4,225		)	759
Less: Net income attributable to noncontrolling interest, net of tax	18			17			19
Net income (loss) attributable to CSC common stockholders	$	961		$	(4,242	)	$	740
Earnings (loss) per common share:
Basic:
Continuing operations	$	3.22		$	(28.31	)	$	4.25
Discontinued operations	3.00			0.94			0.54
	$	6.22		$	(27.37	)	$	4.79
Diluted:
Continuing operations	$	3.20		$	(28.31	)	$	4.20
Discontinued operations	2.98			0.94			0.53
	$	6.18		$	(27.37	)	$	4.73
Cash dividend per common share	$	0.80		$	0.80		$	0.70

(See Notes to Consolidated Financial Statements.)

62

COMPUTER SCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

			Twelve Months Ended
(Amounts in millions)			March 29, 2013			March 30, 2012			April 1, 2011
Net income (loss)			$	979		$	(4,225	)	$	759
Other comprehensive income (loss), net of taxes:
	Foreign currency translation adjustments, net of tax benefit (expense) of $12, $1 and $3 in fiscal 2013, 2012 and 2011		(83		)	(124		)	261
	Pension and other postretirement benefit plans, net of tax:
		Net actuarial (loss) / gain, net of tax benefit (expense) of $38, $150 and $(1) in fiscal 2013, 2012 and 2011	(260		)	(323		)	35
		Prior service (cost) /credit, net of tax (expense) benefit of $(8), $6 and $(19) in fiscal 2013, 2012 and 2011	19			(4		)	31
		Amortization of transition obligation, net of tax benefit (expense) of $0, $0 and $(2) in fiscal 2013, 2012 and 2011	1			2			2
		Amortization of prior service (credit) / cost, net of tax benefit (expense) of $0, $1 and $(1) in fiscal 2013, 2012 and 2011	(1		)	(2		)	2
		Amortization of net actuarial loss, net of tax (expense) of $(25), $(20) and $(19) in fiscal 2013, 2012 and 2011	58			45			38
		Foreign currency exchange rate changes, net of tax (expense) benefit of $(8), $(1) and $1 in fiscal 2013, 2012 and 2011	(14		)	3			(7		)
	Pension and other postretirement benefit plans, net of tax		(197		)	(279		)	101
Other comprehensive (loss) income, net of tax			(280		)	(403		)	362
Comprehensive income (loss)			699			(4,628		)	1,121
		Less: comprehensive (loss) income attributable to noncontrolling interest	(1		)	17			19
Comprehensive income (loss) attributable to CSC common stockholders			$	700		$	(4,645	)	$	1,102

(See Notes to Consolidated Financial Statements.)

63

COMPUTER SCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Cash flows from operating activities:
Net income (loss)	$	979		$	(4,225	)	$	759
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	1,134			1,212			1,140
Goodwill impairment	—			2,745			—
Specified contract charge	—			1,485			—
Settlement charge	—			269			—
Stock based compensation	49			36			56
Deferred taxes	101			(117		)	101
(Gain) loss on dispositions	(797		)	30			(74		)
Provision for losses on accounts receivable	18			18			7
Excess tax benefit from stock based compensation	(3		)	(2		)	(6		)
Unrealized foreign currency exchange gain	(37		)	(8		)	(9		)
Impairment losses and contract write-offs	9			156			23
Cash surrender value in excess of premiums paid	(10		)	(7		)	(6		)
Changes in assets and liabilities, net of effects of acquisitions and dispositions:
Decrease in receivables	55			232			170
Decrease (increase) in prepaid expenses and other current assets	22			(210		)	(116		)
Decrease in accounts payable and accrued expenses	(690		)	(67		)	(234		)
Increase (Decrease) in income taxes payable and income tax liability	50			(136		)	(45		)
Increase (Decrease) in advances contract payments and deferred revenue	270			(247		)	(204		)
Other operating activities, net	(31		)	12			2
Net cash provided by operating activities	1,119			1,176			1,564
Cash flows from investing activities:
Purchases of property and equipment	(395		)	(569		)	(663		)
Outsourcing contracts	(115		)	(179		)	(138		)
Acquisitions, net of cash acquired	(34		)	(374		)	(158		)
Business dispositions	1,108			2			119
Software purchased and developed	(162		)	(227		)	(164		)
Proceeds from sale of property and equipment	32			11			105
Other investing activities, net	22			28			7
Net cash provided by (used in) investing activities	456			(1,308		)	(892		)
Cash flows from financing activities:
Borrowings under lines of credit	128			140			105
Repayment of borrowings under lines of credit	(169		)	(120		)	(1,599		)
Borrowing on long-term debt	1,077			—			—
Principal payments on long-term debt	(1,238		)	(485		)	(92		)
Proceeds from stock options and other common stock transactions	55			15			73
Excess tax benefit from stock based compensation	3			2			6
Repurchase of common stock and acquisition of treasury stock	(283		)	—			(65		)
Dividend payments	(124		)	(124		)	(77		)
Other financing activities, net	(38		)	(9		)	(27		)
Net cash used in financing activities	(589		)	(581		)	(1,676		)
Effect of exchange rate changes on cash and cash equivalents	(25		)	(31		)	57
Net increase (decrease) in cash and cash equivalents	961			(744		)	(947		)
Cash and cash equivalents at beginning of year	1,093			1,837			2,784
Cash and cash equivalents at end of year	$	2,054		$	1,093		$	1,837

(See Notes to Consolidated Financial Statements.)

64

COMPUTER SCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Amounts in millions except shares in thousands)	Common Stock					Additional Paid-in Capital			Earnings Retained for Use in Business			Accumulated Other Comprehensive Loss			Common Stock in Treasury			Total CSC Equity			Non- Controlling Interest			Total Equity
	Shares		Amount
Balance at April 2, 2010	162,234		$	162		$	2,006		$	5,709		$	(1,052	)	$	(379	)	$	6,446		$	62		$	6,508
Net income									740									740			19			759
Other comprehensive income												362						362						362
Stock based compensation expense						56												56						56
Acquisition of treasury stock															(6		)	(6		)				(6		)
Repurchase of common stock	(1,353	)	(1		)	(19		)	(45		)							(65		)				(65		)
Stock option exercises and other common stock transactions	1,992		2			77												79						79
Cash dividends declared									(108		)							(108		)				(108		)
Noncontrolling interest distributions and other																		—			(25		)	(25		)
Balance at April 1, 2011	162,873		$	163		$	2,120		$	6,296		$	(690	)	$	(385	)	$	7,504		$	56		$	7,560
Net (loss) income									(4,242		)							(4,242		)	17			(4,225		)
Other comprehensive loss												(403		)				(403		)				(403		)
Stock based compensation expense						36												36						36
Acquisition of treasury stock															(5		)	(5		)				(5		)
Stock option exercises and other common stock transactions	847		1			12												13						13
Cash dividends declared									(124		)							(124		)				(124		)
Noncontrolling interest distributions and other																					(18		)	(18		)
Balance at March 30, 2012	163,720		$	164		$	2,168		1,930			$	(1,093	)	$	(390	)	$	2,779		$	55		$	2,834
Net income									961									961			18			979
Other comprehensive loss												(261		)				(261		)	(19		)	(280		)
Stock-based compensation expense						48												48						48
Acquisition of treasury stock															(11		)	(11		)				(11		)
Repurchase of common stock	(6,708	)	(7		)	(94		)	(204		)							(305		)				(305		)
Stock option exercises and other common stock transactions	1,972		2			45												47						47
Cash dividends declared									(123		)							(123		)				(123		)
Noncontrolling interest distributions and other																		—			(29		)	(29		)
Balance at March 29, 2013	158,984		$	159		$	2,167		$	2,564		$	(1,354	)	$	(401	)	$	3,135		$	25		$	3,160

(See Notes to Consolidated Financial Statements.)

65

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

The accompanying consolidated financial statements and notes are those of Computer Sciences Corporation, its subsidiaries, and those business entities in which the Company maintains a controlling interest, hereafter collectively referred to as “CSC” or “the Company.” Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are accounted for by the cost method. All intercompany transactions and balances have been eliminated.

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The Consolidated Statements of Operations, Consolidated Statements of Comprehensive Income, and related notes, for the fiscal years ended March 30, 2012 and April 1, 2011 have been recast from those presented in previously filed Forms 10-K and Form S-3 to reflect discontinued operations of three businesses sold in fiscal 2013 (see Note 3).

The Consolidated Balance Sheet for the year ended March 30, 2012 has not been recast to reflect the assets and liabilities divested as a result of sale of the three businesses. The Consolidated Statements of Cash Flows for all the fiscal years presented include both continuing and the discontinued operations.

For classification of certain assets and liabilities of our U.S. federal government contracts as current or long-term, we use the duration of the related contract as our operating cycle, which is generally longer than one year.

Use of Estimates

GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. These estimates are based on management’s best knowledge of historical experience, current events, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates. Amounts subject to significant judgment and estimates include, but are not limited to, contracts accounted for using the percentage-of-completion method, cash flows used in the evaluation of impairment of goodwill and other long-lived assets, intangible assets, certain deferred costs, collectability of receivables, reserves for uncertain tax benefits, valuation allowances on deferred tax assets, loss accruals for litigation, pension related liabilities, inputs used for computing stock-based compensation and the fair value of derivative instruments.

The Company's income (loss) from continuing operations, before taxes and noncontrolling interests, and diluted earnings per share (EPS) from continuing operations included the following adjustments due to changes in in estimated profitability on fixed price contracts accounted for under the percentage-of-completion method for the fiscal years presented:

	Twelve Months Ended
(Amounts in millions), except per share data	March 29, 2013			March 30, 2012			April 1, 2011
Gross favorable	$	143		$	58		$	53
Gross unfavorable (1)	(122		)	(289		)	(130		)
Total net adjustments, before taxes and noncontrolling interests (2)	$	21		$	(231	)	$	(77	)
Impact on diluted EPS from continuing operations	$	(0.10	)	$	(1.30	)	$	(0.42	)

⁽¹⁾ Fiscal 2012 does not include the contract charge related to the Company’s contract with the NHS of $1,485 million (see Note 18).

⁽²⁾  Quarterly changes in estimated profitability on the same fixed price contract are disclosed gross as either favorable or unfavorable.

66

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Revenue Recognition

The Company's primary service offerings are information technology (IT) outsourcing, and both IT and other professional services. Revenues are recognized when persuasive evidence of an arrangement exists, services or products have been provided to the client, the sales price is fixed or determinable, and collectability is reasonably assured. For non-software arrangements that include multiple-elements, revenue recognition involves the identification of separate units of accounting after consideration of combining and/or segmenting contracts and allocation of the arrangement consideration to the units of accounting on the basis of their relative selling price. Revenue under such contracts is recognized based upon the levels of services delivered in the periods in which they are provided. Upfront fees for the contract set-up activities are deferred and recognized ratably over the period of performance. Costs are expensed as incurred except for direct and incremental set-up costs that are capitalized and amortized over the life of the agreement (see Outsourcing Contract Costs below). See the section below regarding software transactions that include multiple elements.

The Company provides these services under time and materials, cost-reimbursable, unit-price and fixed-price contracts, the revenue for which is recognized in the following manner:

Time and materials contracts - Revenue is recorded at agreed-upon billing rates at the time services are provided.

Cost-reimbursable contracts - Revenue is recorded at the time costs are incurred and associated fees are recognized when probable and estimable by applying an estimated factor to costs as incurred, such factor being determined by the contract provisions and prior experience.

Unit-price contracts - Revenue is recognized on unit-price contracts based on unit metrics multiplied by the agreed upon contract unit price or when services are delivered.

Fixed-price contracts - For certain fixed-price contracts, revenue is recognized under the percentage-of-completion method as described below; these include certain software development projects, all long-term construction-type contracts, and certain fixed-price arrangements with the U.S. federal government. For other fixed-price contracts, revenue is recognized based on the proportion of the services delivered to date as a percentage of the total services to deliver over the contract term. If output or input measures are not available or cannot be reasonably estimated, revenues are recognized ratably over the contract term.

Under the percentage-of-completion method, progress towards completion is measured based on either achievement of specified contract milestones, costs incurred as a proportion of estimated total costs, or other measures of progress when available. Profit in a given period is reported at the estimated profit margin to be achieved on the overall contract. This method can result in the recognition of unbilled receivables, the deferral of costs as work in process, or deferral of profit on these contracts. Contracts that require estimates at completion using the percentage-of-completion method accounted for approximately 17.9% of the Company's revenues for fiscal 2013. Management regularly reviews project profitability and underlying estimates. Revisions to the estimates at completion are reflected in results of operations as a change in accounting estimate in the period in which the facts that give rise to the revision become known by management. Provisions for estimated losses at completion, if any, are recognized in the period in which the loss becomes evident. The provision includes estimated costs in excess of estimated revenue and any profit margin previously recognized.

Multiple-element software sales - For multiple-element arrangements that involve the sale of CSC proprietary software, post contract customer support, and other software-related services, vendor-specific objective evidence (VSOE) of fair value is required to allocate and recognize revenue for each element. VSOE of fair value is determined based on the price charged where each deliverable is sold separately. In situations where VSOE of fair value exists for all undelivered elements but not a delivered element (typically the software license element), the residual method is used to allocate revenue to the undelivered elements equal to their VSOE value with the remainder allocated to the delivered element. If significant customization is required, and VSOE is available to support accounting for the software as a separate unit of account, software revenue is recognized as the related software customization services are performed in accordance with the percentage-of-completion method described above. In situations where VSOE of fair value does not exist for all of the undelivered software-related elements, revenue is deferred until only one undelivered element remains and then recognized following the pattern of delivery of the final undelivered element.

67

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Depreciation and Amortization

The Company’s depreciation and amortization policies are as follows:

Property and Equipment:
Buildings	Up to 40 years
Computers and related equipment	3 to 5 years
Furniture and other equipment	2 to 15 years
Leasehold improvements	Shorter of lease term or useful life
Software	2 to 10 years
Outsourcing contract costs	Contract life, excluding option years
Customer related intangibles	Expected customer service life
Acquired contract related intangibles	Contract life and first contract renewal, where applicable

The cost of property and equipment, less applicable residual values, is depreciated using predominately the straight-line method. Depreciation commences when the specific asset is complete, installed and ready for normal use. Depreciation expense for fiscal years 2013, 2012, and 2011 was $715 million, $759 million, and $688 million, respectively.

Software and outsourcing contract costs are amortized using predominately the straight-line method. Acquired contract related and customer related intangible assets are amortized in proportion to the estimated undiscounted cash flows projected over the estimated life of the asset or on a straight-line basis if such cash flows cannot be reliably estimated.

Software Development Costs

The Company capitalizes costs incurred to develop commercial software products after technological feasibility has been established. Costs incurred to establish technological feasibility are charged to expense as incurred. Enhancements to software products are capitalized where such enhancements extend the life or significantly expand the marketability of the products. Amortization of capitalized software development costs is determined separately for each software product. Annual amortization expense is calculated based on the greater of (a) the ratio of current gross revenues for each product to the total of current anticipated future gross revenues for the product or (b) the straight-line method over the estimated economic life of the product.

Unamortized capitalized software costs associated with commercial software products are regularly evaluated for impairment on a product-by-product basis by a comparison of the unamortized balance to the product’s net realizable value. The net realizable value is the estimated future gross revenues from that product reduced by the related estimated future costs. When the unamortized balance exceeds the net realizable value, the unamortized balance is written down to the net realizable value and an impairment charge is recorded.

The Company capitalizes costs incurred to develop internal-use computer software. Internal and external costs incurred in connection with development of upgrades or enhancements that result in additional functionality are also capitalized. These capitalized costs are amortized on a straight-line basis over the estimated useful life of the software. Purchased software is capitalized and amortized over the estimated useful life of the software.

Outsourcing Contract Costs

Costs on outsourcing contracts, including costs incurred for bid and proposal activities, are generally expensed as incurred. However, certain costs incurred upon initiation of an outsourcing contract are deferred and expensed over the contract life. These costs represent incremental external costs or certain specific internal costs that are directly related to the contract acquisition or transition activities. Such capitalized costs can be separated into two principal categories: contract acquisition costs and transition/set-up costs. The primary types of costs that may be capitalized include labor and related fringe benefits, subcontractor costs, travel costs, and premiums on asset purchases.

68

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Premiums are amounts paid to customers in excess of the fair market value of assets acquired. Fixed assets acquired in connection with outsourcing transactions are capitalized at fair value and depreciated consistent with the fixed asset policies described above. Premiums paid are capitalized as outsourcing contract costs and amortized over the contract life. The amortization of outsourcing contract cost premiums is accounted for as a reduction in revenue. The second principal category of capitalized outsourcing costs is transition/set-up costs. Such costs are primarily associated with the installation of systems and processes and are amortized over the contract life.

In the event indications exist that an outsourcing contract cost balance related to a particular contract may be impaired, undiscounted estimated cash flows of the contract are projected over its remaining term and compared to the associated long-lived asset group including the unamortized outsourcing contract cost balance. If the projected cash flows are not adequate to recover the unamortized cost balance of the asset group, the balance would be adjusted based on the fair value of the long-lived assets group in the period such a determination is made. The primary indicator used to determine when impairment testing should be performed is when a contract is materially underperforming, or is expected to materially underperform in the future, as compared to the original bid model or subsequent annual budgets.

Terminations of outsourcing contracts, including transfer of assets either back to the customer or to another IT provider, prior to the end of their committed contract terms, are infrequent due to the complex transition of personnel, assets, methodologies, and processes involved with outsourcing transactions. In the event of an early termination, the Company and the customer, pursuant to certain contractual provisions, engage in discussions to determine the recovery of unamortized contract costs, lost profits, transfer of personnel, rights to implemented systems and processes, as well as other matters.

Stock-Based Compensation

The Company provides different forms of stock-based compensation to its employees and nonemployee directors. For awards settled in shares, the Company recognizes compensation expense based on the grant-date fair value net of estimated forfeitures. For awards settled in cash, the Company recognizes compensation expense based on the fair value at each reporting date net of estimated forfeitures. The Company recognized stock-based compensation expense for fiscal 2013, fiscal 2012, and fiscal 2011 as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Cost of services	$	22	$	15	$	12
Selling, general and administrative	27		21		44
Total	$	49	$	36	$	56
Total, net of tax	$	31	$	23	$	35

The Company’s overall stock-based compensation granting practice has not changed year-over-year,except that with fiscal 2012's long-term incentive program, service-based restricted stock units (RSUs) and performance-based RSUs represent a larger portion of total stock-based compensation awards than in the past.

The increase in fiscal 2013 stock-based compensation expense was primarily due to performance-based RSUs granted in fiscal 2013 that increased the expense by $15 million. This increase was partially offset by a $3 million reduction of expense as a result of adjustments for expected achievement of the specified performance criteria for performance-based RSUs granted in previous fiscal years. Fiscal 2012 stock-based compensation expense included a $12 million reduction to expense for expected achievement of the specified performance criteria for performance-based RSUs granted in previous fiscal years. There were no such adjustments in fiscal 2011.

The Company periodically evaluates its significant assumptions used in the fair value calculation. Beginning in fiscal 2011, the Company modified certain underlying assumptions in the fair value calculations, which did not have a material impact on the fair value calculations, as described below.

The Company uses the Black-Scholes-Merton model in determining the fair value of options granted. The expected term is calculated based on the Company’s historical experience with respect to its stock plan activity in combination with an

69

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

estimate of when vested and unexercised option shares will be exercised. The Company uses separate assumptions for the expected term of options granted based on two separate job tier classifications which had distinct historical exercise behavior. This resulted in separate fair value calculations by job tier. The risk-free interest rate is based on the zero coupon interest rate of U.S. government issued Treasury strips with a period commensurate with the expected term of the options. In determining the overall risk-free interest rate for fiscal 2013, a range of interest rates from 0.82% to 1.44% was applied depending on the expected life of the grant. The Company continued to base expected volatility on a blended approach using an equal weighting of implied volatility and historical volatility. However, beginning with the first quarter of fiscal 2011, the historical volatility calculation was based on the Company’s six-year and seven-year historical daily closing price, rather than the ten-year historical used in prior periods, in order to bring this factor more closely into alignment with the expected terms of the stock options. The range of volatility used for fiscal 2013 was 32% to 38%. The dividend yield assumption was added concurrent with the introduction of a cash dividend in fiscal 2011 and is based on the respective fiscal year dividend payouts. Forfeitures are estimated based on historical experience and adjustments are made annually to reflect actual forfeiture experience.

The weighted average grant date fair values of stock options granted during fiscal 2013, fiscal 2012, and fiscal 2011 were $7.37, $10.17, and $12.95 per share, respectively. In calculating the compensation expense for its stock incentive plans, the Company used the following weighted average assumptions:

	Fiscal Year
	2013		2012		2011
Risk-free interest rate	1.15	%	1.80	%	2.37	%
Expected volatility	36	%	31	%	28	%
Expected term (in years)	6.59		6.11		5.85
Dividend yield	2.86	%	1.79	%	1.17	%

During fiscal 2013, fiscal 2012, and fiscal 2011, the Company's actual tax benefit realized for tax deductions from exercising stock options was of $9 million, $7 million, and $11 million, respectively, and an excess tax benefit of $3 million, $2 million, and $6 million, respectively, related to all of its stock incentive plans.

Acquisition Accounting and Goodwill

Under acquisition accounting, the purchase price is allocated to the underlying tangible and intangible assets acquired and liabilities assumed based upon their respective fair market values, with the excess recorded as goodwill. Acquisition-related costs are expensed in the periods in which the costs are incurred, and the results of operations of acquired businesses are included in the Consolidated Financial Statements from the acquisition date.

The Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if circumstances change, of if an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount. A significant amount of judgment is involved in determining whether an event indicating impairment has occurred between annual testing dates. Such indicators may include: a significant decline in expected future cash flows; a significant adverse change in legal factors or in the business climate; unanticipated competition; the disposal of a significant component of a reporting unit; and the testing for recoverability of a significant asset group within a reporting unit.

The goodwill impairment test initially involves the assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is not more likely than not, then the subsequent two-step process is not required, although the Company has the option to bypass this initial qualitative assessment and proceed directly to step one of the two-step process. If the Company determines that it is more likely than not, then it proceeds with the subsequent two-step goodwill impairment testing process. The first step is to compare each reporting unit’s fair value to its carrying value. If the reporting unit’s fair value exceeds its carrying value, no further procedures are required. However, if a reporting unit’s fair value is less than its carrying value, an impairment of goodwill may exist, requiring a second step to measure the amount of impairment loss. In the second step, the reporting unit’s fair value is allocated to all of the assets and liabilities of the reporting unit, including any unrecognized intangible assets, in a hypothetical analysis to

70

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

calculate the implied fair value of goodwill in the same manner as if the reporting unit was being acquired in a business acquisition. If the implied fair value of goodwill is less than the recorded goodwill, an impairment charge is recorded in operations for the difference.

The Company estimates the fair value of each reporting unit using a combination of the income approach and the market approach. The income approach incorporates the use of a discounted cash flow method in which the estimated future cash flows and terminal values for each reporting unit are discounted to a present value using a discount rate. Cash flow projections are based on management's estimates of economic and market conditions, which drive key assumptions of revenue growth rates, operating margins, capital expenditures and working capital requirements. The discount rate in turn is based on the specific risk characteristics of each reporting unit, the weighted-average cost of capital and its underlying forecasts. The market approach estimates fair value by applying performance-metric multiples to the reporting unit's prior and expected operating performance. The multiples are derived from comparable publicly traded companies that have operating and investment characteristics similar to the reporting unit. If the fair value of the reporting unit derived using the income approach is significantly different from the fair value estimate using the market approach, the Company reevaluates its assumptions used in the two models. The fair values determined by the market approach and income approach, as described above, are weighted to determine the fair value for each reporting unit. The weighted values assigned to each reporting unit are driven by two primary factors: 1) the number of comparable publicly traded companies used in the market approach, and 2) the similarity of the operating and investment characteristics of the reporting units to the comparable publicly traded companies used in the market approach.

In order to assess the reasonableness of the calculated reporting unit fair values, the Company also compares the sum of all of its reporting units’ fair values to the Company's market capitalization (per-share stock price multiplied by the number of shares outstanding) and calculates an implied control premium (the excess of the sum of the reporting units’ fair values over the market capitalization). The Company evaluates the reasonableness of the control premium by comparing it to control premiums of recent comparable transactions. If the implied control premium is not reasonable in light of these recent transactions, the Company reevaluates its fair value estimates of the reporting units by adjusting the discount rates and/or other assumptions. As a result, when CSC’s stock price is low, this reevaluation can result in lower estimated fair values of the reporting units.

Fair Value

The Company uses the fair value measurement guidance to value certain of its assets and liabilities. Under this guidance, assets and liabilities are required to be valued based on assumptions used by a market participant, consistent with the following hierarchy of inputs:

Level 1—	Quoted prices unadjusted for identical assets or liabilities in an active market.
Level 2—	Inputs other than quoted prices that are observable, either directly or indirectly, for similar assets or liabilities.
Level 3—	Unobservable inputs that reflect the entity’s own assumptions which market participants would use in pricing the asset or liability.

The assets and liabilities which are valued using the fair value measurement guidance, on a recurring basis, include the Company’s money market funds and money market deposits, time deposits, short-term investments, pension assets, and foreign currency derivatives comprised of forward and option contracts. The fair value of the forward contracts is based on quoted prices for similar but not identical derivative financial instruments; as such, the inputs are considered Level 2 inputs. Option contracts are valued using inputs which are based on quoted pricing intervals from external valuation models, which do not involve management judgment and as such, these inputs are considered Level 2 inputs. Certain pension assets are valued using model based pricing methods that use observable market data; as such these inputs are considered Level 2 inputs. There were no significant assets or liabilities measured at fair value on a recurring basis using significant unobservable (Level 3) inputs.

Certain assets and liabilities are measured at fair value on a non-recurring basis. These include acquired assets and liabilities in a business combination, equity method investments, asset retirement obligations, long-lived assets and

71

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

goodwill, which are recognized at fair value to the extent that they are deemed to be impaired or are classified as long-lived assets held to be disposed of by sale. The fair value in these instances is determined using Level 3 inputs.

Receivables

Receivables consist of amounts billed and currently due from customers, amounts earned but unbilled (including contracts measured under the percentage-of-completion method of accounting), amounts retained by the customer until the completion of a specified contract, completion of U.S. federal government audit activities audit activities, negotiation of contract modification, and claims.

Allowances for uncollectible billed trade receivables are estimated based on a combination of write-off history, aging analysis and any specific known collectability issues. Unbilled amounts under contracts in progress that are recoverable do not have an allowance for credit losses. Adjustments to unbilled amounts under contracts in progress related to credit quality, should they occur, would be recorded as a reduction of revenue.

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or group of assets may not be recoverable. Recoverability of long-lived assets or groups of assets is assessed based on a comparison of the carrying amount to the estimated future net cash flows. If estimated future undiscounted net cash flows are less than the carrying amount, an expense is recorded in the amount, if any, required to reduce the carrying amount to fair value. Fair value is determined based on a discounted cash flow approach or, when available and appropriate, to comparable market values. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

Income Taxes

Accounting for income taxes requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities. The Company maintains valuation allowances when, based on the weight of available evidence, it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company takes into account such factors as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of realization of a deferred tax asset.

The Company recognizes uncertain tax positions in the financial statements when it is more likely than not that the tax position will be sustained upon examination. Uncertain tax positions are measured based on the probabilities that the uncertain tax position will be realized upon final settlement (see Note 10).

Cash and Cash Equivalents

The Company considers investments with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of time deposits, money market funds and money market deposit accounts with a number of institutions that have high credit ratings.

Cash Flows

Cash payments for interest on indebtedness and cash payments for taxes on income are as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Interest	$	186	$	177	$	173
Taxes on income, net of refunds	214		139		219

72

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Non-cash investing activities include the following:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Capital expenditures in accounts payable and accrued expenses	$	32	$	47	$	122
Capital expenditures through capital lease obligations	181		270		289
Assets acquired under long-term financing	26		32		115

Non-cash financing activities include common stock dividends of $30 million which are declared but not yet paid as of March 29, 2013.

Foreign Currency

The Company has determined that, generally, the local currency of its foreign affiliates is their functional currency. Accordingly, the assets and liabilities of the foreign affiliates are translated from their respective functional currency to U.S. dollars using year-end exchange rates, income and expense accounts are translated at the average rates in effect during the year, and equity accounts are translated at historical rates. The resulting translation adjustment is reported in the Statement of Other Comprehensive Income and recorded as part of accumulated other comprehensive income (AOCI). The amount of currency translation adjustment included in AOCI, for the years ended March 29, 2013, March 30, 2012 and April 1, 2011, was $(83) million(net of taxes of $12 million),$(124) million (net of taxes of $1 million) and $261 million (net of taxes of $3 million), respectively.

To manage the exposure to movements in foreign currency exchange rates, the Company uses foreign currency forward contracts and option contracts (see Note 7). The use of these derivative instruments is intended to offset, to the extent possible, the gains and losses from remeasurement of the Company’s foreign currency denominated monetary assets and liabilities. Gains and losses from remeasurement of the Company’s foreign currency denominated assets and liabilities, and remeasurement and settlement of the related foreign currency derivatives are recorded in Other (income) expense.

Earnings (Loss) Per Share

Basic earnings (loss) per common share (EPS) are computed using the weighted average number of common shares outstanding during the period. Diluted EPS reflect the incremental shares issuable upon the assumed exercise of stock options and equity awards.

73

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	Twelve Months Ended
(Amounts in millions, except per-share data)	March 29, 2013		March 30, 2012			April 1, 2011
Net income (loss) attributable to CSC common shareholders:
From continuing operations	$	497	$	(4,387	)	$	657
From discontinued operations	464		145			83
	$	961	$	(4,242	)	$	740
Common share information:
Weighted average common shares outstanding for basic EPS	$	154.590	$	155.012		$	154.488
Dilutive effect of stock options and equity awards	0.967		—			2.117
Shares for diluted earnings (loss) per share	$	155.557	$	155.012		$	156.605
Earnings (loss) per share – basic and diluted:
Basic EPS:
Continuing operations	$	3.22	$	(28.31	)	$	4.25
Discontinued operations	3.00		0.94			0.54
Total	$	6.22	$	(27.37	)	$	4.79
Diluted EPS:
Continuing operations	$	3.20	$	(28.31	)	$	4.20
Discontinued operations	2.98		0.94			0.53
Total	$	6.18	$	(27.37	)	$	4.73

The computation of diluted EPS does not include stock options which are antidilutive, as their exercise price exceeded the average market price of the Company’s common stock. The number of shares related to such stock options were 14,755,024, 17,592,316, and 9,431,834, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. In addition, the computation of diluted EPS for the year ended March 30, 2012, excluded options to purchase 442,228 shares of common stock and 1,064,959 RSUs whose effect, if included, would have been anti-dilutive due to the Company’s net loss.

New Accounting Standards

During fiscal year 2013, the Company adopted the following recent Accounting Standard Updates (ASUs):

On June 16, 2011, the FASB issued ASU 2011-05, “Presentation of Comprehensive Income,” which revises the manner in which entities present comprehensive income in their financial statements. The new guidance removes the presentation options in ASC 220 "Comprehensive Income" and requires entities to report components of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements. The Company adopted the amendments in this update effective at the beginning of fiscal 2013 using the two-statement approach.

On September 15, 2011, the FASB issued ASU 2011-08, “Testing Goodwill for Impairment,” which revises guidance on testing goodwill for impairment. The amendments in the ASU allow an entity the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines that it is not more likely than not, then performing the two-step impairment is unnecessary. However, if the entity concludes that fair value is more likely than not less than carrying value, then it is required to perform the first step of the two-step impairment test and calculate the fair value of the reporting unit to compare with the carrying value of the reporting unit as described in ASC 350-20-35-4. The entity may bypass the initial qualitative assessment for any reporting unit in any period and proceed directly to the first step of the two-step impairment test. The entity may resume performing the qualitative assessment in any subsequent period. The Company adopted the amendments in the update effective at the beginning of fiscal 2013 on a prospective basis, and they did not have a material effect on CSC's Consolidated Financial Statements.

74

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Standards Issued But Not Yet Effective

The following ASUs were recently issued but have not yet been adopted by CSC:

On December 16, 2011, the FASB issued ASU 2011-11, “Disclosures about Offsetting Assets and Liabilities,” which was subsequently amended on January 31, 2013 when the FASB issued ASU 2013-01 “Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities”. Together these Updates provide guidance on disclosure of information pertaining to the offsetting (netting) of assets and liabilities in the financial statements. The amendments in these ASUs affect all entities that have financial instruments and derivative instruments that are either (1) offset in accordance with either ASC 210-20-45 or ASC 815-10-45, or (2) subject to an enforceable master netting arrangement or similar agreement. ASU 2011-11 amends the existing disclosure requirements on offsetting in ASC 210-20-50 by requiring disclosures relating to gross amounts of recognized assets and liabilities, the amounts that are offset, net amounts presented in the balance sheet, and amounts subject to an enforceable master netting arrangement or similar agreement. The amendments in these updates become effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The adoption of the amendments of these updates is not expected to have a material effect on CSC's Consolidated Financial Statements.

On February6, 2013, the FASB issued ASU 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income”, which requires entities to report the effect of significant reclassifications out of AOCI on the respective line items in net income unless the amounts are not reclassified in their entirety to net income. For amounts that are not required to be reclassified in their entirety to net income in the same reporting period, entities are required to cross-reference other disclosures that provide additional detail about those amounts. The amendments are effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2012. The Company is currently evaluating the impact of the adoption of these amendments.

In February 2013, the FASB issued ASU No.2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date” which requires an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance in this ASU also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December15, 2013. CSC will be required to adopt the amendments in this ASU beginning in fiscal 2015. We are currently evaluating the impact that the adoption may have on CSC's Consolidated Financial Statements.

In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830): “Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” which resolves the diversity in practice about whether Subtopic 810-10, Consolidation - Overall, or Subtopic 830-30, Foreign Currency Matters - Translation of Financial Statements, applies to the release of the cumulative translation adjustment into net income when a parent either sells a part of or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. In addition, the amendments resolve the diversity in practice for the treatment of business combinations achieved in stages (i.e. step acquisitions) involving a foreign entity. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December15, 2013. CSC will be required to adopt the amendments in this ASU beginning in fiscal 2015. The adoption of the amendments of these updates is not expected to have a material effect on CSC's Consolidated Financial Statements.

75

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 2 – Investigations and Out of Period Adjustments

Summary of Audit Committee and SEC Investigations Related to the Out of Period Adjustments

As previously disclosed in fiscal 2012 and fiscal 2011, the Company initiated an investigation into out of period adjustments resulting from certain accounting errors in our Managed Services Sector (MSS) segment, primarily involving accounting irregularities in the Nordic region. Initially, the investigation was conducted by Company personnel, but outside Company counsel and forensic accountants retained by such counsel later assisted in the Company's investigation. On January 28, 2011, the Company was notified by the SEC's Division of Enforcement that it had commenced a formal civil investigation relating to these matters, which investigation has been expanded to other matters subsequently identified by the SEC, including matters specified in subpoenas issued to the Company from time to time by the SEC's Division of Enforcement as well as matters under investigation by the Audit Committee, as further described below. The Company is cooperating in the SEC's investigation.

On May 2, 2011, the Audit Committee commenced an independent investigation into the matters relating to the MSS segment and the Nordic region, matters identified by subpoenas issued by the SEC's Division of Enforcement, and certain other accounting matters identified by the Audit Committee and retained independent counsel to represent CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with such independent investigation. Independent counsel retained forensic accountants to assist with their work. Independent counsel also represents CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with the investigation by the SEC's Division of Enforcement.

The Audit Committee’s investigation was expanded to encompass (i) the Company’s operations in Australia, (ii) certain aspects of the Company’s accounting practices within its Americas Outsourcing operation, and (iii) certain of the Company’s accounting practices that involve the percentage-of-completion accounting method, including the Company’s contract with the U.K. National Health Service (NHS). In the course of the Audit Committee's expanded investigation, accounting errors and irregularities were identified. As a result, certain personnel have been reprimanded, suspended, terminated and/or have resigned. The Audit Committee determined in August 2012 that its independent investigation was complete. The Audit Committee instructed its independent counsel to cooperate with the SEC's Division of Enforcement by completing production of documents and providing any further information requested by the SEC's Division of Enforcement.

In addition to the matters noted above, the SEC's Division of Enforcement is continuing its investigation involving its concerns with certain of the Company's prior disclosure and accounting determinations with respect to the Company's contract with the NHS and the possible impact of such matters on the Company's financial statements for years prior to the Company's current fiscal year. The Company and the Audit Committee and its independent counsel are investigating these matters and are continuing to cooperate with the SEC's Division of Enforcement in its investigation of prior disclosures of the Company's contract with the NHS. The SEC's investigative activities are ongoing.

In addition, the SEC's Division of Corporation Finance has issued comment letters to the Company requesting, among other things, additional information regarding its previously disclosed adjustments in connection with the above-referenced accounting errors, the Company's conclusions relating to the materiality of such adjustments, and the Company's analysis of the effectiveness of its disclosure controls and procedures and its internal control over financial reporting. The SEC's Division of Corporation Finance's comment letter process is ongoing, and the Company is continuing to cooperate with that process.

The investigation being conducted by the SEC's Division of Enforcement and the review of our financial disclosures by the SEC's Division of Corporation Finance are continuing and could identify other accounting errors, irregularities or other areas of review. As a result, we have incurred and may continue to incur significant legal and accounting expenditures. We are unable to predict how long the SEC's Division of Enforcement's investigation will continue or whether, at the conclusion of its investigation, the SEC will seek to impose fines or take other actions against the Company. In addition, we are unable to predict the timing of the completion of the SEC's Division of Corporation Finance's review of our financial disclosures or the outcome of such review. Publicity surrounding the foregoing or any enforcement action as a result of the SEC's investigation, even if ultimately resolved favorably for us, could have an adverse impact on the Company's

76

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

reputation, business, financial condition, results of operations or cash flows. The Company is unable to estimate any possible loss or range of loss associated with these matters.

Out of Period Adjustments Financial Impact Summary

Cumulative Impact of Out of Period Adjustments

The rollover impact on income (loss) from continuing operations before taxes of the recorded out of period adjustments in fiscal 2013, 2012 and 2011 is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2011 Adjustments			Fiscal 2012 Adjustments			Fiscal 2013 Adjustments			Total Adjustments
Fiscal 2013	$	—		$	—		$	6		$	6
Fiscal 2012	—			79			7			86
Fiscal 2011	52			(29		)	(22		)	1
Fiscal 2010	(48		)	(9		)	14			(43		)
Prior fiscal years (unaudited)	(4		)	(41		)	(4		)	(49		)

See Note 16 for a summary of the effect of the pre-tax out of period adjustments on the Company's segment results for fiscal 2013, 2012 and 2011.

Fiscal 2013 Adjustments Financial Impact Summary

During fiscal 2013, the Company identified and recorded net adjustments decreasing income from continuing operations before taxes by $6 million that should have been recorded in prior fiscal years. This net impact on income from continuing operations before taxes for fiscal 2013 is comprised of the following:

• net adjustments decreasing fourth quarter pre-tax income by $9 million resulting primarily from the correction of inappropriately capitalized operating costs originating from MSS, a software revenue recognition correction originating from the Company's Business Solutions and Services (BSS) segment and the correction of understated payroll and related expenses at Corporate;

• net adjustments decreasing third quarter pre-tax income by $1 million primarily resulting from the correction of useful lives of property and equipment in service at a BSS contract that were inconsistent with established CSC accounting conventions;

• net adjustments increasing second quarter pre-tax income by $5 million primarily resulting from the correction of accounting errors identified by the Company related to costs incurred under the NHS contract (see below for more discussion of out of period adjustments related to the Company's NHS contract); and

• net adjustments decreasing first quarter pre-tax income by $1 million primarily resulting from the corrections of fiscal 2012 revenue recognized on a software contract in the Company's BSS segment, corrections of fiscal 2012 restructuring cost accruals originating primarily from the Company's BSS and MSS segments and corrections to record adjustments originating primarily from the Company's North American Public Sector (NPS) and MSS segments that were identified late in the close process but not included in the Company's consolidated fiscal 2012 financial statements

Adjustments recorded during fiscal 2013 that should have been recorded in prior fiscal years increased income from continuing operations by $7 million. This increase is attributable to the tax effect of the adjustments described above and $5 million of discrete tax benefits that should have been recorded in prior fiscal years. The discrete tax benefits are primarily attributable to the adjustment of the deferred tax liability related to intellectual property assets.

NHS

As previously disclosed in fiscal 2012 and in the first quarter of fiscal 2013, the Company had identified certain additional items related to the investigation of the Company's use of the percentage-of-completion accounting method used on the NHS contract. During the second quarter of fiscal 2013, based on its analysis of these items, the Company recorded net

77

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

credits of $9 million in pre-tax out of period adjustments impacting prior fiscal years. During the third quarter of fiscal 2013, the Company identified additional prior period errors. Such errors identified in the third quarter, which were self-correcting in the third quarter of fiscal 2012, have no impact on income from continuing operations before taxes for fiscal 2013. The accounting errors identified during fiscal 2013 are primarily related to either costs incurred under the contract or the estimation of contract revenues and costs at completion, which resulted in the overstatement of income from continuing operations before taxes. The Company has concluded that there is no cumulative impact of this overstatement as a result of the $1.5 billion specified contract charge recorded as of December 30, 2011 being overstated by the same amount.

The Company has concluded that the errors identified during fiscal 2013 do not appear to have any impact on amounts charged to the NHS. Based on information provided by independent counsel, the Company believes that a small portion of such adjustments should be characterized as intentional accounting irregularities. The impact on income (loss) from continuing operations before taxes of the out of period adjustments identified in fiscal 2013 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2013 Adjustments
Fiscal 2013	$	(9	)
Fiscal 2012	10
Fiscal 2011	(15		)
Fiscal 2010	18
Prior fiscal years (unaudited)	(4		)

The following table summarizes the cumulative effect on net income attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2013 under the rollover method. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2013, but had no net impact on the full year fiscal 2013 results:

	Fiscal 2013
	Quarter Ended
(Amounts in millions)	June 29, 2012			September 28, 2012			December 28, 2012			March 29, 2013			Total
NHS adjustments	$	—		$	(9	)	$	—		$	—		$	(9	)
Other adjustments	3			12			4			(4		)	15
Effect on income from continuing operations before taxes	3			3			4			(4		)	6
Taxes on income	(2		)	(1		)	(4		)	(1		)	(8		)
Other income tax adjustments	(2		)	—			(2		)	(1		)	(5		)
Effect on income from discontinued operations, net of taxes	—			—			(28		)	28			—
Effect on net income attributable to CSC common shareholders	$	(1	)	$	2		$	(30	)	$	22		$	(7	)

78

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Out of period adjustments recorded in fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 29, 2013 under the rollover method:

	Twelve Months Ended March 29, 2013
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	14,993		14			$	15,007
Costs of services (excludes depreciation and amortization and restructuring costs)	11,851			6			11,857
Selling, general and administrative (excluding restructuring costs)	1,195			(1		)	1,194
Depreciation and amortization	1,076			(2		)	1,074
Restructuring costs	264			5			269
Interest expense	183			—			183
Other (income) expense	(34		)	—			(34		)
Income from continuing operations before taxes	480			6			486
Taxes on income	(35		)	13			(22		)
Income from continuing operations	515			(7		)	508
Income from discontinued operations, net of taxes	464			—			464
Net income attributable to CSC common shareholders	961			(7		)	954
EPS – Diluted
Continuing operations	$	3.20		$	(0.04	)	$	3.16
Discontinued operations	2.98			—			2.98
Total	$	6.18		$	(0.04	)	$	6.14

The out of period adjustments affecting income from continuing operations before taxes during the twelve months ended March 29, 2013 under the rollover method are related to the following consolidated balance sheet line items:

• Accounts receivable ($1 milliondecrease);

• Prepaid expenses and other current assets ($15 millionincrease);

• Outsourcing contract costs ($1 milliondecrease);

• Other assets ($6 milliondecrease);

• Property and equipment ($5 milliondecrease);

• Accrued payroll and related costs ($9 millionincrease);

• Accrued expenses and other current liabilities ($12 milliondecrease); and

• Deferred revenue ($13 millionincrease).

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2013 is immaterial to the consolidated results, financial position and cash flows for fiscal 2013 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2013.

Fiscal 2012 Adjustments Financial Impact Summary

As previously disclosed, during fiscal 2012, the Company recorded various pre-tax adjustments that should have been recorded in prior fiscal years. The aggregate fiscal 2012 adjustments increased the loss from continuing operations before taxes by $79 million ($63 million net of tax) and were comprised of $13 million of charges relating to operations in the Nordic region, $23 million of charges relating to the Company's operations in Australia, and $25 million of charges originating from the NHS contract in the Company's BSS segment. Additionally, $16 million and $2 million of charges were recorded in the NPS segment and other operations of the Company, respectively. The fiscal 2012 out of period adjustments primarily related to the Company’s MSS and BSS segments, with $37 million and $26 million of adjustments within MSS and BSS, respectively. Further adjustments were identified and recorded in fiscal 2013 related to fiscal 2012 that increased the net error by $7 million.

79

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Nordic Region

The Company attributes the $13 million in pre-tax adjustments recorded in the Nordic region in fiscal 2012 to miscellaneous errors and not to any accounting irregularities or intentional misconduct other than a $1 million operating lease adjustment noted in the first quarter of fiscal 2012 which was a refinement of an error previously corrected and reported in fiscal 2011.

Australia

As previously disclosed, in the course of the Australia investigation initiated in fiscal 2012, accounting errors and irregularities were identified. As a result, certain personnel in Australia have been reprimanded, terminated and/or resigned. The Company attributes the $23 million of pre-tax adjustments recorded in fiscal 2012 to either intentional accounting irregularities (intentional irregularities) or other accounting errors (Other Errors). Other Errors include both unintentional errors and errors for which the categorization is unclear. The categorizations were provided to the Company through the independent investigation. The impact of the adjustments on income (loss) from continuing operations before taxes is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2008 & Prior (unaudited)			Fiscal 2009 (unaudited)			Fiscal 2010			Fiscal 2011			Total
Intentional irregularities	$	10		$	(7	)	$	(4	)	$	1		$	—
Other Errors	(7		)	(16		)	3			(3		)	(23		)
	$	3		$	(23	)	$	(1	)	$	(2	)	$	(23	)

NHS

As previously disclosed, in fiscal 2012, $25 million of out of period adjustments reducing income from continuing operations related to the Company's NHS contract were identified and recorded. During the course of the investigation in fiscal 2012 of the percentage-of-completion accounting method used on the Company's NHS contract, certain accounting errors were identified related to costs incurred under the contract, which resulted in errors in the recognition of income from continuing operations that would have reduced by approximately $24 million the $1.5 billion write-off recorded by the Company in the third quarter of fiscal 2012. Although the Company has concluded that these errors do not appear to have any impact on amounts charged to the NHS, the errors have impacted the operating income recognized on the NHS contract. The exclusion of certain costs incurred under the contract caused the estimated margin at completion, which determines the operating income that is booked when revenue milestones are achieved, to be overstated. Although the Company has concluded that there is no cumulative impact as a result of the $1.5 billion charge relating to the NHS contract recorded as of December 30, 2011, operating income from fiscal year 2007 through and including fiscal 2011 has been overstated by a total of approximately $24 million and, therefore, the charge taken by the Company as of December 30, 2011 was overstated by approximately the same amount.

Certain additional items had been identified related to the NHS contract that could have had an effect on the amount and the allocation of the out of period adjustments for fiscal 2012 and prior fiscal years. These additional items were subject to further investigation and therefore were not recorded in fiscal 2012. See our discussion of fiscal 2013 adjustments above for further information regarding the impact of such items.

Certain CSC finance employees based in the U. K. were aware prior to fiscal 2012 of the aforementioned errors, but those employees failed to appropriately correct the errors. Therefore, the Company has classified these errors as intentional. Such categorization was provided to the Company through the independent investigation. As a result, certain personnel have been suspended.

80

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The impact on income (loss) from continuing operations before taxes of the $25 million of out of period adjustments identified in fiscal 2012 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2012 Adjustments
Fiscal 2012	$	25
Fiscal 2011	(7		)
Fiscal 2010	(4		)
Prior fiscal years (unaudited)	(14		)

NPS

As previously reported, in fiscal 2012 the Company identified and recorded pre-tax adjustments reducing income from continuing operations before taxes by $16 million. Such adjustments were identified by the Company and were primarily related to the percentage-of-completion accounting adjustments.

Americas Outsourcing

As previously disclosed, in the course of the independent investigation of Americas Outsourcing accounting practices, accounting conventions used by Americas Outsourcing relating to intraperiod cost allocations were determined to be unintentional accounting errors. The errors did not have an impact on a fiscal year basis. The Company also determined that other operating units employed similar practices and made necessary corrections.

The following table summarizes the cumulative effect on the fiscal 2012 net loss attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2012 and fiscal 2013 under the rollover method. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2012, but had no net impact on the full year fiscal 2012 results:

	Fiscal 2012
	Quarter Ended
(Amounts in millions)	July 1, 2011			September 30, 2011			December 30, 2011			March 30, 2012			Total
Operating costs inappropriately capitalized	$	1		$	—		$	—		$	—		$	1
Misapplication of US GAAP	1			(1		)	2			(1		)	1
Miscellaneous errors	2			7			—			2			11
Total Nordic adjustments	4			6			2			1			13
Operating costs inappropriately capitalized	—			11			—			—			11
Misapplication of US GAAP	—			8			—			1			9
Miscellaneous errors	—			2			2			(1		)	3
Total Australia adjustments	—			21			2			—			23
NHS adjustments	(2		)	(2		)	46			(7		)	35
NPS adjustments	3			1			(5		)	11			10
Other adjustments	2			(11		)	5			9			5
Effect on income (loss) from continuing operations before taxes	7			15			50			14			86
Taxes on income	(2		)	(3		)	(2		)	(4		)	(11		)
Other income tax adjustments	1			14			(10		)	(5		)	—
Effect on net income (loss) attributable to CSC common shareholders	$	6		$	26		$	38		$	5		$	75

81

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Out of period adjustments recorded during fiscal 2012 and fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 30, 2012 under the rollover method:

	Twelve Months Ended March 30, 2012
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,364		$	56		$	15,420
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs)	13,019			(27		)	12,992
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	1,281			3			1,284
Selling, general and administrative (excludes restructuring costs)	1,128			2			1,130
Depreciation and amortization	1,147			(2		)	1,145
Restructuring costs	140			(5		)	135
Interest expense	175			(3		)	172
Other (income) expense	(6		)	2			(4		)
Loss from continuing operations before taxes	(4,454		)	86			(4,368		)
Taxes on income	(84		)	11			(73		)
Loss from continuing operations	(4,370		)	75			(4,295		)
Income from discontinued operations, net of taxes	145			—			145
Net loss attributable to CSC common shareholders	(4,242		)	75			(4,167		)
EPS – Diluted
Continuing operations	$	(28.31	)	$	0.48		$	(27.83	)
Discontinued operations	0.94						0.94
Total	$	(27.37	)	$	0.48		$	(26.89	)

The out of period adjustments affecting loss from continuing operations before taxes during the twelve months ended March 30, 2012 under the rollover method are related to the following consolidated balance sheet line items:

• Accounts receivable ($66 milliondecrease);

• Prepaid expenses and other current assets ($44 millionincrease);

• Other assets ($6 millionincrease);

• Property and equipment ($29 milliondecrease);

• Accrued payroll and related costs ($2 milliondecrease);

• Accrued expenses and other current liabilities ($46 millionincrease); and

• Deferred revenue ($3 milliondecrease).

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2012 and fiscal 2013 is immaterial to the consolidated results, financial position and cash flows for fiscal 2012 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2012 and fiscal 2013.

Fiscal 2011 Adjustments Financial Impact Summary

As previously reported, during fiscal 2011, the Company recorded $52 million of pre-tax adjustments that should have been recorded in prior fiscal years. The total out of period adjustments recorded in fiscal 2011 were comprised of $92 million of charges reducing income from continuing operations before taxes originating out of the Company’s MSS operations in the Nordic region, and $40 million of adjustments increasing income from continuing operations before taxes, with $36 million of the $40 million within MSS. Further adjustments were identified and recorded in fiscal 2012 and 2013 related to fiscal 2011 that reduced the net error by $29 million and $22 million, respectively.

82

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Nordic Region

As noted above, during fiscal 2011, the Company commenced an investigation into accounting irregularities in the Nordic region. Based upon the Company's investigation, review of underlying documentation for certain transactions and balances, review of contract documentation and discussions with Nordic personnel, the Company attributes the majority of the $92 million of pre-tax adjustments recorded in the Nordic region in fiscal 2011 to accounting irregularities arising from suspected intentional misconduct by certain former employees in our Danish subsidiaries. These accounting irregularities included the inappropriate capitalization of operating costs, the misapplication of U.S. GAAP and miscellaneous errors.

The following table summarizes the cumulative effect on the fiscal 2011 net income attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2011, 2012 and 2013. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2011, but had no net impact on the full year fiscal 2011 results:

	Fiscal 2011
	Quarter Ended
(Amounts in millions)	July 2, 2010			October 1, 2010			December 31, 2010			April 1, 2011			Total
Operating costs inappropriately capitalized	$	15		$	38		$	8		$	6		$	67
Misapplication of US GAAP	4			3			6			(1		)	12
Miscellaneous errors	1			(1		)	9			(2		)	7
Total Nordic adjustments	20			40			23			3			86
Operating costs inappropriately capitalized	—			(1		)	(1		)	—			(2		)
Misapplication of US GAAP	—			1			3			(1		)	3
Miscellaneous errors	(4		)	5			(2		)	(3		)	(4		)
Total Australia adjustments	(4		)	5			—			(4		)	(3		)
NHS adjustments	(10		)	(2		)	(5		)	(5		)	(22		)
NPS adjustments	4			2			(10		)	(7		)	(11		)
Other adjustments	(9		)	(8		)	(18		)	(14		)	(49		)
Effect on income from continuing operations before taxes	1			37			(10		)	(27		)	1
Taxes on income	4			1			9			10			24
Other income tax adjustments	(1		)	(13		)	(6		)	18			(2		)
Effect on net income attributable to CSC common shareholders	$	4		$	25		$	(7	)	$	1		$	23

83

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Out of period adjustments recorded during fiscal 2011, 2012 and 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended April 1, 2011 under the rollover method:

	Twelve Months Ended April 1, 2011
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,582		$	1		$	15,583
Costs of services (excludes depreciation and amortization)	12,578			(4		)	12,574
Selling, general and administrative	949			1			950
Depreciation and amortization	1,068			3			1,071
Interest expense	167			—			167
Other (income) expense	(21		)	—			(21		)
Income from continuing operations before taxes	878			1			879
Taxes on income	202			(22		)	180
Income from continuing operations	676			23			699
Income from discontinued operations, net of taxes	83			—			83
Net income attributable to CSC common shareholders	740			23			763
EPS – Diluted
Continuing operations	$	4.20		$	0.15		$	4.35
Discontinued operations	0.53			—			0.53
Total	$	4.73		$	0.15		$	4.88

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2013, 2012, and 2011 is immaterial to the consolidated results, financial position and cash flows for fiscal 2011 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2011.

Note 3 – Divestitures

Discontinued Operations

During fiscal 2013, CSC completed the divestiture of three businesses within its BSS Segment: the U.S.-based credit services business, the Italian consulting and system integration business, and an enterprise systems integration business in Malaysia and Singapore. These divestitures reflect the Company's ongoing service portfolio optimization initiative to focus on next-generation technology services and are presented in the Company's Consolidated Statements of Operations as discontinued operations.

The Company received cash proceeds of $1,001 million for the sale of its U.S. based credit services business, including a $1 million working capital adjustment. For its sale of the enterprise system integration business, the Company received $90 million in cash and expects to receive another $14 million for working capital and other adjustments. For the disposal of its Italian consulting and system integration business, the Company paid $35 million (plus $8 million of cash included in the divested entity's net assets sold), but expects to receive $6 million back from the buyer for a purchase price adjustment. Both the $14 million and $6 million described above were recorded as receivables.

These three divestitures resulted in a total pre-tax gain of $769 million (after-tax gain of $417 million), representing the excess of the net proceeds over the carrying value of the net assets of the divested businesses and transaction costs of $11 million. The divested assets and liabilities included current assets of $129 million, property and equipment and other long-lived assets of $11 million, goodwill of $241 million, and liabilities of $85 million.

During fiscal 2012, CSC recorded a pre-tax loss from discontinued operations of $2 million to reflect purchase price adjustments in accordance with the purchase agreement related to the fourth quarter fiscal 2011 divestiture discussed below. In fiscal 2012, CSC also recorded a $3 million adjustment to the taxes on gain on discontinued operations recorded in fiscal 2011. The adjustment reflects a change in the estimated tax provision made in fiscal 2011.

84

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

During fiscal 2011, CSC completed the divestiture of two businesses within its NPS segment whose ultimate customer was the U.S. federal government. One divestiture resulted in cash consideration of $56 million, and the second divestiture resulted in cash consideration of $65 million, of which $63 million was received in fiscal 2011 and the remaining $2 million was collected in fiscal 2012. Both of the divestitures were driven by the Governmental Organizational Conflict of Interest concerns. The divestitures resulted in total pre-tax gains of $59 million (after-tax gains of approximately $28 million) representing the excess of the proceeds over the carrying value of the net assets of the divested businesses (which included current assets of $38 million, property and equipment and other long-lived assets of $8 million, goodwill of $23 million, liabilities of $12 million), net of transaction costs of $5 million.

Following is the summary of the results of the discontinued operations:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012			April 1, 2011
Operations
Revenue	$	395	$	513		$	562
Income from discontinued operations, before taxes	84		107			100
Tax expense (benefit)	37		(37		)	45
Net income from discontinued operations	47		144			55
Disposal
Gain (loss) on disposition	$	769	$	(2	)	$	59
Tax expense (benefit)	352		(3		)	31
Gain on disposition, net of taxes	417		1			28
Income from discontinued operations, net of taxes	$	464	$	145		$	83

In fiscal 2013, the primary difference between the book and tax gain on the sale of the U.S.-based credit services business was the write-off of approximately $241 million of goodwill, a majority of which was non-deductible for tax purposes. The income tax expense recorded includes an allocation of a deferred tax charge related to such goodwill. In addition, there was a significant tax benefit realized on the divestment of the Italian consulting and system integration business. The gain from the sale of the enterprise systems integration business in Malaysia and Singapore was exempt from income tax. In fiscal 2011, the primary difference between the book and tax gain on the sale of an NPS business was related to goodwill that was not tax deductible for tax purposes.

For fiscal 2012, discontinued operations reflects a tax benefit of approximately $82 million due to the change in tax status of one of the Company's foreign subsidiaries. This change in tax status resulted in a deemed liquidation for U.S. tax purposes and triggered various deductions which resulted in an income tax benefit. This benefit was allocable to discontinued operations as such foreign subsidiary was disposed of during the current fiscal year.

Other Divestiture

In fiscal year 2013, the Company also sold Paxus, its Australian information technology staffing business unit, which was included in the Company's BSS Segment. This divestiture did not qualify to be presented as discontinued operations due to CSC's significant continuing business relationship with the divested entity.

The total consideration for this divestiture was $79 million, of which $63 million was received in cash and $16 million was recorded as a receivable. This sale resulted in a pre-tax gain of $38 million, representing the excess of the proceeds over the carrying value of the net assets divested, net of transaction costs of $3 million. The divested assets and liabilities included current assets of $41 million, property and equipment and other long-lived assets of $2 million, and liabilities of $5 million. There was no tax expense or benefit on the gain on sale of Paxus because the Company had sufficient capital losses in its Australian business unit to completely offset the capital gain.

85

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 4 – Acquisitions

Fiscal 2013 Acquisition

In the second quarter of fiscal 2013, CSC acquired a privately-held entity for $35 million in an all-cash transaction. The entity was acquired primarily to enhance CSC's strategy of offering customers greater value through data expertise and intellectual property. The purchase price was allocated to net assets acquired based on their estimated fair values at the date of acquisition as: $4 million to current assets, $8 million to acquired intangible assets, $2 million to liabilities, and $25 million to goodwill. The goodwill is associated with the NPS segment and is expected to be tax deductible. The pro forma financial information for this acquisition is not presented as this acquisition is not material to CSC’s consolidated results.

Fiscal 2012 Acquisitions

iSOFT Acquisition

On July 29, 2011, CSC completed the acquisition of iSOFT Group Limited (iSOFT), a publicly-held company listed on the Australian Securities Exchange. iSOFT is a global healthcare information technology company providing advanced application solutions principally to secondary care providers across both the public and private sectors. The acquisition complements and strengthens CSC’s software products, healthcare integration and services portfolio, and its healthcare research and development capabilities.

CSC acquired all of the outstanding shares in iSOFT for cash consideration of $200 million and the assumption of debt of $315 million, of which $298 million was repaid immediately after the acquisition.  The acquisition was funded through CSC’s existing cash balances.

Prior to the acquisition, the Company and iSOFT had a subcontracting agreement related to the development and delivery of software and IT services under the Company’s NHS contract. The agreement was effectively settled upon the completion of the acquisition. The Company determined that the subcontract was at market and no settlement gain or loss was recognized on the pre-existing relationship.

The results of iSOFT have been included in the Company’s consolidated financial statements from the date of acquisition within its Business Solutions and Services (BSS) segment. For the twelve months ended March 30, 2012, iSOFT contributed revenues of $139 million and an operating loss of $93 million, including the effect of purchase accounting adjustments, primarily relating to amortization of intangibles. The operating loss was offset by currency gains of $18 million, resulting in an effective loss of $75 million before interest and taxes. The currency gains, which resulted from unhedged inter-company loans, are included in other income. The following unaudited pro forma summary presents consolidated information of the Company as if the acquisition of iSOFT had occurred on April 3, 2010 for all periods presented:

	As Reported					Pro Forma - Unaudited
	Twelve Months Ended					Twelve Months Ended
(Amounts in millions, except per-share data)	March 30, 2012			April 1, 2011		March 30, 2012			April 1, 2011
Revenue	$	15,364		$	15,582	$	15,442		$	15,776
Net (loss) income attributable to CSC common shareholders	(4,242		)	740		(4,344		)	618
Basic EPS	$	(27.37	)	$	4.79	$	(28.02	)	$	4.00
Diluted EPS	(27.37		)	4.73		(28.02		)	3.95

The pro forma financial information above is not indicative of the results that would have actually been obtained if the acquisition had occurred on April 3, 2010, or that may be obtained in the future. No effect has been given to cost reductions or operating synergies relating to the integration of iSOFT in the Company’s operations. The information for the twelve months ended March 30, 2012 has been adjusted to exclude $37 million of goodwill impairment recorded by iSOFT in June 2011, and the twelve months ended April 1, 2011 information has been adjusted to exclude $290 million of goodwill impairment recorded by iSOFT in June 2010. Additionally, the twelve months ended March 30, 2012 information

86

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

has been adjusted to exclude the transaction costs of $11 million, and the twelve months ended April 1, 2011 information has been adjusted to include the transaction costs of $11 million.

The fair values of the assets acquired and liabilities assumed at the date of acquisition, including adjustments to the valuation of net assets acquired based on additional information that subsequently became available during fiscal 2012, are summarized as follows:

(Amounts in millions)	Estimated Fair Value
Cash and cash equivalents	$	26
Trade and other receivables	114
Other current assets	14
Deferred tax assets	12
Intangible assets	198
Property and equipment	21
Other non-current assets	3
Trade payables and accrued expenses	(62		)
Deferred revenue	(54		)
Debt	(315		)
Deferred taxes, uncertain tax positions, and other long-term liabilities	(59		)
Total identifiable net assets acquired	(102		)
Goodwill	302
Total cash purchase price	$	200

As of the acquisition date, the fair value of receivables approximated book value, which included billed and unbilled receivables and the historical allowance for uncollectible amounts of $10 million.

The components of the definite-lived intangible assets acquired and their respective estimated useful lives were as follows:

(Amounts in millions)	Estimated Fair Value		Estimated Useful Lives (Years)
Customer relationships	$	92	10-13
Software	102		2-7
Trade names	4		1
Total intangible assets	$	198

The entire amount of goodwill is associated with the Company’s BSS segment, and is attributable to expected increases in the Company’s market capabilities, synergies from combining operations, and the value of the acquired workforce. Of the estimated total goodwill, $71 million was estimated to be tax deductible.

AppLabs Acquisition

On September 13, 2011, CSC acquired AppLabs Technologies Private Limited (AppLabs), a Company headquartered in India which significantly enhances CSC’s capabilities in application testing services as well as shortening time-to-market. The AppLabs acquisition will complement CSC’s expertise in financial services, healthcare, manufacturing, chemical, energy and natural resources and technology and consumer verticals.

CSC acquired all outstanding shares of AppLabs for cash consideration of $171 million, which was funded through CSC’s existing cash balances.

87

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The results of AppLabs have been included in the Company’s consolidated financial statements from the date of acquisition. For the twelve months ended March 30, 2012, AppLabs contributed revenues of $60 million and net income of $2 million, including the effect of purchase accounting adjustments, primarily relating to amortization of intangibles. The pro forma financial information for this acquisition is not presented as this acquisition is not material to CSC’s consolidated results.

The fair values of the assets acquired and liabilities assumed at the date of acquisition, including adjustments to the valuation of net assets acquired based on additional information that subsequently became available during fiscal 2012, are summarized as follows:

(Amounts in millions)	Estimated Fair Value
Cash and cash equivalents	$	4
Trade receivables	20
Other current assets	8
Intangible assets	26
Property and equipment	4
Trade payables and accrued expenses	(26		)
Deferred taxes and uncertain tax positions	(20		)
Other liabilities	(2		)
Total identifiable net assets acquired	14
Goodwill	157
Total purchase price	$	171

As of the acquisition date, the fair value of trade receivables approximated book value and was considered fully recoverable.

The components of the definite-lived intangible assets acquired and their respective estimated useful lives are as follows:

(Amounts in millions)	Estimated Fair Value		Estimated Useful Lives (Years)
Customer relationships	$	25	2-8
Software	1		1-5
Total intangible assets	$	26

The entire amount of goodwill is associated with the Company’s Managed Services Sector (MSS) segment and is attributable to expected increases in the Company’s market capabilities and the value of the acquired workforce. None of the goodwill was tax deductible.

Other Acquisitions

During fiscal 2012, CSC also acquired two other small privately-held entities for $28 million in all-cash transactions plus additional consideration of up to $2 million contingent on achievement of agreed revenue targets for future periods through the end of May 2014. The acquisitions will enhance CSC’s offerings in the healthcare information technology and financial services industries.

The results of the acquired businesses have been included in the Company’s consolidated financial statements from the dates of acquisition. The pro forma financial information for these acquisitions is not presented as these acquisitions, both individually and in the aggregate, are not material to CSC’s consolidated results.

The purchase prices were allocated to net assets acquired based on estimates of fair values at the dates of acquisition as: $8 million to current assets, $2 million to property and equipment, $7 million to intangible assets, $6 million to liabilities

88

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

and $17 million to goodwill. Identified intangible assets consist primarily of customer related intangibles with useful lives of 4-10 years. Of the $17 million goodwill, $14 million is associated with the NPS segment and $3 million with the BSS segment. The $14 million goodwill associated with the NPS segment is expected to be tax deductible.

During fiscal 2011, CSC acquired four privately-held companies for $156 million. Two of the acquisitions were related to CSC's NPS segment and enhance the Company's cyber security, intelligence and analysis capabilities that support the national security and intelligence communities. Two of the acquisitions were related to CSC's BSS segment and augment the Company's healthcare business process outsourcing, software design and development, and our consulting practice within the chemical, energy and natural resources markets. The purchase consideration for the acquisitions was allocated to the assets acquired and liabilities assumed, based on their respective fair values at the date of acquisition. The total purchase consideration was allocated as $17 million to current assets, $5 million to property and equipment and other long term assets, $22 million to customer-related intangible assets, $19 million to other intangible assets, $20 million to liabilities assumed, and $113 million to goodwill. Identified other intangible assets include software, noncompetition agreements, trade names and in-process research and development. The weighted average amortization period for the customer-related intangible assets ranges from seven to ten years, and for other intangible assets it ranges from three to eight years. Of the total goodwill, $72 million is associated with CSC’s NPS segment and $41 million with the BSS segment; $69 million of the total goodwill was tax deductible. The aggregate amount of acquisition costs for the transactions amounted to $1 million and was expensed as incurred.

Pro forma financial information is not presented as the impact of these acquisitions was immaterial to CSC’s consolidated results.

Note 5 – Receivables

Receivables consist of the following:

(Amounts in millions)	March 29, 2013		March 30, 2012
Billed trade accounts	$	1,627	$	1,794
Unbilled recoverable amounts under contracts in progress	1,176		1,300
Other receivables	396		163
Total	$	3,199	$	3,257

Unbilled recoverable amounts under contracts in-progress generally become billable upon completion of a specified contract, negotiation of contract modifications, completion of U.S. federal government audit activities, achievement of project milestones or upon acceptance by the customer.

Unbilled recoverable amounts under contracts in progress resulting from sales, primarily to the U.S. and other governments, which are expected to be collected after fiscal year 2014 totaled $48 million.

Note 6 – Fair Value

Fair value measurements on a recurring basis

The following table presents the Company’s assets and liabilities, excluding pension assets (see Note 12), that are measured at fair value on a recurring basis as of March 29, 2013 and March 30, 2012:

89

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	March 29, 2013
			Fair Value Hierarchy
(Amounts in millions)	Fair Value		Level 1		Level 2		Level 3
Assets:
Money market funds and money market deposit accounts	$	464	$	464	$	—	$	—
Time deposits	393		393		—		—
Short term investments	6		6		—		—
Derivative assets	5		—		5		—
Total assets	$	868	$	863	$	5	$	—
Liabilities:
Derivative liabilities	$	11	$	—	$	11	$	—
Total liabilities	$	11	$	—	$	11	$	—
	March 30, 2012
			Fair Value Hierarchy
(Amounts in millions)	Fair Value		Level 1		Level 2		Level 3
Assets:
Money market funds and money market deposit accounts	$	299	$	299	$	—	$	—
Time deposits	102		102		—		—
Short term investments	6		6		—		—
Derivative assets	12		—		12		—
Total assets	$	419	$	407	$	12	$	—
Liabilities:
Derivative liabilities	$	14	$	—	$	14	$	—
Total liabilities	$	14	$	—	$	14	$	—

The Company's money market funds and deposit accounts and time deposits are included in cash and cash equivalents; short-term investments and derivative assets are included in prepaid expenses and other current assets; and derivative liabilities are included in other accrued expenses. Gains and losses from changes in the fair value of derivative assets and liabilities are included in earnings and reported in other (income) expense. There were no transfers between Level 1 and Level 2.

Derivative assets and liabilities include foreign currency forward contracts and currency options. The fair value of foreign currency forward contracts represents the estimated amount required to settle the contracts using current market exchange rates, and is based on the year-end foreign currency exchange rates and forward points. The fair value of currency options is estimated based on external valuation models that use the original strike price, movement and volatility in foreign currency exchange rates, and length of time to expiration as inputs.

Fair value measurements on a non-recurring basis

Assets and liabilities measured at fair value on a nonrecurring basis include goodwill, tangible assets, intangible assets and other contract related long-lived assets. Such assets are reviewed quarterly for impairment indicators. If a triggering event has occurred, the assets are remeasured when the estimated fair value of the corresponding asset or asset group is less than the carrying value. The fair value measurements, in such instances, are based on significant unobservable inputs (Level 3). There were no significant impairments recorded during the fiscal year ended March 29, 2013.

90

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

During fiscal 2012, as a result of annual and interim goodwill impairment assessments, goodwill was impaired with a charge of $2,745 million (see Note 9). The Company used the combination of the income and the market approach techniques to measure fair value of its reporting units, and a combination of the income, cost and market approach techniques to determine the fair value of the assets and liabilities comprising reporting units. The fair value adjustment to goodwill was computed as the difference between the fair value of the reporting unit and the fair value of underlying assets and liabilities. The unobservable inputs used to fair value the reporting units were based on Company-specific information such as revenue and cost growth rates, profit margins and discount rates. The unobservable inputs used to fair value the underlying assets and liabilities were also based on Company-specific information such as estimates of revenue and cost growth rates, profit margins, discount rates, cost estimates and guideline transactions data.

Additionally, during fiscal 2012, due to performance issues on certain of its outsourcing contracts, the Company recorded impairment of primarily long-lived assets of $156 million. The Company used the income approach technique to fair value the assets. The unobservable inputs used were based on Company specific information and included, primarily, estimates of revenue and cost growth rates, profit margins and discount rates.

Financial Instruments

The carrying amounts of the Company’s financial instruments with short-term maturities are deemed to approximate their market values. The carrying amount of the Company’s long-term debt, excluding capital leases and including mandatorily redeemable preferred stock outstanding, was $2,119 million and $1,073 million and the estimated fair value was $2,324 million and $1,190 million as of March 29, 2013, and March 30, 2012, respectively. The fair value of long-term debt is estimated based on the current interest rates offered to the Company for instruments with similar terms and remaining maturities and are classified as Level 2.

The primary financial instruments which potentially subject the Company to concentrations of credit risk are accounts receivable. The Company’s customer base includes Fortune 500 companies, the U.S. federal and other governments and other significant, well-known companies operating in North America, Europe and the Pacific Rim. Credit risk with respect to accounts receivable is minimized because of the nature and diversification of the Company’s customer base. Furthermore, the Company continuously reviews its accounts receivables and records provisions for doubtful accounts as needed.

The Company’s credit risk is also affected by customers in bankruptcy proceedings; however, because most of these proceedings involve business reorganizations rather than liquidations and the nature of the Company’s services are often considered essential to the operational continuity of these customers, the Company is generally able to avoid or mitigate significant adverse financial impact in these cases. As of March 29, 2013, the Company had $16 million of accounts receivable, $11 million of related allowance for doubtful accounts, and $1 million of other assets with customers involved in bankruptcy proceedings.

Note 7 – Foreign Currency Derivative Instruments

As a large global organization, the Company faces exposure to adverse movements in foreign currency exchange rates. During the ordinary course of business, the Company enters into certain contracts denominated in foreign currency. Potential foreign currency exposures arising from these contracts are analyzed during the contract bidding process. The Company generally manages these transactions by incurring costs to service contracts in the same currency in which revenue is received. Short-term contract financing requirements are met by borrowing in the same currency. By generally matching revenues, costs and borrowings to the same currency, the Company has been able to substantially mitigate foreign currency risk to earnings. However, as business practices evolve, the Company is increasing its use of offshore support and is therefore becoming more exposed to currency fluctuations.

The Company established policies and procedures to manage the exposure to fluctuations in foreign currency by using short-term foreign currency forward and option contracts to hedge certain foreign currency assets and liabilities, including intercompany loans, and certain revenues denominated in non-functional currencies. The Company uses these instruments as economic hedges and not for speculative or trading purposes. For accounting purposes, these foreign currency contracts are not designated as hedges, as defined under ASC 815, “Derivatives and Hedging” and all changes in fair value are reported as part of other (income) expense.

91

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The notional amount of the foreign currency forward contracts outstanding as of March 29, 2013 and March 30, 2012 was $993 million and $2,138 million, respectively. The notional amount of option contracts outstanding as of March 29, 2013 and March 30, 2012 was $744 million and $785 million, respectively.

The estimated fair values of the foreign currency derivative assets and liabilities were $5 million and $11 million, respectively, as of March 29, 2013, and $12 million and $14 million, respectively, as of March 30, 2012 (see Note 6).

As a result of the use of derivative instruments, the Company is subject to counterparty credit risks. To mitigate this risk, the Company enters into forward and option contracts with several financial institutions and regularly reviews its credit exposure and the creditworthiness of the counterparties. As of March 29, 2013, there were four counterparties with concentration of credit risk. The maximum amount of loss for the four counterparties, based on gross fair value of the foreign currency derivative instruments, that the Company could incur, is $5 million.

Note 8 – Intangible Assets

A summary of amortizable intangible assets is as follows:

	As of
	March 29, 2013
(Amounts in millions)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Outsourcing contract costs	$	1,473	$	968	$	505
Software	2,134		1,523		611
Customer and other intangible assets	512		281		231
Total intangible assets	$	4,119	$	2,772	$	1,347

	As of
	March 30, 2012
(Amounts in millions)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Outsourcing contract costs	$	1,802	$	1,240	$	562
Software	2,130		1,481		649
Customer and other intangible assets	599		306		293
Total intangible assets	$	4,531	$	3,027	$	1,504

Amortization expense for the years ended March 29, 2013, March 30, 2012, and April 1, 2011 was $414 million, $442 million, and $444 million, respectively, including reductions of revenue for amortization of outsourcing contract cost premiums of $40 million, $53 million, and $63 million in each of the respective years (see Note 1).

Estimated amortization related to intangible assets, including amortization of contract cost premium, as of March 29, 2013, for fiscal 2014 through fiscal 2018, is as follows: $351 million, $292 million, $211 million, $158 million, and $112 million, respectively.

Purchased and internally developed software, net of accumulated amortization, consisted of the following:

(Amounts in millions)	March 29, 2013		March 30, 2012
Purchased software	$	297	$	353
Internally developed commercial software	304		293
Internally developed internal-use software	10		3
Total	$	611	$	649

92

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Amortization expense related to purchased software was $143 million, $149 million, and $135 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. Amortization expense related to internally developed commercial software was $53 million, $47 million, and $34 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. Amortization expense related to internally developed internal-use software was $2 million, $4 million, and $6 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively.

During fiscal 2012, the Company recorded $75 million as an impairment of its intangible assets, primarily due to performance issues on certain long-term outsourcing contracts within its MSS segment. The intangible assets impacted included primarily, software and capitalized transition costs. The Company used the income approach technique to fair value the assets. The unobservable inputs used were based on Company specific information and included, primarily, estimates of revenue and cost growth rates, profit margins and discount rates. The impairment was recorded as a part of cost of services.

Note 9 – Goodwill

The following tables summarize the changes in the carrying amount of goodwill by segment for the years ended March 29, 2013, and March 30, 2012, respectively:

(Amounts in millions)	NPS		MSS			BSS			Total
Goodwill, gross	$	768	$	2,221		$	1,527		$	4,516
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 30, 2012, net	768		147			837			1,752
Additions	25		—			—			25
Deductions	—		—			(241		)	(241		)
Foreign currency translation	—		(11		)	(9		)	(20		)
Other reclassifications	—		(11		)	11			—
Goodwill, gross	793		2,199			1,288			4,280
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 29, 2013, net	$	793	$	125		$	598		$	1,516

(Amounts in millions)	NPS		MSS			BSS			Total
Goodwill, gross	$	753	$	1,965		$	1,339		$	4,057
Accumulated impairment losses	—		—			(19		)	(19		)
Balance as of April 1, 2011, net	753		1,965			1,320			4,038
Additions	15		157			304			476
Foreign currency translation	—		3			(20		)	(17		)
Other reclassifications	—		96			(96		)	—
Impairment losses	—		(2,074		)	(671		)	(2,745		)
Goodwill, gross	768		2,221			1,527			4,516
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 30, 2012, net	$	768	$	147		$	837		$	1,752

The fiscal 2013 addition to goodwill of $25 million relates to an acquisition in the NPS segment (see Note 4). The reduction of $241 million relates to the divestiture of a business in the BSS segment (see Note 3). The foreign currency translation amount relates to the impact of currency movements on non-U.S. dollar denominated goodwill balances.

93

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In the beginning of fiscal 2013, the Company changed its reporting units within its BSS segment: it combined the iSOFT and BSS-Health reporting units with the NHS contract into one reporting unit named BSS-Global Health. This change reflected the integration of all aspects of the Company's healthcare businesses and the resulting management and monitoring of the healthcare businesses' operating results. As a result of this change in reporting units, $11 million of MSS' goodwill was reclassified to BSS. This change was made prior to the Company's first quarter fiscal 2013 goodwill impairment assessment. The Company's fiscal 2013 quarterly assessments and annual testing for impairment of goodwill were performed on the basis of the new reporting units.

The fiscal 2012 additions to goodwill of $476 million consist of: 1) $475 million related to the acquisition of four new businesses, one in the NPS segment, one in the MSS segment and two in the BSS segment ; and 2) $1 million of contingent consideration paid upon the achievement of contractually-defined revenue target relating to a fiscal 2009 NPS acquisition (see Note 4). The other reclassification relates to goodwill associated with the relative value attributable to MSS of its portion of the NHS contract cash flows. The impairment losses, which are discussed further below, included goodwill write-downs in three of the Company’s eight fiscal 2012 reporting units, two of which were in the BSS segment and the third of which was in the MSS segment.

As noted in Note 1, the Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if an event occurs, or circumstances change, that would more likely than not reduce the fair value of a reporting unit below its carrying amount.

During the second quarter of fiscal 2013, the Company performed its annual impairment test of goodwill, choosing to bypass the initial qualitative assessment and proceeding directly to the first step of the impairment test for all reporting units, and concluded that no impairment had occurred.

Due to the divestiture of our credit services business in the third quarter of fiscal 2013, which caused the allocation of $241 million of goodwill from the BSS-Financial Services (BSS-FS) reporting unit to that disposed business, we assessed the goodwill remaining on the BSS-FS balance sheet for potential impairment. The Company performed the first step of the two-step of the goodwill impairment test and concluded that the goodwill remaining on the BSS-FS balance sheet, after allocation of goodwill to the divested business, was not impaired.

During the fourth quarter of fiscal 2013, the Company assessed whether there were events or change in circumstances that would more likely than not reduce the fair value of any of its reporting units below their carrying amounts. The Company considered, among other factors, any significant changes in the Company's fiscal 2013 forecast since the annual impairment test was performed, the outlook for the Company's business and industry, including the impact of sequestration by the U.S. federal government, the Company's market capitalization, and the current economic environment and outlook. Based on that assessment, the Company determined that there have been no events or changes in circumstances that would more likely than not reduce the fair value of any of its reporting units below their carrying amounts, and, as a result, it was unnecessary to perform the first step of the two-step impairment testing process as of March 29, 2013. Any adverse changes in the business climate or in CSC's operating results could result in the need to perform additional impairment analyses of goodwill prior to the next annual test, which may result in impairment charges. 

In fiscal 2012, the Company initiated its annual goodwill analysis in the second quarter and concluded that fair value was below carrying value for three reporting units: MSS, Global Business Solutions (BSS-GBS) and the Healthcare Group (BSS-Health). Management believed that the decline in the estimated fair values of these reporting units during the second quarter was a result of a number of factors, including: the significant decline in the Company’s overall stock price over the first six months of fiscal 2012; an overall decline in the broader stock market which resulted in reduced performance metric multiples at comparable public companies; uncertainty caused by concerns about the ongoing SEC investigation into reported errors and irregularities; concerns about the Company’s growth prospects in light of operational issues at its MSS reporting unit; uncertainty over the continuation of the Company’s NHS contract in light of comments made by government officials in the U.K.; and government budget pressures on customers worldwide. Lower than forecast operating performance also impacted the reporting units’ fair value calculations. Prior to the second quarter of fiscal 2012, the Company's stock price declines were considered temporary. In addition, an evaluation of historical and

94

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

forecast operating results did not indicate it was more likely than not that the fair value of any reporting unit had fallen below carrying value, and therefore no interim goodwill impairment test was warranted prior to the second quarter.

At the end of the second quarter and subsequent to the date of the annual goodwill impairment test, the Company determined that sufficient indicators existed to require performance of an additional interim goodwill impairment analysis as of September 30, 2011. These indicators included: a further significant and sustained decline in CSC’s stock price which resulted in a market capitalization, adjusted for control premium, decreasing to an amount less than book value and remaining there for some time; further decreases in the performance metric multiples of comparable public companies, driving the market approach valuations lower; and additional evidence of certain reporting units’ performance which fell short of forecasts used in the annual market- and income-based tests. In this interim goodwill impairment test, the BSS-GBS reporting unit again failed step one of the two-step test.

During the process of conducting the second step of the annual goodwill impairment tests, the Company identified significant previously unrecognized intangible assets, primarily relating to customer relationships and technology. The unrecognized intangible assets, estimated at approximately $1.3 billion, were predominantly attributable to unrecognized customer relationship assets in the MSS reporting unit and were driven by the Company’s high customer retention rates in this business. The combination of these previously unrecognized intangible assets and other unrecognized fair value changes to the carrying values of other assets and liabilities, together with the lower reporting unit fair values calculated in step one, resulted in an implied fair value of goodwill substantially below the carrying value of goodwill for the MSS, BSS-GBS and BSS-Health reporting units. As a result, the Company recorded its best estimate of the goodwill impairment charge of $2,685 million, of which $2,074 million related to the MSS reporting unit, $453 million related to the BSS-GBS reporting unit, and $158 million related to the BSS-Health reporting unit. As of September 30, 2011, MSS had $143 million of remaining goodwill, which was all attributable to the fiscal 2012 second-quarter acquisition of AppLabs (see Note 4). The BSS-GBS reporting unit had no remaining goodwill, and the BSS-Health reporting unit had $60 million of remaining goodwill.

The September 30, 2011 interim goodwill tests indicated that the fair values of two additional reporting units—BSS-Health and BSS-iSOFT—passed step one (after the impairment charges discussed above) but were not considered to be substantially in excess of carrying values. BSS-Health fair value was estimated to be approximately 6% in excess of carrying value, and as noted above had a remaining goodwill balance, after impairments recorded in the second quarter, of $60 million at September 30, 2011, including $18 million that was allocated from the iSOFT acquisition. BSS-iSOFT, which was acquired during the second quarter (see Note 4) was a new reporting unit in fiscal 2012, and its estimated fair value approximated its carrying value due to the proximity of its acquisition to the date of the interim goodwill impairment test.

During the third quarter of fiscal 2012, the Company completed all analyses related to its annual and second quarter interim goodwill impairment tests and reduced the impairment loss recorded in the second quarter by $3 million. The entire adjustment was in the BSS-Health reporting unit, and resulted from finalizing tax estimates and customer/technology asset fair values. Thus, the total second quarter goodwill impairment loss was $2,682 million, with ($3 million) of it recorded in the third quarter.

At the end of the third quarter of fiscal 2012, the Company assessed whether there were any events or circumstances that would more likely than not reduce the fair value of a reporting unit below its carrying value. The Company concluded that such indicators were present for two of its fiscal 2012 reporting units, BSS-Health and BSS-iSOFT. With respect to BSS-Health, the loss of a significant customer, the failure to win some major bids for new business, and reduction in forecasted earnings was considered a triggering event for an interim goodwill impairment test. For BSS-iSOFT, the recent developments on the NHS contract were considered a triggering event (see Note 18). There were no triggering events for the remaining reporting units with goodwill.

In conducting step one of the goodwill impairment test for the BSS-Health reporting unit in the third quarter of fiscal 2012, the factors stated above resulted in a reassessment of forecasted cash flow assumptions under an income approach, as well as a revised valuation using a market-multiples fair value approach, which resulted in the weighted-average fair value of the reporting unit being lower than its carrying value. This required the Company to perform the second step of the two-step test process, as noted below. For the BSS-iSOFT reporting unit, the weighted-average fair value was estimated

95

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

to be greater than its carrying value due to better-than-forecast performance by the core iSOFT business, and step two of the impairment assessment was not required.

During the process of conducting step two of the interim goodwill impairment test for BSS-Health, the Company estimated the fair value of its tangible assets and the unrecognized intangible assets, primarily customer relationship and technology assets, and recorded an impairment charge of $63 million. As a result, as of December 30, 2011, the BSS-Health reporting unit had no remaining goodwill.

The Company tested its long-lived assets for impairment in conjunction with the annual and the second and third quarter interim goodwill impairment tests and concluded that these assets were not impaired.

At the end of the fourth quarter of 2012, the Company assessed whether there were events or change in circumstances that would more likely than not reduce the fair value of any of its reporting units below their carrying amounts. There were no such indicators for any of the reporting units with goodwill, and therefore, an interim goodwill test was not required.

Note 10 – Income Taxes

The sources of (loss) income from continuing operations, before income taxes, classified between domestic entities and those entities domiciled outside of the United States, are as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Domestic entities	$	(25	)	$	(1,807	)	$	489
Entities outside the United States	505			(2,647		)	389
Total	$	480		$	(4,454	)	$	878

The income tax (benefit) expense on (loss) income from continuing operations is comprised of:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Current:
Federal	$	(307	)	$	(72	)	$	(13	)
State	(3		)	11			18
Foreign	174			94			96
	(136		)	33			101
Deferred:
Federal	84			(140		)	89
State	(16		)	(22		)	7
Foreign	33			45			5
	101			(117		)	101
Total income tax expense (benefit)	$	(35	)	$	(84	)	$	202

The current (benefit) provision for fiscal years 2013, 2012, and 2011, includes interest and penalties of $10 million, $(53) million, and $5 million, respectively, for uncertain tax positions.

96

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The major elements contributing to the difference between the U.S. federal statutory tax rate of 35% and the effective tax rate (ETR) for continuing operations are as follows:

	Twelve Months Ended
	March 29, 2013		March 30, 2012		April 1, 2011
Statutory rate	35.0	%	(35.0	)%	35.0	%
State income tax, net of federal tax	(0.6	)	(0.3	)	1.3
Change in uncertain tax positions	1.2		0.6		(2.8	)
Foreign tax rate differential	(66.8	)	(0.8	)	(5.4	)
Income tax credits	(0.4	)	(1.0	)	(9.6	)
Valuation allowance	77.1		18.1		2.5
Change in entity tax status	(0.3	)	(0.7	)	—
Loss on sale of securities	(51.8	)	—		—
Tax audit settlements	—		(2.5	)	—
Goodwill impairment	—		18.8		—
Other items, net	(0.7	)	0.9		2.0
Effective tax rate	(7.3	)%	(1.9	)%	23.0	%

In fiscal 2013, the ETR was primarily driven by:

• The Company executed an internal restructuring whereby a significant operating subsidiary was recapitalized. Certain securities issued pursuant to the recapitalization were subsequently sold to a third party. The sale resulted in the recognition of a capital loss of approximately $640 million, which reduced tax expense and the ETR by $248 million and 51.8%, respectively.

• A valuation allowance recorded for certain of the Company's German subsidiaries related to net operating losses and other net deferred tax assets. The impact to tax expense and the ETR was an increase of $77 million and 16%, respectively.

• An increase in the valuation allowance determined on a tax jurisdictional basis due to several factors including: (i) a shift in the global mix of income which increased tax expense and the ETR by $27.6 million and 5.8%, respectively (ii) capital gains from the sale of certain other assets which decreased tax expense and the ETR by $11.5 million and 2.4%, respectively and (iii) state capital losses and credits not expected to be fully utilized within the carryforward period which increased tax expense and the ETR by $29.6 million and 6.2%, respectively.

• Local losses on investment write-downs in Luxembourg (i) increased the valuation allowance and the ETR by $240.5 million and 50.2%, respectively, and (ii) decreased the foreign rate differential and ETR by $240.5 million and by 50.2%, respectively.

For the tax impact of discontinued operations, see Note 3.

97

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The deferred tax assets (liabilities) are as follows:

(Amounts in millions)	March 29, 2013			March 30, 2012
Deferred Tax Assets
Employee benefits	$	558		$	705
Tax loss/credit carryforwards	1,110			899
Accrued interest	47			52
State taxes	13			13
Cumulative foreign exchange gain/loss	14			6
Other assets	111			92
Total Deferred Tax Assets	1,853			1,767
Valuation allowance	(1,298		)	(951		)
Net Deferred Tax Assets	555			816
Deferred Tax Liabilities
Depreciation and amortization	(322		)	(387		)
Contract accounting	(53		)	(90		)
Investment basis differences	(128		)	(128		)
Other liabilities	(75		)	(65		)
Total Deferred Tax Liabilities	(578		)	(670		)
Total Deferred Tax Assets (Liabilities)	$	(23	)	$	146

Income tax related assets are included in the accompanying balance sheet as follows:

• Prepaid expenses and other current assets include the current portion of deferred tax assets of $24 million and $19 million as of March 29, 2013 and March 30, 2012, respectively. 

• Receivables include income taxes receivable of $239 million and $98 million as of March 29, 2013 and March 30, 2012, respectively, and the current portion of the receivable for uncertain tax positions of $8 million and $0 million as of March 29, 2013 and March 30, 2012, respectively.

• Other assets include non-current deferred tax assets of $184 million and $272 million as of March 29, 2013 and March 30, 2012, respectively, and non-current income taxes receivable and prepaid taxes of $70 million and $154 million as of March 29, 2013 and March 30, 2012, respectively.

Income tax related liabilities are included in the accompanying balance sheet as follows:

• Income taxes payable and deferred income taxes consist of the current portion of deferred tax liabilities of $0 million and $46 million as of March 29, 2013 and March 30, 2012, respectively, the current portion of income taxes payable of $41 million and $11 million as of March 29, 2013 and March 30, 2012 respectively.

• Income tax liabilities and deferred income taxes included in non-current liabilities consist of non-current liability for uncertain tax positions of $270 million and $257 million as of March 29, 2013 and March 30, 2012, respectively, and the non-current portion of deferred tax liabilities of $231 million and $99 million as of March 29, 2013 and March 30, 2012, respectively, the non-current portion of income taxes payable of $0 million and $1 million as of March 29, 2013 and March 30, 2012, respectively.

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized and adjusts the valuation allowance accordingly. In determining whether the deferred tax assets are realizable, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, taxable income in prior carryback years, projected future taxable income, tax planning strategies and recent financial operations. Valuation allowances are evaluated periodically and will be subject to change in each future reporting period as a result of changes in one or more of these factors. The change in the valuation allowance was $347 million in fiscal year 2013. This change is primarily due to the following:

98

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

• a full valuation allowance recorded in Germany for certain subsidiaries due to expected cumulative losses;

• a decrease in the valuation allowance in the U.K. related to current year income;

• an increase in the valuation allowance in Luxembourg due to local losses on investment write-downs; and

• a valuation allowance recorded against state capital loss carryforwards.

The Company has available foreign net operating loss (NOL) carryforwards of $3,661 million and $3,272 million, federal NOL carryforwards of $5 million and $14 million, and state NOL carryforwards of $782 million and $467 million as of March 29, 2013 and March 30, 2012, respectively. The Company has foreign capital loss carryforwards of $45 million and $0 million as of March 29, 2013 and March 30, 2012, respectively. The Company also has state credit carryforwards of $67 million and $69 million and state capital loss carryforwards of $411 million and $0 million as of March 29, 2013 and March 30, 2012, respectively. The foreign NOL carryforwards as of March 29, 2013 can be carried over indefinitely, except for $122 million which expire at various dates through 2021. The federal NOL carryforwards as of March 29, 2013 expire at various dates through 2032. The state NOL and credit carryforwards as of March 29, 2013 expire at various dates through 2033. The state capital loss carryforwards as of March 29, 2013 expire in 2018.

The Company is currently the beneficiary of tax holiday incentives in India, most of which expired in fiscal year 2011. The remaining tax holiday incentives in India will expire through 2026. As a result of the tax holiday incentives, the Company’s tax expense was reduced by approximately $3 million, $1 million, and $13 million, during fiscal years 2013, 2012, and 2011, respectively. The per share effects were $0.02, $0.01, and $0.08, for fiscal years 2013, 2012, and 2011, respectively.

In general, it is the practice and intention of the Company to reinvest the earnings of its non-U.S. subsidiaries in those operations. As of March 29, 2013, the Company has not made a provision for U.S. income tax or additional foreign withholding taxes with respect to accumulated taxable earnings of foreign subsidiaries where the foreign investment of such earnings is essentially permanent in duration. Generally, such amounts would become subject to U.S. taxation upon the remittance of dividends and under certain other circumstances. The cumulative undistributed positive earnings of the Company's foreign subsidiaries were approximately $2,977 million as of March 29, 2013. It is not practicable to estimate the tax cost of repatriating the cumulative undistributed taxable earnings of these foreign subsidiaries to the United States.

The Company accounts for income tax uncertainties in accordance with ASC 740-10, which prescribes a recognition threshold and measurement criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more-likely-than-not recognition threshold is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold should be derecognized in the first subsequent financial reporting period in which that threshold is no longer met. ASC 740 also provides guidance on the accounting for and disclosure of liabilities for uncertain tax positions, interest and penalties.

As of March 29, 2013, the Company’s liability for uncertain tax positions was $262 million, including interest of $38 million, penalties of $17 million, and net of tax attributes of $32 million. As of March 30, 2012, the Company’s liability for uncertain tax positions was $257 million, including interest of $31 million, penalties of $15 million, and net of tax attributes of $76 million.

99

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes):

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Balance at Beginning of Fiscal Year	$	287		$	426		$	442
Gross increases related to prior year tax positions	7			27			22
Gross decreases related to prior year tax positions	(40		)	(134		)	(41		)
Gross increases related to current year tax positions	8			29			14
Settlements and statute of limitation expirations	(18		)	(115		)	(15		)
Current year acquisitions	—			56			—
Foreign exchange and others	(3		)	(2		)	4
Balance at End of Fiscal Year	$	241		$	287		$	426

The Company’s liability for uncertain tax positions at March 29, 2013, March 30, 2012, and April 1, 2011, includes $148 million, $155 million, and $266 million, respectively, related to amounts that, if recognized, would affect the effective tax rate (excluding related interest and penalties).

The Company recognizes interest accrued related to uncertain tax positions and penalties as a component of income tax expense. During the year ended March 29, 2013, the Company accrued interest expense of $7 million ($5 million net of tax) and accrued penalties of $2 million, and as of March 29, 2013, has recognized a liability for interest of $38 million ($28 million net of tax) and penalties of $17 million. During the year ended March 30, 2012, the Company had a net reduction of interest of $56 million ($36 million net of tax) and had a net reduction of penalties of $14 million, and as of March 30, 2012, recognized a liability for interest of $31 million ($23 million net of tax) and penalties of $15 million. During the year ended April 1, 2011, the Company accrued interest expense of $3 million ($2 million net of tax) and accrued penalties of $2 million, and as of April 1, 2011, recognized a liability for interest of $88 million ($58 million net of tax) and penalties of $29 million.

Tax Examination Status:

The Company is currently under examination in several tax jurisdictions. A summary of the tax years that remain subject to examination in certain of the Company’s major tax jurisdictions are:

Jurisdiction:	Tax Years that Remain Subject to Examination (Fiscal Year Ending):
United States – Federal	2008 and forward
United States – Various States	2001 and forward
Australia	2009 and forward
Canada	2006 and forward
Denmark	2007 and forward
France	2009 and forward
Germany	2006 and forward
India	2007 and forward
United Kingdom	2010 and forward

It is reasonably possible that during the next twelve months the Company's liability for uncertain tax positions may change by a significant amount. The IRS is examining the Company's federal income tax returns for fiscal year 2008 through 2010, and the Company expects to reach a settlement during fiscal year 2014. The significant items subject to examination primarily include foreign income inclusion under subpart F and related foreign tax credits. In addition, the

100

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Company may settle certain other tax examinations, have lapses in statutes limitations, or voluntarily settle income tax positions in negotiated settlements for different amounts than the Company has accrued as uncertain tax positions. The Company may need to accrue and ultimately pay additional amounts for tax positions that previously met a more likely than not standard if such positions are not upheld. Conversely, the Company could settle positions with the tax authorities for amounts lower than those that have been accrued or extinguish a position though payment. The Company believes the outcomes which are reasonably possible within the next twelve months may result in a reduction in liability for uncertain tax positions of up to $92 million, excluding interest and penalties.

Note 11 – Debt

The following is a summary of the Company's debt as of March 29, 2013 and March 30, 2012:

(Amounts in millions)	March 29, 2013		March 30, 2012
4.45% term notes, due September 2022	$	349	$	—
6.50% term notes, due March 2018	998		997
2.50% term notes, due September 2015	350		—
5.50% term notes, due March 2013	—		699
5.00% term notes, due February 2013	—		300
Four-year term loan credit facility	250		—
Mandatorily redeemable preferred stock outstanding	59		—
Note payable of consolidated subsidiary	62		—
Capitalized lease liabilities	561		574
Borrowings for assets acquired under long-term financing	98		84
Other borrowings	5		86
Total debt	2,732		2,740
Less: short term debt and current maturities of long term debt	234		1,254
Total long-term debt	$	2,498	$	1,486

Term notes and term loan credit facility

On September 18, 2012, the Company issued $700 million of senior unsecured and unsubordinated notes (new term notes) comprised of $350 million of 2.50% Senior Notes due September 15, 2015 and $350 million of 4.45% Senior Notes due September 15, 2022. The new term notes were recorded net of debt discount of $1 million. The Company also incurred deferred debt issuance costs of $5 million, which along with the debt discount will be amortized over the respective terms of the new term notes using the effective interest method. The new term notes are senior unsecured and unsubordinated obligations and rank equally with all other existing and future senior unsecured and unsubordinated indebtedness, including any borrowings under the existing $1.5 billion Credit Facility (discussed below), and senior to all future subordinated debt. Interest is payable semi-annually on September 15 and March 15 beginning March 15, 2013. The proceeds from the new term notes were used to redeem a portion of the 5.50% term notes due March 2013 and the 5.00% term notes due February 2013, as described below.

In addition, on September 18, 2012, the Company entered into a four-year, unsecured, delayed-draw $250 million term loan credit facility (term loan) maturing on September 18, 2016. Under the term loan, the Company has an option to request an increase in the commitment up to a maximum amount of $350 million. Interest on borrowings under the new facility is based on prime rate or LIBOR plus a daily margin, and is payable quarterly. Quarterly principal repayments of 2.5% of borrowings commence December 31, 2013. Costs associated with establishing the term loan of $1 million have been deferred and will be amortized over the term of the agreement. On October 17, 2012, the Company borrowed $250 million under the term loan and used the proceeds to redeem a portion of the 5.50% and 5.00% term notes due in the fourth quarter of 2013, as described below.

101

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On September 12, 2012, the Company delivered a notice of early redemption with respect to the Company’s outstanding $700 million 5.50% Senior Notes due March 2013 and $300 million 5.00% Senior Notes due February 2013. On October 19, 2012, the Company used the proceeds received from the issuance of new term notes and the $250 million drawn from the term loan credit facility to fund the early redemption of the 5.00% and 5.50% term notes due February 2013 and March 2013, respectively, resulting in the recognition of a $19 million loss recorded to interest expense.

Both the new term notes and the new term loan credit facility agreement contain representations, warranties, and covenants customary for arrangements of these types, as well as customary events of default, including a cross-default to payment defaults on principal payments aggregating $125 million or to other events if the effect is to accelerate or permit acceleration of such debt.

Both the term loan credit facility and the $1.5 billion Credit Facility (see below) require the Company to: (1) maintain a minimum interest coverage ratio of consolidated Earnings Before Interest, Taxes, Depreciation and Amortization adjusted for other non-cash charges as defined by the credit agreement (EBITDA), to consolidated interest expense for the period of four consecutive fiscal quarters ending on or immediately prior to such period not to be less than 3.00 to 1.00; and (2) not permit at the end of any quarterly financial reporting period the ratio of consolidated total debt to consolidated EBITDA for the period of four consecutive fiscal quarters ending on or immediately prior to such date, to exceed 3.00 to 1.00. The Company was in compliance with these financial covenants as of March 29, 2013 and March 30, 2012.

Mandatorily redeemable preferred stock and note payable of a consolidated subsidiary

Mandatorily redeemable preferred stock

In March 2013, CSC entered into a financing agreement with a bank involving the sale of the Company's interest in mandatorily redeemable preferred stock (the preferred stock) of one of its wholly-owned subsidiaries (the Subsidiary). Such preferred stock is mandatorily redeemable on the tenth anniversary of its issuance (in 2023) but can be optionally redeemed by the Subsidiary at any time after the fifth anniversary of issuance. Therefore, the preferred stock was accounted for as a liability and is presented as long-term debt within the consolidated balance sheet.

The preferred stock has a stated value of $63 million (the initial liquidation preference) and was recorded at its issue date fair value of $59 million. The difference between the initial fair value and the stated value will be accreted over the term of the preferred stock. The Company incurred debt issuance costs of $1 million associated with the issuance of the preferred stock. These costs have been deferred and will be amortized over ten years using the effective interest method.

The preferred stock requires payment of cumulative preferred dividends at 3.48% per annum for the first five years. In addition, the holder of the preferred stock has a remarketing option, exercisable by the holder after five years from initial issuance, that if exercised, requires the assistance of the Subsidiary to remarket the Series A preferred stock, which under certain circumstances, may result in changes to the thereafter dividend rate in order to successfully remarket the securities. Dividends are payable on a quarterly basis and any unpaid dividends are subject to an incremental interest rate margin of 2.50%. The preferred shares also participate at 3.80% in 1) dividends paid on the Subsidiary's common stock and in 2) any future appreciation (as defined in the agreement) of the Subsidiary's common stock equity value (variable redemption premium). The liquidation preference of the preferred stock is the sum of the stated value of the shares, accrued but unpaid dividends, and any unpaid variable redemption premium.

Note payable

Concurrent with the financing agreement mentioned above, the Company entered into a separate credit agreement with a bank to sell the Company's interest in a five-year note receivable due 2018 issued by the Subsidiary for cash consideration of £41 million ($62 million as of March 29, 2013). The Company incurred $1 million of debt issuance costs associated with the note payable. These costs have been deferred and will be amortized over five years using the effective interest method.

The note bears interest in British pounds at a variable rate based on LIBOR and is payable on a quarterly basis. Although the note is due in five years, the Subsidiary has the option to repay the principal amount of the note plus any unpaid accrued interest beginning upon its third anniversary from issuance. As part of the sale of the note to the bank, the Company became a guarantor of the Subsidiary's note payable. The financing agreement and the credit agreement

102

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

require the Subsidiary to retain a minimum amount of assets. The Company and the Subsidiary were in compliance with all financial covenants at March 29, 2013.

Capital lease liabilities

Capitalized lease liabilities represent obligations due under capital leases for the use of computers and other equipment. The gross amount of assets recorded under capital leases was $1,095 million with accumulated amortization of $465 million, as of March 29, 2013, and $940 million with accumulated amortization of $341 million, as of March 30, 2012.

Borrowings for assets acquired under long-term financing

Certain asset purchases under outsourcing contracts were financed by borrowings from customers. These borrowings carry a rate of interest from 0.0% to 4.9% and will mature over the next five years. Gross amounts of assets purchased under long-term financings included $69 million and $44 million in property and equipment, $54 million and $45 million in software, $90 million and $86 million in outsourcing contract costs and $10 million and $10 million in other intangible assets as of March 29, 2013 and March 30, 2012, respectively.

Other borrowings

Several foreign subsidiaries of the Company had no borrowings outstanding, as of March 29, 2013, and $43 million of borrowings outstanding, as of March 30, 2012, under uncommitted lines of credit with certain foreign banks. CSC has provided parent guarantees for these short-term lines of credit which carry no commitment fees or significant covenants. In addition, the Company had $5 million and $43 million of other borrowings outstanding as of March 29, 2013 and March 30, 2012, respectively, consisting of other interest bearing debt and notes payable.

Commercial paper

The Company typically issues commercial paper with average maturities of one to three months. The commercial paper is backed by the $1.5 billion Credit Facility discussed below. As of both March 29, 2013 and March 30, 2012, the Company had no borrowings outstanding against commercial paper.

Credit facility

On March 18, 2011, the Company entered into a committed, unsecured line of credit for $1.5 billion (Credit Facility) that expires on March 18, 2015. The Credit Facility bears a variable rate of interest. The Company can elect to borrow at a prime rate, as published by the Bank of America, plus a margin or at a one, two, three, or six month LIBOR plus a margin. The margin varies with the credit ratings of the Company. As of both March 29, 2013 and March 30, 2012, the Company had no amounts outstanding under this Credit Facility.

Expected maturities of long-term debt, including borrowings for asset financing but excluding future minimum capital lease payments, for years subsequent to March 29, 2013, are as follows:

Fiscal Year	Amount (in millions)
2014	$	52
2015	71
2016	381
2017	194
2018	1,064
Thereafter	409
Total	$	2,171

103

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The future minimum lease payments required to be made under the capital leases as of March 29, 2013, are as follows:

Fiscal Year	Amount (in millions)
2014	$	221
2015	195
2016	115
2017	73
2018	38
Thereafter	97
Total minimum lease payments	739
Less: Amount representing interest	178
Present value of net minimum lease payments	561
Less: Current maturities of capital lease obligations	182
Long-term capitalized lease liabilities	$	379

Note 12 – Pension and Other Benefit Plans

The Company and its subsidiaries offer a number of pension and postretirement benefits, life insurance benefits, deferred compensation, and other plans, as described below. All plans are accounted for using the guidance of ASC 710 "Compensation - General" and ASC 715 “Compensation—Retirement Benefits” and are measured as of the end of the fiscal year.

Contributory, defined benefit pension plans have been generally available to U.S. and U.K. employees. However, the largest U.S. and U.K. defined benefit plans were frozen for most participants in prior years. Certain non-U.S. employees are enrolled in defined benefit pension plans in the country of domicile. In addition, the Company has two supplemental executive retirement plans (SERP), which are non-qualified, noncontributory pension plans. The Company provides subsidized healthcare and life insurance retirement benefits for certain U.S. employees and retirees, generally for those employed prior to August 1992, as well as healthcare, dental and life insurance benefits for certain non-U.S. employees. A significant number of employees outside the U.S. are covered by government sponsored programs at no direct cost to the Company other than related payroll taxes.

CSC utilizes actuarial methods to recognize the expense for pension and other postretirement benefit plans. Inherent in the application of these actuarial methods are key assumptions, including, but not limited to, discount rates and expected long-term rates of return on plan assets. Changes in the related pension and other postretirement benefit costs may occur in the future due to changes in the underlying assumptions, changes in the number and composition of plan participants and changes in the level of benefits provided.

As discussed in Note 17, the Company initiated restructuring activities in both fiscal 2013 and 2012. The Fiscal 2012 Plan restructuring resulted in contractual termination benefit charges for some employees participating in a certain U.K. pension plan. During fiscal 2012, the Company recognized $20 million in expected contractual termination benefits which are reflected in the projected benefit obligation at the end of fiscal 2012 and recognized as expense in net periodic pension cost during fiscal 2012. During fiscal 2013, the projected benefit obligation and the net periodic pension cost reflect adjustments to the original estimates for actual contractual termination benefits paid in relation to the Fiscal 2012 Plan in the amount of $(3) million. Additionally, the Fiscal 2013 Plan restructuring resulted in expected contractual termination benefits for some employees participating in this same U.K. pension plan. During fiscal 2013, the Company recognized $23 million in expected contractual termination benefits which are reflected in the projected benefit obligation at the end of fiscal 2013 and recognized as expense in net periodic pension cost during fiscal 2013.

Effective July 1, 2012 a certain Norway pension plan was amended to change the index used to benchmark pension payment increases. The plan was remeasured at July 1, 2012 resulting in a reduction to the projected benefit obligation of $28 million, improving the plan's funded status. The plan's fiscal 2013 expense was also remeasured for the remaining 9 months of the fiscal year using a discount rate of 4%.

104

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On December 31, 2012, the Company made a discretionary cash contribution of $400 million to its largest U.S. pension plan resulting in a remeasurement of the plan. The effects of this remeasurement were recorded during the fourth quarter of fiscal 2013 and resulted in a reduction of net periodic pension cost of $7.6 million for fiscal 2013 and additional plan liabilities of $379 million using a new discount rate of 4%.

On March 26, 2013, the Company and its Canadian subsidiary made additional discretionary cash contributions of $80 million and $20 million, respectively, to its various U.S. pension plans and to its largest Canadian pension plan.

Effective December 31, 2012, a second U.S. pension plan was remeasured as a result of a plan amendment which ceased benefit accruals on or after January 5, 2013. The effects of this remeasurement were recorded during the fourth quarter of fiscal 2013 and resulted in a reduction of net periodic pension cost of $1.1 million for fiscal 2013 and additional plan liabilities of $3 million using a new discount rate of 4.2%

On April 7, 2010, the Company announced an action to discontinue the accrual of future benefits for certain U.K. pension plans, effective July 1, 2010. As a result of this plan amendment, the Company recognized a curtailment loss of $0.4 million in the fourth quarter of fiscal 2010. In addition, the Company remeasured the amended U.K. plans’ pension expense for fiscal 2011 to reflect (a) a new discount rate of 5.6%, (b) the year-to-date increase in plan assets, and (c) the change in amortization basis to the expected average remaining life of plan participants. The U.K. plans’ discount rate was derived from a published rate: Markit iBoxx GBP Corporates AA 15+ Years Index. This remeasurement resulted in a $75 million reduction to the pension benefit obligation.

In response to the passage of the Patient Protection and Affordable Care Act of 2010 (PPACA), a number of changes were made to the underlying healthcare coverage offered to certain US retirees. In conjunction with those changes, the Company established limits on the level of employer subsidy it will provide to some retirees. The plans were amended and the impact of these changes is first reflected on April 1, 2011. In addition, although many administrative provisions of PPACA have not yet been promulgated by regulatory agencies, CSC included its best estimate of their financial impact into the benefit obligation for its U.S. postretirement benefit plans as of March 30, 2012, and the impact on fiscal 2012’s net periodic benefit cost was immaterial. In 2012, the retiree medical plans were further amended to allow Medicare Part D subsidies from 2012 and beyond to be collected by the healthcare provider. This subsequent change is reflected as of March 30, 2012 and the impact on fiscal 2012's net periodic benefit cost was immaterial.

Pension Plans

The following tables provide reconciliations of the changes in the plans’ projected benefit obligations and assets, and a statement of their funded status:

Reconciliation of Projected Benefit Obligation	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Projected benefit obligation at beginning of year	$	3,284		$	2,921		$	2,732		$	2,470
Service cost	10			10			25			33
Interest cost	153			164			123			128
Plan participants’ contributions	3			3			7			8
Amendments	—			—			(28		)	(11		)
Business/contract acquisitions/divestitures	—			—			(9		)	61
Contractual termination benefits	—			—			19			20
Settlement/curtailment	(5		)	—			(37		)	(36		)
Actuarial loss (gain)	194			314			400			151
Benefits paid	(133		)	(128		)	(79		)	(70		)
Foreign currency exchange rate changes	—			—			(141		)	(22		)
Projected benefit obligation at end of year	$	3,506		$	3,284		$	3,012		$	2,732

105

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Reconciliation of Fair Value of Plan Assets	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Fair value of plan assets at beginning of year	$	2,419		$	2,276		$	2,295		$	2,083
Actual return on plan assets	245			140			314			148
Employer contribution	591			128			157			121
Plan participants’ contributions	3			3			7			8
Benefits paid	(133		)	(128		)	(79		)	(70		)
Business/contract acquisitions/divestitures	—			—			5			47
Plan settlement	—			—			(30		)	(31		)
Foreign currency exchange rate changes	—			—			(119		)	(11		)
Fair value of plan assets at end of year	$	3,125		$	2,419		$	2,550		$	2,295
Funded status at end of year	$	(381	)	$	(865	)	$	(462	)	$	(437	)

The following table provides the amounts recorded in the Company’s consolidated balance sheet:

	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Non-current assets	$	—		$	—		$	23		$	13
Current liabilities - Accrued expenses and other current liabilities	(7		)	(8		)	(3		)	(9		)
Non-current liabilities - Other long-term liabilities	(374		)	(857		)	(482		)	(441		)
Net amount recorded	$	(381	)	$	(865	)	$	(462	)	$	(437	)

The following is a summary of amounts in accumulated other comprehensive loss, before tax effects, as of March 29, 2013 and March 30, 2012 that have not been recognized in the consolidated statements of operations as components of net periodic pension cost:

	U.S. Plans				Non-U.S. Plans
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013			March 30, 2012
Net transition obligation	$	—	$	—	$	3		$	5
Prior service cost	5		7		(24		)	2
Net actuarial loss	1,140		1,077		895			712
Accumulated other comprehensive loss	$	1,145	$	1,084	$	874		$	719

The following table summarizes the weighted average assumptions used in the determination of the Company’s pension plans’ benefit obligations as of March 29, 2013 and March 30, 2012:

	U.S. Plans				Non-U.S. Plans
	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Discount rate	4.4	%	4.8	%	4.1	%	4.7	%
Rates of increase in compensation levels (1)	4.1	%	4.1	%	3.5	%	4.1	%

(1) The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average rate for all pension plans, including frozen plans, is 0.6% and 0.7%, respectively, for U.S. Plans, and 0.6% and 0.9%, respectively, for Non-U.S. Plans.

106

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table lists selected information for the pension plans as of March 29, 2013 and March 30, 2012:

	U.S. Plans				Non-U.S. Plans
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Projected benefit obligation	$	3,506	$	3,284	$	3,012	$	2,732
Accumulated benefit obligation	3,487		3,259		2,969		2,655
Fair value of plan assets	3,125		2,419		2,550		2,295

	Plans with Projected Benefit Obligation In Excess of Plan Assets (U.S. and Non-U.S.)				Plans with Accumulated Benefit Obligation in Excess of Plan Assets (U.S. and Non-U.S.)
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Projected benefit obligation	$	6,270	$	5,845	$	6,132	$	5,844
Accumulated benefit obligation	6,217		5,770		6,100		5,770
Fair value of plan assets	5,405		4,531		5,276		4,530

The net periodic pension cost for U.S. and non-U.S. pension plans included the following components:

	U.S. Plans									Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011			March 29, 2013			March 30, 2012			April 1, 2011
Service cost	$	10		$	10		$	9		$	25		$	33		$	32
Interest cost	153			164			164			123			128			122
Expected return on assets	(160		)	(146		)	(157		)	(124		)	(129		)	(128		)
Amortization of transition obligation	—			—			—			1			1			1
Amortization of prior service costs	2			2			2			(1		)	1			1
Amortization of unrecognized net loss	42			32			23			20			13			18
Contractual termination benefit	—			—			—			20			20			—
Settlement/curtailment	—			—			—			—			2			—
Net periodic pension cost	$	47		$	62		$	41		$	64		$	69		$	46

Other before tax changes in plan assets and benefit obligations recognized in other comprehensive income during fiscal years 2013, 2012 and 2011 included the following components:

	U.S. Plans									Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011			March 29, 2013			March 30, 2012			April 1, 2011
Net actuarial (gain) / loss	$	105		$	319		$	83		$	201		$	133		$	(118	)
Prior service (credit) / cost	—			—			—			(27		)	(11		)	—
Amortization of:
Transition (asset) /obligation	—			—			—			(1		)	(1		)	(1		)
Prior service (credit) / cost	(2		)	(2		)	(2		)	1			(1		)	(1		)
Net actuarial (gain) / loss	(42		)	(32		)	(23		)	(25		)	(20		)	(24		)
Foreign currency exchange rate changes	—			—			—			6			(4		)	—
Total recognized in other comprehensive income	$	61		$	285		$	58		$	155		$	96		$	(144	)

107

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Other comprehensive (gain) loss related to unamortized pension costs for the years ended March 29, 2013, March 30, 2012, and April 1, 2011 was $210 million (net of taxes of $6 million), $257 million (net of taxes of $124 million), and $(62) million (net of taxes of $20 million), respectively.

The estimated net transitional obligation, prior service cost and actuarial loss for defined benefit plans that will be amortized from accumulated other comprehensive income into net periodic pension cost over the next fiscal year are $1 million, $(1) million and $66 million, respectively.

The weighted-averages of the assumptions used to determine net periodic pension cost were:

	U.S. Plans						Non-U.S. Plans
	March 29, 2013		March 30, 2012		April 1, 2011		March 29, 2013		March 30, 2012		April 1, 2011
Discount or settlement rates	4.6	%	5.7	%	6.2	%	4.7	%	5.2	%	5.3	%
Expected long-term rates of return on assets	6.8	%	7.5	%	8.3	%	5.4	%	6.1	%	6.7	%
Rates of increase in compensation levels (1)	4.1	%	4.3	%	4.3	%	4.1	%	4.1	%	4.1	%

(1) The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average for all pension plans, including frozen plans, is 0.7% and 0.7%, respectively, for U.S. Plans, and 0.9% and 1.0%, respectively, for Non-U.S. Plans.

U.S. pension assets are held in a trust that includes both separate accounts and commingled funds. Non-U.S. assets are subject to country specific regulations and invest primarily in commingled funds. The U.S. pension trust and the U.K. pension plans account for 90% of the total pension plan assets.

Information about the expected cash flows for pension plans as of March 29, 2013, is as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Employer contributions:
2014 (expected)	$	8	$	115
Expected Benefit Payments:
2014	$	151	$	84
2015	152		83
2016	165		86
2017	176		94
2018	188		99
2019-2023	1,069		595

No plan assets are expected to be returned to the Company in the next fiscal year.

108

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Other Postretirement Benefit Plans

The following tables provide reconciliations of the changes in postretirement plans’ benefit obligations and assets and a statement of their funded status:

Reconciliation of Accumulated Postretirement Benefit Obligation
(Amounts in millions)	March 29, 2013			March 30, 2012
Accumulated benefit obligation at beginning of year	$	253		$	214
Service cost	4			3
Interest cost	11			11
Plan participants’ contributions	—			—
Business/contract acquisitions/divestitures	—			—
Amendments	—			21
Actuarial loss (gain)	(6		)	20
Benefits paid	(10		)	(16		)
Retiree drug subsidy reimbursement	1			1
Foreign currency exchange rate changes	—			(1		)
Accumulated benefit obligation at end of year	$	253		$	253
Reconciliation of Fair Value of Plan Assets
(Amounts in millions)	March 29, 2013			March 30, 2012
Fair value of plan assets at beginning of year	$	81		$	79
Actual return on plan assets	7			5
Employer contribution	6			13
Plan participants’ contributions	—			—
Benefits paid	(10		)	(16		)
Fair value of plan assets at end of year	$	84		$	81
Funded status at end of year	$	(169	)	$	(172	)

The following table provides the amounts recorded in the Company’s consolidated balance sheets:

(Amounts in millions)	March 29, 2013			March 30, 2012
Current liabilities - Accrued expenses and other current liabilities	$	(5	)	$	(5	)
Non-current liabilities - Other long-term liabilities	(164		)	(167		)
Net amount recorded	$	(169	)	$	(172	)

The following is a summary of amounts in accumulated other comprehensive loss as of March 29, 2013 and March 30, 2012 that have not been recognized in the consolidated statements of operations as components of net periodic benefit cost:

(Amounts in millions)	March 29, 2013			March 30, 2012
Net transition obligation	$	—		$	—
Prior service (gain) cost	(17		)	(19		)
Net actuarial loss	99			123
Accumulated other comprehensive loss	$	82		$	104

109

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table lists selected information for other postretirement benefit plans as of March 29, 2013 and March 30, 2012:

					Plans with Accumulated Postretirement Benefit Obligation in Excess of the Fair Value of Plan Assets
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Accumulated postretirement benefit obligation	$	253	$	253	$	253	$	253
Fair value of plan assets	84		81		84		81

As of March 29, 2013 and March 30, 2012, the Company had no postretirement healthcare plan assets outside the U.S. Benefits paid include amounts paid directly from plan assets and amounts paid by the Company.    

The following table summarizes the weighted average assumptions used in the determination of the Company’s postretirement benefit obligations as of March 29, 2013 and March 30, 2012:

	March 29, 2013		March 30, 2012
Discount rate	4.1	%	4.5	%

The assumed healthcare cost trend rate used in measuring the accumulated postretirement benefit obligation was 4.5% for fiscal 2013, declining to 2.3% for 2026 and subsequent years for retirees whose age is less than 65. For retirees whose age is 65 or older, the assumed healthcare cost trend used in measuring accumulated postretirement benefit obligation was 3.6% for fiscal 2013, declining to 2.3% for 2026 and subsequent years. Assumed healthcare cost trend rates have a significant effect on the amounts reported for the healthcare plans. A one-percentage point change in the assumed healthcare cost trend rates would have had the following effect:

	One Percentage Point
(Amounts in millions)	Increase		Decrease
Effect on accumulated postretirement benefit obligation as of March 29, 2013	$	14	$	(12	)
Effect on net periodic postretirement benefit cost for fiscal 2013	1		(1		)

The net periodic benefit cost for other postretirement benefit plans included the following components:

(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Service cost	$	4		$	3		$	4
Interest cost	11			11			14
Expected return on assets	(5		)	(6		)	(6		)
Amortization of transition obligation	—			1			2
Amortization of prior service costs	(2		)	(6		)	—
Recognized actuarial loss	16			13			10
Net provision for postretirement benefits	$	24		$	16		$	24

110

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Other before tax changes in plan assets and benefit obligations recognized in other comprehensive income during fiscal years 2013, 2012 and 2011 included the following components:

(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Net actuarial (gain) / loss	$	(8	)	$	21		$	(1	)
Prior service (credit) / cost	—			21			(50		)
Amortization of:
Transition (asset) /obligation	—			(1		)	(3		)
Prior service (credit) / cost	2			6			—
Actuarial (gain) / loss	(16		)	(13		)	(10		)
Foreign currency exchange rate changes	—			—			—
Total recognized in other comprehensive income	$	(22	)	$	34		$	(64	)

Other comprehensive (gain) loss related to unamortized postretirement benefit plan costs for the years ended March 29, 2013, March 30, 2012, and April 1, 2011 was $(13) million (net of taxes of $9 million), $22 million (net of taxes of $12 million), and $(39) million (net of taxes of $21 million), respectively.

The estimated net transitional obligation, prior service gain and actuarial loss for other postretirement benefit plans that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year are $0 million, $(2) million and $13 million, respectively.

The weighted-averages of the assumptions used to determine net periodic benefit cost were as follows. See the above discussion of Pension Plans for how the assumptions are developed.

Fiscal Year End	2013		2012		2011
Discount or settlement rates	4.5	%	5.3	%	6.1	%
Expected long-term rates of return on assets(1)	6.5	%	7.2	%	8.3	%

⁽¹⁾ The Company had no other postretirement benefit plan assets outside the U.S.

Information about the expected cash flows for other postretirement benefit plans follows. No significant cash flow is expected for other postretirement benefit plans outside the U.S.

(Amounts in millions)	Employer Contributions
2014 (expected)	$	9
Expected Benefit Payments
2014	$	13
2015	15
2016	16
2017	17
2018	18
2019-2023	94

No plan assets are expected to be returned to the Company in the next fiscal year.

Retirement Plan Asset Strategy

The Company’s investment goals and risk management strategy for plan assets takes into account a number of factors, including the time horizon of the pension plans’ obligations. Plan assets are invested in various asset classes that are expected to produce a sufficient level of diversification and a reasonable amount of investment return over the long term. Sufficient liquidity is maintained to meet benefit obligations as they become due. Third party investment managers are

111

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

employed to invest assets in both passively-indexed and actively-managed strategies. Equities are primarily invested broadly in domestic and foreign companies across market capitalizations and industries. Fixed income securities are invested broadly, primarily in government treasury, corporate credit, mortgage backed and asset backed investments.

Risks include, but are not limited to, longevity risk, inflation risk, and the risk of other changes in market conditions that reduce the value of plan assets. Also, a decline in the yield of high quality corporate bonds may adversely affect discount rates resulting in an increase in the pension and other post retirement obligations. These risks, among others, could cause the plans’ funded status to deteriorate, increasing reliance on Company contributions. Generally, derivatives are permitted although their current use is limited. They are primarily used in the U.S. pension trust fixed income portfolios for duration and interest rate risk management and equity portfolios to gain market exposure, and are expected to be used in the U.K. pension schemes for inflation risk management. The Company also has investments in insurance contracts to pay plan benefits in certain countries.

For the U.S. pension trust, an allocation range by asset class is developed. The allocation had a significant weighting to equity investments in part due to the relatively long duration of the plans’ obligations. For the majority of the fiscal year, the allocation range for the U.S. pension trust was 49% – 66% equities, 34% – 44% fixed income securities and 0% – 10% cash and other investments. Asset allocations are monitored closely and investment reviews are conducted regularly. The Company consults with internal and external advisors regarding asset strategy and on March 21, 2013 adopted an allocation range for the U.S. pension trust of 37% - 66% equities, 29% - 44% fixed income securities, 0% - 25% alternative investments, and 0% - 10% cash and other investments. The alternative investments allocation may include, but is not limited to, hedge funds, real estate, commodities, private equity and infrastructure investments.

For the U.K. pension schemes, the Company's second largest pension plans by assets and projected liabilities, a target allocation by asset class is developed. The allocation had a significant weighting to equity investments in part due to the relatively long duration of the plans' obligations. For the majority of the fiscal year the allocation targets for the U.K. pension schemes were 40% equities, 31% fixed income securities, and 29% indexed-Gilts. Asset allocations are monitored closely by the schemes' trustees and investment reviews are conducted regularly.

Retirement Plan Asset Valuation Techniques

Cash equivalents are primarily short term money market commingled funds that are categorized as Level 2, except for funds that have quoted prices in active markets, which are classified as Level 1. They are valued at cost plus accrued interest which approximates fair value.

Fixed income separate accounts are categorized as Level 2. These investments are generally priced using model-based pricing methods that use observable market data as inputs. Broker dealer bids or quotes of securities with similar characteristics may also be used.

Domestic and global equity separate accounts are categorized as Level 1 if the securities trade on national or international exchanges and are valued at their last reported closing price.

Insurance contracts purchased to cover benefits payable to retirees are valued using the assumptions used to value the projected benefit obligation. Most of the plans' insurance contracts are categorized as level 2 while one plan has a level 3 insurance contract.

The fair value of our pension plan assets and postretirement benefit plans by investment category and the corresponding level within the fair value hierarchy as of March 29, 2013 are as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Fair value of pension plan assets	$	3,125	$	2,550
Fair value of other postretirement benefit plan assets	84		—
Total fair value of retirement plan assets as of March 29, 2013	$	3,209	$	2,550

112

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. Pension and Other Postretirement Benefit Plans
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	Global/International	$	31	$	38	$	—	$	69
	U.S. Domestic Stocks	51		—		—		51
	Domestic Equity commingled funds	5		1,325		—		1,330
	Global Equity commingled funds	—		380		—		380
	Global Equity mutual funds	83		—		—		83
Fixed Income:
	U.S. Treasuries	—		87		—		87
	U.S. Government Agencies	—		11		—		11
	Non U.S. Government	—		5		—		5
	Mortgage and asset backed securities	—		131		—		131
	Corporate(b)	—		74		—		74
	Fixed income commingled funds	3		959		—		962
Cash equivalents		8		117		—		125
Total		$	181	$	3,127	$	—	$	3,308
Unsettled Trade Receivable and Accrued Income								79
Unsettled Trade Payable and Accrued Expenses								(178		)
Fair value of assets for U.S. pension and postretirement medical plans as of March 29, 2013								$	3,209

Non-U.S. Pension Plan Assets
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	U.S./North American Equity commingled funds	$	—	$	54	$	—	$	54
	Global/International Equity commingled funds	—		915		—		915
	Global equity mutual funds	—		—		—		—
Fixed Income:
	Fixed income commingled funds	—		1,311		—		1,311
Insurance contracts		—		157		6		163
Cash equivalents		—		25		—		25
Other		—		83		—		83
Total		$	—	$	2,545	$	6	$	2,551
Unsettled Trades								(1		)
Fair value of non-U.S. pension assets as of March 29, 2013								$	2,550

(a) The majority of retirement plan assets are invested in a variety of commingled funds and fixed income. This results in a high amount of Level 2 investments.

(b) Primarily investment grade.

113

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Below is a reconciliation of the assets valued using significant unobservable inputs (Level 3):

	Non-U.S. Plans Insurance Contracts
(Amounts in millions)
Beginning balance as of March 30, 2012	$	5
Actual return on plan assets relating to assets still held at the reporting date	1
Actual return on plan assets relating to assets sold during the period	—
Purchases, sales, and settlements	—
Transfers in and / or out of Level 3	—
Changes due to exchange rates	—
Ending balance as of March 29, 2013	$	6

The fair value of our pension plan assets and postretirement benefit plans by investment category and the corresponding level within the fair value hierarchy as of March 30, 2012, are as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Fair value of pension plan assets	$	2,419	$	2,295
Fair value of other postretirement benefit plan assets	81		—
Total fair value of retirement plan assets as of March 30, 2012	$	2,500	$	2,295

U.S. Pension and Other Postretirement Benefit Plans
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	Global/International	$	25	$	34	$	—	$	59
	U.S. Domestic Stocks	40		—		—		40
	Domestic Equity commingled funds	5		1,040		—		1,045
	Global Equity commingled funds	—		250		—		250
	Global Equity mutual funds	93		—		—		93
Fixed Income:
	U.S. Treasuries	—		72		—		72
	U.S. Government Agencies	—		10		—		10
	Non U.S. Government	—		2		—		2
	Mortgage and asset backed securities	—		118		—		118
	Corporate(b)	—		82		—		82
	Fixed income commingled funds	3		689		—		692
Cash equivalents		8		58		—		66
Total		$	174	$	2,355	$	—	$	2,529
Unsettled Trade Receivable and Accrued Income								84
Unsettled Trade Payable and Accrued Expenses								(113		)
Fair value of assets for U.S. pension and postretirement medical plans as of March 30, 2012								$	2,500

114

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NON-U.S. PENSION PLAN ASSETS
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	U.S./North American Equity commingled funds	$	—	$	40	$	—	$	40
	Global/International Equity commingled funds	—		757		—		757
	Global equity mutual funds	78		—		—		78
Fixed Income:
	Fixed income commingled funds	115		1,104		—		1,219
Insurance contracts		—		141		5		146
Cash equivalents		—		13		—		13
Other		—		42		—		42
Total		$	193	$	2,097	$	5	$	2,295
Unsettled Trades								—
Fair value of non-U.S. pension assets as of March 30, 2012								$	2,295

(a) The majority of retirement plan assets are invested in a variety of commingled funds and fixed income. This results in a high amount of Level 2 investments.

(b) Primarily investment grade.

Below is a reconciliation of the assets valued using significant unobservable inputs (Level 3):

	Non-U.S. Plans Insurance Contracts
(Amounts in millions)
Beginning balance as of April 1, 2011	$	—
Asset acquired in purchase of iSOFT	3
Actual return on plan assets relating to assets still held at the reporting date	—
Actual return on plan assets relating to assets sold during the period	—
Purchases, sales, and settlements	2
Transfers in and / or out of Level 3	—
Changes due to exchange rates	—
Ending balance as of March 30, 2012	$	5

The asset allocation of pension plans at March 29, 2013 and March 30, 2012, respectively, is as follows:

	U.S. Plans				Non-U.S. Plans
Asset Category	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Equity securities	58	%	59	%	38	%	38	%
Debt securities	38	%	39	%	51	%	53	%
Cash and other	4	%	2	%	11	%	9	%
Total	100	%	100	%	100	%	100	%

115

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The asset allocation for U.S. other postretirement benefit plans at March 29, 2013 and March 30, 2012, respectively, is as follows:

	Percentage of Plan Assets at Year End
Asset Category	March 29, 2013		March 30, 2012
Equity securities	29	%	30	%
Debt securities	19	%	20	%
Cash and other	52	%	50	%
Total	100	%	100	%

Return on Assets

In the U.S., the Company uses a “building block” approach to compute the expected long-term rate of return using major asset classes expected in the plan. Starting with long run projected bond yields, an equity risk premium is added to estimate the equity long-term rate of return. Consideration is also given to the extent active management is employed in each asset class. A single expected long-term rate of return on plan assets is then calculated by weighting each asset class. Historical returns and peer data were also reviewed

Retirement Plan Discount Rate

The U.S. discount rate assumption is prepared with a two step process; the first step discounts the stream of expected annual benefit payments using high-quality corporate bond yields. In step two, the sum of each year’s discounted benefit payments are used to determine a single equivalent discount rate. In fiscal 2013, the discount rates for the U.S. pension and other postretirement plans were developed using a single yield curve, the Aon Hewitt AA Only Above Median Curve. This yield curve is a hypothetical AA or greater yield curve represented by a series of annualized individual spot discount rates going out 99 years. This curve provides a more transparent view to the underlying bonds and is available daily which provides for a discount rate to be calculated specific to the Company's fiscal year end. For years prior to fiscal 2013, the U.S. discount rates were determined using an average of two nationally recognized independent third party yield curves.

In fiscal 2012 the UK pension plans began using the AA Corporate Bond Mercer Pension Discount Yield Curve to set the discount rate. This yield curve approach determines a single equivalent discount rate from a curve based on market data using sample scheme cash flow data as a proxy to scheme specific liability cash flows. The benefits of the Mercer Pension Discount Yield Curve over the iBoxx GBP Corporates AA +15 index is that it provides the flexibility to use cash flow data over the average duration of the pension scheme's liabilities rather than over a set time period of 15 years. For years prior to fiscal 2012, the U.K. discount rate assumption was set by reference to the yield on the iBoxx GBP AA rated +15 years corporate bond index with an appropriate adjustment for duration if necessary after considering yield curve models and conditions in credit markets.

Other Benefit Plans

The Company sponsors several defined contribution plans for substantially all U.S. employees and certain foreign employees. The plans allow employees to contribute a portion of their earnings in accordance with specified guidelines. At March 29, 2013, plan assets included 10,730,413 shares of the Company’s common stock. During fiscal 2013, fiscal 2012, and fiscal 2011, the Company contributed $213 million, $223 million, and $207 million, respectively.

Pursuant to collective bargaining agreements, the Company makes contributions, generally at a stated hourly rate, to various multi-employer pension funds on behalf of its union-represented employees. All of these plans are within the Company's NPS segment. None of the contributions by the Company are individually significant to the multi-employer plans nor do they have a material impact on the Company's financial statements. The risks of participating in these multi-employer plans are different from single-employer plans. If a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers. The Company's contributions for fiscal years 2013, 2012, and 2011 were $11 million, $11 million, and $10 million, respectively.

116

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Effective August 14, 1995, the Company adopted the Computer Sciences Corporation Deferred Compensation Plan (the Plan). The Plan consists of two separate plans, one for the benefit of key executives and one for the benefit of non-employee directors. Pursuant to the Plan, certain management and highly compensated employees are eligible to defer all or a portion of their regular salary that exceeds the limitation set forth in Internal Revenue Section 401(a)(17) and all or a portion of their incentive compensation, and non-employee directors are eligible to defer up to 100% of their compensation. Each plan participant is fully vested in all deferred compensation and earnings credited to his or her account. The liability, which is included in “Other long-term liabilities” under the Plan, amounted to $125 million as of March 29, 2013 and $129 million as of March 30, 2012. The Company’s expense under the Plan totaled $8 million, $8 million, and $8 million, for fiscal 2013, fiscal 2012, and fiscal 2011, respectively.

Note 13 – Stockholders’ Equity

Stock Repurchase Program

In December 2010, the Company’s board of directors approved a share repurchase program authorizing up to $1 billion in share repurchases of the Company’s outstanding common stock. CSC has been implementing the program through purchases made in open market transactions in compliance with Securities and Exchange Commission rules, market conditions, and applicable state and federal legal requirements. The timing, volume, and nature of share repurchases will be at the discretion of management, and may be suspended or discontinued at any time. No end date has been established for the repurchase program.

During fiscal 2013, 6,707,652 shares were purchased through open market purchases for an aggregate consideration of$305 million at a weighted average price of $45.47 per share. Of the aggregate consideration of $305 million, $22 million was recorded as an accrued liability for shares purchased but not yet settled in cash by March 29, 2013. During fiscal 2011, 1,353,000 shares were purchased through open market purchases for an aggregate consideration of $65 million at a weighted average price of $48.01 per share. For fiscal 2013 and 2011, the shares repurchased were retired immediately and included in the category of authorized but unissued shares. The excess of purchase price over par value of the shares repurchased was allocated between additional paid-in capital and retained earnings.    

During fiscal 2012, no shares were purchased through open market purchases.

Treasury Stock Transactions

In fiscal 2013, the Company accepted 91,921 shares of its common stock in lieu of cash in connection with exercise of stock options, and 209,056 shares in lieu of cash in connection with the tax withholdings associated with the release of common stock upon vesting of restricted stock and restricted stock units.

Similarly, in fiscal 2012, the Company accepted 21,755 shares of its common stock in lieu of cash in connection with exercise of stock options, and 104,117 shares in lieu of cash in connection with the tax withholdings associated with the release of common stock upon vesting of restricted stock and restricted stock units.

Dividends

During fiscal 2013, the Company declared cash dividends per common share of $0.80 totaling $123 million. Of the total dividends declared, $30 million was declared but unpaid as of March 29, 2013. Such dividends were paid on April 15 ,2013.

Similarly, during fiscal 2012, the Company declared cash dividends per common share of $0.80 totaling $124 million. Of the total dividends declared, $31 million was unpaid as of March 30, 2012.

117

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss for fiscal 2013 are as follows:

(Amounts in millions)	Foreign Currency Translation Adjustments			Pension and Other Postretirement Benefit Plans			Accumulated Other Comprehensive Loss
Balance at April 2, 2010	$	23		(1,075		)	(1,052		)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	261			101			362
Balance at April 1, 2011	$	284		(974		)	(690		)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	(124		)	(279		)	(403		)
Balance at March 30, 2012	$	160		$	(1,253	)	$	(1,093	)
Current-period other comprehensive (loss) income, net of taxes and non-controlling interest	(83		)	(178		)	(261		)
Balance at March 29, 2013	$	77		$	(1,431	)	$	(1,354	)

Note 14 – Stock Incentive Plans

Employee Incentives

The Company has three stock incentive plans which authorize the issuance of stock options, restricted stock and other stock-based incentives to employees upon terms approved by the Compensation Committee of the Board of Directors. The Company issues authorized but previously unissued shares upon the exercise of stock options, the granting of restricted stock awards and the settlement of restricted stock units (RSUs). There were no restricted stock awards outstanding in fiscal years 2013, 2012 and 2011. As of March 29, 2013, 11,977,359 shares of CSC common stock were available for the grant of future stock options, restricted stock or other stock-based incentives to employees. See Stock-Based Compensation section of Note 1 for further details.

Stock Options

The Company’s standard vesting schedule for stock options is one-third on each of the first three anniversaries of the grant date. Stock options are generally granted for a term of ten years. Information concerning stock options granted under stock incentive plans during fiscal 2013, fiscal 2012, and fiscal 2011 is as follows:

118

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	Number of Option Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value (In millions)
Outstanding as of April 2, 2010	17,008,397		$	46.36	5.58	$	141
Granted	2,818,874		48.23
Exercised	(1,868,544	)	40.61			22
Canceled/Forfeited	(324,612	)	46.00
Expired	(573,922	)	55.52
Outstanding as of April 1, 2011	17,060,193		47.00		5.54	69
Granted	2,457,509		38.18
Exercised	(428,844	)	35.95			5
Canceled/Forfeited	(579,069	)	41.75
Expired	(776,227	)	49.05
Outstanding as of March 30, 2012	17,733,562		46.13		5.08	1
Granted	3,707,172		27.46
Exercised	(1,497,686	)	39.27			10
Canceled/Forfeited	(1,113,422	)	35.36
Expired	(3,689,059	)	45.28
Outstanding as of March 29, 2013	15,140,567		43.23		5.45	113
Vested and expected to vest in the future as of March 29, 2013	14,885,162		43.47		5.38	108
Exercisable as of March 29, 2013	10,694,088		47.92		4.05	36

	March 29, 2013
	Options Outstanding				Options Exercisable
Range of Option Exercise Price	Number Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Number Exercisable	Weighted Average Exercise Price
$23.06-$39.04	5,269,835	$	31.56	7.79	1,392,011	$	36.87
$39.11-$48.61	6,075,780	45.73		4.77	5,531,586	45.82
$48.65-$60.25	3,794,952	55.06		3.27	3,770,491	55.08
	15,140,567				10,694,088

The total grant date fair value of stock options vested during fiscal 2013, fiscal 2012, and fiscal 2011, was $20 million, $27 million, and $40 million, respectively. The cash received from stock options exercised during fiscal 2013, fiscal 2012, and fiscal 2011, was $55 million, $15 million, and $73 million, respectively.

As of March 29, 2013, there was $27 million of unrecognized compensation expense related to unvested stock options, net of expected forfeitures. The cost is expected to be recognized over a weighted-average period of 1.91 years.

119

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Restricted Stock Units

RSUs consist of equity awards with the right to receive one share of common stock of the Company issued at a price of $0. Upon the settlement date, RSUs are settled in shares of CSC common stock and dividend equivalents. If, prior to the vesting of the RSU in full, the employee’s status as a full-time employee is terminated, then the RSU is automatically canceled on the employment termination date and any unvested shares are forfeited.

The Company grants RSUs with service and performance-based vesting terms. Service-based RSUs, generally vest over periods of three to five years. The number of performance-based RSUs that ultimately vest is dependent upon the Company’s achievement of certain specified performance criteria over a three-year period. Awards are settled for shares of CSC common stock and dividend equivalents upon the filing with the SEC of the Annual Report on Form 10-K for the last fiscal year of the performance period if the specified performance criteria is met. In fiscal 2013, performance-based RSU awards granted include the potential for accelerated vesting of 25% of the shares granted after the first and second fiscal years if certain company performance targets are met early. Compensation expense during the performance period is estimated at each reporting date using management’s expectation of the probable achievement of the specified performance criteria and is adjusted to the extent the expected achievement changes. In the table below, such awards are reflected at the number of shares to be settled upon achievement of target performance measures.

Certain executives were awarded service-based RSUs for which the shares are released over the ten anniversaries following the executive’s termination, provided the executive remains a full-time employee of the Company until reaching the earlier of age 65 or age 55 and over with at least ten years of service and after termination complies with certain non-competition covenants during the ten-year period.

Information concerning RSUs granted under stock incentive plans during fiscal 2013, fiscal 2012, and fiscal 2011, is as follows:

	Number of Shares		Weighted Average Fair Value
Outstanding as of April 2, 2010	1,154,668		$	45.88
Granted	492,523		48.15
Settled	(151,893	)	50.40
Canceled/Forfeited	(16,728	)	51.94
Outstanding as of April 1, 2011	1,478,570		46.10
Granted	1,009,743		35.45
Settled	(419,351	)	48.21
Canceled/Forfeited	(328,037	)	41.44
Outstanding as of March 30, 2012	1,740,925		40.29
Granted	1,724,639		26.12
Settled	(423,321	)	33.17
Canceled/Forfeited	(778,971	)	38.27
Outstanding as of March 29, 2013	2,263,272		31.53

As of March 29, 2013, there was $34 million of unrecognized compensation expense related to unvested restricted stock units, net of expected forfeitures. The cost is expected to be recognized over a weighted-average period of 2.18 years.

Nonemployee Director Incentives

The Company has two stock incentive plans which authorize the issuance of stock options, restricted stock and other stock-based incentives to nonemployee directors upon terms approved by the Company’s Board of Directors. As of March 29, 2013, 72,400 shares of CSC common stock remained available for the grant to nonemployee directors of future RSUs or other stock-based incentives.

120

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Generally, RSU awards to nonemployee directors vest in full as of the next annual meeting of the Company’s stockholders following the date they are granted and are issued at a price of $0. Information concerning RSUs granted to nonemployee directors during fiscal 2013, fiscal 2012, and fiscal 2011 is as follows:

	Number of Shares		Weighted Average Fair Value
Outstanding as of April 2, 2010	133,221		$	46.47
Granted	25,700		39.46
Settled	(180	)	42.69
Canceled/Forfeited	—		—
Outstanding as of April 1, 2011	158,741		45.34
Granted	37,800		30.07
Settled	(180	)	42.69
Canceled/Forfeited	—		—
Outstanding as of March 30, 2012	196,361		42.81
Granted	42,800		30.30
Settled	(50,716	)	43.30
Canceled/Forfeited	—		—
Outstanding as of March 29, 2013	188,445		39.85

When a holder of RSUs ceases to be a director of the Company, the vested RSUs are settled for shares of CSC common stock and dividend equivalents with respect to such shares. At the holder’s election, the RSUs may be settled (i) in their entirety, upon the day the holder ceases to be a director, or (ii) in substantially equal amounts upon the first five, ten or fifteen anniversaries of such termination of service.

Note 15 – Other (Income) Expense, Net

The components of other (income) expense, net for fiscal 2013, fiscal 2012, and fiscal 2011 are:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Foreign currency loss (gain)	$	17		$	4		$	(2	)
Equity in earnings of unconsolidated affiliates	(9		)	(10		)	(11		)
Other gains	(42		)	—			(8		)
Total	$	(34	)	$	(6	)	$	(21	)

Foreign currency (gains) losses are due to the impact of movement in foreign currency exchange rates on the Company’s foreign currency denominated assets and liabilities, the related hedges including options to manage its exposure to economic risk, and the cost of the Company’s hedging program. The costs of the Company’s hedging program for fiscal years 2013, 2012, and 2011 were $5 million, $6 million and $4 million, respectively.   For fiscal years 2013, 2012, and 2011, foreign currency (gains) losses due to movements of foreign currency exchange rates, primarily between the U.S. dollar and the Indian rupee, which impacted the market valuation of the Company's foreign currency options, were $10 million, $(6) million and $(1) million, respectively. In addition, the Company also realized losses of $2 million, $4 million and $(6) million in fiscal 2013, 2012, and 2011 from settled option contracts, respectively.

Other gains for fiscal 2013 primarily included a gain of $38 million related to the sale of Paxus, the Company's Australian staffing business. For fiscal 2011, the gains reflected disposal of certain minority investments.

Equity in earnings of unconsolidated affiliates is primarily within the Company’s NPS segment.

121

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 16 – Segment and Geographic Information

CSC provides IT and business process outsourcing, consulting, systems integration and other IT services to its customers. The Company targets the delivery of these services within three broad lines of business or sectors: NPS, MSS, and BSS.

The Company’s reportable segments are as follows:

• NPS – The NPS segment provides services to the U.S. federal government and its agencies, civil departments and branches of military, and operates principally within a regulatory environment subject to governmental contracting and accounting requirements, including Federal Acquisition Regulations, Cost Accounting Standards and audits by various U.S. federal agencies.

• MSS – The MSS segment provides large-scale and mid-size outsourcing solutions and services to customers globally.

• BSS – The BSS segment provides industry specific consulting and systems integration services, business process outsourcing, and intellectual property-based software solutions.

The following table summarizes operating results by reportable segment. BSS results for fiscal 2012 and fiscal 2011, and MSS results for fiscal 2012 have been adjusted from amounts previously reported to reflect the removal of revenue and costs associated with discontinued operations (see Note 3).

Twelve Months Ended
(Amounts in millions)	NPS(1)		MSS		BSS(2)			Corporate			Eliminations			Total
March 29, 2013
Revenues	$	5,391	$	6,457	$	3,272		$	13		$	(140	)	$	14,993
Operating income (loss)	519		361		136			(116		)	—			900
Depreciation and amortization	160		765		137			14			—			1,076
March 30, 2012
Revenues	$	5,703	$	6,602	$	3,180		$	13		$	(134	)	$	15,364
Operating income (loss)	132		17		(1,443		)	(65		)	—			(1,359		)
Depreciation and amortization	162		815		154			16			—			1,147
April 1, 2011
Revenues	$	6,002	$	6,583	$	3,110		$	14		$	(127	)	$	15,582
Operating income (loss)	528		481		188			(72		)	—			1,125
Depreciation and amortization	133		777		127			31			—			1,068

⁽¹⁾  The fiscal 2012 amounts include $42 million reduction of revenue and $269 million in reduction in operating income as a result of the settlement of claims with the U.S. government (see Note 19).

⁽²⁾  The fiscal 2012 amounts include $204 million reduction of revenue and $1,485 million in reduction of operating income as a result of the charge associated with the NHS contract (see Note 18).

Operating income provides useful information to the Company’s management for assessment of the Company’s performance and results of operations. Components of the measure are utilized to determine executive compensation along with other measures.

Reconciliation of consolidated operating (loss) income to (loss) income from continuing operations before taxes is as follows:

122

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Operating income (loss)	$	900		$	(1,359	)	$	1,125
Corporate G&A	(293		)	(219		)	(138		)
Interest expense	(183		)	(175		)	(167		)
Interest income	22			38			37
Goodwill impairment	—			(2,745		)	—
Other income (expense), net	34			6			21
Income (loss) from continuing operations before taxes	$	480		$	(4,454	)	$	878

During fiscal 2013, fiscal 2012, and fiscal 2011, the Company recorded certain pre-tax out-of-period adjustments which should have been recorded in prior fiscal years (See Note 2). The following tables summarize the effect of the pre-tax out-of-period adjustments on the Company's segment results for fiscal 2013, fiscal 2012 and fiscal 2011, if the adjustments had been recorded in the appropriate year.

Twelve Months Ended	NPS
(Amounts in millions)	As Reported		Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	5,391	$	—		$	5,391
Operating income	519		6			525
Depreciation and amortization	160		—			160
March 30, 2012
Revenues	$	5,703	$	5		$	5,708
Operating income	132		10			142
Depreciation and amortization	162		—			162
April 1, 2011
Revenues	$	6,002	$	—		$	6,002
Operating income	528		(11		)	517
Depreciation and amortization	133		—			133

123

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Twelve Months Ended	MSS
(Amounts in millions)	As Reported		Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	6,457	$	1		$	6,458
Operating income	361		3			364
Depreciation and amortization	765		—			765
March 30, 2012
Revenues	$	6,602	$	6		$	6,608
Operating income	17		33			50
Depreciation and amortization	815		(2		)	813
April 1, 2011
Revenues	$	6,583	$	34		$	6,617
Operating income	481		45			526
Depreciation and amortization	777		3			780

Twelve Months Ended	BSS
(Amounts in millions)	As Reported			Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	3,272		$	13		$	3,285
Operating income	136			(8		)	128
Depreciation and amortization	137			(2		)	135
March 30, 2012
Revenues	$	3,180		$	45		$	3,225
Operating loss	(1,443		)	43			(1,400		)
Depreciation and amortization	154			—			154
April 1, 2011
Revenues	$	3,110		$	(33	)	$	3,077
Operating income	188			(29		)	159
Depreciation and amortization	127			—			127

Revenue by country is based on the location of the selling business unit. Property and equipment, total assets and capital expenditures (purchase of property and equipment) information is based on the physical location of the asset. Geographic revenue, property and equipment, net, total assets, and capital expenditures for the three years ended March 29, 2013, March 30, 2012, and April 1, 2011, are as follows:

124

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

	March 29, 2013
(Amounts in millions)	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,345	$	1,729	$	2,217	$	1,702	$	14,993
Property and Equipment, net	1,273		320		217		374		2,184
Total Assets	6,454		1,389		1,487		1,921		11,251
Capital Expenditures	290		70		80		128		568

	March 30, 2012
	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,475	$	1,576	$	2,446	$	1,867	$	15,364
Property and Equipment, net	1,406		367		237		431		2,441
Total Assets	6,198		1,329		1,115		2,547		11,189
Capital Expenditures	444		77		90		218		829

	April 1, 2011
	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,923	$	1,869	$	2,276	$	1,514	$	15,582
Property and Equipment, net	1,396		403		291		406		2,496
Total Assets	6,855		2,998		3,884		2,383		16,120
Capital Expenditures	577		116		100		179		972

The Company derives a significant portion of its revenues from departments and agencies of the U.S. federal government which accounted for 34%, 36%, and 37% of the Company’s revenues for fiscal 2013, fiscal 2012, and fiscal 2011, respectively. At March 29, 2013 and March 30, 2012, approximately 30% and 33% of the Company’s net accounts receivables was due from the U.S. federal government. No single commercial customer exceeded 10% of the Company’s revenues during fiscal 2013, fiscal 2012, or fiscal 2011.

Note 17 – Restructuring Costs

The Company recorded restructuring costs of $264 million and $140 million for fiscal years 2013 and 2012, respectively, as described below. There were no restructuring costs for fiscal 2011.

Fiscal 2013 Plan

In September 2012, the Company initiated restructuring actions (the Fiscal 2013 Plan) across its business segments. The objectives of the Fiscal 2013 Plan are to (i) further increase the use of lower cost off-shore resources, and (ii) reduce headcount in order to align resources to support business needs, including the assessment of management span of control and layers. Actions under the Fiscal 2013 Plan commenced in September 2012 and are expected to continue through fiscal 2014.

Total restructuring costs for the Fiscal 2013 Plan recorded during fiscal 2013 were $233 million, including pension benefit augmentations of $21 million, that are owed to certain employees in accordance with legal or contractual obligations, and which will be paid out over several years as part of normal pension distributions. The total restructuring costs also included $17 million of professional fees incurred for restructuring related consultancy.

125

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The composition of the restructuring liability for the Fiscal 2013 Plan as of March 29, 2013 is as follows:

(Amounts in millions)	Restructuring liability as of March 30, 2012		Costs expensed in fiscal 2013		Less: costs not affecting restructuring liability (1)			Cash paid			Other(3)			Restructuring liability as of March 29, 2013
Workforce reductions	$	—	$	206	$	(22	)	$	(27	)	$	(2	)	$	155
Facilities costs	—		10		—			—			—			10
Other(2)	—		17		—			(6		)	—			11
	$	—	$	233	$	(22	)	$	(33	)	$	(2	)	$	176

⁽¹⁾  Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾  Other direct costs associated with the restructuring program.

⁽³⁾  Foreign currency translation adjustments.

Fiscal 2012 Plan

In March 2012, the Company initiated restructuring actions (the Fiscal 2012 plan) primarily impacting its MSS segment. The objectives of the Fiscal 2012 plan were to (i) align the Company's workforce across various geographies with business needs, (ii) increase use of lower cost off-shore resources, and (iii) optimize utilization of facilities. Actions under the Fiscal 2012 plan commenced in March 2012 and were carried out through fiscal 2013.

The restructuring costs for the Fiscal 2012 plan recorded during the year ended March 29, 2013 and March 30, 2012 were $31 million and $140 million, respectively, and were associated primarily with employee terminations. The net restructuring costs include pension benefit augmentations of $1 million and $20 million for fiscal 2013 and fiscal 2012, respectively, that were due to certain employees in accordance with legal or contractual obligations, which will paid out over several years as part of normal pension distributions.

The composition of the restructuring liability for the Fiscal 2012 plan as of March 29, 2013 is as follows:

(Amounts in millions)	Restructuring liability as of March 30, 2012		Costs expensed in fiscal 2013		Less: costs not affecting restructuring liability (1)			Cash paid			Other (2)			Restructuring liability as of March 29, 2013
Workforce reductions	$	110	$	31	$	(1	)	$	(129	)	$	(2	)	$	9
Facilities costs	9		—		—			(4		)	—			5
Total	$	119	$	31	$	(1	)	$	(133	)	$	(2	)	$	14

⁽¹⁾ Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾ Foreign currency translation adjustments

The composition of the restructuring liability for the Fiscal 2012 plan as of March 30, 2012 is as follows:

(Amounts in millions)	Restructuring liability as of April 1, 2011		Costs expensed in fiscal 2012		Less: costs not affecting restructuring liability (1)			Cash paid		Other (2)			Restructuring liability as of March 30, 2012
Workforce reductions	$	—	$	131	$	(20	)	$	—	$	(1	)	$	110
Facilities costs	—		9		—			—		—			9
Total	$	—	$	140	$	(20	)	$	—	$	(1	)	$	119

⁽¹⁾ Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾ Foreign currency translation adjustments

126

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The composition of restructuring costs, by segment, for fiscal 2013 and 2012 is as follows:

	Twelve Months Ended March 29, 2013
(Amounts in millions)	Fiscal 2013 Plan		Fiscal 2012 Plan		Total
NPS	$	13	$	—	$	13
MSS	181		9		190
BSS	17		22		39
Corporate	22		—		22
Total	$	233	$	31	$	264

	Twelve Months Ended March 30, 2012
(Amounts in millions)	Fiscal 2012 Plan
NPS	$	1
MSS	108
BSS	31
Corporate	—
Total	$	140

Of the total $190 million restructuring liability as of March 29, 2013, $186 million is included in accrued expenses and other current liabilities and $4 million is included in other long-term liabilities. Of the total $119 million restructuring liability as of March 30, 2012, $112 million was included in accrued expenses and other current liabilities and $7 million was included in other long-term liabilities.

Note 18 – Contract with the U.K. National Health Service

Interim Agreement Contract Change Note

On August 31, 2012, the Company and the NHS entered into a binding interim agreement which has been approved by all required U.K. government officials ("interim agreement contract change note" or "IACCN"). The IACCN, which is described in greater detail below, amended the terms of the parties' then current contract under which the Company has developed and deployed an integrated patient records system using the Company's Lorenzo Regional Care software product. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain financial terms of the IACCN. The IACCN, and such letter agreement, forms the basis on which the parties will subsequently finalize a full restatement of the contract through a revised project agreement. The revised project agreement will consolidate the three regional contracts which comprise the Company's NHS contract into a single agreement. CSC and the NHS are in the process of negotiating the revised project agreement.

Under the IACCN, the parties redefined the scope of the Lorenzo products and established deployment and ongoing service pricing. CSC will deliver additional Lorenzo implementations based on demand from individual NHS trusts. A more flexible arrangement than under the contract terms existing prior to the IACCN has been established for these trusts to combine additional clinical modules with the core care management functionality of the Lorenzo solution to meet their specific requirements. CSC and the NHS also agreed to a process for trusts which wish to take the Lorenzo products within the NHS-designated North, Midlands and East regions of England (NME) to obtain central funding from the U.K. Department of Health for implementation of the Lorenzo products. Separately, CSC may offer the Lorenzo solution throughout the rest of England where trusts select CSC's solutions through separate competitive processes. Under the IACCN, the NHS is no longer subject to trust volume commitments and CSC has agreed to non-exclusive deployment rights in its designated regions. New trusts taking deployments of the Lorenzo product will receive ongoing managed services from CSC for a period of five years from the date of Lorenzo deployment by such trust, provided deployment is complete or substantially complete by July 2016. Beyond its Lorenzo offerings, CSC continues to provide a wide range of

127

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

other solutions and services to the NHS, including general practitioner, ambulance and community systems, digital imaging and other related services.

Pursuant to the letter agreement signed on March 28, 2013, the parties agreed to modify a small number of financial terms of the IACCN and the NHS confirmed it would make a change compensation payment in accordance with the terms of the IACCN. The NHS paid the change compensation payment of £10 million ($15 million) net of value added tax to CSC on March 28, 2013 in full and final satisfaction of all costs and claims by CSC arising from changes to the Lorenzo software product that CSC delivered up to a certain version of the product, in addition to a small number of other changes.

Historical Background Concerning NHS Contract

The Company and the NHS are parties to a contract (originally having a value of £2.9 billion or approximately $5.4 billion at originally announced exchange rates) under which the Company has developed and deployed an integrated electronic patient records system. The NHS contract was amended in April 2009 and the parties entered into variation agreements subsequent to the 2009 amendment agreeing to various operational terms and conditions. The 2009 amendment included mutual releases of all claims existing at the time of the amendment.

In 2010, as part of the U.K. government's austerity program and to address delays in development and deployments, the Company and the NHS discussed modification of the contract scope in order to reduce the total contract value by £500 million. During the fourth quarter of fiscal year 2011, additional scope modification and total contract value reduction were discussed, bringing the combined total contract value reductions to £764 million, which would have reduced the total contract value to approximately £2.1 billion or $3.2 billion (at the March 29, 2013 exchange rate). Terms related to this scope modification and contract value reduction were included in a negotiated but unsigned non-binding memorandum of understanding (MOU), which MOU included a legally binding standstill agreement which provided that, while the parties were negotiating a contract amendment to implement the terms of the MOU, neither party would pursue any claims against the other party.Negotiation of the terms of the MOU was confirmed by the NHS to be substantially completed in May 2011, but CSC was subsequently informed by the NHS in December 2011 that neither the MOU nor the related contract amendment then under discussion would be approved by the U.K. government.

Based on subsequent discussions between CSC and the NHS regarding proposals advanced by both parties reflecting significant scope modifications, a reduced commitment by the NHS for deployment of the Lorenzo software product, revised delivery and payment terms, payments by the NHS for CSC-incurred costs and commitment and contract value reductions that differed materially from those contemplated by the MOU, on March 2, 2012, CSC and the NHS entered into a non-binding letter of intent that included the statement of principles that would serve as the basis for an interim agreement between the parties. The letter of intent contemplated that under the interim agreement, the NHS would provide a commitment of a certain number of trusts to receive the Lorenzo software product, and the Lorenzo product was redefined into deployment units categorized as "Base Product" and "Additional Product" (in each case, as described below) for pricing purposes. The letter of intent also included a standstill agreement related to the Lorenzo product. While the parties originally intended to conclude a binding interim agreement byJune 29, 2012, no agreement was reached by that date. On May 31, 2012, the standstill agreement was extended to August 31, 2012. On August 31, 2012, the parties entered into the IACCN. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain financial terms of the IACCN.

Principal Components of IACCN

The IACCN sets the terms relating to the delivery of the Lorenzo product and associated services as described below.

The key terms introduced by the IACCN are as follows:

1. Under contract terms existing prior to the IACCN, the NHS was committed to purchase the Lorenzo product for multiple trusts. In addition, the Company was the exclusive supplier of such software products and related services to two out of the three regions of the U.K. covered by the existing contract. Under the IACCN, the NHS is no longer subject to any trust volume commitment for the Lorenzo product (there were no changes in quantities for non-Lorenzo deployments), and the Company agreed to non-exclusive deployment rights for all products and services in those regions in which it previously enjoyed exclusivity. As a result, the individual trusts can choose third-party software

128

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

vendors other than CSC to provide a software solution. CSC and the NHS have also agreed to a process for trusts which wish to take the Lorenzo products within the NME regions to obtain central funding from the U.K. Department of Health for implementation of the Lorenzo products. In addition, CSC may offer the Lorenzo solution throughout the rest of England where trusts select CSC's solutions through a separate competitive process.

2. The IACCN creates pricing and payment terms for the Lorenzo product and new terms under which trusts in the contract's NME region that choose the Lorenzo product can access central funds for its deployment, subject to business case justification. While the funding is provided by the NHS, there is a far greater degree of interaction with the trusts under the IACCN, as the Company works with each individual trust to build a business case and seek NHS approval and central funding to proceed.

3. The IACCN has not materially altered the terms relating to non-Lorenzo products. The Company will continue to provide non-Lorenzo deployment, hosting and maintenance services in accordance with contract terms in existence prior to the IACCN. The deployment of the non-Lorenzo products is expected to be completed or substantially completed by fiscal 2015.

4. Under the IACCN, the Lorenzo product is redefined for pricing purposes, with Lorenzo Regional Care comprising the "Base Product," consisting of seven deployment units (or modules) and the "Additional Product," consisting of three other modules. The parties agreed that six of the Base Product's modules had completed the necessary NHS assurances and were ready to deploy to further trusts as of August 31, 2012. The remaining module of the Base Product was similarly accepted by the NHS as complete and ready to deploy to further trusts in early September 2012. The Additional Product's three modules are expected to complete NHS assurance during 2013. Although the NHS assurance of the Base Product's seven modules is complete and the Company and the NHS are committed to complete the assurance of the Additional Product modules, neither the NHS nor any trust is obligated to purchase or deploy any of those modules.

5. New trusts taking deployments of the Lorenzo product will receive ongoing managed services from the Company for a period of five years from the date such deployment is complete, provided deployment is complete or substantially complete by July 7, 2016. The services include hosting of the software and trust data at the Company's data center as well as support and maintenance, including regulatory updates and other changes over the term of the contract. Under contract terms existing prior to the IACCN, all services were to expire upon the end of the contract term of July 7, 2016, subject to an optional one year extension and an exit transition period.

Accounting

Prior to the IACCN, the NHS contract has been accounted for using the percentage-of-completion method based on management's best estimates of total contract revenue and costs.Based on then existing circumstances, CSC revised its estimate of revenues and costs at completion during the third quarter of fiscal 2012 to include only those revenues reasonably assured of collection. As a result of that change, the Company recorded a $1.5 billion contract charge in that quarter, resulting in no material remaining net assets.

The terms of the IACCN represent a significant modification to the prior agreement, including a significant reduction in additional product development and elimination of any commitment by the NHS to future Lorenzo deployments and the Company's exclusivity rights in two of the three contract regions. The Company concluded that it will account for the IACCN as a new contract and will recognize revenue as a services arrangement. Revenue recognition for each trust deployment will begin at the start of the trust's hosting period. Payments from the NHS for deployment of systems will be deferred and recognized over the service period. Direct costs incurred for deployment activities will be deferred and amortized to expense over the service period as well. The total up-front consideration of £78 million ($126 million), including the £68 million ($110 million) net settlement payment and a £10 million ($16 million) escrow release, is primarily attributed to future Lorenzo deployments and will be deferred and recognized as revenue ratably over the term of the contract ending July 2016.

The £10 million ($15 million) payment received on March 28, 2013, as well as future consideration not noted above, when and if earned, will be deferred and amortized over the longer of the term of the contract or the estimated performance period.

129

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 19 – Settlement of Claims with U.S. Government

During the second quarter of fiscal 2012, the Company reached a definitive settlement agreement with the U.S. government in its contract claims asserted under the Contract Disputes Act of 1978 (CDA). Under the terms of the settlement, the Company received $277 million in cash and a five-year extension (four base years plus one option year) with an estimated value of $1 billion to continue to support and expand the capabilities of the systems covered by the original contract scheduled to expire in December 2011. In exchange, the Government received unlimited rights to the Company’s intellectual property developed to support the services delivered under the contract, and CSC dismissed the claims and terminated legal actions against the Government and the Government dismissed its counter claims against CSC. The contract extension contained a Requirements portion (Federal Acquisition Regulation (“FAR”) 16.503) and an Indefinite Quantity portion (FAR 16.504) and is not subject to any minimum values. In December 2011, the Company signed the contract modification based on the terms described above.

The Company recorded a pre-tax charge of $269 million during the second quarter of fiscal 2012 to write down its claim related assets (claim related unbilled receivables of $379 million and deferred costs of $227 million) to reflect the cash received of $277 million, the estimated fair value of the contract extension of $45 million, and previously unapplied payments of $15 million. Of the pre-tax charge of $269 million, $42 million was recorded as a reduction of revenue and $227 million as a separately itemized charge to cost of services. The fair value of the contract extension was recorded as a contract asset and will be amortized as a reduction of revenue over the four year fixed contract term in proportion to the expected revenues or on a straight line basis, whichever is greater.

These claims relate to a contract that was awarded (the “Contract”) in December 1999 as a 10 year fixed price contract. In April 2004, the contract was extended by two additional years. Revenue recorded under the core Contract was initially recognized as a single profit center using the percentage-of-completion method based on the guidance in ASC 605-35, “construction-type and production-type contracts.”

During the course of the contract, CSC incurred significant costs for out-of-scope work that was a result of Government directed changes and delays. Negotiations with the Government were initiated to recover the costs related to this work. During the second quarter of fiscal 2007, the Company filed its 14 interest bearing claims (collectively the “CDA Claims”), then totaling approximately $858 million, with the Government.  On September 11, 2007, the Company initiated litigation at the Armed Services Board of Contract Appeals (“ASBCA”), one of the two forums available for litigation of CDA claims.  

In accordance with accepted practice, the Company amended its CDA Claims twice to reflect adjustments to the total value of the CDA Claims.  On December 24, 2009, the Government made a partial payment of $35 million on one of the CDA Claims.  Thereafter, CSC filed a second amended complaint with the ASBCA reducing the value of its CDA Claims by $35 million. On November 19, 2010, the Government and the Company entered into a formal agreement to stay the CDA Claims litigation and engage in a non-binding alternate dispute resolution (“ADR”) process to resolve all outstanding CDA Claims and other issues associated with the contract. As of July 1, 2011, the Company had fourteen claims totaling approximately $675 million, excluding interest, asserted against the U.S. federal government under a single contract pending before the ASBCA.  

Prior to the settlement, the Company believed it had valid bases for pursuing recovery of the CDA Claims supported by outside counsel’s evaluation of the facts and assistance in the preparation of the claims. To verify its position, CSC requested that outside counsel analyze whether the first two conditions of Paragraph 31 of ASC 605-35-25 were satisfied with respect to the Company’s assertions of government breaches of the contract, government-caused delays and disruption to the Company’s performance of the contract, and unanticipated additional work performed by the Company under the contract. The outside counsel issued an opinion that the Company’s position met the criteria on April 22, 2005, and reiterated that opinion on May 20, 2011.

130

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 20 – Commitments and Contingencies

Commitments

The Company has operating leases for the use of certain real estate and equipment. Substantially all operating leases are non-cancelable or cancelable only by the payment of penalties. All lease payments are based on the lapse of time but include, in some cases, payments for insurance, maintenance and property taxes. There are no purchase options on operating leases at favorable terms, but most real estate leases have one or more renewal options. Certain leases on real estate are subject to annual escalations for increases in utilities and property taxes. Lease rental expense amounted to $319 million, $324 million, and $330 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. In addition, the Company also has $18 million of sublease income to be received through fiscal 2020.

Minimum fixed rentals required for the next five years and thereafter under operating leases in effect at March 29, 2013, are as follows:

Fiscal Year
(Amounts in millions)	Real Estate		Equipment
2014	$	211	$	39
2015	152		26
2016	112		9
2017	82		2
2018	51		—
Thereafter	68		—
	$	676	$	76

The Company has signed long-term purchase agreements with certain software, hardware, telecommunication and other service providers to obtain favorable pricing and terms for services and products that are necessary for the operations of business activities. Under the terms of these agreements, the Company is contractually committed to purchase specified minimums over periods ranging from one to five years. If the Company does not meet the specified minimums, the Company would have an obligation to pay the service provider all or a portion of the shortfall. Minimum purchase commitments are $478 million in fiscal 2014, $161 million in fiscal 2015, $132 million in fiscal 2016, $12 million in fiscal 2017, $2 million in fiscal 2018, and none thereafter.

In the normal course of business, the Company may provide certain clients, principally governmental entities, with financial performance guarantees, which are generally backed by stand-by letters of credit or surety bonds. In general, the Company would only be liable for the amounts of these guarantees in the event that nonperformance by the Company permits termination of the related contract by the Company’s client. As of March 29, 2013, the Company had $122 millionof outstanding letters of credit and surety bonds relating to these performance guarantees. The Company believes it is in compliance with its performance obligations under all service contracts for which there is a financial performance guarantee, and the ultimate liability, if any, incurred in connection with these guarantees will not have a material adverse affect on its consolidated results of operations or financial position.

The Company also uses stand-by letters of credit, in lieu of cash, to support various risk management insurance policies. These letters of credit represent a contingent liability and the Company would only be liable if it defaults on its payment obligations towards these policies. As of March 29, 2013, the Company had $183 million of outstanding stand-by letters of credit. Generally, such guarantees have a one-year term and are renewed annually.

131

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of March 29, 2013:

(Amounts in millions)	Fiscal 2014		Fiscal 2015		Fiscal 2016 and thereafter		Total
Surety bonds	$	29	$	1	$	—	$	30
Letters of credit	58		1		33		92
Stand-by letters of credit	37		132		14		183
Total	$	124	$	134	$	47	$	305

The Company generally indemnifies licensees of its proprietary software products against claims brought by third parties alleging infringement of their intellectual property rights (including rights in patents (with or without geographic limitations), copyright, trademarks and trade secrets). CSC’s indemnification of its licensees relates to costs arising from court awards, negotiated settlements and the related legal and internal costs of those licensees. The Company maintains the right, at its own costs, to modify or replace software in order to eliminate any infringement. Historically, CSC has not incurred any significant costs related to licensee software indemnification.

Contingencies

The Company has a contract with the NHS to develop and deploy an integrated patient records system as a part of the U.K. Government's NHS IT program. On August 31, 2012, the Company and NHS entered into a binding interim agreement contract change note, or IACCN, which amends the terms of the current contract and forms the basis on which the parties will finalize a full restatement of the contract. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain terms of the IACCN. See Note 18 for further information relating to the NHS contract and the IACCN.

As previously disclosed in fiscal 2012 and fiscal 2011, the Company initiated an investigation into out of period adjustments resulting from certain accounting errors in its MSS segment, primarily involving accounting irregularities in the Nordic region. Initially, the investigation was conducted by Company personnel, but outside Company counsel and forensic accountants retained by such counsel later assisted in the Company's investigation. On January 28, 2011, the Company was notified by the SEC's Division of Enforcement that it had commenced a formal civil investigation relating to these matters, which investigation has been expanded to other matters subsequently identified by the SEC, including matters specified in subpoenas issued to the Company from time to time by the SEC's Division of Enforcement as well as matters under investigation by the Audit Committee, as further described below. The Company is cooperating in the SEC's investigation.

On May 2, 2011, the Audit Committee commenced an independent investigation into the matters relating to the MSS segment and the Nordic region, matters identified by subpoenas issued by the SEC's Division of Enforcement, and certain other accounting matters identified by the Audit Committee and retained independent counsel to represent CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with such independent investigation. Independent counsel retained forensic accountants to assist with their work. Independent counsel also represents CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with the investigation by the SEC's Division of Enforcement.

The Audit Committee’s investigation was expanded to encompass (i) the Company’s operations in Australia, (ii) certain aspects of the Company’s accounting practices within its Americas Outsourcing operation, and (iii) certain of the Company’s accounting practices that involve the percentage-of-completion accounting method, including the Company’s contract with the NHS. In the course of the Audit Committee's expanded investigation, accounting errors and irregularities were identified. As a result, certain personnel have been reprimanded, suspended, terminated and/or have resigned. The Audit Committee determined in August 2012 that its independent investigation was complete. The Audit Committee instructed its independent counsel to cooperate with the SEC's Division of Enforcement by completing production of documents and providing any further information requested by the SEC's Division of Enforcement.

132

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In addition to the matters noted above, the SEC's Division of Enforcement is continuing its investigation involving its concerns with certain of the Company's prior disclosure and accounting determinations with respect to the Company's contract with NHS and the possible impact of such matters on the Company's financial statements for years prior to the Company's current fiscal year. The Company and the Audit Committee and its independent counsel are investigating these matters and are continuing to cooperate with the SEC's Division of Enforcement in its investigation of prior disclosures of the Company's contract with the NHS. The SEC's investigative activities are ongoing.

In addition, the SEC's Division of Corporation Finance has issued comment letters to the Company requesting, among other things, additional information regarding its previously disclosed adjustments in connection with the above-referenced accounting errors, the Company's conclusions relating to the materiality of such adjustments, and the Company's analysis of the effectiveness of its disclosure controls and procedures and its internal control over financial reporting. The SEC's Division of Corporation Finance's comment letter process is ongoing, and the Company is continuing to cooperate with that process.

The investigation being conducted by the SEC's Division of Enforcement and the review of our financial disclosures by the SEC's Division of Corporation Finance are continuing and could identify other accounting errors, irregularities or other areas of review. As a result, we have incurred and may continue to incur significant legal and accounting expenditures. We are unable to predict how long the SEC's Division of Enforcement's investigation will continue or whether, at the conclusion of its investigation, the SEC will seek to impose fines or take other actions against the Company. In addition, we are unable to predict the timing of the completion of the SEC's Division of Corporation Finance's review of our financial disclosures or the outcome of such review. Publicity surrounding the foregoing or any enforcement action as a result of the SEC's investigation, even if ultimately resolved favorably for us, could have an adverse impact on the Company's reputation, business, financial condition, results of operations or cash flows. The Company is unable to estimate any possible loss or range of loss associated with these matters at this time. See Note 2 for further information.

Between June 3, 2011, and July 21, 2011, four putative class action complaints were filed in the United States District Court for the Eastern District of Virginia, entitled City of Roseville Employee's Retirement System v. Computer Sciences Corporation, et al. (No. 1:11-cv-00610-TSE-IDD), Murphy v. Computer Sciences Corporation, et al. (No. 1:11-cv-00636-TSE-IDD), Kramer v. Computer Sciences Corporation, et al. (No. 1:11-cv-00751-TSE-IDD) and Goldman v. Computer Sciences Corporation, et al. (No. 1:11-cv-777-TSE-IDD). On August 29, 2011, the four actions were consolidated as In re Computer Sciences Corporation Securities Litigation (No. 1:11-cv-610-TSE-IDD) and Ontario Teachers' Pension Plan Board was appointed lead plaintiff. A consolidated class action complaint was filed by plaintiff on September 26, 2011, and names as defendants CSC, Michael W. Laphen, Michael J. Mancuso and Donald G. DeBuck. A corrected complaint was filed on October 19, 2011. The complaint alleges violations of the federal securities laws in connection with alleged misrepresentations and omissions regarding the business and operations of the Company. Specifically, the allegations arise from the Company's disclosure of the Company's investigation into certain accounting irregularities in the Nordic region and its disclosure regarding the status of the Company's agreement with the NHS. Among other things, the plaintiff seeks unspecified monetary damages. The plaintiff filed a motion for class certification with the court on September 22, 2011, and the defendants filed a motion to dismiss on October 18, 2011. A hearing was held on November 4, 2011.On August 29, 2012, the court issued a Memorandum Opinion and Order granting in part and denying in part the motion to dismiss. The court granted the motion to dismiss with respect to the plaintiff's claims in connection with alleged misrepresentations and omissions concerning the Company's operations in the Nordic Region. The court granted in part and denied in part the motion to dismiss with respect to the plaintiff's claims in connection with alleged misrepresentations and omissions concerning the Company's internal controls and the Company's contract with the NHS. The court also granted the plaintiff leave to amend its complaint by September 12, 2012, and maintained the stay of discovery until the sufficiency of the amended complaint had been decided. The court further denied plaintiff's motion for class certification without prejudice. On September 12, 2012, the plaintiff filed a notice advising the Court that it had determined not to amend its complaint and renewed its motion for class certification. On September 21, 2012, the court issued an Order setting the hearing on the motion for class certification for October 12, 2012, directing the parties to complete discovery by January 11, 2013 and scheduling the final pretrial conference for January 17, 2013. On October 9, 2012, the defendants filed their answer to the plaintiff's complaint. On October 12, 2012, the hearing on the motion for class certification was rescheduled to November 1, 2012. On October 31, 2012, the parties filed a joint motion with the court requesting that the hearing on the motion for class certification be rescheduled to a later date. On November 1, 2012, the court issued an order setting the hearing for class certification for November 15, 2012. On November 30, 2012, the court granted plaintiff's motion for class certification. On December 14, 2012, defendants filed with the Fourth Circuit a petition for permission to

133

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

appeal the class certification order pursuant to Federal Rule of Civil Procedure 23(f). Plaintiff's response to the petition was filed on February 20, 2013. On March 5, 2013, the Fourth Circuit denied the petition for permission to appeal the class certification order. On December 14, 2012, the court issued an order extending the expert discovery deadline to February 25, 2013. On December 20, 2012, the court issued an order extending the fact discovery deadline to February 11, 2013 and the expert discovery deadline to March 25, 2013. On January 13, 2013, the court issued an order extending the expert discovery deadline to April 1, 2013. Motions for summary judgment were filed on March 18, 2013. On May 15, 2013, the Company entered into a stipulation and agreement of settlement with the lead plaintiff to settle all claims in the lawsuit for $97.5 million, which was accrued for as of March 29, 2013 and included in accrued expenses and other current liabilities on the Company's Consolidated Balance Sheet. As of March 29, 2013, the Company has also recorded a receivable of $45 million, which represents the amount recoverable under the Company's corporate insurance policies, and is included in receivables on the Company's Consolidated Balance Sheet. The agreement is subject to approval by the court.

On September 13, 2011, a shareholder derivative action entitled Che Wu Hung v. Michael W. Laphen, et al. (CL 2011 13376) was filed in Circuit Court of Fairfax County, Virginia, against Michael W. Laphen, Michael J. Mancuso, the members of the Audit Committee and the Company as a nominal defendant asserting claims for breach of fiduciary duty and contribution and indemnification relating to alleged failure by the defendants to disclose accounting and financial irregularities in the MSS segment, primarily in the Nordic region, and the Company's performance under the NHS agreement and alleged failure to maintain effective internal controls. The plaintiff seeks damages, injunctive relief and attorneys' fees and costs. On October 24, 2011, the defendants removed the action to the United States District Court for the Eastern District of Virginia. On November 23, 2011, the plaintiff filed a motion to remand the case to state court. Argument was held on December 15, 2011. During argument the plaintiff voluntarily dismissed his complaint without prejudice to refiling the action in state court. The Court granted the plaintiff's request, dismissed the complaint without prejudice and denied the motion to remand as moot. On December 22, 2011, the plaintiff refiled his complaint in Circuit Court of Fairfax County, Virginia in a shareholder derivative action entitled Che Wu Hung v. Michael W. Laphen, et al. (CL 2011 18046). Named as defendants are Michael W. Laphen, Michael J. Mancuso, the members of the Audit Committee and the Company as a nominal defendant. The complaint asserts claims for (i) breach of fiduciary duty relating to alleged failure by the defendants to disclose accounting and financial irregularities in the MSS segment, primarily in the Nordic region, the Company's performance under the NHS agreement and alleged failure to maintain effective internal controls and (ii) corporate waste. The plaintiff seeks damages, injunctive relief and attorneys' fees and costs. On April 6, 2012, the state court stayed the action until the earlier of (i) entry of an order on the pending motion to dismiss In re Computer Sciences Corporation Securities Litigation (No. 1:11-cv-610-TSE-IDD) or (ii) July 5, 2012. On July 20, 2012, the state court renewed the stay until the earlier of (i) entry of an order on the pending motion to dismiss in In re Computer Sciences Corporation Securities Litigation or (ii) October 18, 2012. The stay expired on August 30, 2012 with the entry of the court's order in In re Computer Sciences Corporation Securities Litigation. On October 19, 2012, upon the joint motion of the parties, the state court issued an order staying the action while discovery proceeds in In re Computer Sciences Corporation Securities Litigation. The order requires defendants to provide to the plaintiff certain of the discovery produced in the federal action. On May 10, 2013, the court continued the stay to May 31, 2013 upon joint motion of the parties. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

On May 11, 2012, a separate shareholder derivative action entitled Judy Bainto v. Michael W. Laphen et al. (No. A-12-661695-C), was filed in District Court, Clark County, Nevada, against Messrs. Laphen and Mancuso, members of the Company's Board of Directors and the Company as a nominal defendant. The complaint is substantively similar to the second Hung complaint. On or about August 1, 2012, the court granted the parties' joint motion to extend the time for defendants to respond to the complaint to sixty days after the United States District Court for the Eastern District of Virginia's entry of an order on the pending motion to dismiss the complaint in In re Computer Sciences Corporation Securities Litigation. On September 5, 2012, Defendants notified the court of the Eastern District of Virginia's ruling in In re Computer Sciences Corporation Securities Litigation. On September 11, 2012, the parties filed a joint status report proposing a schedule for the filing of an amended complaint by plaintiff and for motion to dismiss briefing. Plaintiff filed an amended complaint on September 28, 2012. Upon stipulation of the parties, the court consolidated the Bainto case and Himmel case (described below) and deemed the amended complaint filed in Bainto the operative complaint. In addition, on November 8, 2012, upon joint motion of the parties, the court issued an order staying the action while discovery proceeds in In re Computer Sciences Corporation Securities Litigation. The order requires Defendants to provide to the Plaintiffs certain of the discovery produced in the federal action. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

134

COMPUTER SCIENCES CORPORATION - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On October 16, 2012, a separate shareholder derivative action entitled Daniel Himmelv. Michael W. Laphen et al. (No. A-12-670190-C), was filed in District Court, Clark County, Nevada, against Messrs. Laphen and Mancuso, members of the Company's Board of Directors and the Company as a nominal defendant. The Himmel complaint is substantively similar to the Bainto complaint, but includes a claim for unjust enrichment and seeks additional injunctive relief. Upon stipulation of the parties, the court consolidated the Bainto case (describe above) and the Himmel case and deemed the amended complaint filed in Bainto the operative complaint. In addition, on November 8, 2012, upon joint motion of the parties, the court issued an order staying the action while discovery proceeds in In re Computer Sciences Corporation Securities Litigation. The order requires Defendants to provide to the Plaintiffs certain of the discovery produced in the federal action. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

On December 20, 2012, a separate shareholder derivative complaint entitled Shirley Morefield v Irving W. Bailey, II, et al, (Case No. 1:120V1468GBL/TCB) was filed in the United States District Court for the Eastern District of Virginia. The complaint names certain of CSC's current and former directors and officers as defendants and the Company as a nominal defendant. The complaint is similar to the Hung complaint but asserts only a claim for breach of fiduciary duty and alleges that the plaintiff made a demand on the CSC Board prior to commencing suit and that such demand was refused. Motions to dismiss were filed March 18, 2013. On April 8, 2013, Plaintiff filed an amended complaint. Motions to dismiss the amended complaint were filed on April 17, 2013 and were heard on May 10, 2013. A decision is pending. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

On October 19, 2012, a putative class action complaint was filed in the United States District Court of the Southern District of Indiana, entitled Andrea M. Childress v. Experian Information Services, Inc. and CSC Credit Services , Inc. The complaint alleges Fair Credit Reporting Act claims regarding reports prepared about consumers who filed for Chapter 13 bankruptcy protection and subsequently withdrew their bankruptcy filing before court approval of a bankruptcy plan. Plaintiff, on behalf of the class, seeks statutory and punitive damages, injunctive relief and attorneys' fees. On February 4, 2013, CSC was dismissed without prejudice from this lawsuit by plaintiff's notice filed with the court.

The Company's net legal expenses associated with the SEC investigation and class action lawsuits were $33 million, $67 million, and $2 million, for fiscal years 2013, 2012 and 2011, respectively. During fiscal 2013, the Company incurred $78 million, which was partially offset by $45 million of insurance claims.

In addition to the matters noted above, the Company is currently party to a number of disputes which involve or may involve litigation. The Company consults with legal counsel on those issues related to litigation and seeks input from other experts and advisors with respect to such matters in the ordinary course of business. Whether any losses, damages or remedies ultimately resulting from such matters could reasonably have a material effect on the Company's business, financial condition, results of operation, or cash flows will depend on a number of variables, including, for example, the timing and amount of such losses or damages (if any) and the structure and type of any such remedies.  For these reasons, it is not possible to make reasonable estimates of the amount or range of loss that could result from these other matters at this time. Company management does not, however, presently expect any of such other matters to have a material impact on the consolidated financial statements of the Company.

Note 21 – Subsequent Events

On May 15, 2013, CSC and the lead plaintiff in the lawsuit entitled In re Computer Sciences Corporation Securities Litigation (No. 1:11-cv-610-TSE-IDD) pending in the United States District Court for the Eastern District of Virginia entered into a stipulation and agreement of settlement to settle all claims in the lawsuit for $97.5 million. The agreement is subject approval by the court (see Note 20).

On May 13, 2013, CSC entered into an agreement to sell its flood-insurance-related business process outsourcing practice to a financial investor for cash consideration of $46 million. The Company expects to record a gain on the disposal of approximately $31 million.

135

Selected Quarterly Financial Data (Unaudited)

	Fiscal 2013(2)
(Amounts in millions, except per-share amounts)	1st Quarter		2nd Quarter			3rd Quarter			4th Quarter
Revenues	$	3,829	$	3,731		$	3,736		$	3,697
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs of $238 (2013))	3,155		2,905			2,955			2,836
Restructuring costs	27		58			26			153
Income from continuing operations before taxes	47		172			151			110
Income from continuing operations, net of taxes	25		121			120			249
Income from discontinued operations, net of taxes	17		17			393			37
Net income attributable to CSC common shareholders	40		130			510			281
Earnings per common share continuing operations(1)
Basic
Income from continuing operations	$	0.15	$	0.73		$	0.76		$	1.60
Income from discontinued operations	$	0.11	$	0.11		$	2.53		$	0.24
Diluted
Income from continuing operations	$	0.15	$	0.72		$	0.75		$	1.57
Income from discontinued operations	$	0.11	$	0.11		$	2.52		$	0.24
	Fiscal 2012(2)
(Amounts in millions, except per-share amounts)	1st Quarter		2nd Quarter			3rd Quarter			4th Quarter(3)
Revenues	$	3,891	$	3,841		$	3,646		$	3,986
Cost of services (excluding depreciation and amortization, specified contract charge, settlement charge and restructuring costs of $137 (2012))	3,253		3,191			3,150			3,425
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	—		—			1,281			—
Cost of services – settlement charge (excludes amount charged to revenue of $42)	—		227			—			—
Goodwill impairment	—		2,685			60			—
Restructuring costs	—		—			—			140
Income (loss) from continuing operations before taxes	76		(2,883		)	(1,463		)	(184		)
Income (loss) from continuing operations, net of taxes	87		(2,850		)	(1,426		)	(181		)
Income (loss) from discontinued operations, net of taxes	98		(16		)	35			28
Net income (loss) attributable to CSC common shareholders	183		(2,877		)	(1,390		)	(158		)
Earnings (loss) per common share continuing operations(1)
Basic
Income (loss) from continuing operations	$	0.55	$	(18.46	)	$	(9.19	)	$	(1.20	)
Income (loss) from discontinued operations	$	0.63	$	(0.10	)	$	0.23		$	0.18
Diluted
Income (loss) from continuing operations	$	0.54	$	(18.46	)	$	(9.19	)	$	(1.20	)
Income (loss) from discontinued operations	$	0.63	$	(0.10	)	$	0.23		$	0.18

⁽¹⁾  Quarterly earnings per share (EPS) amounts may not total to the full year EPS. EPS is calculated based on weighted average shares outstanding for the period. Quarterly weighted average shares may not equal the full year weighted average shares for the fiscal year.

⁽²⁾  As discussed in Note 2, the Company recorded various out of period adjustments in fiscal 2013 and fiscal 2012. The additional tables below reflect the net effect on the reported amounts above if the adjustments had been reported in the appropriate quarter. There was no change to discontinued operations figures from the out of period adjustments.

⁽³⁾  As discussed in Note 6, in the fourth quarter of fiscal 2012, the Company recognized significant impairments of tangible and intangible assets associated primarily with long-term contracts and significant adverse changes in long-term contracts accounted for under the percentage-of-completion method

136

The following tables show the net effect of the out of period adjustments on selected quarterly reported amounts:

Increase (Decrease)	Fiscal 2013
(Amounts in millions, except per-share amounts)	1st Quarter			2nd Quarter		3rd Quarter			4th Quarter
Revenues	$	8		$	5	$	5		$	(4	)
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs of $238 (2013))	(1		)	13		4			(10		)
Income from continuing operations before taxes	3			3		4			(4		)
Net income attributable to CSC common shareholders	(1		)	2		(30		)	22
Earnings per common share continuing operations
Basic	$	(0.01	)	$	0.01	$	(0.01	)	$	(0.04	)
Diluted	$	(0.01	)	$	0.01	$	(0.01	)	$	(0.04	)

Increase (Decrease)	Fiscal 2012
(Amounts in millions, except per-share amounts)	1st Quarter			2nd Quarter		3rd Quarter			4th Quarter
Revenues	$	(12	)	$	9	$	46		$	13
Cost of services (excluding depreciation and amortization, specified contract charge, settlement charge and restructuring costs of $137 (2012))	(17		)	7		(21		)	4
Cost of services - specified contract charge (excludes amount charged to revenue of $204)	(1		)	—		2			2
Income (loss) from continuing operations before taxes	7			15		50			14
Net income (loss) attributable to CSC common shareholders	6			26		38			5
Earnings (loss) per common share continuing operations
Basic	$	0.04		$	0.17	$	0.24		$	0.03
Diluted	$	0.04		$	0.17	$	0.24		$	0.03

137

COMPUTER SCIENCES CORPORATION AND SUBSIDIARIES

SCHEDULE II, VALUATION AND QUALIFYING ACCOUNTS

(Amounts in millions)	Balance, beginning of period		Charged to cost and expenses		Other(1)			Deductions			Balance, end of period
For year ended March 29, 2013
Allowance for doubtful receivables	$	51	$	16	$	(1	)	$	(18	)	$	48
For year ended March 30, 2012
Allowance for doubtful receivables	46		18		10			(23		)	51
For the year ended April 1, 2011
Allowance for doubtful receivables	47		7		2			(10		)	46

⁽¹⁾  Includes balances from acquisitions, changes in balances due to foreign currency exchange rates and recovery of prior-year charges.

138

Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

“Disclosure controls and procedures” are the controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports filed or submitted by it under the Securities Exchange Act of 1934, as amended (Exchange Act) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. “Disclosure controls and procedures” include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in its Exchange Act reports is accumulated and communicated to the issuer’s management, including its principal executive and financial officers, as appropriate to allow timely decisions regarding required disclosure.

Under the direction of the Company’s Chief Executive Officer and Chief Financial Officer, the Company has evaluated its disclosure controls and procedures as of March 29, 2013 to ensure (i) that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and (ii) that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including the principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of March 29, 2013.

139

Management’s Report on Internal Control over Financial Reporting

The management of Computer Sciences Corporation (the Company) is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the consolidated financial statements for external reporting purposes in accordance with accounting principles generally accepted in the United States of America.

The Company’s internal control over financial reporting includes policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, and receipts and expenditures are being made only in accordance with authorization of management and the directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the Company’s consolidated financial statements. All internal controls, no matter how well designed, have inherent limitations. Therefore, even where internal control over financial reporting is determined to be effective, it can provide only reasonable assurance. Projections of any evaluation of effectiveness to future periods are subject to the risk controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

As of the end of the Company’s 2013 fiscal year, management conducted an assessment of the effectiveness of the Company’s internal control over financial reporting based on the framework established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  Based on this assessment, management has determined that the Company’s internal control over financial reporting, as of March 29, 2013, was effective.

The Company’s internal control over financial reporting as of March 29, 2013, has been audited by the Company’s independent registered public accounting firm, as stated in their report appearing on page 142.

Date: May 15, 2013

140

Changes in Internal Controls Over Financial Reporting

There were no changes in internal controls during the fiscal quarter ended March 29, 2013, which materially affected or are reasonably likely to materially affect, the Company's internal control over financial reporting.

141

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Computer Sciences Corporation

Falls Church, Virginia

We have audited the internal control over financial reporting of Computer Sciences Corporation and subsidiaries (the "Company") as of March 29, 2013, based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company's internal control over financial reporting is a process designed by, or under the supervision of, the company's principal executive and principal financial officers, or persons performing similar functions, and effected by the company's board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 29, 2013, based on the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements and financial statement schedule as of and for the fiscal year ended March 29, 2013 of the Company and our report dated May 15, 2013 expressed an unqualified opinion on those financial statements and financial statement schedule.

/s/ DELOITTE & TOUCHE LLP

McLean, Virginia

May 15, 2013

142

Item 9B. Other Information

None.

PART III

Certain information required by Part III is omitted from this Annual Report on Form 10-K and is incorporated herein by reference to the definitive proxy statement with respect to our 2013 Annual Meeting of Stockholders (the “Proxy Statement”), which we will file with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year covered by this Report.

Item 10. Directors, Executive Officers and Corporate Governance

Information regarding executive officers of the Company is included in Part I under the caption “Executive Officers of the Registrant.” Other information required by this Item will appear in the Proxy Statement under the headings “Proposal 1-Election of Directors”; "Additional Information-Section 16(a) Beneficial Ownership Reporting Compliance"; “Corporate Governance”; and “Additional Information-Business for 2013 Annual Meeting,” which sections are incorporated herein by reference.

Information about the Code of Business Conduct governing our Chief Executive Officer, Chief Financial Officer, Controller can be found on our website, www.csc.com, under the Investor Relations - Corporate Governance tab.

The Company intends to disclose required information regarding any amendment to or waiver under the Code of Business Conduct referred to above by posting such information on our website within four business days after any such amendment or waiver.

Item 11. Executive Compensation

Information required by this Item will appear in the Proxy Statement under the headings “Executive Compensation” and “Corporate Governance,” which sections are incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table gives information about our Common Stock that may be issued under our equity compensation plans as of March 29, 2013. See Note 14, “Stock Incentive Plans,” to the Consolidated Financial Statements included herein for information regarding the material features of these plans.

Plan category	Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)	Weighted-average exercise price of outstanding options, warrants and rights (b)		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)
Equity compensation plans approved by security holders	17,591,879	$	37.21	12,049,759	1
Equity compensation plans not approved by security holders	—	—		—
Total	17,591,879			12,049,759

¹Includes 3,000 shares available for future issuance under the 2006 Non-Employee Director Incentive Plan. This plan permits shares to be issued pursuant to stock options, restricted stock, and RSUs. Includes 69,400 shares available for future issuance under the 2010 Non-Employee Director Incentive Plan. This plan permits shares to be issued pursuant to RSUs and restricted stock.

Includes 2,291,508 and 1,908,592 shares available for future issuance under the 2004 and 2007 Incentive Plans, respectively. Each of these plans permits shares to be issued pursuant to stock options, restricted stock or RSUs, or pursuant to performance awards payable in shares of CSC stock, restricted stock, RSUs or any combination of the foregoing. Of the shares available for issuance under the 2007 plan, 1,908,592 shares are available for future grant as stock options with each option granted counted as one share against the available shares under such plan or assuming no options are granted, 954,296 shares are available for future awards of restricted stock or RSUs, after giving effect to the requirement set forth in the 2007 plan that a grant of one share of restricted stock or one RSU be counted as two shares against the available shares under such plan.

Includes 7,777,259 shares available for future granting under the 2011 Omnibus Incentive Plan. This plan permits shares to be issued pursuant to stock options, restricted stock or RSUs, or pursuant to performance awards payable in shares of CSC stock, restricted stock, RSUs or any

143

combination of the foregoing. Of the shares available for issuance under the 2011 Omnibus Incentive Plan, 7,777,259 shares are available for future grant as stock options with each option granted counted as one share against the available shares under such plan or assuming no options are granted, 3,888,630 shares are available for future awards of restricted stock or RSUs, after giving effect to the requirement set forth in the 2011 Omnibus Incentive Plan that a grant of one share of restricted stock or one RSU be counted as two shares against the available shares under such plan.

Other information required by this Item will appear in the Proxy Statement under the heading “Stock Ownership,” which section is incorporated herein by reference.

144

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information required by this Item will appear in the Proxy Statement under the heading “Corporate Governance,” which section is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services

Information required by this Item will appear in the Proxy Statement under the heading “Proposal 5-Ratification of Independent Auditors-Fees,” which section is incorporated herein by reference.

Item 15. Exhibits, Financial Schedules

(1) and (2) Consolidated Financial Statements and Financial Statement Schedule

These documents are included in the response to Item 8 of this report. See the index on page 58.

(3) Exhibits

The following exhibits are filed with this report or incorporated by reference to other filings listed on the Exhibit Index.

Exhibit Number	Description of Exhibit
2.1	Scheme Implementation Agreement by and among Computer Sciences Corporation, CSC Computer Sciences Australia Holdings Pty Limited, and iSOFT Group Limited (incorporated by reference to Exhibit 2 to the Company's Current Report on Form 8-K (filed on April 5, 2011) (file number 11739300))
3.1	Amended and Restated Articles of Incorporation filed with the Nevada Secretary of State on August 9, 2010 (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 2, 2010 (filed August 11, 2010) (file number 101007138))
3.2	Amended and Restated Bylaws dated as of February 7, 2012 (incorporated by reference to Exhibit 3.2 to the Company's Annual Report on Form 10-K for the fiscal year ended March 30, 2012 (filed May 29, 2012) (file number 12874585))
4.1	Indenture dated as of March 3, 2008, for the 5.50% senior notes due 2013 and the 6.50% senior notes due 2018 (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K (filed September 15, 2008) (file number 081071955))
4.2	Indenture dated as of February 10, 2003, by and between the Company and Citibank, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K (filed February 14, 2003) (file number 03568367))
4.3	First Supplemental Indenture dated as of February 14, 2003, by and between the Company and Citibank, N.A., as trustee, and attaching a specimen form of the Notes (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K (filed February 14, 2003) (file number 03568367))
4.4	Indenture dated as of September 18, 2012, for the 2.500% senior notes due 2015 and the 4.450% senior notes due 2022 by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K (filed September 19, 2012) (file number 121100352))
4.5	First Supplemental Indenture dated as of September 18, 2012, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, and attaching a specimen form of the 2.500% Senior Notes due 2015 and the 4.450% Senior Notes due 2022 (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K (filed September 19, 2012) (file number 121100352))
4.6	2.500% Senior Note due 2015 (in global form), dated September 18, 2012, among the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K (filed September 19, 2012) (file number 121100352))
4.7	4.450% Senior Note due 2022 (in global form), dated September 18, 2012, among the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K (filed September 19, 2012) (file number 121100352))
10.1	Asset Purchase Agreement, dated as of December 1, 2012, by and among Computer Sciences Corporation, CSC Credit Services, Inc., Equifax Inc. and Equifax Information Services LLC (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (filed December 3, 2012) (file number 121236237))
10.2	Term Loan Agreement, dated as of September 18 , 2012, by and between the Company, the financial institutions named therein, as lenders, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated September 19, 2012) (filed September 19, 2012) (file number 121100352)
10.3	Credit Agreement dated as of March 18, 2011 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated March 18, 2011) (filed March 22, 2011) (file number 11704203)

145

10.4	1998 Stock Incentive Plan(1) (incorporated by reference to Exhibit 10.10 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 3, 1998) (filed August 14, 1998) (file number 98687059)
10.5	2001 Stock Incentive Plan(1) (incorporated by reference to Appendix B to the Company's Proxy Statement for the Annual Meeting of Stockholders held on August 13, 2001) (filed June 29, 2001) (file number 1672145)
10.6	2004 Incentive Plan(1) (incorporated by reference to Appendix B to the Company's Proxy Statement for the Annual Meeting of Stockholders held on August 9, 2004) (filed June 30, 2004) (file number 04890067)
10.7	2007 Employee Incentive Plan(1) (incorporated by reference to Appendix B to the Company's Proxy Statement for the Annual Meeting of Stockholders held on July 30, 2007) (filed June 29, 2007) (file number 07948632)
10.8	2011 Omnibus Incentive Plan(1) (incorporated by reference to Appendix B to the Company's Proxy Statement for the Annual Meeting of Stockholders held on August 8, 2011) (filed June 24, 2011) (file number 11929448)
10.9	Form of Award Agreement for Employees(1) (incorporated by reference to Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010) (filed February 9, 2011) (file number 11585668)
10.10	Form of Stock Option Agreement for Employees(1) (incorporated by reference to Exhibit 10.7 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010) (filed February 9, 2011) (file number 11585668)
10.11	Form of International Stock Option Agreement for Employees(1) (incorporated by reference to Exhibit 10.8 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010) (filed February 9, 2011) (file number 11585668)
10.12	Form Stock Option Schedule for United Kingdom Employees under the 2001 Employee Incentive Plan(1) (incorporated by reference to Exhibit 10.9 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2011) (filed August 10, 2011) (file number 111024699)
10.13	Form of Restricted Stock Agreements for Employees(1) (incorporated by reference to Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2005) (filed August 5, 2005) (file number 051002523))
10.14	Form of Service Based Restricted Stock Unit Agreement for Employees(1) (incorporated by reference to Exhibit 10.10 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010) (filed February 9, 2011) (file number 11585668)
10.15	Form of Performance Based Restricted Stock Unit Agreement for Employees(1) (incorporated by reference to Exhibit 10.11 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010) (filed February 9, 2011) (file number 11585668)
10.16	Form of Career Shares Restricted Stock Unit Agreement for Employees(1) (incorporated by reference to Exhibit 10.12 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010) (filed February 9, 2011) (file number 11585668)
10.17	Form of International Service Based Restricted Stock Unit Agreement for Employees(1) (incorporated by reference to Exhibit 10.14 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2011) (filed August 10, 2011) (file number 111024699)
10.18	Form of International Performance Based Restricted Stock Unit Agreement for Employees(1) (incorporated by reference to Exhibit 10.15 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2011) (filed August 10, 2011) (file number 111024699)
10.19	Form of International Career Shares Restricted Stock Unit Agreement for Employees(1) (incorporated by reference to Exhibit 10.16 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2011) filed August 10, 2011) (file number 111024699)
10.20	Form of Senior Management and Key Employee Severance Agreement, as amended and restated effective May 20, 2009(1) (incorporated by reference to Exhibit 10.31 to the Company's Annual Report on Form 10-K for the fiscal year ended April 3, 2009) (filed May 29, 2009) (file number 09858607))
10.21	Supplemental Executive Retirement Plan No. 2, effective December 3, 2007(1) (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K dated December 3, 2007) (filed December 4, 2007) (file number 071283050))
10.22	Excess Plan, effective December 3, 2007(1) (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated December 3, 2007) (filed December 4, 2007) (file number 071283050)
10.23	Employment Agreement, dated February 7, 2012, between the Company and J. Michael Lawrie(1) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated February 7, 2012) (filed February 8, 2012) (file number 12581529)
10.24	Service Based Inducement Restricted Stock Unit Award Agreement, dated April 16, 2012, between the Company and J. Michael Lawrie(1) (incorporated by reference to Exhibit 10.21 to the Company's Annual Report on Form 10-K for the fiscal year ended March 30, 2012) (filed May 29, 2012) (file number 12874585)
10.25	Fiscal Year 2013 CEO Stock Option Award Agreement, dated April 16, 2012, between the Company and J. Michael Lawrie(1) (incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K for the fiscal year ended March 30, 2012) (filed May 29, 2012) (file number 12874585))
10.26	Performance Based Inducement Restricted Stock Unit Award Agreement, dated April 16, 2012, between the Company and J. Michael Lawrie(1) (incorporated by reference to Exhibit 10.23 to the Company's Annual Report on Form 10-K for the fiscal year ended March 30, 2012) (filed May 29, 2012) (file number 12874585)

146

10.27	Service Based Inducement Restricted Stock Unit Award Agreement, dated June 15, 2012, between the Company and Paul N. Saleh(1) (incorporated by reference to Exhibit 10.24 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 29, 2012) (filed August 8, 2012) (file number 121016715)
10.28	Service Based Inducement Restricted Stock Unit Award Agreement, dated July 16, 2012, between the Company and Sunita Holzer(1) (incorporated by reference to Exhibit 10.25 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 29, 2012) (filed August 8, 2012) (file number 121016715))
10.29	Form of Performance Based Restricted Stock Unit Award Agreement for Employees(1) (incorporated by reference to Exhibit 10.26 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 29, 2012) (filed August 8, 2012)2012) (file number 121016715)
10.30	Form of International Performance Based Restricted Stock Unit Award Agreement for Employees(1) (incorporated by reference to Exhibit 10.27 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 29, 2012) (filed August 8, 2012) (file number 121016715)
10.31	Service Based Inducement Stock Option Award Agreement, dated August 15, 2012, between the Company and Thomas E. Hogan(1) (incorporated by reference to Exhibit 10.28 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 28, 2012) (filed November 6, 2012) (file number 121182933))
10.32	Deferred Compensation Plan, amended and restated effective December 31, 2012(1) (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q dated February 5, 2013) (filed February 5, 2013) (file number 13572100))
10.33	Severance Plan for Senior Management and Key Employees, amended and restated effective October 28, 2007(1) (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K dated October 28, 2007) (filed November 1, 2007) (file number 071207160)
10.34	Amended and Restated Management Agreement with Michael W. Laphen, effective December 20, 2010(1) (incorporated by reference to Exhibit 10.19 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2010) (filed February 9, 2011) (file number 11585668)
10.35	Form of Indemnification Agreement for officers and directors(1) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated February 18, 2010) (filed February 22, 2010) (file number 10622679)
10.36	2010 Non-Employee Director Stock Incentive Plan(1) (incorporated by reference to Appendix E to the Company's Proxy Statement for the Annual Meeting of Stockholders held on August 9, 2010) (filed June 25, 2010) (file number 10916246)
10.37	1997 Nonemployee Director Stock Incentive Plan(1) (incorporated by reference to Appendix A to the Company's Proxy Statement for the Annual Meeting of Stockholders held on August 11, 1997) (filed July 2, 1997) (file number 97522260)
10.38	2006 Nonemployee Director Incentive Plan(1) (incorporated by reference to Appendix B to the Company's Proxy Statement for the Annual Meeting of Stockholders held on July 31, 2006) (filed June 22, 2006) (file number 06918523)
10.39	Form of Restricted Stock Unit Agreement for directors(1) (incorporated by reference to Exhibit 10.18 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2005) (filed August 5, 2005) (file number 051002523)
10.40	Form of Amendment to Restricted Stock Unit Agreement for directors (1) (incorporated by reference to Exhibit 10.35 to the Company's Current Report on Form 8-K dated December 5, 2005) (filed December 6, 2005) (file number 051246311)
10.41	Form of Restricted Stock Unit Agreement for directors pursuant to the 2010 Non-Employee Director Incentive Plan(1) (incorporated by reference to Exhibit 10.32 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 1, 2011) (filed August 10, 2011) (file number 111024699)
10.42	Retention Letter with William L. Deckelman, Jr. effective August 22, 2011(1) (incorporated by reference to Exhibit 10.34 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2011) (filed November 9, 2011 (file number 111191131)
10.43	Retention Letter with Peter Allen effective August 22, 2011(1) (incorporated by reference to Exhibit 10.35 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2011) (filed November 9, 2011 (file number 111191131)
10.44	Retention Letter with Randy Phillips, effective October 16, 2011(1)(incorporated by reference to Exhibit 10.37 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 30, 2011) (filed February 8, 2012) (file number 12581569)
10.45	Succession Agreement with Michael W. Laphen effective October 18, 2011(1) (incorporated by reference to Exhibit 10.36 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 30, 2011) (filed February 8, 2012) (file number 12581569)
10.46	Separation Agreement with Russell H. Owen effective September 16, 2011 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K dated September 16, 2011) (filed September 16, 2011) (file number 111094271)
21	Significant Active Subsidiaries and Affiliates of the Registrant
23	Consent of Independent Registered Public Accounting Firm
31.1	Section 302 Certification of the Chief Executive Officer
31.2	Section 302 Certification of the Chief Financial Officer
32.1	Section 906 Certification of Chief Executive Officer
32.2	Section 906 Certification of Chief Financial Officer

147

99.1	Revised Financial Information Disclosure as a result of the Company's restructuring (incorporated by reference to Exhibits 99.01, 99.02 and 99.03 to the Company's Current Report on Form 8-K dated December 16, 2008) (filed December 16, 2008) (file number 081252513)
101.INS	XBRL Instance
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation
101.LAB	XBRL Taxonomy Extension Labels
101.PRE	XBRL Taxonomy Extension Presentation
	(1) Management contract or compensatory plan or agreement

148

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			COMPUTER SCIENCES CORPORATION
Dated:	May 15, 2013	By:	/s/ J. Michael Lawrie
		Name:	J. Michael Lawrie
		Title:	President and Chief Executive Officer

149

Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

Signature	Title	Date
/s/ J. Michael Lawrie	President, Chief Executive Officer and Director	May 15, 2013
J. Michael Lawrie	(Principal Executive Officer)
/s/ Paul N. Saleh	Executive Vice President and Chief Financial Officer	May 15, 2013
Paul N. Saleh	(Principal Financial Officer)
/s/ Thomas R. Colan	Vice President and Controller	May 15, 2013
Thomas R. Colan	(Principal Accounting Officer)
/s/ Rodney F. Chase	Chairman of the Board of Directors	May 15, 2013
Rodney F. Chase
	Director
Irving W. Bailey
/s/ David J. Barram	Director	May 15, 2013
David J. Barram
/s/ Stephen L. Baum	Director	May 15, 2013
Stephen L. Baum
/s/ Erik Brynjolfsson	Director	May 15, 2013
Erik Brynjolfsson
/s/ Judith R. Haberkorn	Director	May 15, 2013
Judith R. Haberkorn
/s/ Chong Sup Park	Director	May 15, 2013
Chong Sup Park
/s/ Lawrence A. Zimmerman	Director	May 15, 2013
Lawrence A. Zimmerman

150

EX-21

Exhibit 21

COMPUTER SCIENCES CORPORATION

Significant Active Subsidiaries and Affiliates

As of March 29, 2013

Name	Jurisdiction of Organization
42SIX, LLC	Maryland
Alliance-One Services, Inc.	Delaware
Applabs Limited	United Kingdom
AppLabs Technologies (UK) PVT Ltd	United Kingdom
AppLabs Technologies Private Limited	India
Beijing CSA Computer Sciences Technology Company Limited	P.R.C.
Bridgeforward Software Limited	United Kingdom
Centauri Solutions LLC	Delaware
Century Credit Corporation	Nevada
Century Leasing Corporation	Nevada
Century LLC	Nevada
Century Subsidiary Corporation	Nevada
Computer Sciences Canada Inc.	Canada
Computer Sciences Corporation Business Process Services India Ltd.	India
Computer Sciences Corporation CSCEcuador S.A.	Ecuador
Computer Sciences Corporation d.o.o Beograd	Serbia
Computer Sciences Corporation India Private Limited	India
Computer Sciences España, S.A.	Spain
Computer Sciences Raytheon	Florida
Computer Sciences UK Limited	United Kingdom
Continental Grand, Limited Partnership	Nevada
Continuum (UK) Holdings Limited	United Kingdom
Continuum SOCS S.A.S.	France
Covansys (Asia Pacific) Pte Ltd.	Singapore
Covansys Netherlands B.V.	Netherlands
Covansys S.L.	Spain
CSA (PRC) Company Limited	Hong Kong
CSA MSC Sdn Bhd	Malaysia
CSC (Thailand) Ltd	Thailand
CSC Airline Solutions Danmark A/S	Denmark
CSC Applied Technologies LLC	Delaware
CSC Arabia Ltd.	Saudi Arabia
CSC Asia Holdings Pte Ltd.	Singapore
CSC Australia Pty. Limited	Australia
CSC BPS India Ltd. (f/k/a Fortune InfoTech Ltd.)	India
CSC Bulgaria E.O.O.D.	Bulgaria
CSC Business Systems Limited	United Kingdom
CSC Computer Sciences (Middle East) Limited	United Kingdom
CSC Computer Sciences (Portugal) Lda	Portugal
CSC Computer Sciences (South Africa) (pty) Limited	South Africa
CSC Computer Sciences Argentina S.R.L.	Argentina
CSC Computer Sciences Australia Holdings Pty Limited	Australia
CSC Computer Sciences B.V.	Netherlands
CSC Computer Sciences Bahrain W.L.L.	Bahrain
CSC Computer Sciences Brasil S/A	Brazil
CSC Computer Sciences Capital Limited	United Kingdom
CSC Computer Sciences Capital S.a.r.l.	Luxembourg
CSC Computer Sciences Chile Inversiones Ltda	Chile
CSC Computer Sciences Colombia Ltda.	Colombia
CSC Computer Sciences Consulting Austria GmbH	Austria
CSC Computer Sciences Corporation (Costa Rica), S.A.	Costa Rica
CSC Computer Sciences Corporation Chile S.A.	Chile

1

CSC Computer Sciences do Brasil Ltda.	Brazil
CSC Computer Sciences Egypt Ltd	Egypt
CSC Computer Sciences Financing LLP	United Kingdom
CSC Computer Sciences Finland OY	Finland
CSC Computer Sciences GmbH	Germany
CSC Computer Sciences Holdings France SAS	France
CSC Computer Sciences Holdings S.a.r.l.	Luxembourg
CSC Computer Sciences Honduras, S.A.	Honduras
CSC Computer Sciences International Holdings Limited	United Kingdom
CSC Computer Sciences International Inc.	Nevada
CSC Computer Sciences International Limited	United Kingdom
CSC Computer Sciences International Operations Limited	United Kingdom
CSC Computer Sciences International S.a.r.l.	Luxembourg
CSC Computer Sciences International Services Limited	United Kingdom
CSC Computer Sciences Ireland Limited	Ireland
CSC Computer Sciences Italia S.R.L.	Italy
CSC Computer Sciences Limited	United Kingdom
CSC Computer Sciences Luxembourg SA	Luxembourg
CSC Computer Sciences Nicaragua, Sociedad Anomia	Nicaragua
CSC Computer Sciences Peru S.R.L.	Peru
CSC Computer Sciences Polska Sp. zO.O	Poland
CSC Computer Sciences Romania S.R.L	Romania
CSC Computer Sciences S. de R.L. de C.V.	Mexico
CSC Computer Sciences S.A.	Luxembourg
CSC Computer Sciences S.A.S.	France
CSC Computer Sciences s.r.o.	Czech Republic
CSC Computer Sciences spol. s.r.o.	Slovakia
CSC Computer Sciences UK Holdings Limited	United Kingdom
CSC Computer Sciences US Holdings Two LLC	Delaware
CSC Computer Sciences Venezuela, SA	Venezuela
CSC Computer Sciences VOF/SNC	Belgium
CSC Consular Services Inc.	Nevada
CSC Consulting Group A/S	Denmark
CSC Consulting, Inc.	Massachusetts
CSC Corporation Limited	United Kingdom
CSC Covansys Corporation	Michigan
CSC Cybertek Corporation	Texas
CSC Danmark A/S	Denmark
CSC Datalab A/S	Denmark
CSC Deutschland Akademie GmbH	Germany
CSC Deutschland Consulting GmbH	Germany
CSC Deutschland Services GmbH	Germany
CSC Deutschland Solutions GmbH	Germany
CSC Enformasyon Teknoloji Hismetleri Limited Sirketi	Turkey
CSC Enterprises	Delaware
CSC Financial GmbH	Germany
CSC Financial Services (Pty) Limited	South Africa
CSC Financial Services S.A.S.	France
CSC Financial Solutions Ireland Limited	Ireland
CSC Financial Solutions Limited	United Kingdom
CSC FSG Limited	United Kingdom
CSC Hanford LLC	Nevada
CSC Holdings (SA) (Pty) Limited	South Africa
CSC Hungary Information Technology Services Kft	Hungary
CSC Information Systems LLC	Delaware
CSC Information Technology (Tianjin) Co. Ltd	P.R.C.
CSC Information Technology Services Pte. Ltd.	Singapore
CSC International Systems Management Inc.	Nevada

2

CSC Japan LLC	Japan
CSC Japan, Ltd.	Delaware
CSC Korea YH	Korea
CSC LATAM Company LLC	Nevada
CSC Life Sciences Limited	United Kingdom
CSC Logic, Inc.	Texas
CSC Malaysia Sdn Bhd	Malaysia
CSC Managed Holdings LLC	Nevada
CSC New Zealand Limited	New Zealand
CSC Norge AS	Norway
CSC Property UK Limited	United Kingdom
CSC Scandihealth A/S	Denmark
CSC Scandinavia Holdings A/S	Denmark
CSC Services Management Ireland Limited	Ireland
CSC Servicios, S de R.L. de C.V.	Mexico
CSC Software Technology (Shanghai) Company Ltd.	P.R.C.
CSC Sverige AB	Sweden
CSC Switzerland GmbH	Switzerland
CSC Systems & Solutions LLC	Delaware
CSC Taiwan Limited	Taiwan
CSC Technologies Deutschland GmbH	Germany
CSC Technology Beijing Co., Ltd.	P.R.C.
CSC Technology Hong Kong Limited	Hong Kong
CSC Technology Singapore Pte. Ltd.	Singapore
CSC Vietnam Co., Limited	Vietnam
Datatrac Information Services, Inc.	Texas
Dekru B.V.	Netherlands
DynCorp	Delaware
DynCorp Biotechnology and Health Services, Inc.	Virginia
DynPort Vaccine Company LLC	Virginia
EURL CSC Computer Sciences Corporation	Algeria
Experteam S.A./N.V.	Belgium
HAS Solutions (UK) Limited	United Kingdom
HAS Solutions Pty Ltd	Australia
IBA (Australia) Limited Partnership	Australia
IBA Health (Asia) Holdings Pte Ltd.	Singapore
IBA Health (Asia) Sdn. Bhd.	Malaysia
IBA Health (Europe) Holdings Limited	United Kingdom
IBA Health (Middle East) LLC	Oman
IBA Health (Singapore) Pte Limited	Singapore
IBA Health (UK) Holdings Limited	United Kingdom
IBA Health (UK) Limited	United Kingdom
Image Solutions Europe GmbH	Germany
Implementaciones Soft Sanidad Peru, S.A.C.	Peru
Implementaciones Soft Sanidad, S. A. de C. V.	Mexico
Innovative Banking Solutions AG	Germany
ISI (China) Co., Limited	P.R.C.
iSOFT (New Zealand & Pacific Islands) Limited	New Zealand
iSOFT (Primary Care) Pty Ltd	Australia
iSOFT Applications Limited	United Kingdom
iSOFT Australia Pty Limited	Australia
iSOFT eHealth Pty Ltd	Australia
iSOFT Europe (Holdings) Limited	United Kingdom
iSOFT Europe Limited	United Kingdom
iSOFT Group (UK) Limited	United Kingdom
iSOFT Group Limited - UAE (Dubai) Branch	UAE
iSOFT Group Pty Limited	Australia
iSOFT Health (Asia) Pte Ltd	Singapore

3

iSOFT Health (Ireland) Limited	Ireland
iSOFT Health (South Africa) (Proprietary) Limited	South Africa
iSOFT Health GmbH	Germany
iSOFT Health Limited	United Kingdom
iSOFT Health Logic (Malaysia) Sdn. Bhd.	Malaysia
iSOFT Health Management (India) Private Limited	India
iSOFT Health Services (India) Private Limited	India
iSOFT Health Systems (Malaysia) Sdn.Bhd.	Malaysia
iSOFT Iberia, S.L.	Spain
iSOFT Ireland Limited	Ireland
iSOFT Limited	United Kingdom
iSOFT Medical Systems Limited	United Kingdom
iSOFT Nederland B.V.	Netherlands
iSOFT NZ Limited	New Zealand
iSOFT Overseas Holdings Limited	United Kingdom
iSOFT Protos Limited	United Kingdom
iSOFT R&D Private Limited	India
iSOFT Radiology Systems Limited	United Kingdom
iSOFT Sanidad S.L.	Spain
iSOFT Sanidad, Sucursal Ecuador	Ecuador
iSOFT Solutions (International) Pty Ltd.	Australia
iSOFT Solutions (Thailand) Limited	Thailand
iSOFT Solutions Pty Ltd	Australia
iSOFT Systems Pty Ltd	Australia
iSOFT Technology Limited	United Kingdom
Log.Sec Corporation	Virginia
Maricom Systems Incorporated	Maryland
Mississippi Space Services	Mississippi
Mynd Corporation	South Carolina
Mynd Partners f/k/a Legalgard Partners, L.P.	Pennsylvania
Mynd Partners, L.P. f/k/a Cybertek Solutions, LP	Texas
PDA Software Services, Inc.	Delaware
PT CSC Indonesia	Indonesia
Space Coast Launch Services LLC	Nevada
Technology Service Partners, Inc.	Florida
Terranova Pacific Services (U.K.) Limited	United Kingdom
Test and Experimentation Services Co.	Texas
The Eagle Alliance	Maryland
Tianjin CSA Computer Sciences Technology Company Limited	P.R.C.
UAB CSC Baltic	Lithuania
Ultragenda N.V.	Belgium
Vulnerability Research Labs, LLC	Delaware
Welkin Associates, Ltd	Virginia

4

EX-23

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-120401, 333-50746, 333-00733, 333-33327, 333-75383, 333-58526, 333-67472, 333-149500, 333-149501, 333-170511, 333-103653, 333-181734, 333-181735, 333-72034 on Forms S-8 of our reports dated May 15, 2013 relating to the consolidated financial statements and financial statement schedule of Computer Sciences Corporation and subsidiaries (the “Company”), and the effectiveness of the Company's internal control over financial reporting, appearing in the Annual Report on Form 10-K of the Company for the fiscal year ended March 29, 2013.

/s/ DELOITTE & TOUCHE LLP

McLean, Virginia

May 15, 2013

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, J. Michael Lawrie, certify that:

1.I have reviewed this annual report on Form 10-K of Computer Sciences Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date:	May 15, 2013	/s/ J. Michael Lawrie
		J. Michael Lawrie, President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Paul N. Saleh, certify that:

1.I have reviewed this annual report on Form 10-K of Computer Sciences Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting. 

Date:	May 15, 2013	/s/ Paul N. Saleh
		Paul N. Saleh Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, I, J. Michael Lawrie, President and Chief Executive Officer of Computer Sciences Corporation (the "Company"), hereby certify that:

(1)The Company’s Annual Report on Form 10-K for the fiscal year ended March 29, 2013, (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	May 15, 2013	/s/ J. Michael Lawrie
		J. Michael Lawrie President and Chief Executive Officer

This certification should accompany the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, I, Paul N. Saleh, Executive Vice President and Chief Financial Officer of Computer Sciences Corporation (the "Company"), hereby certify that:

(1)The Company’s Annual Report on Form 10-K for the fiscal year ended March 29, 2013, (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	May 15, 2013	/s/ Paul N. Saleh
		Paul N. Saleh Executive Vice President and Chief Financial Officer

This certification should accompany the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

XML

Intangible Assets (Tables)

12 Months Ended

Mar. 29, 2013

Intangible Assets [Abstract]

Summary of Amortizable Intangible Assets

A summary of amortizable intangible assets is as follows:

	As of
	March 29, 2013
(Amounts in millions)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Outsourcing contract costs	$	1,473	$	968	$	505
Software	2,134		1,523		611
Customer and other intangible assets	512		281		231
Total intangible assets	$	4,119	$	2,772	$	1,347

	As of
	March 30, 2012
(Amounts in millions)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Outsourcing contract costs	$	1,802	$	1,240	$	562
Software	2,130		1,481		649
Customer and other intangible assets	599		306		293
Total intangible assets	$	4,531	$	3,027	$	1,504

Schedule Purchased and Internally Developed Software, Net of Accumulated Amortization

Purchased and internally developed software, net of accumulated amortization, consisted of the following:

(Amounts in millions)	March 29, 2013		March 30, 2012
Purchased software	$	297	$	353
Internally developed commercial software	304		293
Internally developed internal-use software	10		3
Total	$	611	$	649

XML

Investigations and Out of Period Adjustments (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				12 Months Ended											3 Months Ended					12 Months Ended												36 Months Ended	12 Months Ended				36 Months Ended	3 Months Ended	12 Months Ended					36 Months Ended	12 Months Ended		3 Months Ended				12 Months Ended		3 Months Ended					12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended			3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended			3 Months Ended
	Mar. 29, 2013	Dec. 28, 2012	Sep. 28, 2012	Jun. 29, 2012	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Mar. 29, 2013 Adjustments Increase [Member]	Mar. 30, 2012 Adjustments Increase [Member]	Mar. 29, 2013 Adjustments Decrease [Member]	Mar. 30, 2012 Adjustments Decrease [Member]	Mar. 29, 2013 Adjustment Increase/(Decrease) [Member]	Mar. 30, 2012 Adjustment Increase/(Decrease) [Member]	Apr. 01, 2011 Adjustment Increase/(Decrease) [Member]	Mar. 30, 2012 Prior fiscal years (unaudited) Adjustment Increase/(Decrease) [Member]	Mar. 29, 2013 NHS contract [Member]	Dec. 28, 2012 NHS contract [Member]	Sep. 28, 2012 NHS contract [Member]	Jun. 29, 2012 NHS contract [Member]	Dec. 30, 2011 NHS contract [Member]	Mar. 29, 2013 NHS contract [Member]	Mar. 30, 2012 Nordic Operations [Member] Prior fiscal years (unaudited)	Mar. 30, 2012 Nordic Operations [Member] Prior fiscal years (unaudited) Error in accounting for operating lease [Member]	Mar. 30, 2012 Australia Operations [Member] Prior fiscal years (unaudited)	Mar. 30, 2012 NPS [Member] Prior fiscal years (unaudited)	Mar. 30, 2012 Other MSS Operations [Member] Prior fiscal years (unaudited)	Mar. 30, 2012 MSS [Member] Prior fiscal years (unaudited)	Mar. 30, 2012 BSS [Member] Prior fiscal years (unaudited)	Mar. 30, 2012 BSS Segment [Member] NHS contract [Member]	Mar. 29, 2013 Fiscal 2013 Adjustments	Mar. 30, 2012 Fiscal 2013 Adjustments	Apr. 01, 2011 Fiscal 2013 Adjustments	Mar. 31, 2013 Fiscal 2013 Adjustments	Mar. 29, 2013 Fiscal 2013 Adjustments NHS contract [Member]	Mar. 29, 2013 Fiscal 2012 Adjustments	Mar. 30, 2012 Fiscal 2012 Adjustments	Apr. 01, 2011 Fiscal 2012 Adjustments	Mar. 31, 2013 Fiscal 2012 Adjustments	Dec. 30, 2011 Fiscal 2012 Adjustments NHS contract [Member]	Mar. 29, 2013 Fiscal 2012 Adjustments NHS contract [Member]	Mar. 30, 2012 Fiscal 2012 Adjustments NHS contract [Member]	Mar. 29, 2013 Fiscal 2011 Adjustments	Mar. 30, 2012 Fiscal 2011 Adjustments	Apr. 01, 2011 Fiscal 2011 Adjustments	Mar. 31, 2013 Fiscal 2011 Adjustments	Mar. 29, 2013 Fiscal 2011 Adjustments NHS contract [Member]	Mar. 30, 2012 Fiscal 2011 Adjustments NHS contract [Member]	Mar. 29, 2013 Fiscal 2013	Dec. 28, 2012 Fiscal 2013	Sep. 28, 2012 Fiscal 2013	Jun. 29, 2012 Fiscal 2013	Mar. 29, 2013 Fiscal 2013	Mar. 29, 2013 Fiscal 2013 Discrete Tax Benefits [Member]	Sep. 28, 2012 Fiscal 2013 NHS contract [Member]	Mar. 30, 2012 Fiscal 2012 NHS contract [Member]	Dec. 30, 2011 Fiscal 2012 NHS contract [Member]	Sep. 30, 2011 Fiscal 2012 NHS contract [Member]	Jul. 01, 2011 Fiscal 2012 NHS contract [Member]	Mar. 30, 2012 Fiscal 2012 NHS contract [Member]	Mar. 30, 2012 Fiscal 2012 Nordic Operations [Member]	Dec. 30, 2011 Fiscal 2012 Nordic Operations [Member]	Sep. 30, 2011 Fiscal 2012 Nordic Operations [Member]	Jul. 01, 2011 Fiscal 2012 Nordic Operations [Member]	Mar. 30, 2012 Fiscal 2012 Nordic Operations [Member]	Mar. 30, 2012 Fiscal 2012 Australia Operations [Member]	Dec. 30, 2011 Fiscal 2012 Australia Operations [Member]	Sep. 30, 2011 Fiscal 2012 Australia Operations [Member]	Jul. 01, 2011 Fiscal 2012 Australia Operations [Member]	Mar. 30, 2012 Fiscal 2012 Australia Operations [Member]	Mar. 30, 2012 Fiscal 2012 Fiscal 2012 Adjustments NHS contract [Member]	Apr. 01, 2011 Fiscal 2011	Apr. 01, 2011 Fiscal 2011 NHS contract [Member]	Dec. 31, 2010 Fiscal 2011 NHS contract [Member]	Oct. 01, 2010 Fiscal 2011 NHS contract [Member]	Jul. 02, 2010 Fiscal 2011 NHS contract [Member]	Apr. 01, 2011 Fiscal 2011 NHS contract [Member]	Apr. 01, 2011 Fiscal 2011 Nordic Operations [Member]	Dec. 31, 2010 Fiscal 2011 Nordic Operations [Member]	Oct. 01, 2010 Fiscal 2011 Nordic Operations [Member]	Jul. 02, 2010 Fiscal 2011 Nordic Operations [Member]	Apr. 01, 2011 Fiscal 2011 Nordic Operations [Member]	Apr. 01, 2011 Fiscal 2011 Australia Operations [Member]	Dec. 31, 2010 Fiscal 2011 Australia Operations [Member]	Oct. 01, 2010 Fiscal 2011 Australia Operations [Member]	Jul. 02, 2010 Fiscal 2011 Australia Operations [Member]	Apr. 01, 2011 Fiscal 2011 Australia Operations [Member]	Apr. 01, 2011 Fiscal 2011 Other MSS Operations [Member]	Apr. 01, 2011 Fiscal 2011 MSS [Member]	Dec. 30, 2011 Contracts Accounted for under Percentage of Completion, U.S. Claims [Member] NHS contract [Member]	Dec. 30, 2011 Contracts Accounted for under Percentage of Completion, U.S. Claims [Member] NHS contract [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment													$ 79							$ (24)		$ 13	$ 1	$ 23	$ 16	$ 2								$ 9					$ (24)	$ (10)	$ (25)					$ 15	$ 7																							$ 25	$ 52										$ 92						$ (36)	$ (40)		$ (1,500)
Change in accounting estimate, reduction in operating income																																																																																									1,485	1,500
Income from continuing operations, net of tax					497	(4,387)	657								(63)																																								(7)	46	(2)	(2)	35	1	2	6	4	13	0	2	21	0	23			(5)	(5)	(2)	(10)	(22)	3	23	40	20	86	(4)	0	5	(4)	(3)
Accounts receivable										1	66
Prepaid expenses and other current assets	420				420	533		15	44
Outsourcing contract costs adjustments										1
Increase (Decrease) in Other Noncurrent Assets									6	(6)
Property and equipment										5	29
Increase (Decrease) in Employee Related Liabilities								(9)			2
Accrued expenses and other current liabilities	(1,425)				(1,425)	(1,339)			46	(12)
Increase (Decrease) in advances contract payments and deferred revenue					270	(247)	(204)	13			3
Income (loss) from continuing operations before taxes					480	(4,454)	878					6	86	1													(37)	(26)	(25)
Cumulative effect on income (loss) from continuing opertaions, pre tax																0	0	9	0		9									(6)	0	0	(6)		(7)	(79)	0	(86)				22	29	(52)	(1)			(9)	(1)	5	(1)	(6)		9
Cumulative Quantifying Misstatement Effect of Correction Tax	$ 1	$ 4	$ 1	$ 2	$ 8																																															$ 7	$ 5

XML

Restructuring Costs (Tables)

12 Months Ended

Mar. 29, 2013

Restructuring Costs [Abstract]

Schedule of Restructuring and Related Costs

The composition of the restructuring liability for the Fiscal 2012 plan as of March 29, 2013 is as follows:

(Amounts in millions)	Restructuring liability as of March 30, 2012		Costs expensed in fiscal 2013		Less: costs not affecting restructuring liability (1)			Cash paid			Other (2)			Restructuring liability as of March 29, 2013
Workforce reductions	$	110	$	31	$	(1	)	$	(129	)	$	(2	)	$	9
Facilities costs	9		—		—			(4		)	—			5
Total	$	119	$	31	$	(1	)	$	(133	)	$	(2	)	$	14

⁽¹⁾ Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾ Foreign currency translation adjustments

The composition of the restructuring liability for the Fiscal 2012 plan as of March 30, 2012 is as follows:

(Amounts in millions)	Restructuring liability as of April 1, 2011		Costs expensed in fiscal 2012		Less: costs not affecting restructuring liability (1)			Cash paid		Other (2)			Restructuring liability as of March 30, 2012
Workforce reductions	$	—	$	131	$	(20	)	$	—	$	(1	)	$	110
Facilities costs	—		9		—			—		—			9
Total	$	—	$	140	$	(20	)	$	—	$	(1	)	$	119

⁽¹⁾ Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾ Foreign currency translation adjustments

The composition of the restructuring liability for the Fiscal 2013 Plan as of March 29, 2013 is as follows:

(Amounts in millions)	Restructuring liability as of March 30, 2012		Costs expensed in fiscal 2013		Less: costs not affecting restructuring liability (1)			Cash paid			Other(3)			Restructuring liability as of March 29, 2013
Workforce reductions	$	—	$	206	$	(22	)	$	(27	)	$	(2	)	$	155
Facilities costs	—		10		—			—			—			10
Other(2)	—		17		—			(6		)	—			11
	$	—	$	233	$	(22	)	$	(33	)	$	(2	)	$	176

⁽¹⁾  Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾  Other direct costs associated with the restructuring program.

⁽³⁾  Foreign currency translation adjustments.

Schedule of Restructuring Reserve by Type of Cost

The composition of restructuring costs, by segment, for fiscal 2013 and 2012 is as follows:

	Twelve Months Ended March 29, 2013
(Amounts in millions)	Fiscal 2013 Plan		Fiscal 2012 Plan		Total
NPS	$	13	$	—	$	13
MSS	181		9		190
BSS	17		22		39
Corporate	22		—		22
Total	$	233	$	31	$	264

	Twelve Months Ended March 30, 2012
(Amounts in millions)	Fiscal 2012 Plan
NPS	$	1
MSS	108
BSS	31
Corporate	—
Total	$	140

XML

Income Taxes Income Tax Holiday (Details) (Holiday tax incentives in India [Member], USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Holiday tax incentives in India [Member]
Income Tax Holiday [Line Items]
Last year of tax holiday expiration	2011
Additional year of tax holiday extension	2026
Reduction in tax expense due to tax holiday incentives	$ 3	$ 1	$ 13
Reduction in tax expense due to tax holiday incentives per share (in dollars per share)	$ 0.02	$ 0.01	$ 0.08

XML

Investigations and Out of Period Adjustments (Cumulative Rollover Impact) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended			36 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Mar. 31, 2013
Fiscal 2013 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	$ 6	$ 0	$ 0	$ 6
Fiscal 2012 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	7	79	0	86
Fiscal 2011 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	(22)	(29)	52	1
Fiscal 2010 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	14	(9)	(48)	(43)
Adjustments relating to fiscal years prior to 2010
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	$ (4)	$ (41)	$ (4)	$ (49)

XML

Pension and Other Benefit Plans Schedule of Defined Benefit Disclosure table (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended								0 Months Ended	12 Months Ended				0 Months Ended	12 Months Ended		0 Months Ended	12 Months Ended	0 Months Ended																																																																																																																																																																																																																																			12 Months Ended													12 Months Ended
	Mar. 29, 2013 number_of_plans	Mar. 30, 2012	Apr. 01, 2011	Apr. 02, 2010	Mar. 29, 2013 US pension plans [Member]	Mar. 30, 2012 US pension plans [Member]	Mar. 29, 2013 Non-US pension plans [Member]	Mar. 30, 2012 Non-US pension plans [Member]	Mar. 21, 2013 Equity Securities [Member] US pension plans [Member]	Mar. 29, 2013 Equity Securities [Member] US pension plans [Member]	Mar. 29, 2013 Equity Securities [Member] Non-US pension plans [Member]	Mar. 29, 2013 Insurance contracts [Member] Level 3 [Member]	Mar. 30, 2012 Insurance contracts [Member] Level 3 [Member]	Mar. 21, 2013 Fixed Income Securities [Member] US pension plans [Member]	Mar. 29, 2013 Fixed Income Securities [Member] US pension plans [Member]	Mar. 29, 2013 Fixed Income Securities [Member] Non-US pension plans [Member]	Mar. 21, 2013 Cash and Other Investments [Member]	Mar. 29, 2013 Cash and Other Investments [Member] US pension plans [Member]	Mar. 21, 2013 Alternative Investments [Member] US pension plans [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global/International [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities US Domestic Stocks [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Domestic Equity commingled funds [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity commingled funds [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Equity Securities Global Equity mutual funds [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Treasuries [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income US Government Agencies [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Non US Government [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed income mortgage asset backed securities [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Level 1 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Level 1 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Level 3 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Level 3 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Total [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income Corporate [Member] Total [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Fixed Income commingled funds [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Cash equivalents [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Total [Member] Level 1 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Total [Member] Level 1 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Total [Member] Level 2 [Member]		Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Total [Member] Level 2 [Member]		Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Total [Member] Level 3 [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Total [Member] Level 3 [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Total [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Total [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Unsettled Trade Receivable and Accrued Income [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Unsettled Trade Receivable and Accrued Income [Member]	Mar. 29, 2013 US pension and other postretirement benefit plans [Member] Unsettled trade payables and accrued expenses [Member]	Mar. 30, 2012 US pension and other postretirement benefit plans [Member] Unsettled trade payables and accrued expenses [Member]	Mar. 29, 2013 Non-US pension plans [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global/International [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global/International [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global/International [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global/International [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global/International [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global/International [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global/International [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global/International [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities Global Equity mutual funds [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Fixed Income commingled funds [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Fixed Income commingled funds [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Fixed Income commingled funds [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Fixed Income commingled funds [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Fixed Income commingled funds [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Fixed Income commingled funds [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Fixed Income commingled funds [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Fixed Income commingled funds [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Cash equivalents [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Cash equivalents [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Cash equivalents [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Cash equivalents [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Cash equivalents [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Cash equivalents [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Cash equivalents [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Cash equivalents [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Total [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Total [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Total [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Total [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Total [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Total [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Unsettled Trade Receivable and Accrued Income [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Unsettled Trade Receivable and Accrued Income [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Equity Securities US/North American Equity commingled funds [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Insurance contracts [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Insurance contracts [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Insurance contracts [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Insurance contracts [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Insurance contracts [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Insurance contracts [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Insurance contracts [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Insurance contracts [Member] Total [Member]	Mar. 29, 2013 Non-US pension plans [Member] Other Investments [Member] Level 1 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Other Investments [Member] Level 1 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Other Investments [Member] Level 2 [Member]		Mar. 30, 2012 Non-US pension plans [Member] Other Investments [Member] Level 2 [Member]		Mar. 29, 2013 Non-US pension plans [Member] Other Investments [Member] Level 3 [Member]	Mar. 30, 2012 Non-US pension plans [Member] Other Investments [Member] Level 3 [Member]	Mar. 29, 2013 Non-US pension plans [Member] Other Investments [Member] Total [Member]	Mar. 30, 2012 Non-US pension plans [Member] Other Investments [Member] Total [Member]	Mar. 29, 2013 Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 30, 2012 Pension Plans, Defined Benefit [Member] US pension plans [Member]	Apr. 01, 2011 Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 29, 2013 Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 30, 2012 Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Apr. 01, 2011 Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 30, 2012 Other Postretirement Benefit Plans, Defined Benefit [Member]	Apr. 01, 2011 Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 30, 2012 Other Postretirement Benefit Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 30, 2012 Other Postretirement Benefit Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 29, 2013 Key executives [Member] number_of_plans	Mar. 29, 2013 Non-employee directors [Member] number_of_plans
Deferred Compensation Arrangements [Abstract]
Number of plans within deferred compensation plan	2																																																																																																																																																																																																																																																																		1	1
Maximum amount of compensation that plan participant is allowed to defer of their eligible compensation (in hundreths)																																																																																																																																																																																																																																																																			100.00%	100.00%
The liability included in other long-term liabilities under the plan	$ 125		$ 129
The company's expense under the plan	8		8	8
Retirement Plan Asset Strategy [Abstract]
Defined Benefit Plan Target Plan Asset Allocations Range Minimum									37.00%	49.00%				29.00%	34.00%		0.00%	0.00%	0.00%
Defined Benefit Plan, Target Plan Asset Allocations Range Maximum									66.00%	66.00%	40.00%			44.00%	44.00%	31.00%	10.00%	10.00%	25.00%
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	5	0			3,209	2,500	2,550	2,295				5								3,209	2,500	31	25	38	[1]	34	[1]	0	0	69	59	51	40	0	[1]	0	[1]	0	0	51	40	5	5	1,325	[1]	1,040	[1]	0	0	1,330	1,045	0	0	380	[1]	250	[1]	0	0	380	250	83	93	0	[1]	0	[1]	0	0	83	93	0	0	87	[1]	72	[1]	0	0	87	72	0	0	11	[1]	10	[1]	0	0	11	10	0	0	5	[1]	2	[1]	0	0	5	2	0	0	131	[1]	118	[1]	0	0	131	118	0	[2]	0	[2]	74	[1],[2]	82	[1],[2]	0	[2]	0	[2]	74	[2]	82	[2]	3	3	959	[1]	689	[1]	0	0	962	692	8	8	117	[1]	58	[1]	0	0	125	66	181	174	3,127	[1]	2,355	[1]	0	0	3,308	2,529	79	84	(178)	(113)	2,550	2,295	0	0	915	[1]	757	[1]	0	0	915	757	0	78	0	[1]	0	[1]	0	0	0	78	0	115	1,311	[1]	1,104	[1]	0	0	1,311	1,219	0	0	25	[1]	13	[1]	0	0	25	13	0	193	2,545	[1]	2,097	[1]	6	5	2,551	2,295	(1)	0	0	0	54	[1]	40	[1]	0	0	54	40	0	0	157	[1]	141	[1]	6	5	163	146	0	0	83	[1]	42	[1]	0	0	83	42	2,419	2,276		2,295	2,083		81	79		84	81	0	0
Asset acquired in purchase of iSOFT		3
Actual return on plan assets relating to assets still held at the reporting date		0										1
Actual return on plan assets relateing to assets sold during the period		0										0
Purchases, sales, and settlements		2										0
Transfers in and / or out of Level 3		0											0
Changes due to exchange rates		0										0																																																																																																																																																																																																																																										0	0		(141)	(22)		0	(1)
Ending balance		5	0		3,209	2,500	2,550	2,295				6	5							3,209	2,500	31	25	38	[1]	34	[1]	0	0	69	59	51	40	0	[1]	0	[1]	0	0	51	40	5	5	1,325	[1]	1,040	[1]	0	0	1,330	1,045	0	0	380	[1]	250	[1]	0	0	380	250	83	93	0	[1]	0	[1]	0	0	83	93	0	0	87	[1]	72	[1]	0	0	87	72	0	0	11	[1]	10	[1]	0	0	11	10	0	0	5	[1]	2	[1]	0	0	5	2	0	0	131	[1]	118	[1]	0	0	131	118	0	[2]	0	[2]	74	[1],[2]	82	[1],[2]	0	[2]	0	[2]	74	[2]	82	[2]	3	3	959	[1]	689	[1]	0	0	962	692	8	8	117	[1]	58	[1]	0	0	125	66	181	174	3,127	[1]	2,355	[1]	0	0	3,308	2,529	79	84	(178)	(113)	2,550	2,295	0	0	915	[1]	757	[1]	0	0	915	757	0	78	0	[1]	0	[1]	0	0	0	78	0	115	1,311	[1]	1,104	[1]	0	0	1,311	1,219	0	0	25	[1]	13	[1]	0	0	25	13	0	193	2,545	[1]	2,097	[1]	6	5	2,551	2,295	(1)	0	0	0	54	[1]	40	[1]	0	0	54	40	0	0	157	[1]	141	[1]	6	5	163	146	0	0	83	[1]	42	[1]	0	0	83	42	3,125	2,419	2,276	2,550	2,295	2,083	84	81	79	84	81	0	0
Defined Benefit Plan, Expected Return on Plan Assets																																																																																																																																																																																																																																																						$ 160	$ 146	$ 157	$ 124	$ 129	$ 128	$ 5	$ 6	$ 6

[1] The majority of retirement plan assets are invested in a variety of commingled funds and fixed income. This results in a high amount of Level 2 investments.

[2] Primarily investment grade.

XML

Other (Income) Expense, Net (Tables)

12 Months Ended

Mar. 29, 2013

Other Income and Expenses [Abstract]

Schedule of Other Income (Expense)

The components of other (income) expense, net for fiscal 2013, fiscal 2012, and fiscal 2011 are:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Foreign currency loss (gain)	$	17		$	4		$	(2	)
Equity in earnings of unconsolidated affiliates	(9		)	(10		)	(11		)
Other gains	(42		)	—			(8		)
Total	$	(34	)	$	(6	)	$	(21	)

XML

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Mar. 29, 2013

Summary of Significant Accounting Policies [Abstract]

Schedule of Change in Accounting Estimate

The Company's income (loss) from continuing operations, before taxes and noncontrolling interests, and diluted earnings per share (EPS) from continuing operations included the following adjustments due to changes in in estimated profitability on fixed price contracts accounted for under the percentage-of-completion method for the fiscal years presented:

	Twelve Months Ended
(Amounts in millions), except per share data	March 29, 2013			March 30, 2012			April 1, 2011
Gross favorable	$	143		$	58		$	53
Gross unfavorable (1)	(122		)	(289		)	(130		)
Total net adjustments, before taxes and noncontrolling interests (2)	$	21		$	(231	)	$	(77	)
Impact on diluted EPS from continuing operations	$	(0.10	)	$	(1.30	)	$	(0.42	)

⁽¹⁾ Fiscal 2012 does not include the contract charge related to the Company’s contract with the NHS of $1,485 million (see Note 18).

⁽²⁾  Quarterly changes in estimated profitability on the same fixed price contract are disclosed gross as either favorable or unfavorable.

Depreciation And Amortization Schedule Of Estimated Useful Lives By Asset [Table Text Block]

The Company’s depreciation and amortization policies are as follows:

Property and Equipment:
Buildings	Up to 40 years
Computers and related equipment	3 to 5 years
Furniture and other equipment	2 to 15 years
Leasehold improvements	Shorter of lease term or useful life
Software	2 to 10 years
Outsourcing contract costs	Contract life, excluding option years
Customer related intangibles	Expected customer service life
Acquired contract related intangibles	Contract life and first contract renewal, where applicable

Stock-based compensation expense recognized by line item detail

The Company recognized stock-based compensation expense for fiscal 2013, fiscal 2012, and fiscal 2011 as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Cost of services	$	22	$	15	$	12
Selling, general and administrative	27		21		44
Total	$	49	$	36	$	56
Total, net of tax	$	31	$	23	$	35

Weighted average assumptions used to calculate compensation expense

The weighted average grant date fair values of stock options granted during fiscal 2013, fiscal 2012, and fiscal 2011 were $7.37, $10.17, and $12.95 per share, respectively. In calculating the compensation expense for its stock incentive plans, the Company used the following weighted average assumptions:

	Fiscal Year
	2013		2012		2011
Risk-free interest rate	1.15	%	1.80	%	2.37	%
Expected volatility	36	%	31	%	28	%
Expected term (in years)	6.59		6.11		5.85
Dividend yield	2.86	%	1.79	%	1.17	%

Cash payments for interest on indebtedness and for taxes, supplemental information on cash flow

Cash payments for interest on indebtedness and cash payments for taxes on income are as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Interest	$	186	$	177	$	173
Taxes on income, net of refunds	214		139		219

Non-cash investing activities

Non-cash investing activities include the following:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Capital expenditures in accounts payable and accrued expenses	$	32	$	47	$	122
Capital expenditures through capital lease obligations	181		270		289
Assets acquired under long-term financing	26		32		115

Schedule of earnings per share

Basic earnings (loss) per common share (EPS) are computed using the weighted average number of common shares outstanding during the period. Diluted EPS reflect the incremental shares issuable upon the assumed exercise of stock options and equity awards.

	Twelve Months Ended
(Amounts in millions, except per-share data)	March 29, 2013		March 30, 2012			April 1, 2011
Net income (loss) attributable to CSC common shareholders:
From continuing operations	$	497	$	(4,387	)	$	657
From discontinued operations	464		145			83
	$	961	$	(4,242	)	$	740
Common share information:
Weighted average common shares outstanding for basic EPS	$	154.590	$	155.012		$	154.488
Dilutive effect of stock options and equity awards	0.967		—			2.117
Shares for diluted earnings (loss) per share	$	155.557	$	155.012		$	156.605
Earnings (loss) per share – basic and diluted:
Basic EPS:
Continuing operations	$	3.22	$	(28.31	)	$	4.25
Discontinued operations	3.00		0.94			0.54
Total	$	6.22	$	(27.37	)	$	4.79
Diluted EPS:
Continuing operations	$	3.20	$	(28.31	)	$	4.20
Discontinued operations	2.98		0.94			0.53
Total	$	6.18	$	(27.37	)	$	4.73

XML

Stockholders' Equity (Details) (USD $)	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Dec. 31, 2010
Stock Repurchase Program [Abstract]
Aggregate consideration	$ 305,000,000		$ 65,000,000
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance at March 30, 2012	(1,093,000,000)	(690,000,000)	(1,052,000,000)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	(261,000,000)	(403,000,000)	362,000,000
Balance at March 29, 2013	(1,354,000,000)	(1,093,000,000)	(690,000,000)
Common Class A [Member] | December 2010 Share Repurchase Program [Member]
Stock Repurchase Program [Abstract]
Share repurchase program				1,000,000,000
Repurchased shares (in shares)	6,707,652	0	1,353,000
Aggregate consideration	305,000,000		65,000,000
Weighted average price (in dollars per share)	$ 45.47		$ 48.01
Common Class A [Member] | December 2010 Share Repurchase Program [Member] | Accrued Liabilities [Member]
Stock Repurchase Program [Abstract]
Aggregate consideration	22,000,000
Common Class A [Member] | Shares Repurchased From Employees Related To Stock Option Plans [Member]
Treasury Stock Transactions [Abstract]
Accepted common stock in lieu of cash in connection with exercise of stock options (in shares)	91,921	21,755
Accepted common stock in lieu of cash in connection with the tax withholdings associated with the vesting and release of common stock (in shares)	209,056	104,117
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance at March 30, 2012	160,000,000	284,000,000	23,000,000
Current-period other comprehensive loss income, net of taxes and non-controlling interests	(83,000,000)	(124,000,000)	261,000,000
Balance at March 29, 2013	77,000,000	160,000,000	284,000,000
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance at March 30, 2012	(1,253,000,000)	(974,000,000)	(1,075,000,000)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	(178,000,000)	(279,000,000)	101,000,000
Balance at March 29, 2013	$ (1,431,000,000)	(1,253,000,000)	$ (974,000,000)

XML

Debt Long-term Debt Instruments (Details)	0 Months Ended					1 Months Ended								12 Months Ended			12 Months Ended					0 Months Ended	12 Months Ended		0 Months Ended	12 Months Ended		0 Months Ended		12 Months Ended					1 Months Ended
	Oct. 19, 2012 USD ($)	Mar. 29, 2013 USD ($)	Sep. 18, 2012 USD ($)	Mar. 30, 2012 USD ($)	Sep. 18, 2012 Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 29, 2013 Mandatorily redeemable preferred stock outstanding [Member] USD ($)	Mar. 30, 2012 Mandatorily redeemable preferred stock outstanding [Member] USD ($)	Mar. 29, 2013 Capitalized lease liabilities [Member] USD ($)	Mar. 30, 2012 Capitalized lease liabilities [Member] USD ($)	Mar. 29, 2013 Borrowings for assets acquired under long-term financing [Member] USD ($)	Mar. 30, 2012 Borrowings for assets acquired under long-term financing [Member] USD ($)	Mar. 29, 2013 Other borrowings [Member] USD ($)	Mar. 30, 2012 Other borrowings [Member] USD ($)	Mar. 29, 2013 4.45% term notes, due September 2022 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 30, 2012 4.45% term notes, due September 2022 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Sep. 18, 2012 4.45% term notes, due September 2022 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 29, 2013 6.50% term notes, due March 2018 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 30, 2012 6.50% term notes, due March 2018 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 29, 2013 2.50% term notes, due September 2015 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 30, 2012 2.50% term notes, due September 2015 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Sep. 18, 2012 2.50% term notes, due September 2015 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Oct. 19, 2012 5.50% term notes, due March 2013 [Member] USD ($)	Mar. 29, 2013 5.50% term notes, due March 2013 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 30, 2012 5.50% term notes, due March 2013 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Oct. 19, 2012 5.00% term notes, due February 2013 [Member] USD ($)	Mar. 29, 2013 5.00% term notes, due February 2013 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Mar. 30, 2012 5.00% term notes, due February 2013 [Member] Senior unsecured and unsubordinated notes [Member] USD ($)	Sep. 18, 2012 Four-year term loan credit facility [Member] USD ($)	Oct. 17, 2012 Four-year term loan credit facility [Member] USD ($)	Mar. 29, 2013 Four-year term loan credit facility [Member] Term loan credit facility [Member] USD ($)	Mar. 30, 2012 Four-year term loan credit facility [Member] Term loan credit facility [Member] USD ($)	Mar. 29, 2013 Line of Credit Due 2015 [Member] USD ($)	Mar. 29, 2013 Other interest bearing debt and notes payable [Member] Other borrowings [Member] USD ($)	Mar. 30, 2012 Other interest bearing debt and notes payable [Member] Other borrowings [Member] USD ($)	Mar. 29, 2013 Subsidiary [Member] Note payable [Member] USD ($)	Mar. 29, 2013 Subsidiary [Member] Note payable [Member] EUR (€)	Mar. 30, 2012 Subsidiary [Member] Note payable [Member] USD ($)
Debt Instrument [Line Items]
Total debt		$ 2,732,000,000		$ 2,740,000,000		$ 59,000,000	$ 0	$ 561,000,000	$ 574,000,000	$ 98,000,000	$ 84,000,000	$ 5,000,000	$ 86,000,000	$ 349,000,000	$ 0		$ 998,000,000	$ 997,000,000	$ 350,000,000	$ 0			$ 0	$ 699,000,000		$ 0	$ 300,000,000			$ 250,000,000	$ 0		$ 5,000,000	$ 43,000,000	$ 62,000,000	€ 41,000,000	$ 0
Less: short term debt and current maturities of long term debt		234,000,000		1,254,000,000
Total long-term debt		2,498,000,000		1,486,000,000
Debt Instrument, Face Amount					700,000,000											350,000,000					350,000,000								250,000,000
Extinguishment of Debt, Amount																						700,000,000			300,000,000
Debt instrument, maturity date														Sep. 30, 2022	Sep. 30, 2022		Mar. 31, 2018	Mar. 31, 2018	Sep. 30, 2015	Sep. 30, 2015			Mar. 31, 2013	Mar. 31, 2013		Feb. 28, 2013	Feb. 28, 2013
Debt instrument, stated interest rate (in hundredths)														4.45%	4.45%		6.50%	6.50%	2.50%	2.50%			5.50%	5.50%		5.00%	5.00%
Gross amount of computer and other equipment under capital lease		1,095,000,000		940,000,000
Amount of multi-year committed revolving credit facility																												350,000,000				1,500,000,000
Debt Instrument, Covenant, Minimum Ratio of Indebtedness to EBITDA																																3.00
Mandatorily Redeemable Preferred Stock, Issued Value						63,000,000
Mandatorily Redeemable Preferred Stock, Fair Value Disclosure						59,000,000
Debt Issuance Cost						1,000,000																													1,000,000
Preferred Stock, Dividend Rate, Percentage						3.48%
Preferred Stock, Initial Dividend Period						5 years
Preferred Stock, Interest Rate on Unpaid Cumulative Dividends						2.50%
Preferred Stock, Dividend Rate, Percentage, After Five Years						3.80%
Debt Instrument, Term																												4 years							5 years
Line of Credit Facility, Periodic Payment Percentage																												2.50%
Line of Credit Facility, Current Borrowing Capacity																												250,000,000
Credit facility expiration date																														Jul. 31, 2012	Jul. 31, 2012	Mar. 18, 2015
Accumulated amortization on computers and other equipment under capital lease		465,000,000		341,000,000
Long-term Debt, by Maturity [Abstract]
2014		52,000,000
2015		71,000,000
2016		381,000,000
2017		194,000,000
2018		1,064,000,000
Thereafter		409,000,000
Total		2,171,000,000
Debt Instrument, Unamortized Discount					1,000,000
Unamortized Debt Issuance Expense					5,000,000
Gains (Losses) on Extinguishment of Debt	(19,000,000)
Debt Instrument, Covenant, Aggregate Principal Payment Amount			$ 125,000,000

XML

Commitments and Contingencies (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Schedule of future minimum lease payments, operating leases [Line Items]
Lease rental expense	$ 319	$ 324	$ 330
Sublease income	18
Minimum purchase commitments [Abstract]
Term of contractual purchase commitments, minimum (in years)	1 year
Term of contractual purchase commitments, maximum (in years)	5 years
Fiscal 2014	478
Fiscal 2015	161
Fiscal 2016	132
Fiscal 2017	12
Fiscal 2018	2
Thereafter	0
Real Estate [Member]
Operating Leases, Future Minimum Payments Due [Abstract]
2014	211
2015	152
2016	112
2017	82
2018	51
Thereafter	68
Total future minimum lease payments	676
Equipment [Member]
Operating Leases, Future Minimum Payments Due [Abstract]
2014	39
2015	26
2016	9
2017	2
2018	0
Thereafter	0
Total future minimum lease payments	$ 76

XML

Investigations and Out of Period Adjustments (Other Adjustments) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				12 Months Ended
	Mar. 29, 2013	Dec. 28, 2012	Sep. 28, 2012	Jun. 29, 2012	Mar. 29, 2013
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative Quantifying Misstatement Effect of Correction Tax	$ (1)	$ (4)	$ (1)	$ (2)	$ (8)
Cumulative effect of correction on net income (loss), net of tax	22	(30)	2	(1)	(7)
NHS contract [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	0	0	(9)	0	(9)
Other Operations [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	(4)	4	12	3	15
Cumulative effect of correction on net income (loss), net of tax	(1)	(2)	0	(2)	(5)
Continuing Operations [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect on income (loss) from continuing opertaions, pre tax	(4)	4	3	3	6
Discontinued Operations [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Cumulative effect of correction on net income (loss), net of tax	$ 28	$ (28)	$ 0	$ 0	$ 0

XML

Debt Capital Leases (Details) (USD $) In Millions, unless otherwise specified	Mar. 29, 2013
Capital Lease Obligations [Abstract]
2014	$ 221
2015	195
2016	115
2017	73
2018	38
Thereafter	97
Total minimum lease payments	739
Less: Amount representing interest	178
Present value of net minimum lease payments	561
Less: Current maturities of capital lease obligations	182
Long-term capitalized lease liabilities	$ 379

XML

Restructuring Costs (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013		Mar. 30, 2012		Apr. 01, 2011
Restructuring Reserve [Roll Forward]
Restructuring liability at beginning of period	$ 0	[1]
Restructuring costs	264		140		0
Costs not affecting restructuring liability	0	[1],[2]
Cash paid	(6)	[1]
Other	0	[1],[3]
Restructuring liability at end of period	11	[1]	0	[1]
Restructuring liability	190		119
Increase (Decrease) in Accrued Liabilities	186		112
Increase (Decrease) in Other Accrued Liabilities	4		7
MSS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	190
BSS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	39
NPS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	13
Corporate [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	22
Restructuring Plan Fiscal 2013 Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring liability at beginning of period	0
Restructuring costs	233
Costs not affecting restructuring liability	(22)	[2]
Cash paid	(33)
Other	(2)	[3]
Restructuring liability at end of period	176
Restructuring Plan Fiscal 2013 Plan [Member] | Pension Benefit Augmentation [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	21
Restructuring Plan Fiscal 2013 Plan [Member] | Workforce reductions
Restructuring Reserve [Roll Forward]
Restructuring liability at beginning of period	0
Restructuring costs	206
Costs not affecting restructuring liability	(22)	[2]
Cash paid	(27)
Other	(2)	[3]
Restructuring liability at end of period	155
Restructuring Plan Fiscal 2013 Plan [Member] | Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring liability at beginning of period	0
Restructuring costs	10
Costs not affecting restructuring liability	0	[2]
Cash paid	0
Other	0	[3]
Restructuring liability at end of period	10
Restructuring Plan Fiscal 2013 Plan [Member] | Professional Fees [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	17	[1]
Restructuring Plan Fiscal 2013 Plan [Member] | MSS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	181
Restructuring Plan Fiscal 2013 Plan [Member] | BSS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	17
Restructuring Plan Fiscal 2013 Plan [Member] | NPS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	13
Restructuring Plan Fiscal 2013 Plan [Member] | Corporate [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	22
Restructuring Plan Fiscal 2012 Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring liability at beginning of period	119		0
Restructuring costs	31		140
Costs not affecting restructuring liability	(1)	[2]	(20)	[2]
Cash paid	(133)		0
Other	(2)	[4]	(1)	[4]
Restructuring liability at end of period	14		119
Restructuring Plan Fiscal 2012 Plan [Member] | Pension Benefit Augmentation [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	1		20
Restructuring Plan Fiscal 2012 Plan [Member] | Workforce reductions
Restructuring Reserve [Roll Forward]
Restructuring liability at beginning of period	110		0
Restructuring costs	31		131
Costs not affecting restructuring liability	(1)	[2]	(20)	[2]
Cash paid	(129)		0
Other	(2)	[4]	(1)	[4]
Restructuring liability at end of period	9		110
Restructuring Plan Fiscal 2012 Plan [Member] | Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring liability at beginning of period	9		0
Restructuring costs	0		9
Costs not affecting restructuring liability	0	[2]	0	[2]
Cash paid	(4)		0
Other	0	[4]	0	[4]
Restructuring liability at end of period	5		9
Restructuring Plan Fiscal 2012 Plan [Member] | MSS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	9		108
Restructuring Plan Fiscal 2012 Plan [Member] | BSS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	22		31
Restructuring Plan Fiscal 2012 Plan [Member] | NPS [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	0		1
Restructuring Plan Fiscal 2012 Plan [Member] | Corporate [Member]
Restructuring Reserve [Roll Forward]
Restructuring costs	$ 0		$ 0

[1] Other direct costs associated with the restructuring program.

[2] Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

[3] Foreign currency translation adjustments.

[4] Foreign currency translation adjustments

XML

Stock Incentive Plans (Details) (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Apr. 02, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of incentive plans within the employee or nonemployee plan	3
Number of common shares available for grant at period end	11,977,359
Additional disclosures - stock options [Abstract]
Weighted average exercise price - granted (in dollars per share)	$ 7.37	$ 10.17	$ 12.95
Aggregate disclosures [Abstract]
Total grant date fair value of stock options vested during the period	$ 20	$ 27	$ 40
Cash received from stock awards exercised during the period	55	15	73
Total unrecognized compensation expense related to unvested awards, net of expected forfeitures	27
Weighted average period over which cost is expected to be recognized (in years)	1 year 10 months 28 days
Stock Options [Member]
Information regarding stock options granted during the period [Roll Forward]
Outstanding beginning of period (in shares)	17,733,562	17,060,193	17,008,397
Granted (in shares)	3,707,172	2,457,509	2,818,874
Exercised (in shares)	(1,497,686)	(428,844)	(1,868,544)
Canceled/Forfeited (in shares)	(1,113,422)	(579,069)	(324,612)
Expired (in shares)	(3,689,059)	(776,227)	(573,922)
Outstanding end of period (in shares)	15,140,567	17,733,562	17,060,193	17,008,397
Vested and expected to vest [Abstract]
Vested and expected to vest in the future as of period end (in shares)	14,885,162
Exercisable as of period end (in shares)	10,694,088
Additional disclosures - stock options [Abstract]
Weighted average exercise price -beginning of period (in dollars per share)	$ 46.13	$ 47.00	$ 46.36
Weighted average exercise price - granted (in dollars per share)	$ 27.46	$ 38.18	$ 48.23
Weighted average exercise price - exercised (in dollars per share)	$ 39.27	$ 35.95	$ 40.61
Weighted average exercise price - cancelled/forfeited (in dollars per share)	$ 35.36	$ 41.75	$ 46.00
Weighted average exercise price - expired (in dollars per share)	$ 45.28	$ 49.05	$ 55.52
Weighted average exercise price - end of period (in dollars per share)	$ 43.23	$ 46.13	$ 47.00	$ 46.36
Weighted average exercise price vested and expected to vest as of period end (in dollars per share)	$ 43.47
Weighted average exercise price exercisable as of period end (in dollars per share)	$ 47.92
Weighted average remaining contractual life (in years)	5 years 5 months 12 days	5 years 0 months 29 days	5 years 6 months 15 days	5 years 6 months 29 days
Weighted average remaining contractual life vested and expected to vest in the future as of period end (in years)	5 years 4 months 17 days
Weighted average remaining contractual life exercisable as of period end (in years)	4 years 0 months 18 days
Aggregate intrinsic value	113	1	69	141
Aggregate intrinsic value vested and expected to vest in the future as of period end	108
Aggregate intrinsic value exercisable as of period end	36
Aggregate disclosures [Abstract]
Total intrinsic value of options exercised during the period	10	5	22
Other stock based incentives [Member]
Equity instruments other than options nonvested [Roll Forward]
Equity instruments other than options nonvested - beginning balance (in shares)		1,740,925	1,478,570	1,154,668
Equity instruments other than options nonvested - granted (in shares)	1,724,639		1,009,743	492,523
Equity instruments other than options nonvested - released/redeemed (in shares)	(423,321)		(419,351)	(151,893)
Equity instruments other than options nonvested - canceled/forfeited (in shares)	(778,971)		(328,037)	(16,728)
Equity instruments other than options nonvested - ending balance (in shares)	2,263,272		1,740,925	1,478,570
Additional disclosures other than options [Abstract]
Weighted average fair value other than options - beginning balance (in dollars per share)	$ 40.29	$ 46.10	$ 45.88
Weighted average fair value other than options - granted (in dollars per share)	$ 26.12	$ 35.45	$ 48.15
Weighted average fair value other than options - released/redeemed (in dollars per share)	$ 33.17	$ 48.21	$ 50.40
Weighted average fair value other than options - canceled/forfeited (in dollars per share)	$ 38.27	$ 41.44	$ 51.94
Weighted average fair value other than options - ending balance (in dollars per share)	$ 31.53	$ 40.29	$ 46.10	$ 45.88
Other stock based incentives [Member] | Service-based RSU's [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of anniversaries following the executive's termination that the shares are redeemable	10
Total Restricted Stock Awards And Other Stock Based Incentives [Member]
Aggregate disclosures [Abstract]
Total unrecognized compensation expense related to unvested awards, net of expected forfeitures	$ 34
Weighted average period over which cost is expected to be recognized (in years)	2 years 2 months 5 days
Restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issue price of award (in dollars per share)	$ 0
Minimum [Member] | Other stock based incentives [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period - minimum (in years)	3 years
Maximum [Member] | Other stock based incentives [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period - minimum (in years)	5 years
Nonemployee Director Incentives [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of incentive plans within the employee or nonemployee plan	2
Number of common shares available for grant at period end	72,400
Equity instruments other than options nonvested [Roll Forward]
Equity instruments other than options nonvested - beginning balance (in shares)		196,361	158,741	133,221
Equity instruments other than options nonvested - granted (in shares)	42,800		37,800	25,700
Equity instruments other than options nonvested - released/redeemed (in shares)	(50,716)		(180)	(180)
Equity instruments other than options nonvested - canceled/forfeited (in shares)	0		0	0
Equity instruments other than options nonvested - ending balance (in shares)	188,445		196,361	158,741
Additional disclosures other than options [Abstract]
Weighted average fair value other than options - beginning balance (in dollars per share)	$ 42.81	$ 45.34	$ 46.47
Weighted average fair value other than options - granted (in dollars per share)	$ 30.30	$ 30.07	$ 39.46
Weighted average fair value other than options - released/redeemed (in dollars per share)	$ 43.30	$ 42.69	$ 42.69
Weighted average fair value other than options - canceled/forfeited (in dollars per share)	$ 0.00	$ 0.00	$ 0.00
Weighted average fair value other than options - ending balance (in dollars per share)	$ 39.85	$ 42.81	$ 45.34	$ 46.47

XML

Contract with the U.K. National Health Service (Details)	0 Months Ended								3 Months Ended
	Mar. 27, 2013 USD ($)	Mar. 27, 2013 GBP (£)	Aug. 31, 2012 USD ($) Contracts	Aug. 31, 2012 GBP (£)	Mar. 29, 2013 USD ($)	Mar. 29, 2013 GBP (£)	Apr. 01, 2011 USD ($)	Apr. 01, 2011 GBP (£)	Dec. 30, 2011 NHS contract [Member] Contracts Accounted for under Percentage of Completion, U.S. Claims [Member] USD ($)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of Regional Contracts Consolidated Upon Revised Agreement			3	3
Proceeds from Customers to Settle Disputed Amounts, Net of Value Added Tax	$ 15,000,000	£ 10,000,000	$ 110,000,000	£ 68,000,000
U.K. National Health (NHS) original contract value					5,400,000,000	2,900,000,000
Amount of initial contract value reduction						500,000,000
Estimated reduction in total contract value								764,000,000
Reduced U.K. National Health (NHS) contract							3,200,000,000	2,100,000,000
Change in accounting estimate, reduction in operating income									1,485,000,000
Contract Modification, Total Consideration To Be Received			126,000,000	78,000,000
Contract Modification, Amount Held in Escrow			$ 16,000,000	£ 10,000,000

XML

Pension and Other Benefit Plans (Details) (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended				0 Months Ended				0 Months Ended			12 Months Ended				12 Months Ended												3 Months Ended		12 Months Ended										12 Months Ended						0 Months Ended	12 Months Ended														0 Months Ended	12 Months Ended		0 Months Ended		12 Months Ended							12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Jul. 01, 2012	Mar. 26, 2013 US pension plans [Member]	Dec. 31, 2012 US pension plans [Member]	Mar. 29, 2013 US pension plans [Member]	Mar. 30, 2012 US pension plans [Member]	Mar. 26, 2013 Non-US pension plans [Member]	Mar. 29, 2013 Non-US pension plans [Member]	Mar. 30, 2012 Non-US pension plans [Member]	Mar. 29, 2013 Pension Plans, Defined Benefit [Member]	Mar. 30, 2012 Pension Plans, Defined Benefit [Member]	Apr. 01, 2011 Pension Plans, Defined Benefit [Member]	Dec. 31, 2012 Pension Plans, Defined Benefit [Member]	Mar. 29, 2013 Pension Plans, Defined Benefit [Member] US pension plans [Member]		Mar. 30, 2012 Pension Plans, Defined Benefit [Member] US pension plans [Member]		Apr. 01, 2011 Pension Plans, Defined Benefit [Member] US pension plans [Member]		Mar. 29, 2013 Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]		Mar. 30, 2012 Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]		Apr. 01, 2011 Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]		Apr. 02, 2010 Pension Plans, Defined Benefit [Member] UK pension plans [Member]	Apr. 01, 2011 Pension Plans, Defined Benefit [Member] UK pension plans [Member]	Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member]		Mar. 30, 2012 Other Postretirement Benefit Plans, Defined Benefit [Member]		Apr. 01, 2011 Other Postretirement Benefit Plans, Defined Benefit [Member]		Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 30, 2012 Other Postretirement Benefit Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 30, 2012 Other Postretirement Benefit Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member] Retirees less than 65 years old [Member]	Mar. 29, 2013 Other Postretirement Benefit Plans, Defined Benefit [Member] Retirees over 65 years old [Member]	Mar. 29, 2013 Weighted Average [Member] US pension plans [Member]	Mar. 30, 2012 Weighted Average [Member] US pension plans [Member]	Mar. 29, 2013 Weighted Average [Member] Non-US pension plans [Member]	Mar. 30, 2012 Weighted Average [Member] Non-US pension plans [Member]	Mar. 21, 2013 Equity Securities [Member] US pension plans [Member]	Mar. 29, 2013 Equity Securities [Member] US pension plans [Member]	Mar. 29, 2013 Equity Securities [Member] Non-US pension plans [Member]	Mar. 29, 2013 Equity Securities [Member] Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 30, 2012 Equity Securities [Member] Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 29, 2013 Equity Securities [Member] Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 30, 2012 Equity Securities [Member] Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 29, 2013 Equity Securities [Member] Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 30, 2012 Equity Securities [Member] Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 29, 2013 Debt Securities [Member] Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 30, 2012 Debt Securities [Member] Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 29, 2013 Debt Securities [Member] Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 30, 2012 Debt Securities [Member] Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 29, 2013 Debt Securities [Member] Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 30, 2012 Debt Securities [Member] Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 21, 2013 Fixed Income Securities [Member] US pension plans [Member]	Mar. 29, 2013 Fixed Income Securities [Member] US pension plans [Member]	Mar. 29, 2013 Fixed Income Securities [Member] Non-US pension plans [Member]	Mar. 21, 2013 Alternative Investments [Member] US pension plans [Member]	Mar. 21, 2013 Cash and Other Investments [Member]	Mar. 29, 2013 Cash and Other Investments [Member] US pension plans [Member]	Mar. 29, 2013 Cash and Other Investments [Member] Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 30, 2012 Cash and Other Investments [Member] Pension Plans, Defined Benefit [Member] US pension plans [Member]	Mar. 29, 2013 Cash and Other Investments [Member] Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 30, 2012 Cash and Other Investments [Member] Pension Plans, Defined Benefit [Member] Non-US pension plans [Member]	Mar. 29, 2013 Cash and Other Investments [Member] Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 30, 2012 Cash and Other Investments [Member] Other Postretirement Benefit Plans, Defined Benefit [Member]	Mar. 29, 2013 Indexed-Gifts [Member] Non-US pension plans [Member]	Mar. 29, 2013 Fiscal 2012 Adjustments Pension Plans, Defined Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Target Plan Asset Allocations Range Maximum																																														66.00%	66.00%	40.00%													44.00%	44.00%	31.00%	25.00%	10.00%	10.00%							29.00%
Plan amendment [Abstract]
Gain or loss resulting from plan amendments						$ 7.6									$ 1.1
New discount rate for the plan's pension expense as a result of the plan amendment (in hundredths)																													5.60%
Reduction to the pension benefit obligation as a result of plan amendment				28																								75
Additional liabilities as a result of remeasurement							379					3
Defined Contribution Plan, Employer Discretionary Contribution Amount					80	400			20
Curtailment loss																												0.4
Defined benefit plan change in benefit obligation [Roll Forward]
Projected benefit obligation																3,284		2,921				2,732		2,470						253		214
Service cost																10		10		9		25		33		32				4		3		4
Interest cost																153		164		164		123		128		122				11		11		14
Plan participants' contributions																3		3				7		8						0		0
Amendments																0		0				(28)		(11)						0		21
Business/contract acquisitions																0		0				(9)		61						0		0
Contractual termination benefit																0		0				19		20
Retiree drug subsidy reimbursement																														1		1
Settlement/curtailment																(5)		0				(37)		(36)
Actuarial loss (gain)																194		314				400		151						(6)		20
Benefits paid																(133)		(128)				(79)		(70)						(10)		(16)
Foreign currency exchange rate changes		0														0		0				(141)		(22)						0		(1)
Accumulated benefit obligation at end of year																3,506		3,284		2,921		3,012		2,732		2,470				253		253		214
Change in fair value of plan assets [Roll Forward]
Beginning balance	5	0					3,209	2,500		2,550	2,295					2,419		2,276				2,295		2,083						81		79				84	81	0	0
Actual return on plan assets																245		140				314		148						7		5
Employer contribution	11	11	10													591		128				157		121						6		13
Plan participants' contributions																3		3				7		8						0		0
Benefits paid																(133)		(128)				(79)		(70)						(10)		(16)
Business/contract acquisitions																0		0				5		47
Plan settlement																0		0				(30)		(31)
Foreign currency exchange rate changes																0		0				(119)		(11)
Ending balance		5	0				3,209	2,500		2,550	2,295					3,125		2,419		2,276		2,550		2,295		2,083				84		81		79		84	81	0	0
Funded status of plan assets [Abstract]
Funded status at end of year																(381)		(865)				(462)		(437)						(169)		(172)
Amounts recorded in consolidated balance sheet [Abstract]
Non-current assets																0		0				23		13
Current liabilities - Accrued expenses and other current liabilities																(7)		(8)				(3)		(9)						(5)		(5)
Non-current liabilities - Other long-term liabilities																(374)		(857)				(482)		(441)						(164)		(167)
Net amount recorded																(381)		(865)				(462)		(437)						(169)		(172)
Amounts in accumulated other comprehensive income (loss) before tax not recognized in the consolidated statements of operations as components of net periodic benefit cost [Abstract]
Net transition obligation																0		0				3		5						0		0
Prior service (gain) cost																5		7				(24)		2						(17)		(19)
Net actuarial loss																1,140		1,077				895		712						99		123
Accumulated other comprehensive loss																1,145		1,084				874		719						82		104
Weighted Average assumptions used in the determination of other post retirement benefit obligations [Abstract]
Discount rate (in hundredths)				4.00%		4.00%									4.20%	4.40%		4.80%				4.10%		4.70%						4.10%		4.50%
Rates of increase in compensation levels (in hundredths)																4.10%	[1]	4.10%	[1]			3.50%	[1]	4.10%	[1]																	0.60%	0.70%	0.60%	0.90%
Selected information for pension and postretirement benefit plans [Abstract]
Projected benefit obligation																3,284		2,921				2,732		2,470						253		214
Accumulated benefit obligation																3,487		3,259				2,969		2,655						253		253
Fair value of plan assets		5	0				3,209	2,500		2,550	2,295					3,125		2,419		2,276		2,550		2,295		2,083				84		81		79		84	81	0	0
Plans with projected benefit obligation in excess of plan assets [Abstract]
Projected benefit obligation - projected												6,270	5,845
Accumulated benefit obligation - projected												6,217	5,770
Fair value of plan assets - projected												5,405	4,531
Plans with accumulated benefit obligation in excess of the fair value of plan assets [Abstract]
Projected benefit obligation - accumulated												6,132	5,844
Accumulated benefit obligation - accumulated												6,100	5,770
Fair value of plan assets - accumulated												5,276	4,530																	84		81
Components of net periodic benefit cost [Abstract]
Service cost																10		10		9		25		33		32				4		3		4
Interest cost																153		164		164		123		128		122				11		11		14
Expected return on assets																(160)		(146)		(157)		(124)		(129)		(128)				(5)		(6)		(6)
Amortization of transition obligation																0		0		0		1		1		1				0		1		2
Amortization of prior service costs																2		2		2		(1)		1		1				(2)		(6)		0
Amortization of unrecognized net loss																42		32		23		20		13		18				16		13		10
Contractual termination benefit												23	20			0		0		0		20		20		0																																																(3)
Settlement/curtailment																0		0		0		0		2		0
Net periodic pension cost																47		62		41		64		69		46				24		16		24
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss), Net Gain (Loss), before Tax [Abstract]
Net actuarial (gain) / loss																105		319		83		201		133		(118)				(8)		21		(1)
Prior service (credit) / cost																0		0		0		(27)		(11)		0				0		21		(50)
Transition (asset) /obligation	(1)	(2)	(2)													0		0		0		(1)		(1)		(1)				0		(1)		(3)
Prior service (credit) / cost	1	2	(2)													(2)		(2)		(2)		1		(1)		(1)				2		6		0
Net actuarial (gain) / loss																(42)		(32)		(23)		(25)		(20)		(24)				(16)		(13)		(10)
Foreign currency exchange rate changes																0		0		0		6		(4)		0				0		0		0
Total recognized in other comprehensive income																61		285		58		155		96		(144)				(22)		34		(64)
Net unamortized gain (loss), before tax												210	257	(62)																(13)		22		(39)
Net unamortized gain (loss), net of tax												6	124	20																9		12		21
Estimated amounts amortized from accumulated other comprehensive income into net periodic benefit cost over the next fiscal year [Abstract]
Estimated net transitional obligation amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year												1																		0
Estimated prior service cost (gain) amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year												(1)																		(2)
Estimated actuarial loss amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year												66																		13
Weighted average assumptions used to determine net periodic benefit cost [Abstract]
Discount or settlement rates (in hundredths)																4.60%		5.70%		6.20%		4.70%		5.20%		5.30%				4.50%		5.30%		6.10%
Expected long-term rates of return on assets (in hundredths)																6.80%		7.50%		8.30%		5.40%		6.10%		6.70%				6.50%	[2]	7.20%	[2]	8.30%	[2]
Rates of increase in compensation levels (in hundredths)																4.10%	[3]	4.30%	[3]	4.30%	[3]	4.10%	[3]	4.10%	[3]	4.10%	[3]															0.70%	0.70%	0.90%	1.00%
Percentage of total pension plan assets for which the US pension trust and UK pension plans assets are made												90.00%
Expected cash flows for pension and postretirement benefit plans [Abstract]
2014 (expected)																8						115								9
Expected benefit payments [Abstract]
2014																151						84								13
2015																152						83								15
2016																165						86								16
2017																176						94								17
2018																188						99								18
2019-2023																1,069						595								94
Assumed healthcare cost trend rate used in measuring the expected benefit obligation [Abstract]
Defined benefit plan health care cost trend rate assumed for next fiscal year (in hundredths)																																								4.50%	3.60%
Ultimate health care cost trend rate (in hundredths)																																								2.30%	2.30%
Effect of a one-percentage point change in assumed health care cost trend rates [Abstract]
Effect on accumulated postretirement benefit obligation as of March 29, 2013																														14
Effect on accumulated postretirement benefit obligation as of March 29, 2013																														(12)
Effect on net periodic postretirement benefit cost for fiscal 2013																														1
Effect on net periodic postretirement benefit cost for fiscal 2013																														(1)
Asset allocation of postretirement benefit plans [Abstract]
Actual Plan asset allocations																100.00%		100.00%				100.00%		100.00%						100.00%		100.00%																	58.00%	59.00%	38.00%	38.00%	29.00%	30.00%	38.00%	39.00%	51.00%	53.00%	19.00%	20.00%							4.00%	2.00%	11.00%	9.00%	52.00%	50.00%
Defined contribution pension and other postretirement plans disclosure [Abstract]
Number of shares of common stock included in plan assets at period end	10,730,413
Amount of company contribution during the fiscal year	$ 213	$ 223	$ 207

[1] The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average rate for all pension plans, including frozen plans, is 0.6% and 0.7%, respectively, for U.S. Plans, and 0.6% and 0.9%, respectively, for Non-U.S. Plans.

[2] The Company had no other postretirement benefit plan assets outside the U.S.

[3] The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average for all pension plans, including frozen plans, is 0.7% and 0.7%, respectively, for U.S. Plans, and 0.9% and 1.0%, respectively, for Non-U.S. Plans.

XML

Income Taxes Income Tax Contingency (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at Beginning of Fiscal Year	$ 287	$ 426	$ 442
Gross increases related to prior year tax positions	7	27	22
Gross decreases related to prior year tax positions	(40)	(134)	(41)
Gross increases related to current year tax positions	8	29	14
Settlements	(18)	(115)	(15)
Curreny year acquisitions	0	56	0
Foreign exchange and others	(3)	(2)	4
Balance at End of Fiscal Year	241	287	426
Cumulative Undistributed Earnings Of Foreign Subsidiaries	2,977
Internal Revenue Service [Member]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Total liability for uncertain tax positions	262	257
Interest liability related to uncertain tax positions	38	31	88
Income tax penalty liability related to uncertain tax positions	17	15	29
Total liability for uncertain tax positions - tax attributes component	32	76
Liability for uncertain tax positions that if recognized would affect the effective tax rate	148	155	266
Interest expense (benefit) accrued related to uncertain tax positions	7	56	3
Interest expense (benefit) accrued related to uncertain tax positions, net of tax	5	36	2
Net release (accrual) of income tax penalties accrued related to uncertain tax positions	2	14	2
Interest liability related to uncertain tax positions, net of tax	$ 28	$ 23	$ 58

XML

Segment and Geographic Information

12 Months Ended

Mar. 29, 2013

Segment and Geographic Information [Abstract]

Segment and Geographic Information

Segment and Geographic Information

CSC provides IT and business process outsourcing, consulting, systems integration and other IT services to its customers. The Company targets the delivery of these services within three broad lines of business or sectors: NPS, MSS, and BSS.

The Company’s reportable segments are as follows:

• NPS – The NPS segment provides services to the U.S. federal government and its agencies, civil departments and branches of military, and operates principally within a regulatory environment subject to governmental contracting and accounting requirements, including Federal Acquisition Regulations, Cost Accounting Standards and audits by various U.S. federal agencies.

• MSS – The MSS segment provides large-scale and mid-size outsourcing solutions and services to customers globally.

• BSS – The BSS segment provides industry specific consulting and systems integration services, business process outsourcing, and intellectual property-based software solutions.

The following table summarizes operating results by reportable segment. BSS results for fiscal 2012 and fiscal 2011, and MSS results for fiscal 2012 have been adjusted from amounts previously reported to reflect the removal of revenue and costs associated with discontinued operations (see Note 3).

Twelve Months Ended
(Amounts in millions)	NPS(1)		MSS		BSS(2)			Corporate			Eliminations			Total
March 29, 2013
Revenues	$	5,391	$	6,457	$	3,272		$	13		$	(140	)	$	14,993
Operating income (loss)	519		361		136			(116		)	—			900
Depreciation and amortization	160		765		137			14			—			1,076
March 30, 2012
Revenues	$	5,703	$	6,602	$	3,180		$	13		$	(134	)	$	15,364
Operating income (loss)	132		17		(1,443		)	(65		)	—			(1,359		)
Depreciation and amortization	162		815		154			16			—			1,147
April 1, 2011
Revenues	$	6,002	$	6,583	$	3,110		$	14		$	(127	)	$	15,582
Operating income (loss)	528		481		188			(72		)	—			1,125
Depreciation and amortization	133		777		127			31			—			1,068

⁽¹⁾  The fiscal 2012 amounts include $42 million reduction of revenue and $269 million in reduction in operating income as a result of the settlement of claims with the U.S. government (see Note 19).

⁽²⁾  The fiscal 2012 amounts include $204 million reduction of revenue and $1,485 million in reduction of operating income as a result of the charge associated with the NHS contract (see Note 18).

Operating income provides useful information to the Company’s management for assessment of the Company’s performance and results of operations. Components of the measure are utilized to determine executive compensation along with other measures.

Reconciliation of consolidated operating (loss) income to (loss) income from continuing operations before taxes is as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Operating income (loss)	$	900		$	(1,359	)	$	1,125
Corporate G&A	(293		)	(219		)	(138		)
Interest expense	(183		)	(175		)	(167		)
Interest income	22			38			37
Goodwill impairment	—			(2,745		)	—
Other income (expense), net	34			6			21
Income (loss) from continuing operations before taxes	$	480		$	(4,454	)	$	878

During fiscal 2013, fiscal 2012, and fiscal 2011, the Company recorded certain pre-tax out-of-period adjustments which should have been recorded in prior fiscal years (See Note 2). The following tables summarize the effect of the pre-tax out-of-period adjustments on the Company's segment results for fiscal 2013, fiscal 2012 and fiscal 2011, if the adjustments had been recorded in the appropriate year.

Twelve Months Ended	NPS
(Amounts in millions)	As Reported		Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	5,391	$	—		$	5,391
Operating income	519		6			525
Depreciation and amortization	160		—			160
March 30, 2012
Revenues	$	5,703	$	5		$	5,708
Operating income	132		10			142
Depreciation and amortization	162		—			162
April 1, 2011
Revenues	$	6,002	$	—		$	6,002
Operating income	528		(11		)	517
Depreciation and amortization	133		—			133

Twelve Months Ended	MSS
(Amounts in millions)	As Reported		Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	6,457	$	1		$	6,458
Operating income	361		3			364
Depreciation and amortization	765		—			765
March 30, 2012
Revenues	$	6,602	$	6		$	6,608
Operating income	17		33			50
Depreciation and amortization	815		(2		)	813
April 1, 2011
Revenues	$	6,583	$	34		$	6,617
Operating income	481		45			526
Depreciation and amortization	777		3			780

Twelve Months Ended	BSS
(Amounts in millions)	As Reported			Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	3,272		$	13		$	3,285
Operating income	136			(8		)	128
Depreciation and amortization	137			(2		)	135
March 30, 2012
Revenues	$	3,180		$	45		$	3,225
Operating loss	(1,443		)	43			(1,400		)
Depreciation and amortization	154			—			154
April 1, 2011
Revenues	$	3,110		$	(33	)	$	3,077
Operating income	188			(29		)	159
Depreciation and amortization	127			—			127

Revenue by country is based on the location of the selling business unit. Property and equipment, total assets and capital expenditures (purchase of property and equipment) information is based on the physical location of the asset. Geographic revenue, property and equipment, net, total assets, and capital expenditures for the three years ended March 29, 2013, March 30, 2012, and April 1, 2011, are as follows:

	March 29, 2013
(Amounts in millions)	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,345	$	1,729	$	2,217	$	1,702	$	14,993
Property and Equipment, net	1,273		320		217		374		2,184
Total Assets	6,454		1,389		1,487		1,921		11,251
Capital Expenditures	290		70		80		128		568

	March 30, 2012
	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,475	$	1,576	$	2,446	$	1,867	$	15,364
Property and Equipment, net	1,406		367		237		431		2,441
Total Assets	6,198		1,329		1,115		2,547		11,189
Capital Expenditures	444		77		90		218		829

	April 1, 2011
	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,923	$	1,869	$	2,276	$	1,514	$	15,582
Property and Equipment, net	1,396		403		291		406		2,496
Total Assets	6,855		2,998		3,884		2,383		16,120
Capital Expenditures	577		116		100		179		972

The Company derives a significant portion of its revenues from departments and agencies of the U.S. federal government which accounted for 34%, 36%, and 37% of the Company’s revenues for fiscal 2013, fiscal 2012, and fiscal 2011, respectively. At March 29, 2013 and March 30, 2012, approximately 30% and 33% of the Company’s net accounts receivables was due from the U.S. federal government. No single commercial customer exceeded 10% of the Company’s revenues during fiscal 2013, fiscal 2012, or fiscal 2011.

XML

Summary of Significant Accounting Policies - Change in Estimates (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013		Mar. 30, 2012		Apr. 01, 2011
Change in Accounting Estimate [Line Items]
Gross favorable	$ 143		$ 58		$ 53
Gross unfavorable	(122)	[1]	(289)	[1]	(130)	[1]
Total net adjustments, before taxes and noncontrolling interests (2)	$ 21	[2]	$ (231)	[2]	$ (77)	[2]
Impact on diluted EPS from continuing operations	$ 0		$ (1.30)		$ (0.42)

[1] Fiscal 2012 does not include the contract charge related to the Company’s contract with the NHS of $1,485 million (see Note 18).

[2] Quarterly changes in estimated profitability on the same fixed price contract are disclosed gross as either favorable or unfavorable.

XML

Debt (Tables)

12 Months Ended

Mar. 29, 2013

Debt, Current [Abstract]

Schedule of long term debt instruments

The following is a summary of the Company's debt as of March 29, 2013 and March 30, 2012:

(Amounts in millions)	March 29, 2013		March 30, 2012
4.45% term notes, due September 2022	$	349	$	—
6.50% term notes, due March 2018	998		997
2.50% term notes, due September 2015	350		—
5.50% term notes, due March 2013	—		699
5.00% term notes, due February 2013	—		300
Four-year term loan credit facility	250		—
Mandatorily redeemable preferred stock outstanding	59		—
Note payable of consolidated subsidiary	62		—
Capitalized lease liabilities	561		574
Borrowings for assets acquired under long-term financing	98		84
Other borrowings	5		86
Total debt	2,732		2,740
Less: short term debt and current maturities of long term debt	234		1,254
Total long-term debt	$	2,498	$	1,486

Schedule of future minimum lease payments required under the capital leases

Expected maturities of long-term debt, including borrowings for asset financing but excluding future minimum capital lease payments, for years subsequent to March 29, 2013, are as follows:

Fiscal Year	Amount (in millions)
2014	$	52
2015	71
2016	381
2017	194
2018	1,064
Thereafter	409
Total	$	2,171

Schedule of long term debt expected maturities

The future minimum lease payments required to be made under the capital leases as of March 29, 2013, are as follows:

Fiscal Year	Amount (in millions)
2014	$	221
2015	195
2016	115
2017	73
2018	38
Thereafter	97
Total minimum lease payments	739
Less: Amount representing interest	178
Present value of net minimum lease payments	561
Less: Current maturities of capital lease obligations	182
Long-term capitalized lease liabilities	$	379

XML

Debt Assets Acquired by Debt (Details) (USD $) In Millions, unless otherwise specified									12 Months Ended
	Mar. 29, 2013 Borrowings for Assets Acquired Under Long-term Financing [Member] Property and equipment [Member]	Mar. 30, 2012 Borrowings for Assets Acquired Under Long-term Financing [Member] Property and equipment [Member]	Mar. 29, 2013 Borrowings for Assets Acquired Under Long-term Financing [Member] Software [Member]	Mar. 30, 2012 Borrowings for Assets Acquired Under Long-term Financing [Member] Software [Member]	Mar. 29, 2013 Borrowings for Assets Acquired Under Long-term Financing [Member] Contract premium costs [Member]	Mar. 30, 2012 Borrowings for Assets Acquired Under Long-term Financing [Member] Contract premium costs [Member]	Mar. 29, 2013 Borrowings for Assets Acquired Under Long-term Financing [Member] Other assets acquired [Member]	Mar. 30, 2012 Borrowings for Assets Acquired Under Long-term Financing [Member] Other assets acquired [Member]	Mar. 29, 2013 Outsourcing contract costs [Member]	Mar. 29, 2013 Outsourcing contract costs [Member] Minimum [Member]	Mar. 29, 2013 Outsourcing contract costs [Member] Maximum [Member]
Schedule of Assets Acquired By Debt [Line Items]
Expected maturity of debt in years									5 years
Weighted average rate of interest (in hundredths)										0.00%	4.90%
Purchased assets financed by borrowing from customers under outsourcing contracts	$ 69	$ 44	$ 54	$ 45	$ 90	$ 86	$ 10	$ 10

XML

Receivables (Tables)

12 Months Ended

Mar. 29, 2013

Receivables [Abstract]

Schedule of receivables

Receivables consist of the following:

(Amounts in millions)	March 29, 2013		March 30, 2012
Billed trade accounts	$	1,627	$	1,794
Unbilled recoverable amounts under contracts in progress	1,176		1,300
Other receivables	396		163
Total	$	3,199	$	3,257

XML

Summary of Significant Accounting Policies - Depreciation and Amortization (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Property, Plant, and Equipment - Useful Life [Abstract]
Depreciation expense	$ 715	$ 759	$ 688
Building [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, minimum (in years)	40 years
Leasehold Improvements [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, description	Shorter of lease term or useful life
Outsourcing contract costs [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, description	Contract life, excluding option years
Customer Relationships [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, description	Expected customer service life
Acquired contract related intangibles [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, description	Contract life and first contract renewal, where applicable
Minimum [Member] | Computers and related equipment [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, minimum (in years)	3 years
Minimum [Member] | Furniture and other equipment [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, minimum (in years)	2 years
Minimum [Member] | Software [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, minimum (in years)	2 years
Maximum [Member] | Computers and related equipment [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, minimum (in years)	5 years
Maximum [Member] | Furniture and other equipment [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, minimum (in years)	15 years
Maximum [Member] | Software [Member]
Property, Plant, and Equipment - Useful Life [Abstract]
Property, plant and equipment useful life, minimum (in years)	10 years

XML

Goodwill (Details) (USD $)	3 Months Ended	12 Months Ended						3 Months Ended	12 Months Ended			12 Months Ended				3 Months Ended		12 Months Ended		3 Months Ended
	Sep. 30, 2011	Mar. 29, 2013	Mar. 30, 2012 Businesses reporting_unit	Apr. 01, 2011	Mar. 29, 2013 NPS [Member]	Mar. 30, 2012 NPS [Member] Businesses	Apr. 01, 2011 NPS [Member]	Sep. 30, 2011 MSS [Member]	Mar. 29, 2013 MSS [Member]	Mar. 30, 2012 MSS [Member] Businesses	Apr. 01, 2011 MSS [Member]	Mar. 29, 2013 BSS [Member] reporting_unit	Mar. 30, 2012 BSS [Member] Businesses	Apr. 01, 2011 BSS [Member]	Sep. 30, 2011 Health [Member]	Sep. 30, 2011 Health [Member] MSS [Member]	Dec. 30, 2011 Health [Member] BSS [Member]	Apr. 01, 2011 Health [Member] BSS [Member]	Sep. 30, 2011 Health [Member] BSS [Member]	Sep. 30, 2011 GBS [Member]	Sep. 30, 2011 GBS [Member] BSS [Member]	Mar. 30, 2012 GBS [Member] BSS [Member]
Changes in the carrying amount of goodwill by segment [Roll Forward]
Goodwill Gross		$ 4,516,000,000	$ 4,057,000,000		$ 768,000,000	$ 753,000,000			$ 2,221,000,000	$ 1,965,000,000		$ 1,527,000,000	$ 1,339,000,000
Goodwill Accumulated impairment loss		(2,764,000,000)	(19,000,000)		0	0			(2,074,000,000)	0		(690,000,000)	(19,000,000)
Goodwill Acquired during period and contingent consideration paid		25,000,000	476,000,000		25,000,000	15,000,000			0	157,000,000		0	304,000,000
Deductions		(241,000,000)			0				0			(241,000,000)
Foreign Currency Translation		(20,000,000)	(17,000,000)		0	0			(11,000,000)	3,000,000		(9,000,000)	(20,000,000)
Goodwill, Other reclassifications		0	0		0	0			(11,000,000)	96,000,000		11,000,000	(96,000,000)
Goodwill impairment		0	(2,745,000,000)	0		0		(2,074,000,000)		(2,074,000,000)			(671,000,000)			(158,000,000)		(63,000,000)		(2,685,000,000)	(453,000,000)
Goodwill Gross		4,280,000,000	4,516,000,000	4,057,000,000	793,000,000	768,000,000			2,199,000,000	2,221,000,000		1,288,000,000	1,527,000,000
Goodwill Impaired Accumulated Impairment loss		(2,764,000,000)	(2,764,000,000)	(19,000,000)	0	0			(2,074,000,000)	(2,074,000,000)		(690,000,000)	(690,000,000)
Goodwill		1,516,000,000	1,752,000,000	4,038,000,000	793,000,000	768,000,000	753,000,000	143,000,000	125,000,000	147,000,000	1,965,000,000	598,000,000	837,000,000	1,320,000,000			0		60,000,000			0
Business Acquisition, Purchase Price Allocation, Goodwill Amount																			18,000,000
Adjustment to Amount of Goodwill Impairment Charge																	3,000,000
Goodwill Impairment Loss for Annual and Second Quarter Test	2,682,000,000
Excess of Estimate, Fair Value of Reporting Unit Over Carrying Value, Percent															6.00%
Goodwill, Other Changes												(11,000,000)
Additions to goodwill related to acquisitions of new businesses			475,000,000
Number of entities acquired			4			1				1			2
Contingent consideration paid						1,000,000
Number Of Reporting Units With Goodwill Impairment			3									2
Number Of Reporting Units To Which Goodwill Has Been Assigned For Impairment Testing			8
Unrecognized Intangible Assets										$ 1,300,000,000

XML

Acquisitions (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended																12 Months Ended		12 Months Ended		12 Months Ended		12 Months Ended			12 Months Ended									12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Mar. 29, 2013 NPS [Member]		Mar. 30, 2012 NPS [Member]		Apr. 01, 2011 NPS [Member] Businesses		Mar. 29, 2013 BSS [Member]		Mar. 30, 2012 BSS [Member]		Apr. 01, 2011 BSS [Member] Businesses		Sep. 28, 2012 Acquisition of privately held entities [Member]	Mar. 30, 2012 AppLabs Acquisition [Member]	Sep. 13, 2011 AppLabs Acquisition [Member]	Mar. 29, 2013 AppLabs Acquisition [Member] Customer Relationships [Member]	Sep. 13, 2011 AppLabs Acquisition [Member] Customer Relationships [Member]	Mar. 29, 2013 AppLabs Acquisition [Member] Software [Member]	Sep. 13, 2011 AppLabs Acquisition [Member] Software [Member]	Mar. 29, 2013 iSOFT Group Limited [Member]	Apr. 01, 2011 iSOFT Group Limited [Member]	Jul. 29, 2011 iSOFT Group Limited [Member]	Mar. 29, 2013 iSOFT Group Limited [Member] Customer Relationships [Member]	Mar. 29, 2013 iSOFT Group Limited [Member] Software [Member]	Mar. 29, 2013 iSOFT Group Limited [Member] Trade Names [Member]	Mar. 30, 2012 Other Acquisition [Member] Businesses	Apr. 01, 2011 Other Acquisition [Member] Businesses	Mar. 30, 2012 Other Acquisition [Member] NPS [Member]	Apr. 01, 2011 Other Acquisition [Member] NPS [Member]	Mar. 30, 2012 Other Acquisition [Member] BSS [Member]	Apr. 01, 2011 Other Acquisition [Member] BSS [Member]	Mar. 30, 2012 Scenario, Previously Reported [Member]
Business Acquisition [Line Items]
Total cash consideration paid																$ 35		$ 171					$ 200		$ 200				$ 28	$ 156
Current assets																4
Intangible assets																8
Liabilities																2
Goodwill																25
Acquired debt paid off																							298
Summary of consolidated information as reported [Abstract]
Revenues	14,993	15,364	15,582														60						139
Net income (loss)	961	(4,242)	740																																(4,242)
Basic EPS (in dollars per share)	$ 6.22	$ (27.37)	$ 4.79
Diluted EPS (in dollars per share)	$ 6.18	$ (27.37)	$ 4.73
Results of acquisitions included in consolidated financial statements [Abstract]
Revenues	14,993	15,364	15,582														60						139
Operating income (loss)	900	(1,359)	1,125	519	[1]	132	[1]	528	[1]	136	[2]	(1,443)	[2]	188	[2]		2						93
Currency gains																							18
Pre-tax net income (loss)	480	(4,454)	878																				75
Assets acquired and liabilities assumed [Abstract]
Cash and cash equivalents																		4					26
Trade and other receivables																		20					114
Other current assets																		8					14
Deferred tax assets																							12
Intangible assets																		26		25		1	198			92	102	4	7	22
Property and equipment																		4					21						2	5
Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets																							3
Trade payables and accrued expenses																		(26)					(62)
Deferred revenue																							(54)
Debt																							(315)
Deferred tax, uncertain tax positions, and other long-term liabilities																							(59)
Total identifiable net assets acquired																		14					(102)
Goodwill																		157					302						17	113		72	3	41
Total purchase price																35		171					200		200				28	156
Current assets																													8	17
Current liabilities																													6
Income tax liabilities and deferred income taxes																		(20)
Other liabilities																		(2)
Business Acquisition, Purchase Price Allocation, Intangible Assets Not Amortizable																														19
Goodwill impairment	0	2,745	0			0						671											37	290
Estimated fair value																		26		25		1	198			92	102	4	7	22
Estimated useful life, lower range																			2 years		1 year					10 years	2 years		4 years
Estimated useful life, upper range																			8 years		5 years					13 years	7 years		10 years
Estimated useful life																												1 year
Fair value of accounts receivable [Abstract]
Uncollectible contractual receivables																							10
Tax deductible goodwill			69																				71								14
Additional consideration of contingent on achievement of agreed revenue targets for future periods																													2
Number of acquisitions (in number of entity)								2						2															2	4
Transaction costs included (excluded) due to integration of acquisition into Company's operations																							11	11
Business Acquisition, Cost of Acquired Entity, Transaction Costs																														1
Net income (loss)	961	(4,242)	740																																(4,242)
Business Acquisition, Purchase Price Allocation, Liabilities Assumed																														20
Unaudited pro forma summary of consolidated information [Abstract]
Revenue		15,442	15,776
Net (loss) income attributable to CSC common shareholders		(4,344)	618
Basic EPS (in dollars per share)		$ (28.02)	$ 4.00
Diluted EPS (in dollars per share)		$ (28.02)	$ 3.95
Net income (loss)	$ 961	$ (4,242)	$ 740																																$ (4,242)

[1] The fiscal 2012 amounts include $42 million reduction of revenue and $269 million in reduction in operating income as a result of the settlement of claims with the U.S. government (see Note 19).

[2] The fiscal 2012 amounts include $204 million reduction of revenue and $1,485 million in reduction of operating income as a result of the charge associated with the NHS contract (see Note 18).

XML

Segment and Geographic Information (Tables)

12 Months Ended

Mar. 29, 2013

Segment and Geographic Information [Abstract]

Operating Results by Reportable Segment

The following table summarizes operating results by reportable segment. BSS results for fiscal 2012 and fiscal 2011, and MSS results for fiscal 2012 have been adjusted from amounts previously reported to reflect the removal of revenue and costs associated with discontinued operations (see Note 3).

Twelve Months Ended
(Amounts in millions)	NPS(1)		MSS		BSS(2)			Corporate			Eliminations			Total
March 29, 2013
Revenues	$	5,391	$	6,457	$	3,272		$	13		$	(140	)	$	14,993
Operating income (loss)	519		361		136			(116		)	—			900
Depreciation and amortization	160		765		137			14			—			1,076
March 30, 2012
Revenues	$	5,703	$	6,602	$	3,180		$	13		$	(134	)	$	15,364
Operating income (loss)	132		17		(1,443		)	(65		)	—			(1,359		)
Depreciation and amortization	162		815		154			16			—			1,147
April 1, 2011
Revenues	$	6,002	$	6,583	$	3,110		$	14		$	(127	)	$	15,582
Operating income (loss)	528		481		188			(72		)	—			1,125
Depreciation and amortization	133		777		127			31			—			1,068

⁽¹⁾  The fiscal 2012 amounts include $42 million reduction of revenue and $269 million in reduction in operating income as a result of the settlement of claims with the U.S. government (see Note 19).

⁽²⁾  The fiscal 2012 amounts include $204 million reduction of revenue and $1,485 million in reduction of operating income as a result of the charge associated with the NHS contract (see Note 18).

Reconciliation of Consolidated Operating Income to Income Before Taxes

Reconciliation of consolidated operating (loss) income to (loss) income from continuing operations before taxes is as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Operating income (loss)	$	900		$	(1,359	)	$	1,125
Corporate G&A	(293		)	(219		)	(138		)
Interest expense	(183		)	(175		)	(167		)
Interest income	22			38			37
Goodwill impairment	—			(2,745		)	—
Other income (expense), net	34			6			21
Income (loss) from continuing operations before taxes	$	480		$	(4,454	)	$	878

Out of period adjustments by segment

The following tables summarize the effect of the pre-tax out-of-period adjustments on the Company's segment results for fiscal 2013, fiscal 2012 and fiscal 2011, if the adjustments had been recorded in the appropriate year.

Twelve Months Ended	NPS
(Amounts in millions)	As Reported		Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	5,391	$	—		$	5,391
Operating income	519		6			525
Depreciation and amortization	160		—			160
March 30, 2012
Revenues	$	5,703	$	5		$	5,708
Operating income	132		10			142
Depreciation and amortization	162		—			162
April 1, 2011
Revenues	$	6,002	$	—		$	6,002
Operating income	528		(11		)	517
Depreciation and amortization	133		—			133

Twelve Months Ended	MSS
(Amounts in millions)	As Reported		Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	6,457	$	1		$	6,458
Operating income	361		3			364
Depreciation and amortization	765		—			765
March 30, 2012
Revenues	$	6,602	$	6		$	6,608
Operating income	17		33			50
Depreciation and amortization	815		(2		)	813
April 1, 2011
Revenues	$	6,583	$	34		$	6,617
Operating income	481		45			526
Depreciation and amortization	777		3			780

Twelve Months Ended	BSS
(Amounts in millions)	As Reported			Increase/ (Decrease)			Adjusted
March 29, 2013
Revenues	$	3,272		$	13		$	3,285
Operating income	136			(8		)	128
Depreciation and amortization	137			(2		)	135
March 30, 2012
Revenues	$	3,180		$	45		$	3,225
Operating loss	(1,443		)	43			(1,400		)
Depreciation and amortization	154			—			154
April 1, 2011
Revenues	$	3,110		$	(33	)	$	3,077
Operating income	188			(29		)	159
Depreciation and amortization	127			—			127

Revenue and property and equipment, net by geographic segment

Geographic revenue, property and equipment, net, total assets, and capital expenditures for the three years ended March 29, 2013, March 30, 2012, and April 1, 2011, are as follows:

	March 29, 2013
(Amounts in millions)	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,345	$	1,729	$	2,217	$	1,702	$	14,993
Property and Equipment, net	1,273		320		217		374		2,184
Total Assets	6,454		1,389		1,487		1,921		11,251
Capital Expenditures	290		70		80		128		568

	March 30, 2012
	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,475	$	1,576	$	2,446	$	1,867	$	15,364
Property and Equipment, net	1,406		367		237		431		2,441
Total Assets	6,198		1,329		1,115		2,547		11,189
Capital Expenditures	444		77		90		218		829

	April 1, 2011
	United States		United Kingdom		Other Europe		Other International		Total
Revenue	$	9,923	$	1,869	$	2,276	$	1,514	$	15,582
Property and Equipment, net	1,396		403		291		406		2,496
Total Assets	6,855		2,998		3,884		2,383		16,120
Capital Expenditures	577		116		100		179		972

XML

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $) In Millions, except Share data, unless otherwise specified	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Common Stock in Treasury [Member]	Total CSC Equity [Member]	Non-Controlling Interest [Member]
Balance at Apr. 02, 2010	$ 6,508	$ 162	$ 2,006	$ 5,709	$ (1,052)	$ (379)	$ 6,446	$ 62
Balance (in shares) at Apr. 02, 2010		162,234,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	759			740			740	19
Other comprehensive income (loss)	362				362		362
Stock based compensation expense	56		56				56
Acquisition of treasury stock	(6)					(6)	(6)
Repurchase of common stock (in shares)		(1,353,000)
Repurchase of common stock	(65)	(1)	(19)	(45)			(65)
Stock option exercises and other common stock transactions (in shares)		1,992,000
Stock option exercises and other common stock transactions	79	2	77				79
Cash dividends declared	(108)			(108)			(108)
Noncontrolling interest distributions and other	(25)						0	(25)
Balance at Apr. 01, 2011	7,560	163	2,120	6,296	(690)	(385)	7,504	56
Balance (in shares) at Apr. 01, 2011		162,873,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(4,225)			(4,242)			(4,242)	17
Other comprehensive income (loss)	(403)				(403)		(403)
Stock based compensation expense	36		36				36
Acquisition of treasury stock	(5)					(5)	(5)
Stock option exercises and other common stock transactions (in shares)		847,000
Stock option exercises and other common stock transactions	13	1	12				13
Cash dividends declared	(124)			(124)			(124)
Noncontrolling interest distributions and other	(18)							(18)
Balance at Mar. 30, 2012	2,834	164	2,168	1,930	(1,093)	(390)	2,779	55
Balance (in shares) at Mar. 30, 2012		163,720,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	979						961	18
Other comprehensive income (loss)	(280)				(261)		(261)	(19)
Stock based compensation expense	48		48				48
Acquisition of treasury stock	(11)					(11)	(11)
Repurchase of common stock (in shares)		(6,708,000)
Repurchase of common stock	(305)	(7)	(94)	(204)			(305)
Stock option exercises and other common stock transactions (in shares)		1,972,000
Stock option exercises and other common stock transactions	47	2	45				47
Cash dividends declared	(123)			(123)			(123)
Noncontrolling interest distributions and other	(29)						0	(29)
Balance at Mar. 29, 2013	$ 3,160	$ 159	$ 2,167	$ 2,564	$ (1,354)	$ (401)	$ 3,135	$ 25
Balance (in shares) at Mar. 29, 2013		158,984,000

XML

Receivables (Details) (USD $) In Millions, unless otherwise specified	Mar. 29, 2013	Mar. 30, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables, net	$ 3,199	$ 3,257
Unbilled recoverable amounts primarily from governments that are expected to be collected after one year	48
Billed trade accounts [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables, net	1,627	1,794
Unbilled recoverable amounts under contracts in progress [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables, net	1,176	1,300
Other receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivables, net	$ 396	$ 163

XML

Pension and Other Benefit Plans (Tables)

12 Months Ended

Mar. 29, 2013

Pension And Other Benefit Plans [Abstract]

Schedule of defined benefit plans disclosures

The weighted-averages of the assumptions used to determine net periodic pension cost were:

	U.S. Plans						Non-U.S. Plans
	March 29, 2013		March 30, 2012		April 1, 2011		March 29, 2013		March 30, 2012		April 1, 2011
Discount or settlement rates	4.6	%	5.7	%	6.2	%	4.7	%	5.2	%	5.3	%
Expected long-term rates of return on assets	6.8	%	7.5	%	8.3	%	5.4	%	6.1	%	6.7	%
Rates of increase in compensation levels (1)	4.1	%	4.3	%	4.3	%	4.1	%	4.1	%	4.1	%

(1) The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average for all pension plans, including frozen plans, is 0.7% and 0.7%, respectively, for U.S. Plans, and 0.9% and 1.0%, respectively, for Non-U.S. Plans.

The following tables provide reconciliations of the changes in the plans’ projected benefit obligations and assets, and a statement of their funded status:

Reconciliation of Projected Benefit Obligation	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Projected benefit obligation at beginning of year	$	3,284		$	2,921		$	2,732		$	2,470
Service cost	10			10			25			33
Interest cost	153			164			123			128
Plan participants’ contributions	3			3			7			8
Amendments	—			—			(28		)	(11		)
Business/contract acquisitions/divestitures	—			—			(9		)	61
Contractual termination benefits	—			—			19			20
Settlement/curtailment	(5		)	—			(37		)	(36		)
Actuarial loss (gain)	194			314			400			151
Benefits paid	(133		)	(128		)	(79		)	(70		)
Foreign currency exchange rate changes	—			—			(141		)	(22		)
Projected benefit obligation at end of year	$	3,506		$	3,284		$	3,012		$	2,732

Reconciliation of Fair Value of Plan Assets	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Fair value of plan assets at beginning of year	$	2,419		$	2,276		$	2,295		$	2,083
Actual return on plan assets	245			140			314			148
Employer contribution	591			128			157			121
Plan participants’ contributions	3			3			7			8
Benefits paid	(133		)	(128		)	(79		)	(70		)
Business/contract acquisitions/divestitures	—			—			5			47
Plan settlement	—			—			(30		)	(31		)
Foreign currency exchange rate changes	—			—			(119		)	(11		)
Fair value of plan assets at end of year	$	3,125		$	2,419		$	2,550		$	2,295
Funded status at end of year	$	(381	)	$	(865	)	$	(462	)	$	(437	)

The following table provides the amounts recorded in the Company’s consolidated balance sheet:

	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Non-current assets	$	—		$	—		$	23		$	13
Current liabilities - Accrued expenses and other current liabilities	(7		)	(8		)	(3		)	(9		)
Non-current liabilities - Other long-term liabilities	(374		)	(857		)	(482		)	(441		)
Net amount recorded	$	(381	)	$	(865	)	$	(462	)	$	(437	)

The following is a summary of amounts in accumulated other comprehensive loss, before tax effects, as of March 29, 2013 and March 30, 2012 that have not been recognized in the consolidated statements of operations as components of net periodic pension cost:

	U.S. Plans				Non-U.S. Plans
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013			March 30, 2012
Net transition obligation	$	—	$	—	$	3		$	5
Prior service cost	5		7		(24		)	2
Net actuarial loss	1,140		1,077		895			712
Accumulated other comprehensive loss	$	1,145	$	1,084	$	874		$	719

The following table summarizes the weighted average assumptions used in the determination of the Company’s pension plans’ benefit obligations as of March 29, 2013 and March 30, 2012:

	U.S. Plans				Non-U.S. Plans
	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Discount rate	4.4	%	4.8	%	4.1	%	4.7	%
Rates of increase in compensation levels (1)	4.1	%	4.1	%	3.5	%	4.1	%

(1) The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average rate for all pension plans, including frozen plans, is 0.6% and 0.7%, respectively, for U.S. Plans, and 0.6% and 0.9%, respectively, for Non-U.S. Plans.

The following table lists selected information for the pension plans as of March 29, 2013 and March 30, 2012:

	U.S. Plans				Non-U.S. Plans
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Projected benefit obligation	$	3,506	$	3,284	$	3,012	$	2,732
Accumulated benefit obligation	3,487		3,259		2,969		2,655
Fair value of plan assets	3,125		2,419		2,550		2,295

	Plans with Projected Benefit Obligation In Excess of Plan Assets (U.S. and Non-U.S.)				Plans with Accumulated Benefit Obligation in Excess of Plan Assets (U.S. and Non-U.S.)
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Projected benefit obligation	$	6,270	$	5,845	$	6,132	$	5,844
Accumulated benefit obligation	6,217		5,770		6,100		5,770
Fair value of plan assets	5,405		4,531		5,276		4,530

The net periodic pension cost for U.S. and non-U.S. pension plans included the following components:

	U.S. Plans									Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011			March 29, 2013			March 30, 2012			April 1, 2011
Service cost	$	10		$	10		$	9		$	25		$	33		$	32
Interest cost	153			164			164			123			128			122
Expected return on assets	(160		)	(146		)	(157		)	(124		)	(129		)	(128		)
Amortization of transition obligation	—			—			—			1			1			1
Amortization of prior service costs	2			2			2			(1		)	1			1
Amortization of unrecognized net loss	42			32			23			20			13			18
Contractual termination benefit	—			—			—			20			20			—
Settlement/curtailment	—			—			—			—			2			—
Net periodic pension cost	$	47		$	62		$	41		$	64		$	69		$	46

Other before tax changes in plan assets and benefit obligations recognized in other comprehensive income during fiscal years 2013, 2012 and 2011 included the following components:

	U.S. Plans									Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011			March 29, 2013			March 30, 2012			April 1, 2011
Net actuarial (gain) / loss	$	105		$	319		$	83		$	201		$	133		$	(118	)
Prior service (credit) / cost	—			—			—			(27		)	(11		)	—
Amortization of:
Transition (asset) /obligation	—			—			—			(1		)	(1		)	(1		)
Prior service (credit) / cost	(2		)	(2		)	(2		)	1			(1		)	(1		)
Net actuarial (gain) / loss	(42		)	(32		)	(23		)	(25		)	(20		)	(24		)
Foreign currency exchange rate changes	—			—			—			6			(4		)	—
Total recognized in other comprehensive income	$	61		$	285		$	58		$	155		$	96		$	(144	)

Information about the expected cash flows for pension plans as of March 29, 2013, is as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Employer contributions:
2014 (expected)	$	8	$	115
Expected Benefit Payments:
2014	$	151	$	84
2015	152		83
2016	165		86
2017	176		94
2018	188		99
2019-2023	1,069		595

The following table summarizes the weighted average assumptions used in the determination of the Company’s postretirement benefit obligations as of March 29, 2013 and March 30, 2012:

	March 29, 2013		March 30, 2012
Discount rate	4.1	%	4.5	%

The weighted-averages of the assumptions used to determine net periodic benefit cost were as follows. See the above discussion of Pension Plans for how the assumptions are developed.

Fiscal Year End	2013		2012		2011
Discount or settlement rates	4.5	%	5.3	%	6.1	%
Expected long-term rates of return on assets(1)	6.5	%	7.2	%	8.3	%

⁽¹⁾ The Company had no other postretirement benefit plan assets outside the U.S.

Information about the expected cash flows for other postretirement benefit plans follows. No significant cash flow is expected for other postretirement benefit plans outside the U.S.

(Amounts in millions)	Employer Contributions
2014 (expected)	$	9
Expected Benefit Payments
2014	$	13
2015	15
2016	16
2017	17
2018	18
2019-2023	94

A one-percentage point change in the assumed healthcare cost trend rates would have had the following effect:

	One Percentage Point
(Amounts in millions)	Increase		Decrease
Effect on accumulated postretirement benefit obligation as of March 29, 2013	$	14	$	(12	)
Effect on net periodic postretirement benefit cost for fiscal 2013	1		(1		)

The net periodic benefit cost for other postretirement benefit plans included the following components:

(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Service cost	$	4		$	3		$	4
Interest cost	11			11			14
Expected return on assets	(5		)	(6		)	(6		)
Amortization of transition obligation	—			1			2
Amortization of prior service costs	(2		)	(6		)	—
Recognized actuarial loss	16			13			10
Net provision for postretirement benefits	$	24		$	16		$	24

Other before tax changes in plan assets and benefit obligations recognized in other comprehensive income during fiscal years 2013, 2012 and 2011 included the following components:

(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Net actuarial (gain) / loss	$	(8	)	$	21		$	(1	)
Prior service (credit) / cost	—			21			(50		)
Amortization of:
Transition (asset) /obligation	—			(1		)	(3		)
Prior service (credit) / cost	2			6			—
Actuarial (gain) / loss	(16		)	(13		)	(10		)
Foreign currency exchange rate changes	—			—			—
Total recognized in other comprehensive income	$	(22	)	$	34		$	(64	)

The following tables provide reconciliations of the changes in postretirement plans’ benefit obligations and assets and a statement of their funded status:

Reconciliation of Accumulated Postretirement Benefit Obligation
(Amounts in millions)	March 29, 2013			March 30, 2012
Accumulated benefit obligation at beginning of year	$	253		$	214
Service cost	4			3
Interest cost	11			11
Plan participants’ contributions	—			—
Business/contract acquisitions/divestitures	—			—
Amendments	—			21
Actuarial loss (gain)	(6		)	20
Benefits paid	(10		)	(16		)
Retiree drug subsidy reimbursement	1			1
Foreign currency exchange rate changes	—			(1		)
Accumulated benefit obligation at end of year	$	253		$	253
Reconciliation of Fair Value of Plan Assets
(Amounts in millions)	March 29, 2013			March 30, 2012
Fair value of plan assets at beginning of year	$	81		$	79
Actual return on plan assets	7			5
Employer contribution	6			13
Plan participants’ contributions	—			—
Benefits paid	(10		)	(16		)
Fair value of plan assets at end of year	$	84		$	81
Funded status at end of year	$	(169	)	$	(172	)

The following table provides the amounts recorded in the Company’s consolidated balance sheets:

(Amounts in millions)	March 29, 2013			March 30, 2012
Current liabilities - Accrued expenses and other current liabilities	$	(5	)	$	(5	)
Non-current liabilities - Other long-term liabilities	(164		)	(167		)
Net amount recorded	$	(169	)	$	(172	)

The following is a summary of amounts in accumulated other comprehensive loss as of March 29, 2013 and March 30, 2012 that have not been recognized in the consolidated statements of operations as components of net periodic benefit cost:

(Amounts in millions)	March 29, 2013			March 30, 2012
Net transition obligation	$	—		$	—
Prior service (gain) cost	(17		)	(19		)
Net actuarial loss	99			123
Accumulated other comprehensive loss	$	82		$	104

The following table lists selected information for other postretirement benefit plans as of March 29, 2013 and March 30, 2012:

					Plans with Accumulated Postretirement Benefit Obligation in Excess of the Fair Value of Plan Assets
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Accumulated postretirement benefit obligation	$	253	$	253	$	253	$	253
Fair value of plan assets	84		81		84		81

Schedule of fair value of financial assets for pension and postretirement benefits

The fair value of our pension plan assets and postretirement benefit plans by investment category and the corresponding level within the fair value hierarchy as of March 29, 2013 are as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Fair value of pension plan assets	$	3,125	$	2,550
Fair value of other postretirement benefit plan assets	84		—
Total fair value of retirement plan assets as of March 29, 2013	$	3,209	$	2,550

U.S. Pension and Other Postretirement Benefit Plans
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	Global/International	$	31	$	38	$	—	$	69
	U.S. Domestic Stocks	51		—		—		51
	Domestic Equity commingled funds	5		1,325		—		1,330
	Global Equity commingled funds	—		380		—		380
	Global Equity mutual funds	83		—		—		83
Fixed Income:
	U.S. Treasuries	—		87		—		87
	U.S. Government Agencies	—		11		—		11
	Non U.S. Government	—		5		—		5
	Mortgage and asset backed securities	—		131		—		131
	Corporate(b)	—		74		—		74
	Fixed income commingled funds	3		959		—		962
Cash equivalents		8		117		—		125
Total		$	181	$	3,127	$	—	$	3,308
Unsettled Trade Receivable and Accrued Income								79
Unsettled Trade Payable and Accrued Expenses								(178		)
Fair value of assets for U.S. pension and postretirement medical plans as of March 29, 2013								$	3,209

Non-U.S. Pension Plan Assets
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	U.S./North American Equity commingled funds	$	—	$	54	$	—	$	54
	Global/International Equity commingled funds	—		915		—		915
	Global equity mutual funds	—		—		—		—
Fixed Income:
	Fixed income commingled funds	—		1,311		—		1,311
Insurance contracts		—		157		6		163
Cash equivalents		—		25		—		25
Other		—		83		—		83
Total		$	—	$	2,545	$	6	$	2,551
Unsettled Trades								(1		)
Fair value of non-U.S. pension assets as of March 29, 2013								$	2,550

(a) The majority of retirement plan assets are invested in a variety of commingled funds and fixed income. This results in a high amount of Level 2 investments.

(b) Primarily investment grade.

Below is a reconciliation of the assets valued using significant unobservable inputs (Level 3):

	Non-U.S. Plans Insurance Contracts
(Amounts in millions)
Beginning balance as of March 30, 2012	$	5
Actual return on plan assets relating to assets still held at the reporting date	1
Actual return on plan assets relating to assets sold during the period	—
Purchases, sales, and settlements	—
Transfers in and / or out of Level 3	—
Changes due to exchange rates	—
Ending balance as of March 29, 2013	$	6

The fair value of our pension plan assets and postretirement benefit plans by investment category and the corresponding level within the fair value hierarchy as of March 30, 2012, are as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Fair value of pension plan assets	$	2,419	$	2,295
Fair value of other postretirement benefit plan assets	81		—
Total fair value of retirement plan assets as of March 30, 2012	$	2,500	$	2,295

U.S. Pension and Other Postretirement Benefit Plans
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	Global/International	$	25	$	34	$	—	$	59
	U.S. Domestic Stocks	40		—		—		40
	Domestic Equity commingled funds	5		1,040		—		1,045
	Global Equity commingled funds	—		250		—		250
	Global Equity mutual funds	93		—		—		93
Fixed Income:
	U.S. Treasuries	—		72		—		72
	U.S. Government Agencies	—		10		—		10
	Non U.S. Government	—		2		—		2
	Mortgage and asset backed securities	—		118		—		118
	Corporate(b)	—		82		—		82
	Fixed income commingled funds	3		689		—		692
Cash equivalents		8		58		—		66
Total		$	174	$	2,355	$	—	$	2,529
Unsettled Trade Receivable and Accrued Income								84
Unsettled Trade Payable and Accrued Expenses								(113		)
Fair value of assets for U.S. pension and postretirement medical plans as of March 30, 2012								$	2,500

NON-U.S. PENSION PLAN ASSETS
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	U.S./North American Equity commingled funds	$	—	$	40	$	—	$	40
	Global/International Equity commingled funds	—		757		—		757
	Global equity mutual funds	78		—		—		78
Fixed Income:
	Fixed income commingled funds	115		1,104		—		1,219
Insurance contracts		—		141		5		146
Cash equivalents		—		13		—		13
Other		—		42		—		42
Total		$	193	$	2,097	$	5	$	2,295
Unsettled Trades								—
Fair value of non-U.S. pension assets as of March 30, 2012								$	2,295

(a) The majority of retirement plan assets are invested in a variety of commingled funds and fixed income. This results in a high amount of Level 2 investments.

(b) Primarily investment grade.

Below is a reconciliation of the assets valued using significant unobservable inputs (Level 3):

	Non-U.S. Plans Insurance Contracts
(Amounts in millions)
Beginning balance as of April 1, 2011	$	—
Asset acquired in purchase of iSOFT	3
Actual return on plan assets relating to assets still held at the reporting date	—
Actual return on plan assets relating to assets sold during the period	—
Purchases, sales, and settlements	2
Transfers in and / or out of Level 3	—
Changes due to exchange rates	—
Ending balance as of March 30, 2012	$	5

The asset allocation of pension plans at March 29, 2013 and March 30, 2012, respectively, is as follows:

	U.S. Plans				Non-U.S. Plans
Asset Category	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Equity securities	58	%	59	%	38	%	38	%
Debt securities	38	%	39	%	51	%	53	%
Cash and other	4	%	2	%	11	%	9	%
Total	100	%	100	%	100	%	100	%

The asset allocation for U.S. other postretirement benefit plans at March 29, 2013 and March 30, 2012, respectively, is as follows:

	Percentage of Plan Assets at Year End
Asset Category	March 29, 2013		March 30, 2012
Equity securities	29	%	30	%
Debt securities	19	%	20	%
Cash and other	52	%	50	%
Total	100	%	100	%

XML

Commitments and Contingencies

12 Months Ended

Mar. 29, 2013

Commitments and Contingencies [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Commitments

The Company has operating leases for the use of certain real estate and equipment. Substantially all operating leases are non-cancelable or cancelable only by the payment of penalties. All lease payments are based on the lapse of time but include, in some cases, payments for insurance, maintenance and property taxes. There are no purchase options on operating leases at favorable terms, but most real estate leases have one or more renewal options. Certain leases on real estate are subject to annual escalations for increases in utilities and property taxes. Lease rental expense amounted to $319 million, $324 million, and $330 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. In addition, the Company also has $18 million of sublease income to be received through fiscal 2020.

Minimum fixed rentals required for the next five years and thereafter under operating leases in effect at March 29, 2013, are as follows:

Fiscal Year
(Amounts in millions)	Real Estate		Equipment
2014	$	211	$	39
2015	152		26
2016	112		9
2017	82		2
2018	51		—
Thereafter	68		—
	$	676	$	76

The Company has signed long-term purchase agreements with certain software, hardware, telecommunication and other service providers to obtain favorable pricing and terms for services and products that are necessary for the operations of business activities. Under the terms of these agreements, the Company is contractually committed to purchase specified minimums over periods ranging from one to five years. If the Company does not meet the specified minimums, the Company would have an obligation to pay the service provider all or a portion of the shortfall. Minimum purchase commitments are $478 million in fiscal 2014, $161 million in fiscal 2015, $132 million in fiscal 2016, $12 million in fiscal 2017, $2 million in fiscal 2018, and none thereafter.

In the normal course of business, the Company may provide certain clients, principally governmental entities, with financial performance guarantees, which are generally backed by stand-by letters of credit or surety bonds. In general, the Company would only be liable for the amounts of these guarantees in the event that nonperformance by the Company permits termination of the related contract by the Company’s client. As of March 29, 2013, the Company had $122 millionof outstanding letters of credit and surety bonds relating to these performance guarantees. The Company believes it is in compliance with its performance obligations under all service contracts for which there is a financial performance guarantee, and the ultimate liability, if any, incurred in connection with these guarantees will not have a material adverse affect on its consolidated results of operations or financial position.

The Company also uses stand-by letters of credit, in lieu of cash, to support various risk management insurance policies. These letters of credit represent a contingent liability and the Company would only be liable if it defaults on its payment obligations towards these policies. As of March 29, 2013, the Company had $183 million of outstanding stand-by letters of credit. Generally, such guarantees have a one-year term and are renewed annually.

The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of March 29, 2013:

(Amounts in millions)	Fiscal 2014		Fiscal 2015		Fiscal 2016 and thereafter		Total
Surety bonds	$	29	$	1	$	—	$	30
Letters of credit	58		1		33		92
Stand-by letters of credit	37		132		14		183
Total	$	124	$	134	$	47	$	305

The Company generally indemnifies licensees of its proprietary software products against claims brought by third parties alleging infringement of their intellectual property rights (including rights in patents (with or without geographic limitations), copyright, trademarks and trade secrets). CSC’s indemnification of its licensees relates to costs arising from court awards, negotiated settlements and the related legal and internal costs of those licensees. The Company maintains the right, at its own costs, to modify or replace software in order to eliminate any infringement. Historically, CSC has not incurred any significant costs related to licensee software indemnification.

Contingencies

The Company has a contract with the NHS to develop and deploy an integrated patient records system as a part of the U.K. Government's NHS IT program. On August 31, 2012, the Company and NHS entered into a binding interim agreement contract change note, or IACCN, which amends the terms of the current contract and forms the basis on which the parties will finalize a full restatement of the contract. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain terms of the IACCN. See Note 18 for further information relating to the NHS contract and the IACCN.

As previously disclosed in fiscal 2012 and fiscal 2011, the Company initiated an investigation into out of period adjustments resulting from certain accounting errors in its MSS segment, primarily involving accounting irregularities in the Nordic region. Initially, the investigation was conducted by Company personnel, but outside Company counsel and forensic accountants retained by such counsel later assisted in the Company's investigation. On January 28, 2011, the Company was notified by the SEC's Division of Enforcement that it had commenced a formal civil investigation relating to these matters, which investigation has been expanded to other matters subsequently identified by the SEC, including matters specified in subpoenas issued to the Company from time to time by the SEC's Division of Enforcement as well as matters under investigation by the Audit Committee, as further described below. The Company is cooperating in the SEC's investigation.

On May 2, 2011, the Audit Committee commenced an independent investigation into the matters relating to the MSS segment and the Nordic region, matters identified by subpoenas issued by the SEC's Division of Enforcement, and certain other accounting matters identified by the Audit Committee and retained independent counsel to represent CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with such independent investigation. Independent counsel retained forensic accountants to assist with their work. Independent counsel also represents CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with the investigation by the SEC's Division of Enforcement.

The Audit Committee’s investigation was expanded to encompass (i) the Company’s operations in Australia, (ii) certain aspects of the Company’s accounting practices within its Americas Outsourcing operation, and (iii) certain of the Company’s accounting practices that involve the percentage-of-completion accounting method, including the Company’s contract with the NHS. In the course of the Audit Committee's expanded investigation, accounting errors and irregularities were identified. As a result, certain personnel have been reprimanded, suspended, terminated and/or have resigned. The Audit Committee determined in August 2012 that its independent investigation was complete. The Audit Committee instructed its independent counsel to cooperate with the SEC's Division of Enforcement by completing production of documents and providing any further information requested by the SEC's Division of Enforcement.

In addition to the matters noted above, the SEC's Division of Enforcement is continuing its investigation involving its concerns with certain of the Company's prior disclosure and accounting determinations with respect to the Company's contract with NHS and the possible impact of such matters on the Company's financial statements for years prior to the Company's current fiscal year. The Company and the Audit Committee and its independent counsel are investigating these matters and are continuing to cooperate with the SEC's Division of Enforcement in its investigation of prior disclosures of the Company's contract with the NHS. The SEC's investigative activities are ongoing.

In addition, the SEC's Division of Corporation Finance has issued comment letters to the Company requesting, among other things, additional information regarding its previously disclosed adjustments in connection with the above-referenced accounting errors, the Company's conclusions relating to the materiality of such adjustments, and the Company's analysis of the effectiveness of its disclosure controls and procedures and its internal control over financial reporting. The SEC's Division of Corporation Finance's comment letter process is ongoing, and the Company is continuing to cooperate with that process.

The investigation being conducted by the SEC's Division of Enforcement and the review of our financial disclosures by the SEC's Division of Corporation Finance are continuing and could identify other accounting errors, irregularities or other areas of review. As a result, we have incurred and may continue to incur significant legal and accounting expenditures. We are unable to predict how long the SEC's Division of Enforcement's investigation will continue or whether, at the conclusion of its investigation, the SEC will seek to impose fines or take other actions against the Company. In addition, we are unable to predict the timing of the completion of the SEC's Division of Corporation Finance's review of our financial disclosures or the outcome of such review. Publicity surrounding the foregoing or any enforcement action as a result of the SEC's investigation, even if ultimately resolved favorably for us, could have an adverse impact on the Company's reputation, business, financial condition, results of operations or cash flows. The Company is unable to estimate any possible loss or range of loss associated with these matters at this time. See Note 2 for further information.

Between June 3, 2011, and July 21, 2011, four putative class action complaints were filed in the United States District Court for the Eastern District of Virginia, entitled City of Roseville Employee's Retirement System v. Computer Sciences Corporation, et al. (No. 1:11-cv-00610-TSE-IDD), Murphy v. Computer Sciences Corporation, et al. (No. 1:11-cv-00636-TSE-IDD), Kramer v. Computer Sciences Corporation, et al. (No. 1:11-cv-00751-TSE-IDD) and Goldman v. Computer Sciences Corporation, et al. (No. 1:11-cv-777-TSE-IDD). On August 29, 2011, the four actions were consolidated as In re Computer Sciences Corporation Securities Litigation (No. 1:11-cv-610-TSE-IDD) and Ontario Teachers' Pension Plan Board was appointed lead plaintiff. A consolidated class action complaint was filed by plaintiff on September 26, 2011, and names as defendants CSC, Michael W. Laphen, Michael J. Mancuso and Donald G. DeBuck. A corrected complaint was filed on October 19, 2011. The complaint alleges violations of the federal securities laws in connection with alleged misrepresentations and omissions regarding the business and operations of the Company. Specifically, the allegations arise from the Company's disclosure of the Company's investigation into certain accounting irregularities in the Nordic region and its disclosure regarding the status of the Company's agreement with the NHS. Among other things, the plaintiff seeks unspecified monetary damages. The plaintiff filed a motion for class certification with the court on September 22, 2011, and the defendants filed a motion to dismiss on October 18, 2011. A hearing was held on November 4, 2011.On August 29, 2012, the court issued a Memorandum Opinion and Order granting in part and denying in part the motion to dismiss. The court granted the motion to dismiss with respect to the plaintiff's claims in connection with alleged misrepresentations and omissions concerning the Company's operations in the Nordic Region. The court granted in part and denied in part the motion to dismiss with respect to the plaintiff's claims in connection with alleged misrepresentations and omissions concerning the Company's internal controls and the Company's contract with the NHS. The court also granted the plaintiff leave to amend its complaint by September 12, 2012, and maintained the stay of discovery until the sufficiency of the amended complaint had been decided. The court further denied plaintiff's motion for class certification without prejudice. On September 12, 2012, the plaintiff filed a notice advising the Court that it had determined not to amend its complaint and renewed its motion for class certification. On September 21, 2012, the court issued an Order setting the hearing on the motion for class certification for October 12, 2012, directing the parties to complete discovery by January 11, 2013 and scheduling the final pretrial conference for January 17, 2013. On October 9, 2012, the defendants filed their answer to the plaintiff's complaint. On October 12, 2012, the hearing on the motion for class certification was rescheduled to November 1, 2012. On October 31, 2012, the parties filed a joint motion with the court requesting that the hearing on the motion for class certification be rescheduled to a later date. On November 1, 2012, the court issued an order setting the hearing for class certification for November 15, 2012. On November 30, 2012, the court granted plaintiff's motion for class certification. On December 14, 2012, defendants filed with the Fourth Circuit a petition for permission to appeal the class certification order pursuant to Federal Rule of Civil Procedure 23(f). Plaintiff's response to the petition was filed on February 20, 2013. On March 5, 2013, the Fourth Circuit denied the petition for permission to appeal the class certification order. On December 14, 2012, the court issued an order extending the expert discovery deadline to February 25, 2013. On December 20, 2012, the court issued an order extending the fact discovery deadline to February 11, 2013 and the expert discovery deadline to March 25, 2013. On January 13, 2013, the court issued an order extending the expert discovery deadline to April 1, 2013. Motions for summary judgment were filed on March 18, 2013. On May 15, 2013, the Company entered into a stipulation and agreement of settlement with the lead plaintiff to settle all claims in the lawsuit for $97.5 million, which was accrued for as of March 29, 2013 and included in accrued expenses and other current liabilities on the Company's Consolidated Balance Sheet. As of March 29, 2013, the Company has also recorded a receivable of $45 million, which represents the amount recoverable under the Company's corporate insurance policies, and is included in receivables on the Company's Consolidated Balance Sheet. The agreement is subject to approval by the court.

On September 13, 2011, a shareholder derivative action entitled Che Wu Hung v. Michael W. Laphen, et al. (CL 2011 13376) was filed in Circuit Court of Fairfax County, Virginia, against Michael W. Laphen, Michael J. Mancuso, the members of the Audit Committee and the Company as a nominal defendant asserting claims for breach of fiduciary duty and contribution and indemnification relating to alleged failure by the defendants to disclose accounting and financial irregularities in the MSS segment, primarily in the Nordic region, and the Company's performance under the NHS agreement and alleged failure to maintain effective internal controls. The plaintiff seeks damages, injunctive relief and attorneys' fees and costs. On October 24, 2011, the defendants removed the action to the United States District Court for the Eastern District of Virginia. On November 23, 2011, the plaintiff filed a motion to remand the case to state court. Argument was held on December 15, 2011. During argument the plaintiff voluntarily dismissed his complaint without prejudice to refiling the action in state court. The Court granted the plaintiff's request, dismissed the complaint without prejudice and denied the motion to remand as moot. On December 22, 2011, the plaintiff refiled his complaint in Circuit Court of Fairfax County, Virginia in a shareholder derivative action entitled Che Wu Hung v. Michael W. Laphen, et al. (CL 2011 18046). Named as defendants are Michael W. Laphen, Michael J. Mancuso, the members of the Audit Committee and the Company as a nominal defendant. The complaint asserts claims for (i) breach of fiduciary duty relating to alleged failure by the defendants to disclose accounting and financial irregularities in the MSS segment, primarily in the Nordic region, the Company's performance under the NHS agreement and alleged failure to maintain effective internal controls and (ii) corporate waste. The plaintiff seeks damages, injunctive relief and attorneys' fees and costs. On April 6, 2012, the state court stayed the action until the earlier of (i) entry of an order on the pending motion to dismiss In re Computer Sciences Corporation Securities Litigation (No. 1:11-cv-610-TSE-IDD) or (ii) July 5, 2012. On July 20, 2012, the state court renewed the stay until the earlier of (i) entry of an order on the pending motion to dismiss in In re Computer Sciences Corporation Securities Litigation or (ii) October 18, 2012. The stay expired on August 30, 2012 with the entry of the court's order in In re Computer Sciences Corporation Securities Litigation. On October 19, 2012, upon the joint motion of the parties, the state court issued an order staying the action while discovery proceeds in In re Computer Sciences Corporation Securities Litigation. The order requires defendants to provide to the plaintiff certain of the discovery produced in the federal action. On May 10, 2013, the court continued the stay to May 31, 2013 upon joint motion of the parties. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

On May 11, 2012, a separate shareholder derivative action entitled Judy Bainto v. Michael W. Laphen et al. (No. A-12-661695-C), was filed in District Court, Clark County, Nevada, against Messrs. Laphen and Mancuso, members of the Company's Board of Directors and the Company as a nominal defendant. The complaint is substantively similar to the second Hung complaint. On or about August 1, 2012, the court granted the parties' joint motion to extend the time for defendants to respond to the complaint to sixty days after the United States District Court for the Eastern District of Virginia's entry of an order on the pending motion to dismiss the complaint in In re Computer Sciences Corporation Securities Litigation. On September 5, 2012, Defendants notified the court of the Eastern District of Virginia's ruling in In re Computer Sciences Corporation Securities Litigation. On September 11, 2012, the parties filed a joint status report proposing a schedule for the filing of an amended complaint by plaintiff and for motion to dismiss briefing. Plaintiff filed an amended complaint on September 28, 2012. Upon stipulation of the parties, the court consolidated the Bainto case and Himmel case (described below) and deemed the amended complaint filed in Bainto the operative complaint. In addition, on November 8, 2012, upon joint motion of the parties, the court issued an order staying the action while discovery proceeds in In re Computer Sciences Corporation Securities Litigation. The order requires Defendants to provide to the Plaintiffs certain of the discovery produced in the federal action. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

On October 16, 2012, a separate shareholder derivative action entitled Daniel Himmelv. Michael W. Laphen et al. (No. A-12-670190-C), was filed in District Court, Clark County, Nevada, against Messrs. Laphen and Mancuso, members of the Company's Board of Directors and the Company as a nominal defendant. The Himmel complaint is substantively similar to the Bainto complaint, but includes a claim for unjust enrichment and seeks additional injunctive relief. Upon stipulation of the parties, the court consolidated the Bainto case (describe above) and the Himmel case and deemed the amended complaint filed in Bainto the operative complaint. In addition, on November 8, 2012, upon joint motion of the parties, the court issued an order staying the action while discovery proceeds in In re Computer Sciences Corporation Securities Litigation. The order requires Defendants to provide to the Plaintiffs certain of the discovery produced in the federal action. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

On December 20, 2012, a separate shareholder derivative complaint entitled Shirley Morefield v Irving W. Bailey, II, et al, (Case No. 1:120V1468GBL/TCB) was filed in the United States District Court for the Eastern District of Virginia. The complaint names certain of CSC's current and former directors and officers as defendants and the Company as a nominal defendant. The complaint is similar to the Hung complaint but asserts only a claim for breach of fiduciary duty and alleges that the plaintiff made a demand on the CSC Board prior to commencing suit and that such demand was refused. Motions to dismiss were filed March 18, 2013. On April 8, 2013, Plaintiff filed an amended complaint. Motions to dismiss the amended complaint were filed on April 17, 2013 and were heard on May 10, 2013. A decision is pending. The Company is unable to estimate any possible loss or range of loss associated with this matter at this time.

On October 19, 2012, a putative class action complaint was filed in the United States District Court of the Southern District of Indiana, entitled Andrea M. Childress v. Experian Information Services, Inc. and CSC Credit Services , Inc. The complaint alleges Fair Credit Reporting Act claims regarding reports prepared about consumers who filed for Chapter 13 bankruptcy protection and subsequently withdrew their bankruptcy filing before court approval of a bankruptcy plan. Plaintiff, on behalf of the class, seeks statutory and punitive damages, injunctive relief and attorneys' fees. On February 4, 2013, CSC was dismissed without prejudice from this lawsuit by plaintiff's notice filed with the court.

The Company's net legal expenses associated with the SEC investigation and class action lawsuits were $33 million, $67 million, and $2 million, for fiscal years 2013, 2012 and 2011, respectively. During fiscal 2013, the Company incurred $78 million, which was partially offset by $45 million of insurance claims.

In addition to the matters noted above, the Company is currently party to a number of disputes which involve or may involve litigation. The Company consults with legal counsel on those issues related to litigation and seeks input from other experts and advisors with respect to such matters in the ordinary course of business. Whether any losses, damages or remedies ultimately resulting from such matters could reasonably have a material effect on the Company's business, financial condition, results of operation, or cash flows will depend on a number of variables, including, for example, the timing and amount of such losses or damages (if any) and the structure and type of any such remedies.  For these reasons, it is not possible to make reasonable estimates of the amount or range of loss that could result from these other matters at this time. Company management does not, however, presently expect any of such other matters to have a material impact on the consolidated financial statements of the Company.

XML

Settlement of Claims with U.S. Government

12 Months Ended

Mar. 29, 2013

Settlement of Claims with U.S. Government [Abstract]

Settlement of Claims with U.S. Government

Settlement of Claims with U.S. Government

During the second quarter of fiscal 2012, the Company reached a definitive settlement agreement with the U.S. government in its contract claims asserted under the Contract Disputes Act of 1978 (CDA). Under the terms of the settlement, the Company received $277 million in cash and a five-year extension (four base years plus one option year) with an estimated value of $1 billion to continue to support and expand the capabilities of the systems covered by the original contract scheduled to expire in December 2011. In exchange, the Government received unlimited rights to the Company’s intellectual property developed to support the services delivered under the contract, and CSC dismissed the claims and terminated legal actions against the Government and the Government dismissed its counter claims against CSC. The contract extension contained a Requirements portion (Federal Acquisition Regulation (“FAR”) 16.503) and an Indefinite Quantity portion (FAR 16.504) and is not subject to any minimum values. In December 2011, the Company signed the contract modification based on the terms described above.

The Company recorded a pre-tax charge of $269 million during the second quarter of fiscal 2012 to write down its claim related assets (claim related unbilled receivables of $379 million and deferred costs of $227 million) to reflect the cash received of $277 million, the estimated fair value of the contract extension of $45 million, and previously unapplied payments of $15 million. Of the pre-tax charge of $269 million, $42 million was recorded as a reduction of revenue and $227 million as a separately itemized charge to cost of services. The fair value of the contract extension was recorded as a contract asset and will be amortized as a reduction of revenue over the four year fixed contract term in proportion to the expected revenues or on a straight line basis, whichever is greater.

These claims relate to a contract that was awarded (the “Contract”) in December 1999 as a 10 year fixed price contract. In April 2004, the contract was extended by two additional years. Revenue recorded under the core Contract was initially recognized as a single profit center using the percentage-of-completion method based on the guidance in ASC 605-35, “construction-type and production-type contracts.”

During the course of the contract, CSC incurred significant costs for out-of-scope work that was a result of Government directed changes and delays. Negotiations with the Government were initiated to recover the costs related to this work. During the second quarter of fiscal 2007, the Company filed its 14 interest bearing claims (collectively the “CDA Claims”), then totaling approximately $858 million, with the Government.  On September 11, 2007, the Company initiated litigation at the Armed Services Board of Contract Appeals (“ASBCA”), one of the two forums available for litigation of CDA claims.  

In accordance with accepted practice, the Company amended its CDA Claims twice to reflect adjustments to the total value of the CDA Claims.  On December 24, 2009, the Government made a partial payment of $35 million on one of the CDA Claims.  Thereafter, CSC filed a second amended complaint with the ASBCA reducing the value of its CDA Claims by $35 million. On November 19, 2010, the Government and the Company entered into a formal agreement to stay the CDA Claims litigation and engage in a non-binding alternate dispute resolution (“ADR”) process to resolve all outstanding CDA Claims and other issues associated with the contract. As of July 1, 2011, the Company had fourteen claims totaling approximately $675 million, excluding interest, asserted against the U.S. federal government under a single contract pending before the ASBCA.  

Prior to the settlement, the Company believed it had valid bases for pursuing recovery of the CDA Claims supported by outside counsel’s evaluation of the facts and assistance in the preparation of the claims. To verify its position, CSC requested that outside counsel analyze whether the first two conditions of Paragraph 31 of ASC 605-35-25 were satisfied with respect to the Company’s assertions of government breaches of the contract, government-caused delays and disruption to the Company’s performance of the contract, and unanticipated additional work performed by the Company under the contract. The outside counsel issued an opinion that the Company’s position met the criteria on April 22, 2005, and reiterated that opinion on May 20, 2011.

XML

Investigations and Out of Period Adjustments (Rollover impact on Income (loss) from continuing operations, before taxes and Impact on Foreign Adjustments) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Dec. 30, 2011	Mar. 29, 2013	Mar. 30, 2012
NHS contract [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment	$ 24
NHS contract [Member] | Fiscal 2013 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment		(9)
NHS contract [Member] | Fiscal 2012 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment	24	10	25
NHS contract [Member] | Fiscal 2011 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment		(15)	(7)
NHS contract [Member] | Fiscal 2010 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment		18	(4)
NHS contract [Member] | Adjustments relating to fiscal years prior to 2010
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment		(4)	(14)
Australia [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(23)
Australia [Member] | Intentional irregularities [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			0
Australia [Member] | Other errors [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(23)
Australia [Member] | Fiscal 2011 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(2)
Australia [Member] | Fiscal 2011 Adjustments | Intentional irregularities [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			1
Australia [Member] | Fiscal 2011 Adjustments | Other errors [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(3)
Australia [Member] | Fiscal 2010 Adjustments
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(1)
Australia [Member] | Fiscal 2010 Adjustments | Intentional irregularities [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(4)
Australia [Member] | Fiscal 2010 Adjustments | Other errors [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			3
Australia [Member] | Adjustments relating to fiscal 2009
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(23)
Australia [Member] | Adjustments relating to fiscal 2009 | Intentional irregularities [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(7)
Australia [Member] | Adjustments relating to fiscal 2009 | Other errors [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			(16)
Australia [Member] | Adjustments relating to fiscal years prior to 2008
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			3
Australia [Member] | Adjustments relating to fiscal years prior to 2008 | Intentional irregularities [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			10
Australia [Member] | Adjustments relating to fiscal years prior to 2008 | Other errors [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of pre-tax adjustment			$ (7)

XML

Stockholders' Equity (Tables)

12 Months Ended

Mar. 29, 2013

Shareholders' Equity [Abstract]

Components of Accumulated Other Comprehensive Loss, Net of Tax Effects

The changes in accumulated other comprehensive loss for fiscal 2013 are as follows:

(Amounts in millions)	Foreign Currency Translation Adjustments			Pension and Other Postretirement Benefit Plans			Accumulated Other Comprehensive Loss
Balance at April 2, 2010	$	23		(1,075		)	(1,052		)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	261			101			362
Balance at April 1, 2011	$	284		(974		)	(690		)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	(124		)	(279		)	(403		)
Balance at March 30, 2012	$	160		$	(1,253	)	$	(1,093	)
Current-period other comprehensive (loss) income, net of taxes and non-controlling interest	(83		)	(178		)	(261		)
Balance at March 29, 2013	$	77		$	(1,431	)	$	(1,354	)

XML

Subsequent Events

12 Months Ended

Mar. 29, 2013

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

On May 15, 2013, CSC and the lead plaintiff in the lawsuit entitled In re Computer Sciences Corporation Securities Litigation (No. 1:11-cv-610-TSE-IDD) pending in the United States District Court for the Eastern District of Virginia entered into a stipulation and agreement of settlement to settle all claims in the lawsuit for $97.5 million. The agreement is subject approval by the court (see Note 20).

On May 13, 2013, CSC entered into an agreement to sell its flood-insurance-related business process outsourcing practice to a financial investor for cash consideration of $46 million. The Company expects to record a gain on the disposal of approximately $31 million.

XML

SCHEDULE II, VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Mar. 29, 2013

Valuation and Qualifying Accounts [Abstract]

SCHEDULE II, VALUATION AND QUALIFYING ACCOUNTS

COMPUTER SCIENCES CORPORATION AND SUBSIDIARIES

SCHEDULE II, VALUATION AND QUALIFYING ACCOUNTS

(Amounts in millions)	Balance, beginning of period		Charged to cost and expenses		Other(1)			Deductions			Balance, end of period
For year ended March 29, 2013
Allowance for doubtful receivables	$	51	$	16	$	(1	)	$	(18	)	$	48
For year ended March 30, 2012
Allowance for doubtful receivables	46		18		10			(23		)	51
For the year ended April 1, 2011
Allowance for doubtful receivables	47		7		2			(10		)	46

⁽¹⁾  Includes balances from acquisitions, changes in balances due to foreign currency exchange rates and recovery of prior-year charges.

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Cash flows from operating activities:
Net income (loss)	$ 979	$ (4,225)	$ 759
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	1,134	1,212	1,140
Goodwill impairment	0	2,745	0
Specified contract charge	0	1,485	0
Settlement charge	0	269	0
Stock based compensation	49	36	56
Deferred taxes	101	(117)	101
(Gain) loss on dispositions	(797)	30	(74)
Provision for losses on accounts receivable	18	18	7
Excess tax benefit from stock based compensation	(3)	(2)	(6)
Unrealized foreign currency exchange gain	(37)	(8)	(9)
Impairment losses and contract write-offs	9	156	23
Cash surrender value in excess of premiums paid	(10)	(7)	(6)
Changes in assets and liabilities, net of effects of acquisitions and dispositions:
Decrease in receivables	55	232	170
Decrease (increase) in prepaid expenses and other current assets	22	(210)	(116)
Decrease in accounts payable and accrued expenses	(690)	(67)	(234)
Increase (Decrease) in income taxes payable and income tax liability	50	(136)	(45)
Increase (Decrease) in advances contract payments and deferred revenue	270	(247)	(204)
Other operating activities, net	(31)	12	2
Net cash provided by operating activities	1,119	1,176	1,564
Cash flows from investing activities:
Purchases of property and equipment	(395)	(569)	(663)
Outsourcing contracts	(115)	(179)	(138)
Acquisitions, net of cash acquired	(34)	(374)	(158)
Business dispositions	1,108	2	119
Software purchased and developed	(162)	(227)	(164)
Proceeds from sale of property and equipment	32	11	105
Other investing activities, net	22	28	7
Net cash provided by (used in) investing activities	456	(1,308)	(892)
Cash flows from financing activities:
Borrowings under lines of credit	128	140	105
Repayment of borrowings under lines of credit	(169)	(120)	(1,599)
Borrowing on long-term debt	1,077	0	0
Principal payments on long-term debt	(1,238)	(485)	(92)
Proceeds from stock options and other common stock transactions	55	15	73
Excess tax benefit from stock based compensation	3	2	6
Repurchase of common stock and acquisition of treasury stock	(283)	0	(65)
Dividend payments	(124)	(124)	(77)
Other financing activities, net	(38)	(9)	(27)
Net cash used in financing activities	(589)	(581)	(1,676)
Effect of exchange rate changes on cash and cash equivalents	(25)	(31)	57
Net increase (decrease) in cash and cash equivalents	961	(744)	(947)
Cash and cash equivalents at beginning of year	1,093	1,837	2,784
Cash and cash equivalents at end of year	$ 2,054	$ 1,093	$ 1,837

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Mar. 29, 2013

Summary of Significant Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. These estimates are based on management’s best knowledge of historical experience, current events, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates. Amounts subject to significant judgment and estimates include, but are not limited to, contracts accounted for using the percentage-of-completion method, cash flows used in the evaluation of impairment of goodwill and other long-lived assets, intangible assets, certain deferred costs, collectability of receivables, reserves for uncertain tax benefits, valuation allowances on deferred tax assets, loss accruals for litigation, pension related liabilities, inputs used for computing stock-based compensation and the fair value of derivative instruments.

Revenue Recognition

Revenue Recognition

The Company's primary service offerings are information technology (IT) outsourcing, and both IT and other professional services. Revenues are recognized when persuasive evidence of an arrangement exists, services or products have been provided to the client, the sales price is fixed or determinable, and collectability is reasonably assured. For non-software arrangements that include multiple-elements, revenue recognition involves the identification of separate units of accounting after consideration of combining and/or segmenting contracts and allocation of the arrangement consideration to the units of accounting on the basis of their relative selling price. Revenue under such contracts is recognized based upon the levels of services delivered in the periods in which they are provided. Upfront fees for the contract set-up activities are deferred and recognized ratably over the period of performance. Costs are expensed as incurred except for direct and incremental set-up costs that are capitalized and amortized over the life of the agreement (see Outsourcing Contract Costs below). See the section below regarding software transactions that include multiple elements.

The Company provides these services under time and materials, cost-reimbursable, unit-price and fixed-price contracts, the revenue for which is recognized in the following manner:

Time and materials contracts - Revenue is recorded at agreed-upon billing rates at the time services are provided.

Cost-reimbursable contracts - Revenue is recorded at the time costs are incurred and associated fees are recognized when probable and estimable by applying an estimated factor to costs as incurred, such factor being determined by the contract provisions and prior experience.

Unit-price contracts - Revenue is recognized on unit-price contracts based on unit metrics multiplied by the agreed upon contract unit price or when services are delivered.

Fixed-price contracts - For certain fixed-price contracts, revenue is recognized under the percentage-of-completion method as described below; these include certain software development projects, all long-term construction-type contracts, and certain fixed-price arrangements with the U.S. federal government. For other fixed-price contracts, revenue is recognized based on the proportion of the services delivered to date as a percentage of the total services to deliver over the contract term. If output or input measures are not available or cannot be reasonably estimated, revenues are recognized ratably over the contract term.

Under the percentage-of-completion method, progress towards completion is measured based on either achievement of specified contract milestones, costs incurred as a proportion of estimated total costs, or other measures of progress when available. Profit in a given period is reported at the estimated profit margin to be achieved on the overall contract. This method can result in the recognition of unbilled receivables, the deferral of costs as work in process, or deferral of profit on these contracts. Contracts that require estimates at completion using the percentage-of-completion method accounted for approximately 17.9% of the Company's revenues for fiscal 2013. Management regularly reviews project profitability and underlying estimates. Revisions to the estimates at completion are reflected in results of operations as a change in accounting estimate in the period in which the facts that give rise to the revision become known by management. Provisions for estimated losses at completion, if any, are recognized in the period in which the loss becomes evident. The provision includes estimated costs in excess of estimated revenue and any profit margin previously recognized.

Multiple-element software sales - For multiple-element arrangements that involve the sale of CSC proprietary software, post contract customer support, and other software-related services, vendor-specific objective evidence (VSOE) of fair value is required to allocate and recognize revenue for each element. VSOE of fair value is determined based on the price charged where each deliverable is sold separately. In situations where VSOE of fair value exists for all undelivered elements but not a delivered element (typically the software license element), the residual method is used to allocate revenue to the undelivered elements equal to their VSOE value with the remainder allocated to the delivered element. If significant customization is required, and VSOE is available to support accounting for the software as a separate unit of account, software revenue is recognized as the related software customization services are performed in accordance with the percentage-of-completion method described above. In situations where VSOE of fair value does not exist for all of the undelivered software-related elements, revenue is deferred until only one undelivered element remains and then recognized following the pattern of delivery of the final undelivered element.

Depreciation and Amortization

Depreciation and Amortization

The Company’s depreciation and amortization policies are as follows:

Property and Equipment:
Buildings	Up to 40 years
Computers and related equipment	3 to 5 years
Furniture and other equipment	2 to 15 years
Leasehold improvements	Shorter of lease term or useful life
Software	2 to 10 years
Outsourcing contract costs	Contract life, excluding option years
Customer related intangibles	Expected customer service life
Acquired contract related intangibles	Contract life and first contract renewal, where applicable

The cost of property and equipment, less applicable residual values, is depreciated using predominately the straight-line method. Depreciation commences when the specific asset is complete, installed and ready for normal use. Depreciation expense for fiscal years 2013, 2012, and 2011 was $715 million, $759 million, and $688 million, respectively.

Software and outsourcing contract costs are amortized using predominately the straight-line method. Acquired contract related and customer related intangible assets are amortized in proportion to the estimated undiscounted cash flows projected over the estimated life of the asset or on a straight-line basis if such cash flows cannot be reliably estimated.

Software Development Costs

Software Development Costs

The Company capitalizes costs incurred to develop commercial software products after technological feasibility has been established. Costs incurred to establish technological feasibility are charged to expense as incurred. Enhancements to software products are capitalized where such enhancements extend the life or significantly expand the marketability of the products. Amortization of capitalized software development costs is determined separately for each software product. Annual amortization expense is calculated based on the greater of (a) the ratio of current gross revenues for each product to the total of current anticipated future gross revenues for the product or (b) the straight-line method over the estimated economic life of the product.

Unamortized capitalized software costs associated with commercial software products are regularly evaluated for impairment on a product-by-product basis by a comparison of the unamortized balance to the product’s net realizable value. The net realizable value is the estimated future gross revenues from that product reduced by the related estimated future costs. When the unamortized balance exceeds the net realizable value, the unamortized balance is written down to the net realizable value and an impairment charge is recorded.

The Company capitalizes costs incurred to develop internal-use computer software. Internal and external costs incurred in connection with development of upgrades or enhancements that result in additional functionality are also capitalized. These capitalized costs are amortized on a straight-line basis over the estimated useful life of the software. Purchased software is capitalized and amortized over the estimated useful life of the software.

Outsourcing Contract Costs

Outsourcing Contract Costs

Costs on outsourcing contracts, including costs incurred for bid and proposal activities, are generally expensed as incurred. However, certain costs incurred upon initiation of an outsourcing contract are deferred and expensed over the contract life. These costs represent incremental external costs or certain specific internal costs that are directly related to the contract acquisition or transition activities. Such capitalized costs can be separated into two principal categories: contract acquisition costs and transition/set-up costs. The primary types of costs that may be capitalized include labor and related fringe benefits, subcontractor costs, travel costs, and premiums on asset purchases.

Premiums are amounts paid to customers in excess of the fair market value of assets acquired. Fixed assets acquired in connection with outsourcing transactions are capitalized at fair value and depreciated consistent with the fixed asset policies described above. Premiums paid are capitalized as outsourcing contract costs and amortized over the contract life. The amortization of outsourcing contract cost premiums is accounted for as a reduction in revenue. The second principal category of capitalized outsourcing costs is transition/set-up costs. Such costs are primarily associated with the installation of systems and processes and are amortized over the contract life.

In the event indications exist that an outsourcing contract cost balance related to a particular contract may be impaired, undiscounted estimated cash flows of the contract are projected over its remaining term and compared to the associated long-lived asset group including the unamortized outsourcing contract cost balance. If the projected cash flows are not adequate to recover the unamortized cost balance of the asset group, the balance would be adjusted based on the fair value of the long-lived assets group in the period such a determination is made. The primary indicator used to determine when impairment testing should be performed is when a contract is materially underperforming, or is expected to materially underperform in the future, as compared to the original bid model or subsequent annual budgets.

Terminations of outsourcing contracts, including transfer of assets either back to the customer or to another IT provider, prior to the end of their committed contract terms, are infrequent due to the complex transition of personnel, assets, methodologies, and processes involved with outsourcing transactions. In the event of an early termination, the Company and the customer, pursuant to certain contractual provisions, engage in discussions to determine the recovery of unamortized contract costs, lost profits, transfer of personnel, rights to implemented systems and processes, as well as other matters.

Stock-Based Compensation

Stock-Based Compensation

The Company provides different forms of stock-based compensation to its employees and nonemployee directors. For awards settled in shares, the Company recognizes compensation expense based on the grant-date fair value net of estimated forfeitures. For awards settled in cash, the Company recognizes compensation expense based on the fair value at each reporting date net of estimated forfeitures. The Company recognized stock-based compensation expense for fiscal 2013, fiscal 2012, and fiscal 2011 as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Cost of services	$	22	$	15	$	12
Selling, general and administrative	27		21		44
Total	$	49	$	36	$	56
Total, net of tax	$	31	$	23	$	35

The Company’s overall stock-based compensation granting practice has not changed year-over-year,except that with fiscal 2012's long-term incentive program, service-based restricted stock units (RSUs) and performance-based RSUs represent a larger portion of total stock-based compensation awards than in the past.

The increase in fiscal 2013 stock-based compensation expense was primarily due to performance-based RSUs granted in fiscal 2013 that increased the expense by $15 million. This increase was partially offset by a $3 million reduction of expense as a result of adjustments for expected achievement of the specified performance criteria for performance-based RSUs granted in previous fiscal years. Fiscal 2012 stock-based compensation expense included a $12 million reduction to expense for expected achievement of the specified performance criteria for performance-based RSUs granted in previous fiscal years. There were no such adjustments in fiscal 2011.

The Company periodically evaluates its significant assumptions used in the fair value calculation. Beginning in fiscal 2011, the Company modified certain underlying assumptions in the fair value calculations, which did not have a material impact on the fair value calculations, as described below.

The Company uses the Black-Scholes-Merton model in determining the fair value of options granted. The expected term is calculated based on the Company’s historical experience with respect to its stock plan activity in combination with an estimate of when vested and unexercised option shares will be exercised. The Company uses separate assumptions for the expected term of options granted based on two separate job tier classifications which had distinct historical exercise behavior. This resulted in separate fair value calculations by job tier. The risk-free interest rate is based on the zero coupon interest rate of U.S. government issued Treasury strips with a period commensurate with the expected term of the options. In determining the overall risk-free interest rate for fiscal 2013, a range of interest rates from 0.82% to 1.44% was applied depending on the expected life of the grant. The Company continued to base expected volatility on a blended approach using an equal weighting of implied volatility and historical volatility. However, beginning with the first quarter of fiscal 2011, the historical volatility calculation was based on the Company’s six-year and seven-year historical daily closing price, rather than the ten-year historical used in prior periods, in order to bring this factor more closely into alignment with the expected terms of the stock options. The range of volatility used for fiscal 2013 was 32% to 38%. The dividend yield assumption was added concurrent with the introduction of a cash dividend in fiscal 2011 and is based on the respective fiscal year dividend payouts. Forfeitures are estimated based on historical experience and adjustments are made annually to reflect actual forfeiture experience.

The weighted average grant date fair values of stock options granted during fiscal 2013, fiscal 2012, and fiscal 2011 were $7.37, $10.17, and $12.95 per share, respectively. In calculating the compensation expense for its stock incentive plans, the Company used the following weighted average assumptions:

	Fiscal Year
	2013		2012		2011
Risk-free interest rate	1.15	%	1.80	%	2.37	%
Expected volatility	36	%	31	%	28	%
Expected term (in years)	6.59		6.11		5.85
Dividend yield	2.86	%	1.79	%	1.17	%

During fiscal 2013, fiscal 2012, and fiscal 2011, the Company's actual tax benefit realized for tax deductions from exercising stock options was of $9 million, $7 million, and $11 million, respectively, and an excess tax benefit of $3 million, $2 million, and $6 million, respectively, related to all of its stock incentive plans.

Acquisition Accounting and Goodwill

Acquisition Accounting and Goodwill

Under acquisition accounting, the purchase price is allocated to the underlying tangible and intangible assets acquired and liabilities assumed based upon their respective fair market values, with the excess recorded as goodwill. Acquisition-related costs are expensed in the periods in which the costs are incurred, and the results of operations of acquired businesses are included in the Consolidated Financial Statements from the acquisition date.

The Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if circumstances change, of if an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount. A significant amount of judgment is involved in determining whether an event indicating impairment has occurred between annual testing dates. Such indicators may include: a significant decline in expected future cash flows; a significant adverse change in legal factors or in the business climate; unanticipated competition; the disposal of a significant component of a reporting unit; and the testing for recoverability of a significant asset group within a reporting unit.

The goodwill impairment test initially involves the assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is not more likely than not, then the subsequent two-step process is not required, although the Company has the option to bypass this initial qualitative assessment and proceed directly to step one of the two-step process. If the Company determines that it is more likely than not, then it proceeds with the subsequent two-step goodwill impairment testing process. The first step is to compare each reporting unit’s fair value to its carrying value. If the reporting unit’s fair value exceeds its carrying value, no further procedures are required. However, if a reporting unit’s fair value is less than its carrying value, an impairment of goodwill may exist, requiring a second step to measure the amount of impairment loss. In the second step, the reporting unit’s fair value is allocated to all of the assets and liabilities of the reporting unit, including any unrecognized intangible assets, in a hypothetical analysis to calculate the implied fair value of goodwill in the same manner as if the reporting unit was being acquired in a business acquisition. If the implied fair value of goodwill is less than the recorded goodwill, an impairment charge is recorded in operations for the difference.

The Company estimates the fair value of each reporting unit using a combination of the income approach and the market approach. The income approach incorporates the use of a discounted cash flow method in which the estimated future cash flows and terminal values for each reporting unit are discounted to a present value using a discount rate. Cash flow projections are based on management's estimates of economic and market conditions, which drive key assumptions of revenue growth rates, operating margins, capital expenditures and working capital requirements. The discount rate in turn is based on the specific risk characteristics of each reporting unit, the weighted-average cost of capital and its underlying forecasts. The market approach estimates fair value by applying performance-metric multiples to the reporting unit's prior and expected operating performance. The multiples are derived from comparable publicly traded companies that have operating and investment characteristics similar to the reporting unit. If the fair value of the reporting unit derived using the income approach is significantly different from the fair value estimate using the market approach, the Company reevaluates its assumptions used in the two models. The fair values determined by the market approach and income approach, as described above, are weighted to determine the fair value for each reporting unit. The weighted values assigned to each reporting unit are driven by two primary factors: 1) the number of comparable publicly traded companies used in the market approach, and 2) the similarity of the operating and investment characteristics of the reporting units to the comparable publicly traded companies used in the market approach.

Fair Value

Fair Value

The Company uses the fair value measurement guidance to value certain of its assets and liabilities. Under this guidance, assets and liabilities are required to be valued based on assumptions used by a market participant, consistent with the following hierarchy of inputs:

Level 1—	Quoted prices unadjusted for identical assets or liabilities in an active market.
Level 2—	Inputs other than quoted prices that are observable, either directly or indirectly, for similar assets or liabilities.
Level 3—	Unobservable inputs that reflect the entity’s own assumptions which market participants would use in pricing the asset or liability.

The assets and liabilities which are valued using the fair value measurement guidance, on a recurring basis, include the Company’s money market funds and money market deposits, time deposits, short-term investments, pension assets, and foreign currency derivatives comprised of forward and option contracts. The fair value of the forward contracts is based on quoted prices for similar but not identical derivative financial instruments; as such, the inputs are considered Level 2 inputs. Option contracts are valued using inputs which are based on quoted pricing intervals from external valuation models, which do not involve management judgment and as such, these inputs are considered Level 2 inputs. Certain pension assets are valued using model based pricing methods that use observable market data; as such these inputs are considered Level 2 inputs. There were no significant assets or liabilities measured at fair value on a recurring basis using significant unobservable (Level 3) inputs.

Certain assets and liabilities are measured at fair value on a non-recurring basis. These include acquired assets and liabilities in a business combination, equity method investments, asset retirement obligations, long-lived assets and goodwill, which are recognized at fair value to the extent that they are deemed to be impaired or are classified as long-lived assets held to be disposed of by sale. The fair value in these instances is determined using Level 3 inputs.

Receivables

Receivables

Receivables consist of amounts billed and currently due from customers, amounts earned but unbilled (including contracts measured under the percentage-of-completion method of accounting), amounts retained by the customer until the completion of a specified contract, completion of U.S. federal government audit activities audit activities, negotiation of contract modification, and claims.

Allowances for uncollectible billed trade receivables are estimated based on a combination of write-off history, aging analysis and any specific known collectability issues. Unbilled amounts under contracts in progress that are recoverable do not have an allowance for credit losses. Adjustments to unbilled amounts under contracts in progress related to credit quality, should they occur, would be recorded as a reduction of revenue.

Valuation of Long-Lived Assets

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or group of assets may not be recoverable. Recoverability of long-lived assets or groups of assets is assessed based on a comparison of the carrying amount to the estimated future net cash flows. If estimated future undiscounted net cash flows are less than the carrying amount, an expense is recorded in the amount, if any, required to reduce the carrying amount to fair value. Fair value is determined based on a discounted cash flow approach or, when available and appropriate, to comparable market values. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

Income Taxes

Income Taxes

Accounting for income taxes requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities. The Company maintains valuation allowances when, based on the weight of available evidence, it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company takes into account such factors as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of realization of a deferred tax asset.

The Company recognizes uncertain tax positions in the financial statements when it is more likely than not that the tax position will be sustained upon examination. Uncertain tax positions are measured based on the probabilities that the uncertain tax position will be realized upon final settlement (see Note 10).

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers investments with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of time deposits, money market funds and money market deposit accounts with a number of institutions that have high credit ratings.

Foreign Currency

Foreign Currency

The Company has determined that, generally, the local currency of its foreign affiliates is their functional currency. Accordingly, the assets and liabilities of the foreign affiliates are translated from their respective functional currency to U.S. dollars using year-end exchange rates, income and expense accounts are translated at the average rates in effect during the year, and equity accounts are translated at historical rates. The resulting translation adjustment is reported in the Statement of Other Comprehensive Income and recorded as part of accumulated other comprehensive income (AOCI). The amount of currency translation adjustment included in AOCI, for the years ended March 29, 2013, March 30, 2012 and April 1, 2011, was $(83) million(net of taxes of $12 million),$(124) million (net of taxes of $1 million) and $261 million (net of taxes of $3 million), respectively.

To manage the exposure to movements in foreign currency exchange rates, the Company uses foreign currency forward contracts and option contracts (see Note 7). The use of these derivative instruments is intended to offset, to the extent possible, the gains and losses from remeasurement of the Company’s foreign currency denominated monetary assets and liabilities. Gains and losses from remeasurement of the Company’s foreign currency denominated assets and liabilities, and remeasurement and settlement of the related foreign currency derivatives are recorded in Other (income) expense.

Earnings per Share

Earnings (Loss) Per Share

Basic earnings (loss) per common share (EPS) are computed using the weighted average number of common shares outstanding during the period. Diluted EPS reflect the incremental shares issuable upon the assumed exercise of stock options and equity awards.

	Twelve Months Ended
(Amounts in millions, except per-share data)	March 29, 2013		March 30, 2012			April 1, 2011
Net income (loss) attributable to CSC common shareholders:
From continuing operations	$	497	$	(4,387	)	$	657
From discontinued operations	464		145			83
	$	961	$	(4,242	)	$	740
Common share information:
Weighted average common shares outstanding for basic EPS	$	154.590	$	155.012		$	154.488
Dilutive effect of stock options and equity awards	0.967		—			2.117
Shares for diluted earnings (loss) per share	$	155.557	$	155.012		$	156.605
Earnings (loss) per share – basic and diluted:
Basic EPS:
Continuing operations	$	3.22	$	(28.31	)	$	4.25
Discontinued operations	3.00		0.94			0.54
Total	$	6.22	$	(27.37	)	$	4.79
Diluted EPS:
Continuing operations	$	3.20	$	(28.31	)	$	4.20
Discontinued operations	2.98		0.94			0.53
Total	$	6.18	$	(27.37	)	$	4.73

The computation of diluted EPS does not include stock options which are antidilutive, as their exercise price exceeded the average market price of the Company’s common stock. The number of shares related to such stock options were 14,755,024, 17,592,316, and 9,431,834, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. In addition, the computation of diluted EPS for the year ended March 30, 2012, excluded options to purchase 442,228 shares of common stock and 1,064,959 RSUs whose effect, if included, would have been anti-dilutive due to the Company’s net loss.

New Accounting Pronouncements and Standards Not Yet Adopted

New Accounting Standards

During fiscal year 2013, the Company adopted the following recent Accounting Standard Updates (ASUs):

On June 16, 2011, the FASB issued ASU 2011-05, “Presentation of Comprehensive Income,” which revises the manner in which entities present comprehensive income in their financial statements. The new guidance removes the presentation options in ASC 220 "Comprehensive Income" and requires entities to report components of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements. The Company adopted the amendments in this update effective at the beginning of fiscal 2013 using the two-statement approach.

On September 15, 2011, the FASB issued ASU 2011-08, “Testing Goodwill for Impairment,” which revises guidance on testing goodwill for impairment. The amendments in the ASU allow an entity the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines that it is not more likely than not, then performing the two-step impairment is unnecessary. However, if the entity concludes that fair value is more likely than not less than carrying value, then it is required to perform the first step of the two-step impairment test and calculate the fair value of the reporting unit to compare with the carrying value of the reporting unit as described in ASC 350-20-35-4. The entity may bypass the initial qualitative assessment for any reporting unit in any period and proceed directly to the first step of the two-step impairment test. The entity may resume performing the qualitative assessment in any subsequent period. The Company adopted the amendments in the update effective at the beginning of fiscal 2013 on a prospective basis, and they did not have a material effect on CSC's Consolidated Financial Statements.

Standards Issued But Not Yet Effective

The following ASUs were recently issued but have not yet been adopted by CSC:

On December 16, 2011, the FASB issued ASU 2011-11, “Disclosures about Offsetting Assets and Liabilities,” which was subsequently amended on January 31, 2013 when the FASB issued ASU 2013-01 “Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities”. Together these Updates provide guidance on disclosure of information pertaining to the offsetting (netting) of assets and liabilities in the financial statements. The amendments in these ASUs affect all entities that have financial instruments and derivative instruments that are either (1) offset in accordance with either ASC 210-20-45 or ASC 815-10-45, or (2) subject to an enforceable master netting arrangement or similar agreement. ASU 2011-11 amends the existing disclosure requirements on offsetting in ASC 210-20-50 by requiring disclosures relating to gross amounts of recognized assets and liabilities, the amounts that are offset, net amounts presented in the balance sheet, and amounts subject to an enforceable master netting arrangement or similar agreement. The amendments in these updates become effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The adoption of the amendments of these updates is not expected to have a material effect on CSC's Consolidated Financial Statements.

On February6, 2013, the FASB issued ASU 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income”, which requires entities to report the effect of significant reclassifications out of AOCI on the respective line items in net income unless the amounts are not reclassified in their entirety to net income. For amounts that are not required to be reclassified in their entirety to net income in the same reporting period, entities are required to cross-reference other disclosures that provide additional detail about those amounts. The amendments are effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2012. The Company is currently evaluating the impact of the adoption of these amendments.

In February 2013, the FASB issued ASU No.2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date” which requires an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance in this ASU also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December15, 2013. CSC will be required to adopt the amendments in this ASU beginning in fiscal 2015. We are currently evaluating the impact that the adoption may have on CSC's Consolidated Financial Statements.

In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830): “Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” which resolves the diversity in practice about whether Subtopic 810-10, Consolidation - Overall, or Subtopic 830-30, Foreign Currency Matters - Translation of Financial Statements, applies to the release of the cumulative translation adjustment into net income when a parent either sells a part of or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. In addition, the amendments resolve the diversity in practice for the treatment of business combinations achieved in stages (i.e. step acquisitions) involving a foreign entity. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December15, 2013. CSC will be required to adopt the amendments in this ASU beginning in fiscal 2015. The adoption of the amendments of these updates is not expected to have a material effect on CSC's Consolidated Financial Statements.

XML

Other (Income) Expense, Net (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Other (Income) Expense [Abstract]
Foreign currency loss (gain)	$ 17	$ 4	$ (2)
Equity in earnings of unconsolidated affiliates	(9)	(10)	(11)
Other gains	(42)	0	(8)
Total	(34)	(6)	(21)
Cost of Company's Hedging Program	5	6	4
Foreign currency (gains) lossses, due to foreign currency exchange rates	(37)	(8)	(9)
Realizes losses from settled option contracts	2	4	(6)
Paxus [Member]
Other (Income) Expense [Abstract]
Pre-tax gain from divestiture	38
Foreign Exchange Option [Member]
Other (Income) Expense [Abstract]
Foreign currency (gains) lossses, due to foreign currency exchange rates	$ 10	$ (6)	$ (1)

XML

Goodwill (Tables)

12 Months Ended

Mar. 29, 2013

Goodwill [Abstract]

Changes in the Carrying Amount of Goodwill by Segment

The following tables summarize the changes in the carrying amount of goodwill by segment for the years ended March 29, 2013, and March 30, 2012, respectively:

(Amounts in millions)	NPS		MSS			BSS			Total
Goodwill, gross	$	768	$	2,221		$	1,527		$	4,516
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 30, 2012, net	768		147			837			1,752
Additions	25		—			—			25
Deductions	—		—			(241		)	(241		)
Foreign currency translation	—		(11		)	(9		)	(20		)
Other reclassifications	—		(11		)	11			—
Goodwill, gross	793		2,199			1,288			4,280
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 29, 2013, net	$	793	$	125		$	598		$	1,516

(Amounts in millions)	NPS		MSS			BSS			Total
Goodwill, gross	$	753	$	1,965		$	1,339		$	4,057
Accumulated impairment losses	—		—			(19		)	(19		)
Balance as of April 1, 2011, net	753		1,965			1,320			4,038
Additions	15		157			304			476
Foreign currency translation	—		3			(20		)	(17		)
Other reclassifications	—		96			(96		)	—
Impairment losses	—		(2,074		)	(671		)	(2,745		)
Goodwill, gross	768		2,221			1,527			4,516
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 30, 2012, net	$	768	$	147		$	837		$	1,752

XML

Summary of Significant Accounting Policies - Stock-Based Compensation (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Apr. 02, 2010
Share-based Compensation [Abstract]
Share-based Compensation	$ 49	$ 36	$ 56
Total net of tax	31	23	35
Restricted Stock or Unit Expense	3	12
Minimum interest rate used to determine overall risk-free interest rate for the period (in hundredths)	0.82%
Maximum interest rate used to determine overall risk-free interest rate for the period (in hundredths)	1.44%
Minimum volatility rate used during the period (in hundredths)	32.00%
Maximum volatility rate used during the period (in hundredths)	38.00%
Weighted average fair value of stock options granted (in dollars per share)	$ 7.37	$ 10.17	$ 12.95
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Risk-free interest rate (in hundredths)	1.15%		1.80%	2.37%
Expected volatility (in hundredths)	36.00%		31.00%	28.00%
Expected term (in years)	6 years 7 months 2 days		6 years 1 month 10 days	5 years 10 months 6 days
Dividend yield (in hundredths)	2.86%		1.79%	1.17%
Income tax benefit for the period regarding compensation expense for stock incentive plan	9	7	11
Term Of Historical Daily Closing Price On Which Historical Volatilty Calculation Was Based In Prior Periods	10 years
Current Term Of Historical Daily Closing Price On Which Historical Volatilty Calculation Was Based	7 years
Excess tax benefit for the period regarding compensation expense for stock incentive plan	3	2	6
Cost of services [Member]
Share-based Compensation [Abstract]
Share-based Compensation	22	15	12
Selling, general and administrative [Member]
Share-based Compensation [Abstract]
Share-based Compensation	27	21	44
Restricted Stock Units (RSUs) [Member]
Share-based Compensation [Abstract]
Restricted Stock or Unit Expense	$ 15

XML

Income Taxes Income Tax Examination (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013
Settlement with Taxing Authority [Member]
Income Tax Examination [Line Items]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit	92
United States - Federal [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2008 and forward
United States - Various States [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2001 and forward
Australia [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2009 and forward
Canada [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2006 and forward
Denmark [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2007 and forward
France [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2009 and forward
Germany [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2006 and forward
India [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2007 and forward
United Kingdom [Member]
Income Tax Examination [Line Items]
Tax Years that Remain Subject to Examination (Fiscal Year Ending)	2010 and forward

XML

CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	Mar. 29, 2013	Mar. 30, 2012
Current assets:
Cash and cash equivalents	$ 2,054	$ 1,093
Receivables, net of allowance for doubtful accounts of $48 (2013) and $51 (2012)	3,199	3,257
Prepaid expenses and other current assets	420	533
Total current assets	5,673	4,883
Intangible and other assets:
Software, net of accumulated amortization of $1,523 (2013) and $1,481 (2012)	611	649
Outsourcing contract costs, net of accumulated amortization of $968 (2013) and $1,240 (2012)	505	562
Goodwill	1,516	1,752
Other assets	762	902
Total intangible and other assets	3,394	3,865
Property and equipment—at cost:
Land, buildings and leasehold improvements	1,228	1,267
Computers and related equipment	3,989	4,357
Furniture and other equipment	392	464
Construction in progress	42	56
Property and equipment - at cost	5,651	6,144
Less: accumulated depreciation and amortization	3,467	3,703
Property and equipment, net	2,184	2,441
Total Assets	11,251	11,189
Current liabilities:
Short-term debt and current maturities of long-term debt	234	1,254
Accounts payable	373	478
Accrued payroll and related costs	653	789
Accrued expenses and other current liabilities	1,425	1,339
Deferred revenue and advance contract payments	630	619
Income taxes payable and deferred income taxes	34	57
Total current liabilities	3,349	4,536
Long-term debt, net of current maturities	2,498	1,486
Income tax liabilities and deferred income taxes	501	357
Other long-term liabilities	1,743	1,976
Commitments and contingencies
CSC stockholders’ equity:
Preferred stock par value $1 per share; authorized 1,000,000 shares; none issued
Common stock, par value $1 per share; authorized 750,000,000 shares; issued 158,984,279 (2013) and 163,719,508 (2012)	159	164
Additional paid-in capital	2,167	2,168
Earnings retained for use in business	2,564	1,930
Accumulated other comprehensive loss	(1,354)	(1,093)
Less: common stock in treasury, at cost, 8,819,517 (2013) and 8,518,540 (2012)	(401)	(390)
Total CSC stockholders’ equity	3,135	2,779
Noncontrolling interest in subsidiaries	25	55
Total Equity	3,160	2,834
Total Liabilities and Equity	$ 11,251	$ 11,189

XML

Stock Incentive Plans (Tables)

12 Months Ended

Mar. 29, 2013

Stock Incentive Plans [Abstract]

Disclosure of share based compensation arrangements by share based payment award

Information concerning RSUs granted under stock incentive plans during fiscal 2013, fiscal 2012, and fiscal 2011, is as follows:

	Number of Shares		Weighted Average Fair Value
Outstanding as of April 2, 2010	1,154,668		$	45.88
Granted	492,523		48.15
Settled	(151,893	)	50.40
Canceled/Forfeited	(16,728	)	51.94
Outstanding as of April 1, 2011	1,478,570		46.10
Granted	1,009,743		35.45
Settled	(419,351	)	48.21
Canceled/Forfeited	(328,037	)	41.44
Outstanding as of March 30, 2012	1,740,925		40.29
Granted	1,724,639		26.12
Settled	(423,321	)	33.17
Canceled/Forfeited	(778,971	)	38.27
Outstanding as of March 29, 2013	2,263,272		31.53

Information concerning stock options granted under stock incentive plans during fiscal 2013, fiscal 2012, and fiscal 2011 is as follows:

	Number of Option Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value (In millions)
Outstanding as of April 2, 2010	17,008,397		$	46.36	5.58	$	141
Granted	2,818,874		48.23
Exercised	(1,868,544	)	40.61			22
Canceled/Forfeited	(324,612	)	46.00
Expired	(573,922	)	55.52
Outstanding as of April 1, 2011	17,060,193		47.00		5.54	69
Granted	2,457,509		38.18
Exercised	(428,844	)	35.95			5
Canceled/Forfeited	(579,069	)	41.75
Expired	(776,227	)	49.05
Outstanding as of March 30, 2012	17,733,562		46.13		5.08	1
Granted	3,707,172		27.46
Exercised	(1,497,686	)	39.27			10
Canceled/Forfeited	(1,113,422	)	35.36
Expired	(3,689,059	)	45.28
Outstanding as of March 29, 2013	15,140,567		43.23		5.45	113
Vested and expected to vest in the future as of March 29, 2013	14,885,162		43.47		5.38	108
Exercisable as of March 29, 2013	10,694,088		47.92		4.05	36

Information concerning RSUs granted to nonemployee directors during fiscal 2013, fiscal 2012, and fiscal 2011 is as follows:

	Number of Shares		Weighted Average Fair Value
Outstanding as of April 2, 2010	133,221		$	46.47
Granted	25,700		39.46
Settled	(180	)	42.69
Canceled/Forfeited	—		—
Outstanding as of April 1, 2011	158,741		45.34
Granted	37,800		30.07
Settled	(180	)	42.69
Canceled/Forfeited	—		—
Outstanding as of March 30, 2012	196,361		42.81
Granted	42,800		30.30
Settled	(50,716	)	43.30
Canceled/Forfeited	—		—
Outstanding as of March 29, 2013	188,445		39.85

Schedule of share based compensation shares authorized under stock option plans by exercise price range

	March 29, 2013
	Options Outstanding				Options Exercisable
Range of Option Exercise Price	Number Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Number Exercisable	Weighted Average Exercise Price
$23.06-$39.04	5,269,835	$	31.56	7.79	1,392,011	$	36.87
$39.11-$48.61	6,075,780	45.73		4.77	5,531,586	45.82
$48.65-$60.25	3,794,952	55.06		3.27	3,770,491	55.08
	15,140,567				10,694,088

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Net income (loss)	$ 979	$ (4,225)	$ 759
Foreign currency translation adjustments, net of tax benefit (expense) of $12, $1 and $3 in fiscal 2013, 2012 and 2011	83	124	(261)
Net actuarial (loss) / gain, net of tax benefit (expense) of $38, $150 and $(1) in fiscal 2013, 2012 and 2011	(260)	(323)	35
Prior service (cost) /credit, net of tax (expense) benefit of $(8), $6 and $(19) in fiscal 2013, 2012 and 2011	19	(4)	31
Amortization of transition obligation, net of tax benefit (expense) of $0, $0 and $(2) in fiscal 2013, 2012 and 2011	1	2	2
Amortization of prior service (credit) / cost, net of tax benefit (expense) of $0, $1 and $(1) in fiscal 2013, 2012 and 2011	(1)	(2)	2
Amortization of net actuarial loss, net of tax (expense) of $(25), $(20) and $(19) in fiscal 2013, 2012 and 2011	58	45	38
Foreign currency exchange rate changes, net of tax (expense) benefit of $(8), $(1) and $1 in fiscal 2013, 2012 and 2011	(14)	3	(7)
Pension and other postretirement benefit plans, net of tax	(197)	(279)	101
Other comprehensive (loss) income, net of tax	(280)	(403)	362
Comprehensive income (loss)	699	(4,628)	1,121
Less: comprehensive (loss) income attributable to noncontrolling interest	(1)	17	19
Comprehensive income (loss) attributable to CSC common stockholders	$ 700	$ (4,645)	$ 1,102

XML

Investigations and Out of Period Adjustments (Cumulative effect on net loss attributable to common shareholders of the consolidated out of period adjustments) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended			3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended	3 Months Ended				12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Mar. 30, 2012 Fiscal 2012	Dec. 30, 2011 Fiscal 2012	Sep. 30, 2011 Fiscal 2012	Jul. 01, 2011 Fiscal 2012	Mar. 30, 2012 Fiscal 2012	Apr. 01, 2011 Fiscal 2011	Dec. 31, 2010 Fiscal 2011	Oct. 01, 2010 Fiscal 2011	Jul. 02, 2010 Fiscal 2011	Apr. 01, 2011 Fiscal 2011	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012	Dec. 30, 2011 Nordic Operations [Member] Fiscal 2012	Sep. 30, 2011 Nordic Operations [Member] Fiscal 2012	Jul. 01, 2011 Nordic Operations [Member] Fiscal 2012	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Dec. 30, 2011 Nordic Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Sep. 30, 2011 Nordic Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Jul. 01, 2011 Nordic Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Dec. 30, 2011 Nordic Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Sep. 30, 2011 Nordic Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Jul. 01, 2011 Nordic Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Dec. 30, 2011 Nordic Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Sep. 30, 2011 Nordic Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Jul. 01, 2011 Nordic Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Mar. 30, 2012 Nordic Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011	Dec. 31, 2010 Nordic Operations [Member] Fiscal 2011	Oct. 01, 2010 Nordic Operations [Member] Fiscal 2011	Jul. 02, 2010 Nordic Operations [Member] Fiscal 2011	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Dec. 31, 2010 Nordic Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Oct. 01, 2010 Nordic Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Jul. 02, 2010 Nordic Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Dec. 31, 2010 Nordic Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Oct. 01, 2010 Nordic Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Jul. 02, 2010 Nordic Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Dec. 31, 2010 Nordic Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Oct. 01, 2010 Nordic Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Jul. 02, 2010 Nordic Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Apr. 01, 2011 Nordic Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012	Dec. 30, 2011 Australia Operations [Member] Fiscal 2012	Sep. 30, 2011 Australia Operations [Member] Fiscal 2012	Jul. 01, 2011 Australia Operations [Member] Fiscal 2012	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Dec. 30, 2011 Australia Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Sep. 30, 2011 Australia Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Jul. 01, 2011 Australia Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012 Operating costs inappropriately capitalized [Member]	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Dec. 30, 2011 Australia Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Sep. 30, 2011 Australia Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Jul. 01, 2011 Australia Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012 Misapplication of US GAAP [Member]	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Dec. 30, 2011 Australia Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Sep. 30, 2011 Australia Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Jul. 01, 2011 Australia Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Mar. 30, 2012 Australia Operations [Member] Fiscal 2012 Miscellaneous errors [Member]	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011	Dec. 31, 2010 Australia Operations [Member] Fiscal 2011	Oct. 01, 2010 Australia Operations [Member] Fiscal 2011	Jul. 02, 2010 Australia Operations [Member] Fiscal 2011	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Dec. 31, 2010 Australia Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Oct. 01, 2010 Australia Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Jul. 02, 2010 Australia Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011 Operating costs inappropriately capitalized [Member]	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Dec. 31, 2010 Australia Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Oct. 01, 2010 Australia Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Jul. 02, 2010 Australia Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011 Misapplication of US GAAP [Member]	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Dec. 31, 2010 Australia Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Oct. 01, 2010 Australia Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Jul. 02, 2010 Australia Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Apr. 01, 2011 Australia Operations [Member] Fiscal 2011 Miscellaneous errors [Member]	Mar. 30, 2012 NHS contract [Member] Fiscal 2012	Dec. 30, 2011 NHS contract [Member] Fiscal 2012	Sep. 30, 2011 NHS contract [Member] Fiscal 2012	Jul. 01, 2011 NHS contract [Member] Fiscal 2012	Mar. 30, 2012 NHS contract [Member] Fiscal 2012	Apr. 01, 2011 NHS contract [Member] Fiscal 2011	Dec. 31, 2010 NHS contract [Member] Fiscal 2011	Oct. 01, 2010 NHS contract [Member] Fiscal 2011	Jul. 02, 2010 NHS contract [Member] Fiscal 2011	Apr. 01, 2011 NHS contract [Member] Fiscal 2011	Mar. 30, 2012 NPS Contract [Member] Fiscal 2012	Dec. 30, 2011 NPS Contract [Member] Fiscal 2012	Sep. 30, 2011 NPS Contract [Member] Fiscal 2012	Jul. 01, 2011 NPS Contract [Member] Fiscal 2012	Mar. 30, 2012 NPS Contract [Member] Fiscal 2012	Apr. 01, 2011 NPS Contract [Member] Fiscal 2011	Dec. 31, 2010 NPS Contract [Member] Fiscal 2011	Oct. 01, 2010 NPS Contract [Member] Fiscal 2011	Jul. 02, 2010 NPS Contract [Member] Fiscal 2011	Apr. 01, 2011 NPS Contract [Member] Fiscal 2011	Mar. 30, 2012 Other errors [Member] Fiscal 2012	Dec. 30, 2011 Other errors [Member] Fiscal 2012	Sep. 30, 2011 Other errors [Member] Fiscal 2012	Jul. 01, 2011 Other errors [Member] Fiscal 2012	Mar. 30, 2012 Other errors [Member] Fiscal 2012	Apr. 01, 2011 Other errors [Member] Fiscal 2011	Dec. 31, 2010 Other errors [Member] Fiscal 2011	Oct. 01, 2010 Other errors [Member] Fiscal 2011	Jul. 02, 2010 Other errors [Member] Fiscal 2011	Apr. 01, 2011 Other errors [Member] Fiscal 2011
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Income from continuing operations, net of tax	$ 497	$ (4,387)	$ 657											$ 1	$ 2	$ 6	$ 4	$ 13	$ 0	$ 0	$ 0	$ 1	$ 1	$ (1)	$ 2	$ (1)	$ 1	$ 1	$ 2	$ 0	$ 7	$ 2	$ 11	$ 3	$ 23	$ 40	$ 20	$ 86	$ 6	$ 8	$ 38	$ 15	$ 67	$ (1)	$ 6	$ 3	$ 4	$ 12	$ (2)	$ 9	$ (1)	$ 1	$ 7	$ 0	$ 2	$ 21	$ 0	$ 23	$ 0	$ 0	$ 11	$ 0	$ 11	$ 1	$ 0	$ 8	$ 0	$ 9	$ (1)	$ 2	$ 2	$ 0	$ 3	$ (4)	$ 0	$ 5	$ (4)	$ (3)	$ 0	$ (1)	$ (1)	$ 0	$ (2)	$ (1)	$ 3	$ 1	$ 0	$ 3	$ (3)	$ (2)	$ 5	$ (4)	$ (4)	$ (7)	$ 46	$ (2)	$ (2)	$ 35	$ (5)	$ (5)	$ (2)	$ (10)	$ (22)	$ 11	$ (5)	$ 1	$ 3	$ 10	$ (7)	$ (10)	$ 2	$ 4	$ (11)	$ 9	$ 5	$ (11)	$ 2	$ 5	$ (14)	$ (18)	$ (8)	$ (9)	$ (49)
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest				14	50	15	7	86	(27)	(10)	37	1	1
Income Tax Expense (Benefit)	(35)	(84)	202	(4)	(2)	(3)	(2)	(11)	10	9	1	4	24
Other Income Tax Benefit Adjustments				(5)	(10)	14	1	0	18	(6)	(13)	(1)	(2)
Net income (loss)	$ 961	$ (4,242)	$ 740	$ 5	$ 38	$ 26	$ 6	$ 75	$ 1	$ (7)	$ 25	$ 4	$ 23

XML

Discontinued operations (Tables)

12 Months Ended

Mar. 29, 2013

Discontinued operations [Abstract]

Summary of Discontinued Operations

Following is the summary of the results of the discontinued operations:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012			April 1, 2011
Operations
Revenue	$	395	$	513		$	562
Income from discontinued operations, before taxes	84		107			100
Tax expense (benefit)	37		(37		)	45
Net income from discontinued operations	47		144			55
Disposal
Gain (loss) on disposition	$	769	$	(2	)	$	59
Tax expense (benefit)	352		(3		)	31
Gain on disposition, net of taxes	417		1			28
Income from discontinued operations, net of taxes	$	464	$	145		$	83

XML

Foreign Currency Derivative Instruments (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013 counterparty	Mar. 30, 2012
Derivative [Line Items]
Estimated fair value of foreign currency derivative assets	$ 5	$ 12
Estimated fair value of foreign currency derivative liabilities	11	14
Number of counterparties with concentration of credit risk	4
Maximum amount of loss, based on gross fair value, due to concentration of credit risk	5
Forward Contracts [Member]
Derivative [Line Items]
Notional amount of derivatives outstanding	993	2,138
Option Contracts [Member]
Derivative [Line Items]
Notional amount of derivatives outstanding	$ 744	$ 785

XML

Stockholders' Equity

12 Months Ended

Mar. 29, 2013

Shareholders' Equity [Abstract]

Shareholders' Equity

Stockholders’ Equity

Stock Repurchase Program

In December 2010, the Company’s board of directors approved a share repurchase program authorizing up to $1 billion in share repurchases of the Company’s outstanding common stock. CSC has been implementing the program through purchases made in open market transactions in compliance with Securities and Exchange Commission rules, market conditions, and applicable state and federal legal requirements. The timing, volume, and nature of share repurchases will be at the discretion of management, and may be suspended or discontinued at any time. No end date has been established for the repurchase program.

During fiscal 2013, 6,707,652 shares were purchased through open market purchases for an aggregate consideration of$305 million at a weighted average price of $45.47 per share. Of the aggregate consideration of $305 million, $22 million was recorded as an accrued liability for shares purchased but not yet settled in cash by March 29, 2013. During fiscal 2011, 1,353,000 shares were purchased through open market purchases for an aggregate consideration of $65 million at a weighted average price of $48.01 per share. For fiscal 2013 and 2011, the shares repurchased were retired immediately and included in the category of authorized but unissued shares. The excess of purchase price over par value of the shares repurchased was allocated between additional paid-in capital and retained earnings.    

During fiscal 2012, no shares were purchased through open market purchases.

Treasury Stock Transactions

In fiscal 2013, the Company accepted 91,921 shares of its common stock in lieu of cash in connection with exercise of stock options, and 209,056 shares in lieu of cash in connection with the tax withholdings associated with the release of common stock upon vesting of restricted stock and restricted stock units.

Similarly, in fiscal 2012, the Company accepted 21,755 shares of its common stock in lieu of cash in connection with exercise of stock options, and 104,117 shares in lieu of cash in connection with the tax withholdings associated with the release of common stock upon vesting of restricted stock and restricted stock units.

Dividends

During fiscal 2013, the Company declared cash dividends per common share of $0.80 totaling $123 million. Of the total dividends declared, $30 million was declared but unpaid as of March 29, 2013. Such dividends were paid on April 15 ,2013.

Similarly, during fiscal 2012, the Company declared cash dividends per common share of $0.80 totaling $124 million. Of the total dividends declared, $31 million was unpaid as of March 30, 2012.

Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss for fiscal 2013 are as follows:

(Amounts in millions)	Foreign Currency Translation Adjustments			Pension and Other Postretirement Benefit Plans			Accumulated Other Comprehensive Loss
Balance at April 2, 2010	$	23		(1,075		)	(1,052		)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	261			101			362
Balance at April 1, 2011	$	284		(974		)	(690		)
Current-period other comprehensive loss income, net of taxes and non-controlling interests	(124		)	(279		)	(403		)
Balance at March 30, 2012	$	160		$	(1,253	)	$	(1,093	)
Current-period other comprehensive (loss) income, net of taxes and non-controlling interest	(83		)	(178		)	(261		)
Balance at March 29, 2013	$	77		$	(1,431	)	$	(1,354	)

XML

Acquisitions (Tables)

12 Months Ended

Mar. 29, 2013

Acquisitions and Divestitures [Abstract]

Pro Forma Information

The following unaudited pro forma summary presents consolidated information of the Company as if the acquisition of iSOFT had occurred on April 3, 2010 for all periods presented:

	As Reported					Pro Forma - Unaudited
	Twelve Months Ended					Twelve Months Ended
(Amounts in millions, except per-share data)	March 30, 2012			April 1, 2011		March 30, 2012			April 1, 2011
Revenue	$	15,364		$	15,582	$	15,442		$	15,776
Net (loss) income attributable to CSC common shareholders	(4,242		)	740		(4,344		)	618
Basic EPS	$	(27.37	)	$	4.79	$	(28.02	)	$	4.00
Diluted EPS	(27.37		)	4.73		(28.02		)	3.95

Estimated Fair Values of the Assets Acquired and Liabilities Assumed

The fair values of the assets acquired and liabilities assumed at the date of acquisition, including adjustments to the valuation of net assets acquired based on additional information that subsequently became available during fiscal 2012, are summarized as follows:

(Amounts in millions)	Estimated Fair Value
Cash and cash equivalents	$	4
Trade receivables	20
Other current assets	8
Intangible assets	26
Property and equipment	4
Trade payables and accrued expenses	(26		)
Deferred taxes and uncertain tax positions	(20		)
Other liabilities	(2		)
Total identifiable net assets acquired	14
Goodwill	157
Total purchase price	$	171

The fair values of the assets acquired and liabilities assumed at the date of acquisition, including adjustments to the valuation of net assets acquired based on additional information that subsequently became available during fiscal 2012, are summarized as follows:

(Amounts in millions)	Estimated Fair Value
Cash and cash equivalents	$	26
Trade and other receivables	114
Other current assets	14
Deferred tax assets	12
Intangible assets	198
Property and equipment	21
Other non-current assets	3
Trade payables and accrued expenses	(62		)
Deferred revenue	(54		)
Debt	(315		)
Deferred taxes, uncertain tax positions, and other long-term liabilities	(59		)
Total identifiable net assets acquired	(102		)
Goodwill	302
Total cash purchase price	$	200

Intangible Assets Acquired

The components of the definite-lived intangible assets acquired and their respective estimated useful lives are as follows:

(Amounts in millions)	Estimated Fair Value		Estimated Useful Lives (Years)
Customer relationships	$	25	2-8
Software	1		1-5
Total intangible assets	$	26

The components of the definite-lived intangible assets acquired and their respective estimated useful lives were as follows:

(Amounts in millions)	Estimated Fair Value		Estimated Useful Lives (Years)
Customer relationships	$	92	10-13
Software	102		2-7
Trade names	4		1
Total intangible assets	$	198

XML

Other (Income) Expense, Net

12 Months Ended

Mar. 29, 2013

Other Income and Expenses [Abstract]

Other (Income) Expense, Net

Other (Income) Expense, Net

The components of other (income) expense, net for fiscal 2013, fiscal 2012, and fiscal 2011 are:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Foreign currency loss (gain)	$	17		$	4		$	(2	)
Equity in earnings of unconsolidated affiliates	(9		)	(10		)	(11		)
Other gains	(42		)	—			(8		)
Total	$	(34	)	$	(6	)	$	(21	)

Foreign currency (gains) losses are due to the impact of movement in foreign currency exchange rates on the Company’s foreign currency denominated assets and liabilities, the related hedges including options to manage its exposure to economic risk, and the cost of the Company’s hedging program. The costs of the Company’s hedging program for fiscal years 2013, 2012, and 2011 were $5 million, $6 million and $4 million, respectively.   For fiscal years 2013, 2012, and 2011, foreign currency (gains) losses due to movements of foreign currency exchange rates, primarily between the U.S. dollar and the Indian rupee, which impacted the market valuation of the Company's foreign currency options, were $10 million, $(6) million and $(1) million, respectively. In addition, the Company also realized losses of $2 million, $4 million and $(6) million in fiscal 2013, 2012, and 2011 from settled option contracts, respectively.

Other gains for fiscal 2013 primarily included a gain of $38 million related to the sale of Paxus, the Company's Australian staffing business. For fiscal 2011, the gains reflected disposal of certain minority investments.

Equity in earnings of unconsolidated affiliates is primarily within the Company’s NPS segment.

XML

Income Taxes (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Sources of income before income taxes [Abstract]
Domestic entities	$ (25)	$ (1,807)	$ 489
Entities outside the United States	505	(2,647)	389
Income (loss) from continuing operations before taxes	480	(4,454)	878
Income tax expense (benefit) on income from continuing operations, current [Abstract]
Federal	(307)	(72)	(13)
State	(3)	11	18
Foreign	174	94	96
Total Current	(136)	33	101
Income tax expense (benefit) on income from continuing operations, deferred [Abstract]
Federal	84	(140)	89
State	(16)	(22)	7
Foreign	33	45	5
Total Deferred	101	(117)	101
Total income tax expense (benefit)	(35)	(84)	202
Interest and penalties for uncertain tax positions included in current provision (benefit)	10	(53)	5
Difference between the U.S. federal statutory tax rate and effective tax rate [Abstract]
Statutory rate (in hundredths)	35.00%	(35.00%)	35.00%
State income tax, net of federal tax (in hundredths)	(0.60%)	(0.30%)	1.30%
Change in uncertain tax positions (in hundredths)	1.20%	0.60%	(2.80%)
Foreign tax rate differential (in hundredths)	(66.80%)	(0.80%)	(5.40%)
Income tax credits (in hundredths)	(0.40%)	(1.00%)	(9.60%)
Valuation allowance	77.10%	18.10%	2.50%
Change in entity tax status (in hundreths)	(0.30%)	(0.70%)	0.00%
Loss on sale of securities (in hundredths)	51.80%	0.00%	0.00%
Tax audit settlements (in hundredths)	0.00%	(2.50%)	0.00%
Effective income tax rate reconciliation goodwill adjustments	0.00%	18.80%	0.00%
Other items, net (in hundredths)	(0.70%)	0.90%	2.00%
Effective tax rate (in hundredths)	(7.30%)	(1.90%)	23.00%
Available-for-sale Securities, Gross Realized Gain (Loss)	640
Effective Income Tax Rate Reconciliation, Disposition of Asset, Amount	248
Deferred tax assets [Abstract]
Employee benefits	558		705
Tax loss/credit carryforwards	1,110		899
Accrued interest	47		52
State taxes	13		13
Foreign gain/loss on exchange	14		6
Other assets	111		92
Total Deferred Tax Assets	1,853		1,767
Valuation allowance	(1,298)		(951)
Net Assets	555		816
Deferred tax liabilities [Abstract]
Depreciation and amortization	(322)		(387)
Contract accounting	(53)		(90)
Investment basis differences	(128)		(128)
Other liabilities	(75)		(65)
Total Deferred Tax Liabilities	(578)		(670)
Total Deferred Tax Assets (Liabilities)	(23)		146
Net Assets	24	19
Income taxes receivable included in receivables	239	98
Non-current deferred tax assets included in other assets	184	272
Non-current income taxes receivable included in other assets	70	154
Current portion of deferred tax liabilities included in income taxes payable and deferred income taxes	0	46
Current portion of income taxes payable	41	11
Current liability for uncertain tax positions	8	0
Non-current liability for uncertain tax positions	270	257
Deferred Tax Liabilities, Noncurrent	231	99
Accrued Income Taxes, Noncurrent	0	1
Valuation Allowance, Deferred Tax Asset, Change in Amount	347
Cumulative Undistributed Earnings Of Foreign Subsidiaries	2,977
GERMANY
Difference between the U.S. federal statutory tax rate and effective tax rate [Abstract]
Valuation allowance	16.00%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	77.0
Foreign Tax Assets [Member]
Difference between the U.S. federal statutory tax rate and effective tax rate [Abstract]
Valuation allowance	5.80%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	27.6
Gains (Losses) on Sales of Assets [Member]
Difference between the U.S. federal statutory tax rate and effective tax rate [Abstract]
Valuation allowance	2.40%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	11.5
Capital Loss Carryforward [Member]
Difference between the U.S. federal statutory tax rate and effective tax rate [Abstract]
Valuation allowance	6.20%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	29.6
Securities Investment [Member] | LUXEMBOURG | Foreign Tax Authority [Member]
Difference between the U.S. federal statutory tax rate and effective tax rate [Abstract]
Valuation allowance	50.20%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$ 240.5

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parentheticals) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Tax	$ 12	$ 1	$ 3
Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax	(8)	(1)	1
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, Tax	38	150	(1)
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Tax	(8)	6	(19)
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax	0	0	(2)
Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service (Cost) Credit, Tax	0	1	(1)
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Actuarial Gain (Loss) Arising During Period, Tax	$ (25)	$ (20)	$ (19)

XML

CONSOLIDATED BALANCE SHEETS Parenthetical (USD $) In Millions, except Share data, unless otherwise specified	Mar. 29, 2013	Mar. 30, 2012
Current assets:
Allowance for doubtful accounts	$ 48	$ 51
Intangible and other assets:
Accumulated amortization	2,772	3,027
CSC stockholders' equity:
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, authorized (in shares)	750,000,000	750,000,000
Common stock, issued (in shares)	158,984,279	163,719,508
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock in treasury, at cost (in shares)	8,819,517	8,518,540
Software [Member]
Intangible and other assets:
Accumulated amortization	1,523	1,481
Outsourcing contract costs [Member]
Intangible and other assets:
Accumulated amortization	$ 968	$ 1,240

XML

Intangible Assets

12 Months Ended

Mar. 29, 2013

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Intangible Assets

Intangible Assets

A summary of amortizable intangible assets is as follows:

	As of
	March 29, 2013
(Amounts in millions)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Outsourcing contract costs	$	1,473	$	968	$	505
Software	2,134		1,523		611
Customer and other intangible assets	512		281		231
Total intangible assets	$	4,119	$	2,772	$	1,347

	As of
	March 30, 2012
(Amounts in millions)	Gross Carrying Value		Accumulated Amortization		Net Carrying Value
Outsourcing contract costs	$	1,802	$	1,240	$	562
Software	2,130		1,481		649
Customer and other intangible assets	599		306		293
Total intangible assets	$	4,531	$	3,027	$	1,504

Amortization expense for the years ended March 29, 2013, March 30, 2012, and April 1, 2011 was $414 million, $442 million, and $444 million, respectively, including reductions of revenue for amortization of outsourcing contract cost premiums of $40 million, $53 million, and $63 million in each of the respective years (see Note 1).

Estimated amortization related to intangible assets, including amortization of contract cost premium, as of March 29, 2013, for fiscal 2014 through fiscal 2018, is as follows: $351 million, $292 million, $211 million, $158 million, and $112 million, respectively.

Purchased and internally developed software, net of accumulated amortization, consisted of the following:

(Amounts in millions)	March 29, 2013		March 30, 2012
Purchased software	$	297	$	353
Internally developed commercial software	304		293
Internally developed internal-use software	10		3
Total	$	611	$	649

Amortization expense related to purchased software was $143 million, $149 million, and $135 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. Amortization expense related to internally developed commercial software was $53 million, $47 million, and $34 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. Amortization expense related to internally developed internal-use software was $2 million, $4 million, and $6 million, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively.

During fiscal 2012, the Company recorded $75 million as an impairment of its intangible assets, primarily due to performance issues on certain long-term outsourcing contracts within its MSS segment. The intangible assets impacted included primarily, software and capitalized transition costs. The Company used the income approach technique to fair value the assets. The unobservable inputs used were based on Company specific information and included, primarily, estimates of revenue and cost growth rates, profit margins and discount rates. The impairment was recorded as a part of cost of services.

XML

SCHEDULE II, VALUATION AND QUALIFYING ACCOUNTS (Details) (Allowance for Doubtful Accounts [Member], USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013		Mar. 30, 2012		Apr. 01, 2011
Allowance for Doubtful Accounts [Member]
Movement in valuation allowances and reserves [Roll Forward]
Balance, beginning of period	$ 51		$ 46		$ 47
Charged to cost and expenses	16		18		7
Other	(1)	[1]	10	[1]	2	[1]
Deductions	(18)		(23)		(10)
Balance, end of period	$ 48		$ 51		$ 46

[1] Includes balances from acquisitions, changes in balances due to foreign currency exchange rates and recovery of prior-year charges.

XML

Commitments and Contengencies (Contingencies) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended			2 Months Ended	0 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Jul. 21, 2011 Pending Litigation [Member] lawsuit	May 15, 2013 United States District Court, Eastern District of Virginia [Member] Subsequent Event [Member] Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of pending class action complaints				4
Litigation settlement amount					$ 97.5
Related receivable, pending corporate insurance claim	45
Legal Fees	33	67	2
Legal Fees, Gross	$ 78

XML

Document And Entity Information (USD $)	12 Months Ended
	Mar. 29, 2013	May 03, 2013	Sep. 28, 2012
Entity Information [Line Items]
Entity Registrant Name	COMPUTER SCIENCES CORP
Entity Central Index Key	0000023082
Current Fiscal Year End Date	--03-29
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Mar. 29, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		150,228,623
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 4,956,615,996

XML

Goodwill

12 Months Ended

Mar. 29, 2013

Goodwill [Abstract]

Goodwill

Goodwill

The following tables summarize the changes in the carrying amount of goodwill by segment for the years ended March 29, 2013, and March 30, 2012, respectively:

(Amounts in millions)	NPS		MSS			BSS			Total
Goodwill, gross	$	768	$	2,221		$	1,527		$	4,516
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 30, 2012, net	768		147			837			1,752
Additions	25		—			—			25
Deductions	—		—			(241		)	(241		)
Foreign currency translation	—		(11		)	(9		)	(20		)
Other reclassifications	—		(11		)	11			—
Goodwill, gross	793		2,199			1,288			4,280
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 29, 2013, net	$	793	$	125		$	598		$	1,516

(Amounts in millions)	NPS		MSS			BSS			Total
Goodwill, gross	$	753	$	1,965		$	1,339		$	4,057
Accumulated impairment losses	—		—			(19		)	(19		)
Balance as of April 1, 2011, net	753		1,965			1,320			4,038
Additions	15		157			304			476
Foreign currency translation	—		3			(20		)	(17		)
Other reclassifications	—		96			(96		)	—
Impairment losses	—		(2,074		)	(671		)	(2,745		)
Goodwill, gross	768		2,221			1,527			4,516
Accumulated impairment losses	—		(2,074		)	(690		)	(2,764		)
Balance as of March 30, 2012, net	$	768	$	147		$	837		$	1,752

The fiscal 2013 addition to goodwill of $25 million relates to an acquisition in the NPS segment (see Note 4). The reduction of $241 million relates to the divestiture of a business in the BSS segment (see Note 3). The foreign currency translation amount relates to the impact of currency movements on non-U.S. dollar denominated goodwill balances.

In the beginning of fiscal 2013, the Company changed its reporting units within its BSS segment: it combined the iSOFT and BSS-Health reporting units with the NHS contract into one reporting unit named BSS-Global Health. This change reflected the integration of all aspects of the Company's healthcare businesses and the resulting management and monitoring of the healthcare businesses' operating results. As a result of this change in reporting units, $11 million of MSS' goodwill was reclassified to BSS. This change was made prior to the Company's first quarter fiscal 2013 goodwill impairment assessment. The Company's fiscal 2013 quarterly assessments and annual testing for impairment of goodwill were performed on the basis of the new reporting units.

The fiscal 2012 additions to goodwill of $476 million consist of: 1) $475 million related to the acquisition of four new businesses, one in the NPS segment, one in the MSS segment and two in the BSS segment ; and 2) $1 million of contingent consideration paid upon the achievement of contractually-defined revenue target relating to a fiscal 2009 NPS acquisition (see Note 4). The other reclassification relates to goodwill associated with the relative value attributable to MSS of its portion of the NHS contract cash flows. The impairment losses, which are discussed further below, included goodwill write-downs in three of the Company’s eight fiscal 2012 reporting units, two of which were in the BSS segment and the third of which was in the MSS segment.

As noted in Note 1, the Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if an event occurs, or circumstances change, that would more likely than not reduce the fair value of a reporting unit below its carrying amount.

During the second quarter of fiscal 2013, the Company performed its annual impairment test of goodwill, choosing to bypass the initial qualitative assessment and proceeding directly to the first step of the impairment test for all reporting units, and concluded that no impairment had occurred.

Due to the divestiture of our credit services business in the third quarter of fiscal 2013, which caused the allocation of $241 million of goodwill from the BSS-Financial Services (BSS-FS) reporting unit to that disposed business, we assessed the goodwill remaining on the BSS-FS balance sheet for potential impairment. The Company performed the first step of the two-step of the goodwill impairment test and concluded that the goodwill remaining on the BSS-FS balance sheet, after allocation of goodwill to the divested business, was not impaired.

During the fourth quarter of fiscal 2013, the Company assessed whether there were events or change in circumstances that would more likely than not reduce the fair value of any of its reporting units below their carrying amounts. The Company considered, among other factors, any significant changes in the Company's fiscal 2013 forecast since the annual impairment test was performed, the outlook for the Company's business and industry, including the impact of sequestration by the U.S. federal government, the Company's market capitalization, and the current economic environment and outlook. Based on that assessment, the Company determined that there have been no events or changes in circumstances that would more likely than not reduce the fair value of any of its reporting units below their carrying amounts, and, as a result, it was unnecessary to perform the first step of the two-step impairment testing process as of March 29, 2013. Any adverse changes in the business climate or in CSC's operating results could result in the need to perform additional impairment analyses of goodwill prior to the next annual test, which may result in impairment charges. 

In fiscal 2012, the Company initiated its annual goodwill analysis in the second quarter and concluded that fair value was below carrying value for three reporting units: MSS, Global Business Solutions (BSS-GBS) and the Healthcare Group (BSS-Health). Management believed that the decline in the estimated fair values of these reporting units during the second quarter was a result of a number of factors, including: the significant decline in the Company’s overall stock price over the first six months of fiscal 2012; an overall decline in the broader stock market which resulted in reduced performance metric multiples at comparable public companies; uncertainty caused by concerns about the ongoing SEC investigation into reported errors and irregularities; concerns about the Company’s growth prospects in light of operational issues at its MSS reporting unit; uncertainty over the continuation of the Company’s NHS contract in light of comments made by government officials in the U.K.; and government budget pressures on customers worldwide. Lower than forecast operating performance also impacted the reporting units’ fair value calculations. Prior to the second quarter of fiscal 2012, the Company's stock price declines were considered temporary. In addition, an evaluation of historical and forecast operating results did not indicate it was more likely than not that the fair value of any reporting unit had fallen below carrying value, and therefore no interim goodwill impairment test was warranted prior to the second quarter.

At the end of the second quarter and subsequent to the date of the annual goodwill impairment test, the Company determined that sufficient indicators existed to require performance of an additional interim goodwill impairment analysis as of September 30, 2011. These indicators included: a further significant and sustained decline in CSC’s stock price which resulted in a market capitalization, adjusted for control premium, decreasing to an amount less than book value and remaining there for some time; further decreases in the performance metric multiples of comparable public companies, driving the market approach valuations lower; and additional evidence of certain reporting units’ performance which fell short of forecasts used in the annual market- and income-based tests. In this interim goodwill impairment test, the BSS-GBS reporting unit again failed step one of the two-step test.

During the process of conducting the second step of the annual goodwill impairment tests, the Company identified significant previously unrecognized intangible assets, primarily relating to customer relationships and technology. The unrecognized intangible assets, estimated at approximately $1.3 billion, were predominantly attributable to unrecognized customer relationship assets in the MSS reporting unit and were driven by the Company’s high customer retention rates in this business. The combination of these previously unrecognized intangible assets and other unrecognized fair value changes to the carrying values of other assets and liabilities, together with the lower reporting unit fair values calculated in step one, resulted in an implied fair value of goodwill substantially below the carrying value of goodwill for the MSS, BSS-GBS and BSS-Health reporting units. As a result, the Company recorded its best estimate of the goodwill impairment charge of $2,685 million, of which $2,074 million related to the MSS reporting unit, $453 million related to the BSS-GBS reporting unit, and $158 million related to the BSS-Health reporting unit. As of September 30, 2011, MSS had $143 million of remaining goodwill, which was all attributable to the fiscal 2012 second-quarter acquisition of AppLabs (see Note 4). The BSS-GBS reporting unit had no remaining goodwill, and the BSS-Health reporting unit had $60 million of remaining goodwill.

The September 30, 2011 interim goodwill tests indicated that the fair values of two additional reporting units—BSS-Health and BSS-iSOFT—passed step one (after the impairment charges discussed above) but were not considered to be substantially in excess of carrying values. BSS-Health fair value was estimated to be approximately 6% in excess of carrying value, and as noted above had a remaining goodwill balance, after impairments recorded in the second quarter, of $60 million at September 30, 2011, including $18 million that was allocated from the iSOFT acquisition. BSS-iSOFT, which was acquired during the second quarter (see Note 4) was a new reporting unit in fiscal 2012, and its estimated fair value approximated its carrying value due to the proximity of its acquisition to the date of the interim goodwill impairment test.

During the third quarter of fiscal 2012, the Company completed all analyses related to its annual and second quarter interim goodwill impairment tests and reduced the impairment loss recorded in the second quarter by $3 million. The entire adjustment was in the BSS-Health reporting unit, and resulted from finalizing tax estimates and customer/technology asset fair values. Thus, the total second quarter goodwill impairment loss was $2,682 million, with ($3 million) of it recorded in the third quarter.

At the end of the third quarter of fiscal 2012, the Company assessed whether there were any events or circumstances that would more likely than not reduce the fair value of a reporting unit below its carrying value. The Company concluded that such indicators were present for two of its fiscal 2012 reporting units, BSS-Health and BSS-iSOFT. With respect to BSS-Health, the loss of a significant customer, the failure to win some major bids for new business, and reduction in forecasted earnings was considered a triggering event for an interim goodwill impairment test. For BSS-iSOFT, the recent developments on the NHS contract were considered a triggering event (see Note 18). There were no triggering events for the remaining reporting units with goodwill.

In conducting step one of the goodwill impairment test for the BSS-Health reporting unit in the third quarter of fiscal 2012, the factors stated above resulted in a reassessment of forecasted cash flow assumptions under an income approach, as well as a revised valuation using a market-multiples fair value approach, which resulted in the weighted-average fair value of the reporting unit being lower than its carrying value. This required the Company to perform the second step of the two-step test process, as noted below. For the BSS-iSOFT reporting unit, the weighted-average fair value was estimated to be greater than its carrying value due to better-than-forecast performance by the core iSOFT business, and step two of the impairment assessment was not required.

During the process of conducting step two of the interim goodwill impairment test for BSS-Health, the Company estimated the fair value of its tangible assets and the unrecognized intangible assets, primarily customer relationship and technology assets, and recorded an impairment charge of $63 million. As a result, as of December 30, 2011, the BSS-Health reporting unit had no remaining goodwill.

The Company tested its long-lived assets for impairment in conjunction with the annual and the second and third quarter interim goodwill impairment tests and concluded that these assets were not impaired.

At the end of the fourth quarter of 2012, the Company assessed whether there were events or change in circumstances that would more likely than not reduce the fair value of any of its reporting units below their carrying amounts. There were no such indicators for any of the reporting units with goodwill, and therefore, an interim goodwill test was not required.

XML

Stockholders' Equity Dividends Disclosure (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Stockholders' Equity Attributable to Parent [Abstract]
Common Stock, Dividends, Per Share, Declared	$ 0.8	$ 0.80	$ 0.70
Dividends declared	$ 123	$ 124
Dividends declared not paid	$ 30	$ 31

XML

Commitments and Contingencies (Guarantor Obligations) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013
Guarantor Obligations [Line Items]
Line of credit, term	1 year
Fiscal 2014	$ 124
Fiscal 2015	134
Fiscal 2016 and thereafter	47
Total	305
Outstanding letters of credit and surety bonds against performance guarantees [Member]
Guarantor Obligations [Line Items]
Guarantee obligations maximum exposure	122
Surety Bonds [Member]
Guarantor Obligations [Line Items]
Fiscal 2014	29
Fiscal 2015	1
Fiscal 2016 and thereafter	0
Total	30
Letters of credit [Member]
Guarantor Obligations [Line Items]
Fiscal 2014	58
Fiscal 2015	1
Fiscal 2016 and thereafter	33
Total	92
Standby letters of credit [Member]
Guarantor Obligations [Line Items]
Guarantee obligations maximum exposure	183
Fiscal 2014	37
Fiscal 2015	132
Fiscal 2016 and thereafter	14
Total	$ 183

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Income Statement [Abstract]
Revenues	$ 14,993	$ 15,364	$ 15,582
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs of $238 (2013) and $137 (2012))	11,851	13,019	12,578
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	0	1,281	0
Cost of services – settlement charge (excludes amount charged to revenue of $42)	0	227	0
Selling, general and administrative (excludes restructuring costs of $26 (2013) and $3 (2012))	1,195	1,128	949
Depreciation and amortization	1,076	1,147	1,068
Goodwill impairment	0	2,745	0
Restructuring costs	264	140	0
Interest expense	183	175	167
Interest income	(22)	(38)	(37)
Other income, net	(34)	(6)	(21)
Total costs and expenses	14,513	19,818	14,704
Income (loss) from continuing operations before taxes	480	(4,454)	878
Taxes on income	(35)	(84)	202
Income (loss) from continuing operations	515	(4,370)	676
Income from discontinued operations, net of taxes	464	145	83
Net income (loss)	979	(4,225)	759
Less:
Net income attributable to noncontrolling interest, net of tax	18	17	19
Net income (loss) attributable to CSC common stockholders	$ 961	$ (4,242)	$ 740
Earnings (loss) per common share - Basic:
Continuing operations (in dollars per share)	$ 3.22	$ (28.31)	$ 4.25
Discontinued operations (in dollars per share)	$ 3.00	$ 0.94	$ 0.54
Basic EPS (in dollars per share)	$ 6.22	$ (27.37)	$ 4.79
Earnings (loss) per common share - Diluted:
Continuing operations (in dollars per share)	$ 3.20	$ (28.31)	$ 4.20
Discontinued operations (in dollars per share)	$ 2.98	$ 0.94	$ 0.53
Diluted EPS (in dollars per share)	$ 6.18	$ (27.37)	$ 4.73
Cash dividend per common share (in dollars per share)	$ 0.8	$ 0.80	$ 0.70

XML

Discontinued operations

12 Months Ended

Mar. 29, 2013

Discontinued operations [Abstract]

Discontinued operations

Divestitures

Discontinued Operations

During fiscal 2013, CSC completed the divestiture of three businesses within its BSS Segment: the U.S.-based credit services business, the Italian consulting and system integration business, and an enterprise systems integration business in Malaysia and Singapore. These divestitures reflect the Company's ongoing service portfolio optimization initiative to focus on next-generation technology services and are presented in the Company's Consolidated Statements of Operations as discontinued operations.

The Company received cash proceeds of $1,001 million for the sale of its U.S. based credit services business, including a $1 million working capital adjustment. For its sale of the enterprise system integration business, the Company received $90 million in cash and expects to receive another $14 million for working capital and other adjustments. For the disposal of its Italian consulting and system integration business, the Company paid $35 million (plus $8 million of cash included in the divested entity's net assets sold), but expects to receive $6 million back from the buyer for a purchase price adjustment. Both the $14 million and $6 million described above were recorded as receivables.

These three divestitures resulted in a total pre-tax gain of $769 million (after-tax gain of $417 million), representing the excess of the net proceeds over the carrying value of the net assets of the divested businesses and transaction costs of $11 million. The divested assets and liabilities included current assets of $129 million, property and equipment and other long-lived assets of $11 million, goodwill of $241 million, and liabilities of $85 million.

During fiscal 2012, CSC recorded a pre-tax loss from discontinued operations of $2 million to reflect purchase price adjustments in accordance with the purchase agreement related to the fourth quarter fiscal 2011 divestiture discussed below. In fiscal 2012, CSC also recorded a $3 million adjustment to the taxes on gain on discontinued operations recorded in fiscal 2011. The adjustment reflects a change in the estimated tax provision made in fiscal 2011.

During fiscal 2011, CSC completed the divestiture of two businesses within its NPS segment whose ultimate customer was the U.S. federal government. One divestiture resulted in cash consideration of $56 million, and the second divestiture resulted in cash consideration of $65 million, of which $63 million was received in fiscal 2011 and the remaining $2 million was collected in fiscal 2012. Both of the divestitures were driven by the Governmental Organizational Conflict of Interest concerns. The divestitures resulted in total pre-tax gains of $59 million (after-tax gains of approximately $28 million) representing the excess of the proceeds over the carrying value of the net assets of the divested businesses (which included current assets of $38 million, property and equipment and other long-lived assets of $8 million, goodwill of $23 million, liabilities of $12 million), net of transaction costs of $5 million.

Following is the summary of the results of the discontinued operations:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012			April 1, 2011
Operations
Revenue	$	395	$	513		$	562
Income from discontinued operations, before taxes	84		107			100
Tax expense (benefit)	37		(37		)	45
Net income from discontinued operations	47		144			55
Disposal
Gain (loss) on disposition	$	769	$	(2	)	$	59
Tax expense (benefit)	352		(3		)	31
Gain on disposition, net of taxes	417		1			28
Income from discontinued operations, net of taxes	$	464	$	145		$	83

In fiscal 2013, the primary difference between the book and tax gain on the sale of the U.S.-based credit services business was the write-off of approximately $241 million of goodwill, a majority of which was non-deductible for tax purposes. The income tax expense recorded includes an allocation of a deferred tax charge related to such goodwill. In addition, there was a significant tax benefit realized on the divestment of the Italian consulting and system integration business. The gain from the sale of the enterprise systems integration business in Malaysia and Singapore was exempt from income tax. In fiscal 2011, the primary difference between the book and tax gain on the sale of an NPS business was related to goodwill that was not tax deductible for tax purposes.

For fiscal 2012, discontinued operations reflects a tax benefit of approximately $82 million due to the change in tax status of one of the Company's foreign subsidiaries. This change in tax status resulted in a deemed liquidation for U.S. tax purposes and triggered various deductions which resulted in an income tax benefit. This benefit was allocable to discontinued operations as such foreign subsidiary was disposed of during the current fiscal year.

Other Divestiture

In fiscal year 2013, the Company also sold Paxus, its Australian information technology staffing business unit, which was included in the Company's BSS Segment. This divestiture did not qualify to be presented as discontinued operations due to CSC's significant continuing business relationship with the divested entity.

The total consideration for this divestiture was $79 million, of which $63 million was received in cash and $16 million was recorded as a receivable. This sale resulted in a pre-tax gain of $38 million, representing the excess of the proceeds over the carrying value of the net assets divested, net of transaction costs of $3 million. The divested assets and liabilities included current assets of $41 million, property and equipment and other long-lived assets of $2 million, and liabilities of $5 million. There was no tax expense or benefit on the gain on sale of Paxus because the Company had sufficient capital losses in its Australian business unit to completely offset the capital gain.

XML

Investigations and Out of Period Adjustments

12 Months Ended

Mar. 29, 2013

Out of period adjustments [Abstract]

Investigations and Out of Period Adjustments

Investigations and Out of Period Adjustments

Summary of Audit Committee and SEC Investigations Related to the Out of Period Adjustments

As previously disclosed in fiscal 2012 and fiscal 2011, the Company initiated an investigation into out of period adjustments resulting from certain accounting errors in our Managed Services Sector (MSS) segment, primarily involving accounting irregularities in the Nordic region. Initially, the investigation was conducted by Company personnel, but outside Company counsel and forensic accountants retained by such counsel later assisted in the Company's investigation. On January 28, 2011, the Company was notified by the SEC's Division of Enforcement that it had commenced a formal civil investigation relating to these matters, which investigation has been expanded to other matters subsequently identified by the SEC, including matters specified in subpoenas issued to the Company from time to time by the SEC's Division of Enforcement as well as matters under investigation by the Audit Committee, as further described below. The Company is cooperating in the SEC's investigation.

On May 2, 2011, the Audit Committee commenced an independent investigation into the matters relating to the MSS segment and the Nordic region, matters identified by subpoenas issued by the SEC's Division of Enforcement, and certain other accounting matters identified by the Audit Committee and retained independent counsel to represent CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with such independent investigation. Independent counsel retained forensic accountants to assist with their work. Independent counsel also represents CSC on behalf of, and under the exclusive direction of, the Audit Committee in connection with the investigation by the SEC's Division of Enforcement.

The Audit Committee’s investigation was expanded to encompass (i) the Company’s operations in Australia, (ii) certain aspects of the Company’s accounting practices within its Americas Outsourcing operation, and (iii) certain of the Company’s accounting practices that involve the percentage-of-completion accounting method, including the Company’s contract with the U.K. National Health Service (NHS). In the course of the Audit Committee's expanded investigation, accounting errors and irregularities were identified. As a result, certain personnel have been reprimanded, suspended, terminated and/or have resigned. The Audit Committee determined in August 2012 that its independent investigation was complete. The Audit Committee instructed its independent counsel to cooperate with the SEC's Division of Enforcement by completing production of documents and providing any further information requested by the SEC's Division of Enforcement.

In addition to the matters noted above, the SEC's Division of Enforcement is continuing its investigation involving its concerns with certain of the Company's prior disclosure and accounting determinations with respect to the Company's contract with the NHS and the possible impact of such matters on the Company's financial statements for years prior to the Company's current fiscal year. The Company and the Audit Committee and its independent counsel are investigating these matters and are continuing to cooperate with the SEC's Division of Enforcement in its investigation of prior disclosures of the Company's contract with the NHS. The SEC's investigative activities are ongoing.

In addition, the SEC's Division of Corporation Finance has issued comment letters to the Company requesting, among other things, additional information regarding its previously disclosed adjustments in connection with the above-referenced accounting errors, the Company's conclusions relating to the materiality of such adjustments, and the Company's analysis of the effectiveness of its disclosure controls and procedures and its internal control over financial reporting. The SEC's Division of Corporation Finance's comment letter process is ongoing, and the Company is continuing to cooperate with that process.

The investigation being conducted by the SEC's Division of Enforcement and the review of our financial disclosures by the SEC's Division of Corporation Finance are continuing and could identify other accounting errors, irregularities or other areas of review. As a result, we have incurred and may continue to incur significant legal and accounting expenditures. We are unable to predict how long the SEC's Division of Enforcement's investigation will continue or whether, at the conclusion of its investigation, the SEC will seek to impose fines or take other actions against the Company. In addition, we are unable to predict the timing of the completion of the SEC's Division of Corporation Finance's review of our financial disclosures or the outcome of such review. Publicity surrounding the foregoing or any enforcement action as a result of the SEC's investigation, even if ultimately resolved favorably for us, could have an adverse impact on the Company's reputation, business, financial condition, results of operations or cash flows. The Company is unable to estimate any possible loss or range of loss associated with these matters.

Out of Period Adjustments Financial Impact Summary

Cumulative Impact of Out of Period Adjustments

The rollover impact on income (loss) from continuing operations before taxes of the recorded out of period adjustments in fiscal 2013, 2012 and 2011 is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2011 Adjustments			Fiscal 2012 Adjustments			Fiscal 2013 Adjustments			Total Adjustments
Fiscal 2013	$	—		$	—		$	6		$	6
Fiscal 2012	—			79			7			86
Fiscal 2011	52			(29		)	(22		)	1
Fiscal 2010	(48		)	(9		)	14			(43		)
Prior fiscal years (unaudited)	(4		)	(41		)	(4		)	(49		)

See Note 16 for a summary of the effect of the pre-tax out of period adjustments on the Company's segment results for fiscal 2013, 2012 and 2011.

Fiscal 2013 Adjustments Financial Impact Summary

During fiscal 2013, the Company identified and recorded net adjustments decreasing income from continuing operations before taxes by $6 million that should have been recorded in prior fiscal years. This net impact on income from continuing operations before taxes for fiscal 2013 is comprised of the following:

• net adjustments decreasing fourth quarter pre-tax income by $9 million resulting primarily from the correction of inappropriately capitalized operating costs originating from MSS, a software revenue recognition correction originating from the Company's Business Solutions and Services (BSS) segment and the correction of understated payroll and related expenses at Corporate;

• net adjustments decreasing third quarter pre-tax income by $1 million primarily resulting from the correction of useful lives of property and equipment in service at a BSS contract that were inconsistent with established CSC accounting conventions;

• net adjustments increasing second quarter pre-tax income by $5 million primarily resulting from the correction of accounting errors identified by the Company related to costs incurred under the NHS contract (see below for more discussion of out of period adjustments related to the Company's NHS contract); and

• net adjustments decreasing first quarter pre-tax income by $1 million primarily resulting from the corrections of fiscal 2012 revenue recognized on a software contract in the Company's BSS segment, corrections of fiscal 2012 restructuring cost accruals originating primarily from the Company's BSS and MSS segments and corrections to record adjustments originating primarily from the Company's North American Public Sector (NPS) and MSS segments that were identified late in the close process but not included in the Company's consolidated fiscal 2012 financial statements

Adjustments recorded during fiscal 2013 that should have been recorded in prior fiscal years increased income from continuing operations by $7 million. This increase is attributable to the tax effect of the adjustments described above and $5 million of discrete tax benefits that should have been recorded in prior fiscal years. The discrete tax benefits are primarily attributable to the adjustment of the deferred tax liability related to intellectual property assets.

NHS

As previously disclosed in fiscal 2012 and in the first quarter of fiscal 2013, the Company had identified certain additional items related to the investigation of the Company's use of the percentage-of-completion accounting method used on the NHS contract. During the second quarter of fiscal 2013, based on its analysis of these items, the Company recorded net credits of $9 million in pre-tax out of period adjustments impacting prior fiscal years. During the third quarter of fiscal 2013, the Company identified additional prior period errors. Such errors identified in the third quarter, which were self-correcting in the third quarter of fiscal 2012, have no impact on income from continuing operations before taxes for fiscal 2013. The accounting errors identified during fiscal 2013 are primarily related to either costs incurred under the contract or the estimation of contract revenues and costs at completion, which resulted in the overstatement of income from continuing operations before taxes. The Company has concluded that there is no cumulative impact of this overstatement as a result of the $1.5 billion specified contract charge recorded as of December 30, 2011 being overstated by the same amount.

The Company has concluded that the errors identified during fiscal 2013 do not appear to have any impact on amounts charged to the NHS. Based on information provided by independent counsel, the Company believes that a small portion of such adjustments should be characterized as intentional accounting irregularities. The impact on income (loss) from continuing operations before taxes of the out of period adjustments identified in fiscal 2013 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2013 Adjustments
Fiscal 2013	$	(9	)
Fiscal 2012	10
Fiscal 2011	(15		)
Fiscal 2010	18
Prior fiscal years (unaudited)	(4		)

The following table summarizes the cumulative effect on net income attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2013 under the rollover method. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2013, but had no net impact on the full year fiscal 2013 results:

	Fiscal 2013
	Quarter Ended
(Amounts in millions)	June 29, 2012			September 28, 2012			December 28, 2012			March 29, 2013			Total
NHS adjustments	$	—		$	(9	)	$	—		$	—		$	(9	)
Other adjustments	3			12			4			(4		)	15
Effect on income from continuing operations before taxes	3			3			4			(4		)	6
Taxes on income	(2		)	(1		)	(4		)	(1		)	(8		)
Other income tax adjustments	(2		)	—			(2		)	(1		)	(5		)
Effect on income from discontinued operations, net of taxes	—			—			(28		)	28			—
Effect on net income attributable to CSC common shareholders	$	(1	)	$	2		$	(30	)	$	22		$	(7	)

Out of period adjustments recorded in fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 29, 2013 under the rollover method:

	Twelve Months Ended March 29, 2013
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	14,993		14			$	15,007
Costs of services (excludes depreciation and amortization and restructuring costs)	11,851			6			11,857
Selling, general and administrative (excluding restructuring costs)	1,195			(1		)	1,194
Depreciation and amortization	1,076			(2		)	1,074
Restructuring costs	264			5			269
Interest expense	183			—			183
Other (income) expense	(34		)	—			(34		)
Income from continuing operations before taxes	480			6			486
Taxes on income	(35		)	13			(22		)
Income from continuing operations	515			(7		)	508
Income from discontinued operations, net of taxes	464			—			464
Net income attributable to CSC common shareholders	961			(7		)	954
EPS – Diluted
Continuing operations	$	3.20		$	(0.04	)	$	3.16
Discontinued operations	2.98			—			2.98
Total	$	6.18		$	(0.04	)	$	6.14

The out of period adjustments affecting income from continuing operations before taxes during the twelve months ended March 29, 2013 under the rollover method are related to the following consolidated balance sheet line items:

• Accounts receivable ($1 milliondecrease);

• Prepaid expenses and other current assets ($15 millionincrease);

• Outsourcing contract costs ($1 milliondecrease);

• Other assets ($6 milliondecrease);

• Property and equipment ($5 milliondecrease);

• Accrued payroll and related costs ($9 millionincrease);

• Accrued expenses and other current liabilities ($12 milliondecrease); and

• Deferred revenue ($13 millionincrease).

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2013 is immaterial to the consolidated results, financial position and cash flows for fiscal 2013 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2013.

Fiscal 2012 Adjustments Financial Impact Summary

As previously disclosed, during fiscal 2012, the Company recorded various pre-tax adjustments that should have been recorded in prior fiscal years. The aggregate fiscal 2012 adjustments increased the loss from continuing operations before taxes by $79 million ($63 million net of tax) and were comprised of $13 million of charges relating to operations in the Nordic region, $23 million of charges relating to the Company's operations in Australia, and $25 million of charges originating from the NHS contract in the Company's BSS segment. Additionally, $16 million and $2 million of charges were recorded in the NPS segment and other operations of the Company, respectively. The fiscal 2012 out of period adjustments primarily related to the Company’s MSS and BSS segments, with $37 million and $26 million of adjustments within MSS and BSS, respectively. Further adjustments were identified and recorded in fiscal 2013 related to fiscal 2012 that increased the net error by $7 million.

Nordic Region

The Company attributes the $13 million in pre-tax adjustments recorded in the Nordic region in fiscal 2012 to miscellaneous errors and not to any accounting irregularities or intentional misconduct other than a $1 million operating lease adjustment noted in the first quarter of fiscal 2012 which was a refinement of an error previously corrected and reported in fiscal 2011.

Australia

As previously disclosed, in the course of the Australia investigation initiated in fiscal 2012, accounting errors and irregularities were identified. As a result, certain personnel in Australia have been reprimanded, terminated and/or resigned. The Company attributes the $23 million of pre-tax adjustments recorded in fiscal 2012 to either intentional accounting irregularities (intentional irregularities) or other accounting errors (Other Errors). Other Errors include both unintentional errors and errors for which the categorization is unclear. The categorizations were provided to the Company through the independent investigation. The impact of the adjustments on income (loss) from continuing operations before taxes is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2008 & Prior (unaudited)			Fiscal 2009 (unaudited)			Fiscal 2010			Fiscal 2011			Total
Intentional irregularities	$	10		$	(7	)	$	(4	)	$	1		$	—
Other Errors	(7		)	(16		)	3			(3		)	(23		)
	$	3		$	(23	)	$	(1	)	$	(2	)	$	(23	)

NHS

As previously disclosed, in fiscal 2012, $25 million of out of period adjustments reducing income from continuing operations related to the Company's NHS contract were identified and recorded. During the course of the investigation in fiscal 2012 of the percentage-of-completion accounting method used on the Company's NHS contract, certain accounting errors were identified related to costs incurred under the contract, which resulted in errors in the recognition of income from continuing operations that would have reduced by approximately $24 million the $1.5 billion write-off recorded by the Company in the third quarter of fiscal 2012. Although the Company has concluded that these errors do not appear to have any impact on amounts charged to the NHS, the errors have impacted the operating income recognized on the NHS contract. The exclusion of certain costs incurred under the contract caused the estimated margin at completion, which determines the operating income that is booked when revenue milestones are achieved, to be overstated. Although the Company has concluded that there is no cumulative impact as a result of the $1.5 billion charge relating to the NHS contract recorded as of December 30, 2011, operating income from fiscal year 2007 through and including fiscal 2011 has been overstated by a total of approximately $24 million and, therefore, the charge taken by the Company as of December 30, 2011 was overstated by approximately the same amount.

Certain additional items had been identified related to the NHS contract that could have had an effect on the amount and the allocation of the out of period adjustments for fiscal 2012 and prior fiscal years. These additional items were subject to further investigation and therefore were not recorded in fiscal 2012. See our discussion of fiscal 2013 adjustments above for further information regarding the impact of such items.

Certain CSC finance employees based in the U. K. were aware prior to fiscal 2012 of the aforementioned errors, but those employees failed to appropriately correct the errors. Therefore, the Company has classified these errors as intentional. Such categorization was provided to the Company through the independent investigation. As a result, certain personnel have been suspended.

The impact on income (loss) from continuing operations before taxes of the $25 million of out of period adjustments identified in fiscal 2012 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2012 Adjustments
Fiscal 2012	$	25
Fiscal 2011	(7		)
Fiscal 2010	(4		)
Prior fiscal years (unaudited)	(14		)

NPS

As previously reported, in fiscal 2012 the Company identified and recorded pre-tax adjustments reducing income from continuing operations before taxes by $16 million. Such adjustments were identified by the Company and were primarily related to the percentage-of-completion accounting adjustments.

Americas Outsourcing

As previously disclosed, in the course of the independent investigation of Americas Outsourcing accounting practices, accounting conventions used by Americas Outsourcing relating to intraperiod cost allocations were determined to be unintentional accounting errors. The errors did not have an impact on a fiscal year basis. The Company also determined that other operating units employed similar practices and made necessary corrections.

The following table summarizes the cumulative effect on the fiscal 2012 net loss attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2012 and fiscal 2013 under the rollover method. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2012, but had no net impact on the full year fiscal 2012 results:

	Fiscal 2012
	Quarter Ended
(Amounts in millions)	July 1, 2011			September 30, 2011			December 30, 2011			March 30, 2012			Total
Operating costs inappropriately capitalized	$	1		$	—		$	—		$	—		$	1
Misapplication of US GAAP	1			(1		)	2			(1		)	1
Miscellaneous errors	2			7			—			2			11
Total Nordic adjustments	4			6			2			1			13
Operating costs inappropriately capitalized	—			11			—			—			11
Misapplication of US GAAP	—			8			—			1			9
Miscellaneous errors	—			2			2			(1		)	3
Total Australia adjustments	—			21			2			—			23
NHS adjustments	(2		)	(2		)	46			(7		)	35
NPS adjustments	3			1			(5		)	11			10
Other adjustments	2			(11		)	5			9			5
Effect on income (loss) from continuing operations before taxes	7			15			50			14			86
Taxes on income	(2		)	(3		)	(2		)	(4		)	(11		)
Other income tax adjustments	1			14			(10		)	(5		)	—
Effect on net income (loss) attributable to CSC common shareholders	$	6		$	26		$	38		$	5		$	75

Out of period adjustments recorded during fiscal 2012 and fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 30, 2012 under the rollover method:

	Twelve Months Ended March 30, 2012
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,364		$	56		$	15,420
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs)	13,019			(27		)	12,992
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	1,281			3			1,284
Selling, general and administrative (excludes restructuring costs)	1,128			2			1,130
Depreciation and amortization	1,147			(2		)	1,145
Restructuring costs	140			(5		)	135
Interest expense	175			(3		)	172
Other (income) expense	(6		)	2			(4		)
Loss from continuing operations before taxes	(4,454		)	86			(4,368		)
Taxes on income	(84		)	11			(73		)
Loss from continuing operations	(4,370		)	75			(4,295		)
Income from discontinued operations, net of taxes	145			—			145
Net loss attributable to CSC common shareholders	(4,242		)	75			(4,167		)
EPS – Diluted
Continuing operations	$	(28.31	)	$	0.48		$	(27.83	)
Discontinued operations	0.94						0.94
Total	$	(27.37	)	$	0.48		$	(26.89	)

The out of period adjustments affecting loss from continuing operations before taxes during the twelve months ended March 30, 2012 under the rollover method are related to the following consolidated balance sheet line items:

• Accounts receivable ($66 milliondecrease);

• Prepaid expenses and other current assets ($44 millionincrease);

• Other assets ($6 millionincrease);

• Property and equipment ($29 milliondecrease);

• Accrued payroll and related costs ($2 milliondecrease);

• Accrued expenses and other current liabilities ($46 millionincrease); and

• Deferred revenue ($3 milliondecrease).

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2012 and fiscal 2013 is immaterial to the consolidated results, financial position and cash flows for fiscal 2012 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2012 and fiscal 2013.

Fiscal 2011 Adjustments Financial Impact Summary

As previously reported, during fiscal 2011, the Company recorded $52 million of pre-tax adjustments that should have been recorded in prior fiscal years. The total out of period adjustments recorded in fiscal 2011 were comprised of $92 million of charges reducing income from continuing operations before taxes originating out of the Company’s MSS operations in the Nordic region, and $40 million of adjustments increasing income from continuing operations before taxes, with $36 million of the $40 million within MSS. Further adjustments were identified and recorded in fiscal 2012 and 2013 related to fiscal 2011 that reduced the net error by $29 million and $22 million, respectively.

Nordic Region

As noted above, during fiscal 2011, the Company commenced an investigation into accounting irregularities in the Nordic region. Based upon the Company's investigation, review of underlying documentation for certain transactions and balances, review of contract documentation and discussions with Nordic personnel, the Company attributes the majority of the $92 million of pre-tax adjustments recorded in the Nordic region in fiscal 2011 to accounting irregularities arising from suspected intentional misconduct by certain former employees in our Danish subsidiaries. These accounting irregularities included the inappropriate capitalization of operating costs, the misapplication of U.S. GAAP and miscellaneous errors.

The following table summarizes the cumulative effect on the fiscal 2011 net income attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2011, 2012 and 2013. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2011, but had no net impact on the full year fiscal 2011 results:

	Fiscal 2011
	Quarter Ended
(Amounts in millions)	July 2, 2010			October 1, 2010			December 31, 2010			April 1, 2011			Total
Operating costs inappropriately capitalized	$	15		$	38		$	8		$	6		$	67
Misapplication of US GAAP	4			3			6			(1		)	12
Miscellaneous errors	1			(1		)	9			(2		)	7
Total Nordic adjustments	20			40			23			3			86
Operating costs inappropriately capitalized	—			(1		)	(1		)	—			(2		)
Misapplication of US GAAP	—			1			3			(1		)	3
Miscellaneous errors	(4		)	5			(2		)	(3		)	(4		)
Total Australia adjustments	(4		)	5			—			(4		)	(3		)
NHS adjustments	(10		)	(2		)	(5		)	(5		)	(22		)
NPS adjustments	4			2			(10		)	(7		)	(11		)
Other adjustments	(9		)	(8		)	(18		)	(14		)	(49		)
Effect on income from continuing operations before taxes	1			37			(10		)	(27		)	1
Taxes on income	4			1			9			10			24
Other income tax adjustments	(1		)	(13		)	(6		)	18			(2		)
Effect on net income attributable to CSC common shareholders	$	4		$	25		$	(7	)	$	1		$	23

Out of period adjustments recorded during fiscal 2011, 2012 and 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended April 1, 2011 under the rollover method:

	Twelve Months Ended April 1, 2011
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,582		$	1		$	15,583
Costs of services (excludes depreciation and amortization)	12,578			(4		)	12,574
Selling, general and administrative	949			1			950
Depreciation and amortization	1,068			3			1,071
Interest expense	167			—			167
Other (income) expense	(21		)	—			(21		)
Income from continuing operations before taxes	878			1			879
Taxes on income	202			(22		)	180
Income from continuing operations	676			23			699
Income from discontinued operations, net of taxes	83			—			83
Net income attributable to CSC common shareholders	740			23			763
EPS – Diluted
Continuing operations	$	4.20		$	0.15		$	4.35
Discontinued operations	0.53			—			0.53
Total	$	4.73		$	0.15		$	4.88

The Company has determined that the impact of the consolidated out of period adjustments recorded in fiscal 2013, 2012, and 2011 is immaterial to the consolidated results, financial position and cash flows for fiscal 2011 and prior years. Consequently, the cumulative effect of these adjustments was recorded during fiscal 2011.

XML

Stock Incentive Plans

12 Months Ended

Mar. 29, 2013

Stock Incentive Plans

Stock Incentive Plans

Stock Incentive Plans

Employee Incentives

The Company has three stock incentive plans which authorize the issuance of stock options, restricted stock and other stock-based incentives to employees upon terms approved by the Compensation Committee of the Board of Directors. The Company issues authorized but previously unissued shares upon the exercise of stock options, the granting of restricted stock awards and the settlement of restricted stock units (RSUs). There were no restricted stock awards outstanding in fiscal years 2013, 2012 and 2011. As of March 29, 2013, 11,977,359 shares of CSC common stock were available for the grant of future stock options, restricted stock or other stock-based incentives to employees. See Stock-Based Compensation section of Note 1 for further details.

Stock Options

The Company’s standard vesting schedule for stock options is one-third on each of the first three anniversaries of the grant date. Stock options are generally granted for a term of ten years. Information concerning stock options granted under stock incentive plans during fiscal 2013, fiscal 2012, and fiscal 2011 is as follows:

	Number of Option Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value (In millions)
Outstanding as of April 2, 2010	17,008,397		$	46.36	5.58	$	141
Granted	2,818,874		48.23
Exercised	(1,868,544	)	40.61			22
Canceled/Forfeited	(324,612	)	46.00
Expired	(573,922	)	55.52
Outstanding as of April 1, 2011	17,060,193		47.00		5.54	69
Granted	2,457,509		38.18
Exercised	(428,844	)	35.95			5
Canceled/Forfeited	(579,069	)	41.75
Expired	(776,227	)	49.05
Outstanding as of March 30, 2012	17,733,562		46.13		5.08	1
Granted	3,707,172		27.46
Exercised	(1,497,686	)	39.27			10
Canceled/Forfeited	(1,113,422	)	35.36
Expired	(3,689,059	)	45.28
Outstanding as of March 29, 2013	15,140,567		43.23		5.45	113
Vested and expected to vest in the future as of March 29, 2013	14,885,162		43.47		5.38	108
Exercisable as of March 29, 2013	10,694,088		47.92		4.05	36

	March 29, 2013
	Options Outstanding				Options Exercisable
Range of Option Exercise Price	Number Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Number Exercisable	Weighted Average Exercise Price
$23.06-$39.04	5,269,835	$	31.56	7.79	1,392,011	$	36.87
$39.11-$48.61	6,075,780	45.73		4.77	5,531,586	45.82
$48.65-$60.25	3,794,952	55.06		3.27	3,770,491	55.08
	15,140,567				10,694,088

The total grant date fair value of stock options vested during fiscal 2013, fiscal 2012, and fiscal 2011, was $20 million, $27 million, and $40 million, respectively. The cash received from stock options exercised during fiscal 2013, fiscal 2012, and fiscal 2011, was $55 million, $15 million, and $73 million, respectively.

As of March 29, 2013, there was $27 million of unrecognized compensation expense related to unvested stock options, net of expected forfeitures. The cost is expected to be recognized over a weighted-average period of 1.91 years.

Restricted Stock Units

RSUs consist of equity awards with the right to receive one share of common stock of the Company issued at a price of $0. Upon the settlement date, RSUs are settled in shares of CSC common stock and dividend equivalents. If, prior to the vesting of the RSU in full, the employee’s status as a full-time employee is terminated, then the RSU is automatically canceled on the employment termination date and any unvested shares are forfeited.

The Company grants RSUs with service and performance-based vesting terms. Service-based RSUs, generally vest over periods of three to five years. The number of performance-based RSUs that ultimately vest is dependent upon the Company’s achievement of certain specified performance criteria over a three-year period. Awards are settled for shares of CSC common stock and dividend equivalents upon the filing with the SEC of the Annual Report on Form 10-K for the last fiscal year of the performance period if the specified performance criteria is met. In fiscal 2013, performance-based RSU awards granted include the potential for accelerated vesting of 25% of the shares granted after the first and second fiscal years if certain company performance targets are met early. Compensation expense during the performance period is estimated at each reporting date using management’s expectation of the probable achievement of the specified performance criteria and is adjusted to the extent the expected achievement changes. In the table below, such awards are reflected at the number of shares to be settled upon achievement of target performance measures.

Certain executives were awarded service-based RSUs for which the shares are released over the ten anniversaries following the executive’s termination, provided the executive remains a full-time employee of the Company until reaching the earlier of age 65 or age 55 and over with at least ten years of service and after termination complies with certain non-competition covenants during the ten-year period.

Information concerning RSUs granted under stock incentive plans during fiscal 2013, fiscal 2012, and fiscal 2011, is as follows:

	Number of Shares		Weighted Average Fair Value
Outstanding as of April 2, 2010	1,154,668		$	45.88
Granted	492,523		48.15
Settled	(151,893	)	50.40
Canceled/Forfeited	(16,728	)	51.94
Outstanding as of April 1, 2011	1,478,570		46.10
Granted	1,009,743		35.45
Settled	(419,351	)	48.21
Canceled/Forfeited	(328,037	)	41.44
Outstanding as of March 30, 2012	1,740,925		40.29
Granted	1,724,639		26.12
Settled	(423,321	)	33.17
Canceled/Forfeited	(778,971	)	38.27
Outstanding as of March 29, 2013	2,263,272		31.53

As of March 29, 2013, there was $34 million of unrecognized compensation expense related to unvested restricted stock units, net of expected forfeitures. The cost is expected to be recognized over a weighted-average period of 2.18 years.

Nonemployee Director Incentives

The Company has two stock incentive plans which authorize the issuance of stock options, restricted stock and other stock-based incentives to nonemployee directors upon terms approved by the Company’s Board of Directors. As of March 29, 2013, 72,400 shares of CSC common stock remained available for the grant to nonemployee directors of future RSUs or other stock-based incentives.

Generally, RSU awards to nonemployee directors vest in full as of the next annual meeting of the Company’s stockholders following the date they are granted and are issued at a price of $0. Information concerning RSUs granted to nonemployee directors during fiscal 2013, fiscal 2012, and fiscal 2011 is as follows:

	Number of Shares		Weighted Average Fair Value
Outstanding as of April 2, 2010	133,221		$	46.47
Granted	25,700		39.46
Settled	(180	)	42.69
Canceled/Forfeited	—		—
Outstanding as of April 1, 2011	158,741		45.34
Granted	37,800		30.07
Settled	(180	)	42.69
Canceled/Forfeited	—		—
Outstanding as of March 30, 2012	196,361		42.81
Granted	42,800		30.30
Settled	(50,716	)	43.30
Canceled/Forfeited	—		—
Outstanding as of March 29, 2013	188,445		39.85

When a holder of RSUs ceases to be a director of the Company, the vested RSUs are settled for shares of CSC common stock and dividend equivalents with respect to such shares. At the holder’s election, the RSUs may be settled (i) in their entirety, upon the day the holder ceases to be a director, or (ii) in substantially equal amounts upon the first five, ten or fifteen anniversaries of such termination of service.

XML

Income Taxes

12 Months Ended

Mar. 29, 2013

Income Taxes [Abstract]

Income Taxes

Income Taxes

The sources of (loss) income from continuing operations, before income taxes, classified between domestic entities and those entities domiciled outside of the United States, are as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Domestic entities	$	(25	)	$	(1,807	)	$	489
Entities outside the United States	505			(2,647		)	389
Total	$	480		$	(4,454	)	$	878

The income tax (benefit) expense on (loss) income from continuing operations is comprised of:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Current:
Federal	$	(307	)	$	(72	)	$	(13	)
State	(3		)	11			18
Foreign	174			94			96
	(136		)	33			101
Deferred:
Federal	84			(140		)	89
State	(16		)	(22		)	7
Foreign	33			45			5
	101			(117		)	101
Total income tax expense (benefit)	$	(35	)	$	(84	)	$	202

The current (benefit) provision for fiscal years 2013, 2012, and 2011, includes interest and penalties of $10 million, $(53) million, and $5 million, respectively, for uncertain tax positions.

The major elements contributing to the difference between the U.S. federal statutory tax rate of 35% and the effective tax rate (ETR) for continuing operations are as follows:

	Twelve Months Ended
	March 29, 2013		March 30, 2012		April 1, 2011
Statutory rate	35.0	%	(35.0	)%	35.0	%
State income tax, net of federal tax	(0.6	)	(0.3	)	1.3
Change in uncertain tax positions	1.2		0.6		(2.8	)
Foreign tax rate differential	(66.8	)	(0.8	)	(5.4	)
Income tax credits	(0.4	)	(1.0	)	(9.6	)
Valuation allowance	77.1		18.1		2.5
Change in entity tax status	(0.3	)	(0.7	)	—
Loss on sale of securities	(51.8	)	—		—
Tax audit settlements	—		(2.5	)	—
Goodwill impairment	—		18.8		—
Other items, net	(0.7	)	0.9		2.0
Effective tax rate	(7.3	)%	(1.9	)%	23.0	%

In fiscal 2013, the ETR was primarily driven by:

• The Company executed an internal restructuring whereby a significant operating subsidiary was recapitalized. Certain securities issued pursuant to the recapitalization were subsequently sold to a third party. The sale resulted in the recognition of a capital loss of approximately $640 million, which reduced tax expense and the ETR by $248 million and 51.8%, respectively.

• A valuation allowance recorded for certain of the Company's German subsidiaries related to net operating losses and other net deferred tax assets. The impact to tax expense and the ETR was an increase of $77 million and 16%, respectively.

• An increase in the valuation allowance determined on a tax jurisdictional basis due to several factors including: (i) a shift in the global mix of income which increased tax expense and the ETR by $27.6 million and 5.8%, respectively (ii) capital gains from the sale of certain other assets which decreased tax expense and the ETR by $11.5 million and 2.4%, respectively and (iii) state capital losses and credits not expected to be fully utilized within the carryforward period which increased tax expense and the ETR by $29.6 million and 6.2%, respectively.

• Local losses on investment write-downs in Luxembourg (i) increased the valuation allowance and the ETR by $240.5 million and 50.2%, respectively, and (ii) decreased the foreign rate differential and ETR by $240.5 million and by 50.2%, respectively.

For the tax impact of discontinued operations, see Note 3.

The deferred tax assets (liabilities) are as follows:

(Amounts in millions)	March 29, 2013			March 30, 2012
Deferred Tax Assets
Employee benefits	$	558		$	705
Tax loss/credit carryforwards	1,110			899
Accrued interest	47			52
State taxes	13			13
Cumulative foreign exchange gain/loss	14			6
Other assets	111			92
Total Deferred Tax Assets	1,853			1,767
Valuation allowance	(1,298		)	(951		)
Net Deferred Tax Assets	555			816
Deferred Tax Liabilities
Depreciation and amortization	(322		)	(387		)
Contract accounting	(53		)	(90		)
Investment basis differences	(128		)	(128		)
Other liabilities	(75		)	(65		)
Total Deferred Tax Liabilities	(578		)	(670		)
Total Deferred Tax Assets (Liabilities)	$	(23	)	$	146

Income tax related assets are included in the accompanying balance sheet as follows:

• Prepaid expenses and other current assets include the current portion of deferred tax assets of $24 million and $19 million as of March 29, 2013 and March 30, 2012, respectively. 

• Receivables include income taxes receivable of $239 million and $98 million as of March 29, 2013 and March 30, 2012, respectively, and the current portion of the receivable for uncertain tax positions of $8 million and $0 million as of March 29, 2013 and March 30, 2012, respectively.

• Other assets include non-current deferred tax assets of $184 million and $272 million as of March 29, 2013 and March 30, 2012, respectively, and non-current income taxes receivable and prepaid taxes of $70 million and $154 million as of March 29, 2013 and March 30, 2012, respectively.

Income tax related liabilities are included in the accompanying balance sheet as follows:

• Income taxes payable and deferred income taxes consist of the current portion of deferred tax liabilities of $0 million and $46 million as of March 29, 2013 and March 30, 2012, respectively, the current portion of income taxes payable of $41 million and $11 million as of March 29, 2013 and March 30, 2012 respectively.

• Income tax liabilities and deferred income taxes included in non-current liabilities consist of non-current liability for uncertain tax positions of $270 million and $257 million as of March 29, 2013 and March 30, 2012, respectively, and the non-current portion of deferred tax liabilities of $231 million and $99 million as of March 29, 2013 and March 30, 2012, respectively, the non-current portion of income taxes payable of $0 million and $1 million as of March 29, 2013 and March 30, 2012, respectively.

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized and adjusts the valuation allowance accordingly. In determining whether the deferred tax assets are realizable, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, taxable income in prior carryback years, projected future taxable income, tax planning strategies and recent financial operations. Valuation allowances are evaluated periodically and will be subject to change in each future reporting period as a result of changes in one or more of these factors. The change in the valuation allowance was $347 million in fiscal year 2013. This change is primarily due to the following:

• a full valuation allowance recorded in Germany for certain subsidiaries due to expected cumulative losses;

• a decrease in the valuation allowance in the U.K. related to current year income;

• an increase in the valuation allowance in Luxembourg due to local losses on investment write-downs; and

• a valuation allowance recorded against state capital loss carryforwards.

The Company has available foreign net operating loss (NOL) carryforwards of $3,661 million and $3,272 million, federal NOL carryforwards of $5 million and $14 million, and state NOL carryforwards of $782 million and $467 million as of March 29, 2013 and March 30, 2012, respectively. The Company has foreign capital loss carryforwards of $45 million and $0 million as of March 29, 2013 and March 30, 2012, respectively. The Company also has state credit carryforwards of $67 million and $69 million and state capital loss carryforwards of $411 million and $0 million as of March 29, 2013 and March 30, 2012, respectively. The foreign NOL carryforwards as of March 29, 2013 can be carried over indefinitely, except for $122 million which expire at various dates through 2021. The federal NOL carryforwards as of March 29, 2013 expire at various dates through 2032. The state NOL and credit carryforwards as of March 29, 2013 expire at various dates through 2033. The state capital loss carryforwards as of March 29, 2013 expire in 2018.

The Company is currently the beneficiary of tax holiday incentives in India, most of which expired in fiscal year 2011. The remaining tax holiday incentives in India will expire through 2026. As a result of the tax holiday incentives, the Company’s tax expense was reduced by approximately $3 million, $1 million, and $13 million, during fiscal years 2013, 2012, and 2011, respectively. The per share effects were $0.02, $0.01, and $0.08, for fiscal years 2013, 2012, and 2011, respectively.

In general, it is the practice and intention of the Company to reinvest the earnings of its non-U.S. subsidiaries in those operations. As of March 29, 2013, the Company has not made a provision for U.S. income tax or additional foreign withholding taxes with respect to accumulated taxable earnings of foreign subsidiaries where the foreign investment of such earnings is essentially permanent in duration. Generally, such amounts would become subject to U.S. taxation upon the remittance of dividends and under certain other circumstances. The cumulative undistributed positive earnings of the Company's foreign subsidiaries were approximately $2,977 million as of March 29, 2013. It is not practicable to estimate the tax cost of repatriating the cumulative undistributed taxable earnings of these foreign subsidiaries to the United States.

The Company accounts for income tax uncertainties in accordance with ASC 740-10, which prescribes a recognition threshold and measurement criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more-likely-than-not recognition threshold is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold should be derecognized in the first subsequent financial reporting period in which that threshold is no longer met. ASC 740 also provides guidance on the accounting for and disclosure of liabilities for uncertain tax positions, interest and penalties.

As of March 29, 2013, the Company’s liability for uncertain tax positions was $262 million, including interest of $38 million, penalties of $17 million, and net of tax attributes of $32 million. As of March 30, 2012, the Company’s liability for uncertain tax positions was $257 million, including interest of $31 million, penalties of $15 million, and net of tax attributes of $76 million.

The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes):

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Balance at Beginning of Fiscal Year	$	287		$	426		$	442
Gross increases related to prior year tax positions	7			27			22
Gross decreases related to prior year tax positions	(40		)	(134		)	(41		)
Gross increases related to current year tax positions	8			29			14
Settlements and statute of limitation expirations	(18		)	(115		)	(15		)
Current year acquisitions	—			56			—
Foreign exchange and others	(3		)	(2		)	4
Balance at End of Fiscal Year	$	241		$	287		$	426

The Company’s liability for uncertain tax positions at March 29, 2013, March 30, 2012, and April 1, 2011, includes $148 million, $155 million, and $266 million, respectively, related to amounts that, if recognized, would affect the effective tax rate (excluding related interest and penalties).

The Company recognizes interest accrued related to uncertain tax positions and penalties as a component of income tax expense. During the year ended March 29, 2013, the Company accrued interest expense of $7 million ($5 million net of tax) and accrued penalties of $2 million, and as of March 29, 2013, has recognized a liability for interest of $38 million ($28 million net of tax) and penalties of $17 million. During the year ended March 30, 2012, the Company had a net reduction of interest of $56 million ($36 million net of tax) and had a net reduction of penalties of $14 million, and as of March 30, 2012, recognized a liability for interest of $31 million ($23 million net of tax) and penalties of $15 million. During the year ended April 1, 2011, the Company accrued interest expense of $3 million ($2 million net of tax) and accrued penalties of $2 million, and as of April 1, 2011, recognized a liability for interest of $88 million ($58 million net of tax) and penalties of $29 million.

Tax Examination Status:

The Company is currently under examination in several tax jurisdictions. A summary of the tax years that remain subject to examination in certain of the Company’s major tax jurisdictions are:

Jurisdiction:	Tax Years that Remain Subject to Examination (Fiscal Year Ending):
United States – Federal	2008 and forward
United States – Various States	2001 and forward
Australia	2009 and forward
Canada	2006 and forward
Denmark	2007 and forward
France	2009 and forward
Germany	2006 and forward
India	2007 and forward
United Kingdom	2010 and forward

It is reasonably possible that during the next twelve months the Company's liability for uncertain tax positions may change by a significant amount. The IRS is examining the Company's federal income tax returns for fiscal year 2008 through 2010, and the Company expects to reach a settlement during fiscal year 2014. The significant items subject to examination primarily include foreign income inclusion under subpart F and related foreign tax credits. In addition, the Company may settle certain other tax examinations, have lapses in statutes limitations, or voluntarily settle income tax positions in negotiated settlements for different amounts than the Company has accrued as uncertain tax positions. The Company may need to accrue and ultimately pay additional amounts for tax positions that previously met a more likely than not standard if such positions are not upheld. Conversely, the Company could settle positions with the tax authorities for amounts lower than those that have been accrued or extinguish a position though payment. The Company believes the outcomes which are reasonably possible within the next twelve months may result in a reduction in liability for uncertain tax positions of up to $92 million, excluding interest and penalties.

XML

Segment and Geographic Information (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended																		3 Months Ended	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Mar. 29, 2013 NPS [Member]		Mar. 30, 2012 NPS [Member]		Apr. 01, 2011 NPS [Member]		Mar. 29, 2013 NPS [Member] Segment As Reported [Member]	Mar. 30, 2012 NPS [Member] Segment As Reported [Member]	Apr. 01, 2011 NPS [Member] Segment As Reported [Member]	Mar. 29, 2013 NPS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Mar. 30, 2012 NPS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Apr. 01, 2011 NPS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Mar. 29, 2013 NPS [Member] Segment Adjusted [Member]	Mar. 30, 2012 NPS [Member] Segment Adjusted [Member]	Apr. 01, 2011 NPS [Member] Segment Adjusted [Member]	Sep. 30, 2011 MSS [Member]	Mar. 30, 2012 MSS [Member]	Mar. 29, 2013 MSS [Member] Segment As Reported [Member]	Mar. 30, 2012 MSS [Member] Segment As Reported [Member]	Apr. 01, 2011 MSS [Member] Segment As Reported [Member]	Mar. 29, 2013 MSS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Mar. 30, 2012 MSS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Apr. 01, 2011 MSS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Mar. 29, 2013 MSS [Member] Segment Adjusted [Member]	Mar. 30, 2012 MSS [Member] Segment Adjusted [Member]	Apr. 01, 2011 MSS [Member] Segment Adjusted [Member]	Mar. 29, 2013 BSS [Member]		Mar. 30, 2012 BSS [Member]		Apr. 01, 2011 BSS [Member]		Mar. 29, 2013 BSS [Member] Segment As Reported [Member]	Mar. 30, 2012 BSS [Member] Segment As Reported [Member]	Apr. 01, 2011 BSS [Member] Segment As Reported [Member]	Mar. 29, 2013 BSS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Mar. 30, 2012 BSS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Apr. 01, 2011 BSS [Member] Segment Out of Period Adjustments Increase (Decrease) [Member]	Mar. 29, 2013 BSS [Member] Segment Adjusted [Member]	Mar. 30, 2012 BSS [Member] Segment Adjusted [Member]	Apr. 01, 2011 BSS [Member] Segment Adjusted [Member]	Mar. 29, 2013 Corporate [Member]	Mar. 30, 2012 Corporate [Member]	Apr. 01, 2011 Corporate [Member]	Mar. 29, 2013 Eliminations [Member]	Mar. 30, 2012 Eliminations [Member]	Apr. 01, 2011 Eliminations [Member]	Mar. 29, 2013 Contracts Accounted for under Percentage of Completion, U.S. Claims [Member] NPS [Member]	Mar. 29, 2013 Contracts Accounted for under Percentage of Completion, U.K. Contract [Member] BSS [Member]
Segment Reporting Information [Line Items]
Revenues	$ 14,993	$ 15,364	$ 15,582	$ 5,391	[1]	$ 5,703	[1]	$ 6,002	[1]	$ 5,391	$ 5,703	$ 6,002	$ 0	$ 5	$ 0	$ 5,391	$ 5,708	$ 6,002			$ 6,457	$ 6,602	$ 6,583	$ 1	$ 6	$ 34	$ 6,458	$ 6,608	$ 6,617	$ 3,272	[2]	$ 3,180	[2]	$ 3,110	[2]	$ 3,272	$ 3,180	$ 3,110	$ 13	$ 45	$ (33)	$ 3,285	$ 3,225	$ 3,077	$ 13	$ 13	$ 14	$ (140)	$ (134)	$ (127)
Operating income (loss)	900	(1,359)	1,125	519	[1]	132	[1]	528	[1]	519	132	528	6	10	(11)	525	142	517			361	17	481	3	33	45	364	50	526	136	[2]	(1,443)	[2]	188	[2]	136	(1,443)	188	(8)	43	(29)	128	(1,400)	159	(116)	(65)	(72)	0	0	0
Depreciation and amortization	1,076	1,147	1,068	160	[1]	162	[1]	133	[1]	160	162	133	0	0	0	160	162	133			765	815	777	0	(2)	3	765	813	780	137	[2]	154	[2]	127	[2]	137	154	127	(2)	0	0	135	154	127	14	16	31	0	0	0
Change in accounting estimate, reduction in revenue																														204																					42
Change in accounting estimate, reduction in operating income																																																			269	1,485
Reconciliation of Consolidated Operating Income to Income Before Taxes [Abstract]
Operating income (loss)	900	(1,359)	1,125	519	[1]	132	[1]	528	[1]	519	132	528	6	10	(11)	525	142	517			361	17	481	3	33	45	364	50	526	136	[2]	(1,443)	[2]	188	[2]	136	(1,443)	188	(8)	43	(29)	128	(1,400)	159	(116)	(65)	(72)	0	0	0
Corporate G&A	(293)	(219)	(138)
Interest expense	(183)	(175)	(167)
Interest income	22	38	37
Goodwill impairment	0	(2,745)	0			0													(2,074)	(2,074)												(671)
Other income (expense), net	34	6	21
Income (loss) from continuing operations before taxes	$ 480	$ (4,454)	$ 878

[1] The fiscal 2012 amounts include $42 million reduction of revenue and $269 million in reduction in operating income as a result of the settlement of claims with the U.S. government (see Note 19).

[2] The fiscal 2012 amounts include $204 million reduction of revenue and $1,485 million in reduction of operating income as a result of the charge associated with the NHS contract (see Note 18).

XML

Fair Value

12 Months Ended

Mar. 29, 2013

Fair Value [Abstract]

Fair Value

Fair Value

Fair value measurements on a recurring basis

The following table presents the Company’s assets and liabilities, excluding pension assets (see Note 12), that are measured at fair value on a recurring basis as of March 29, 2013 and March 30, 2012:

	March 29, 2013
			Fair Value Hierarchy
(Amounts in millions)	Fair Value		Level 1		Level 2		Level 3
Assets:
Money market funds and money market deposit accounts	$	464	$	464	$	—	$	—
Time deposits	393		393		—		—
Short term investments	6		6		—		—
Derivative assets	5		—		5		—
Total assets	$	868	$	863	$	5	$	—
Liabilities:
Derivative liabilities	$	11	$	—	$	11	$	—
Total liabilities	$	11	$	—	$	11	$	—
	March 30, 2012
			Fair Value Hierarchy
(Amounts in millions)	Fair Value		Level 1		Level 2		Level 3
Assets:
Money market funds and money market deposit accounts	$	299	$	299	$	—	$	—
Time deposits	102		102		—		—
Short term investments	6		6		—		—
Derivative assets	12		—		12		—
Total assets	$	419	$	407	$	12	$	—
Liabilities:
Derivative liabilities	$	14	$	—	$	14	$	—
Total liabilities	$	14	$	—	$	14	$	—

The Company's money market funds and deposit accounts and time deposits are included in cash and cash equivalents; short-term investments and derivative assets are included in prepaid expenses and other current assets; and derivative liabilities are included in other accrued expenses. Gains and losses from changes in the fair value of derivative assets and liabilities are included in earnings and reported in other (income) expense. There were no transfers between Level 1 and Level 2.

Derivative assets and liabilities include foreign currency forward contracts and currency options. The fair value of foreign currency forward contracts represents the estimated amount required to settle the contracts using current market exchange rates, and is based on the year-end foreign currency exchange rates and forward points. The fair value of currency options is estimated based on external valuation models that use the original strike price, movement and volatility in foreign currency exchange rates, and length of time to expiration as inputs.

Fair value measurements on a non-recurring basis

Assets and liabilities measured at fair value on a nonrecurring basis include goodwill, tangible assets, intangible assets and other contract related long-lived assets. Such assets are reviewed quarterly for impairment indicators. If a triggering event has occurred, the assets are remeasured when the estimated fair value of the corresponding asset or asset group is less than the carrying value. The fair value measurements, in such instances, are based on significant unobservable inputs (Level 3). There were no significant impairments recorded during the fiscal year ended March 29, 2013.

During fiscal 2012, as a result of annual and interim goodwill impairment assessments, goodwill was impaired with a charge of $2,745 million (see Note 9). The Company used the combination of the income and the market approach techniques to measure fair value of its reporting units, and a combination of the income, cost and market approach techniques to determine the fair value of the assets and liabilities comprising reporting units. The fair value adjustment to goodwill was computed as the difference between the fair value of the reporting unit and the fair value of underlying assets and liabilities. The unobservable inputs used to fair value the reporting units were based on Company-specific information such as revenue and cost growth rates, profit margins and discount rates. The unobservable inputs used to fair value the underlying assets and liabilities were also based on Company-specific information such as estimates of revenue and cost growth rates, profit margins, discount rates, cost estimates and guideline transactions data.

Additionally, during fiscal 2012, due to performance issues on certain of its outsourcing contracts, the Company recorded impairment of primarily long-lived assets of $156 million. The Company used the income approach technique to fair value the assets. The unobservable inputs used were based on Company specific information and included, primarily, estimates of revenue and cost growth rates, profit margins and discount rates.

Financial Instruments

The carrying amounts of the Company’s financial instruments with short-term maturities are deemed to approximate their market values. The carrying amount of the Company’s long-term debt, excluding capital leases and including mandatorily redeemable preferred stock outstanding, was $2,119 million and $1,073 million and the estimated fair value was $2,324 million and $1,190 million as of March 29, 2013, and March 30, 2012, respectively. The fair value of long-term debt is estimated based on the current interest rates offered to the Company for instruments with similar terms and remaining maturities and are classified as Level 2.

The primary financial instruments which potentially subject the Company to concentrations of credit risk are accounts receivable. The Company’s customer base includes Fortune 500 companies, the U.S. federal and other governments and other significant, well-known companies operating in North America, Europe and the Pacific Rim. Credit risk with respect to accounts receivable is minimized because of the nature and diversification of the Company’s customer base. Furthermore, the Company continuously reviews its accounts receivables and records provisions for doubtful accounts as needed.

The Company’s credit risk is also affected by customers in bankruptcy proceedings; however, because most of these proceedings involve business reorganizations rather than liquidations and the nature of the Company’s services are often considered essential to the operational continuity of these customers, the Company is generally able to avoid or mitigate significant adverse financial impact in these cases. As of March 29, 2013, the Company had $16 million of accounts receivable, $11 million of related allowance for doubtful accounts, and $1 million of other assets with customers involved in bankruptcy proceedings.

XML

Discontinued operations (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended										3 Months Ended		12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Mar. 29, 2013 BSS [Member]	Mar. 29, 2013 CSC Credit Services, Enterprise System Integration Businessa and CSC Italia [Member] BSS [Member] Businesses	Mar. 29, 2013 CSC Credit Services [Member] BSS [Member]	Mar. 29, 2013 Enterprise System Integration Business [Member] BSS [Member]	Mar. 29, 2013 CSC Italia [Member] BSS [Member]	Apr. 01, 2011 NPS Segment, Businesses with Governmental Organization Conflict of Interest [Member] NPS Segment [Member] Businesses	Mar. 29, 2013 NPS Segment, Businesses with Governmental Organization Conflict of Interest [Member] NPS Segment [Member]	Oct. 01, 2010 NPS Segment, Divestiture One [Member] NPS Segment [Member]	Apr. 01, 2011 NPS Segment, Divestiture Two [Member] NPS Segment [Member]	Mar. 29, 2013 Paxus [Member]	Mar. 29, 2013 Paxus [Member] BSS [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Amount of cash consideration received						$ 1,001	$ 90					$ 63	$ 63
Discontinued Operations, Proceeds from Divestirure of Business, Working Capital Adjustment						1	14
Discontinued Operation, Intercompany Amounts with Discontinued Operation before Disposal Transaction, Costs								35
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents								8
Discontinued Operations, Proceeds from Divestirure of Business, Purchase Price Adjustment								6
Accounts Receivable, Net, Current							14	6					16
Number of Divestitures in Period					3				2
Disposal Group, Including Discontinued Operations, Transaction Costs					11									3
Assets of Disposal Group, Including Discontinued Operation, Current					129					38				41
Assets of Disposal Group, Including Discontinued Operation, Noncurrent					11									2
Disposal Group, Including Discontinued Operation, Goodwill					241
Liabilities of Disposal Group, Including Discontinued Operation					85									5
Discontinued Operation, Tax Effect of Discontinued Operation	3	82
Deductions	(241)			(241)
Consideration of divested assets											56	65	79
Amount of cash consideration included in other receivables												2
Pre-tax gain from divestiture									59				38
Net property and equipment derecognized									8
Goodwill derecognized									23
Liabilities derecognized									12
Transaction costs incurred									5
Operations [Abstract]
Revenue	395	513	562
Income from discontinued operations, before taxes	84	107	100
Taxes on income	(37)	37	(45)
Net income from discontinued operations	47	144	55
Disposal [Abstract]
(Loss) gain on disposition, before taxes	769	(2)	59
Taxes on income	(352)	3	(31)
Gain (loss) on disposition, net of taxes	417	1	28						28
Income from discontinued operations, net of taxes	$ 464	$ 145	$ 83

XML

Acquisitions

12 Months Ended

Mar. 29, 2013

Acquisitions and Divestitures [Abstract]

Acquisitions and Divestitures

Acquisitions

Fiscal 2013 Acquisition

In the second quarter of fiscal 2013, CSC acquired a privately-held entity for $35 million in an all-cash transaction. The entity was acquired primarily to enhance CSC's strategy of offering customers greater value through data expertise and intellectual property. The purchase price was allocated to net assets acquired based on their estimated fair values at the date of acquisition as: $4 million to current assets, $8 million to acquired intangible assets, $2 million to liabilities, and $25 million to goodwill. The goodwill is associated with the NPS segment and is expected to be tax deductible. The pro forma financial information for this acquisition is not presented as this acquisition is not material to CSC’s consolidated results.

Fiscal 2012 Acquisitions

iSOFT Acquisition

On July 29, 2011, CSC completed the acquisition of iSOFT Group Limited (iSOFT), a publicly-held company listed on the Australian Securities Exchange. iSOFT is a global healthcare information technology company providing advanced application solutions principally to secondary care providers across both the public and private sectors. The acquisition complements and strengthens CSC’s software products, healthcare integration and services portfolio, and its healthcare research and development capabilities.

CSC acquired all of the outstanding shares in iSOFT for cash consideration of $200 million and the assumption of debt of $315 million, of which $298 million was repaid immediately after the acquisition.  The acquisition was funded through CSC’s existing cash balances.

Prior to the acquisition, the Company and iSOFT had a subcontracting agreement related to the development and delivery of software and IT services under the Company’s NHS contract. The agreement was effectively settled upon the completion of the acquisition. The Company determined that the subcontract was at market and no settlement gain or loss was recognized on the pre-existing relationship.

The results of iSOFT have been included in the Company’s consolidated financial statements from the date of acquisition within its Business Solutions and Services (BSS) segment. For the twelve months ended March 30, 2012, iSOFT contributed revenues of $139 million and an operating loss of $93 million, including the effect of purchase accounting adjustments, primarily relating to amortization of intangibles. The operating loss was offset by currency gains of $18 million, resulting in an effective loss of $75 million before interest and taxes. The currency gains, which resulted from unhedged inter-company loans, are included in other income. The following unaudited pro forma summary presents consolidated information of the Company as if the acquisition of iSOFT had occurred on April 3, 2010 for all periods presented:

	As Reported					Pro Forma - Unaudited
	Twelve Months Ended					Twelve Months Ended
(Amounts in millions, except per-share data)	March 30, 2012			April 1, 2011		March 30, 2012			April 1, 2011
Revenue	$	15,364		$	15,582	$	15,442		$	15,776
Net (loss) income attributable to CSC common shareholders	(4,242		)	740		(4,344		)	618
Basic EPS	$	(27.37	)	$	4.79	$	(28.02	)	$	4.00
Diluted EPS	(27.37		)	4.73		(28.02		)	3.95

The pro forma financial information above is not indicative of the results that would have actually been obtained if the acquisition had occurred on April 3, 2010, or that may be obtained in the future. No effect has been given to cost reductions or operating synergies relating to the integration of iSOFT in the Company’s operations. The information for the twelve months ended March 30, 2012 has been adjusted to exclude $37 million of goodwill impairment recorded by iSOFT in June 2011, and the twelve months ended April 1, 2011 information has been adjusted to exclude $290 million of goodwill impairment recorded by iSOFT in June 2010. Additionally, the twelve months ended March 30, 2012 information has been adjusted to exclude the transaction costs of $11 million, and the twelve months ended April 1, 2011 information has been adjusted to include the transaction costs of $11 million.

The fair values of the assets acquired and liabilities assumed at the date of acquisition, including adjustments to the valuation of net assets acquired based on additional information that subsequently became available during fiscal 2012, are summarized as follows:

(Amounts in millions)	Estimated Fair Value
Cash and cash equivalents	$	26
Trade and other receivables	114
Other current assets	14
Deferred tax assets	12
Intangible assets	198
Property and equipment	21
Other non-current assets	3
Trade payables and accrued expenses	(62		)
Deferred revenue	(54		)
Debt	(315		)
Deferred taxes, uncertain tax positions, and other long-term liabilities	(59		)
Total identifiable net assets acquired	(102		)
Goodwill	302
Total cash purchase price	$	200

As of the acquisition date, the fair value of receivables approximated book value, which included billed and unbilled receivables and the historical allowance for uncollectible amounts of $10 million.

The components of the definite-lived intangible assets acquired and their respective estimated useful lives were as follows:

(Amounts in millions)	Estimated Fair Value		Estimated Useful Lives (Years)
Customer relationships	$	92	10-13
Software	102		2-7
Trade names	4		1
Total intangible assets	$	198

The entire amount of goodwill is associated with the Company’s BSS segment, and is attributable to expected increases in the Company’s market capabilities, synergies from combining operations, and the value of the acquired workforce. Of the estimated total goodwill, $71 million was estimated to be tax deductible.

AppLabs Acquisition

On September 13, 2011, CSC acquired AppLabs Technologies Private Limited (AppLabs), a Company headquartered in India which significantly enhances CSC’s capabilities in application testing services as well as shortening time-to-market. The AppLabs acquisition will complement CSC’s expertise in financial services, healthcare, manufacturing, chemical, energy and natural resources and technology and consumer verticals.

CSC acquired all outstanding shares of AppLabs for cash consideration of $171 million, which was funded through CSC’s existing cash balances.

The results of AppLabs have been included in the Company’s consolidated financial statements from the date of acquisition. For the twelve months ended March 30, 2012, AppLabs contributed revenues of $60 million and net income of $2 million, including the effect of purchase accounting adjustments, primarily relating to amortization of intangibles. The pro forma financial information for this acquisition is not presented as this acquisition is not material to CSC’s consolidated results.

The fair values of the assets acquired and liabilities assumed at the date of acquisition, including adjustments to the valuation of net assets acquired based on additional information that subsequently became available during fiscal 2012, are summarized as follows:

(Amounts in millions)	Estimated Fair Value
Cash and cash equivalents	$	4
Trade receivables	20
Other current assets	8
Intangible assets	26
Property and equipment	4
Trade payables and accrued expenses	(26		)
Deferred taxes and uncertain tax positions	(20		)
Other liabilities	(2		)
Total identifiable net assets acquired	14
Goodwill	157
Total purchase price	$	171

As of the acquisition date, the fair value of trade receivables approximated book value and was considered fully recoverable.

The components of the definite-lived intangible assets acquired and their respective estimated useful lives are as follows:

(Amounts in millions)	Estimated Fair Value		Estimated Useful Lives (Years)
Customer relationships	$	25	2-8
Software	1		1-5
Total intangible assets	$	26

The entire amount of goodwill is associated with the Company’s Managed Services Sector (MSS) segment and is attributable to expected increases in the Company’s market capabilities and the value of the acquired workforce. None of the goodwill was tax deductible.

Other Acquisitions

During fiscal 2012, CSC also acquired two other small privately-held entities for $28 million in all-cash transactions plus additional consideration of up to $2 million contingent on achievement of agreed revenue targets for future periods through the end of May 2014. The acquisitions will enhance CSC’s offerings in the healthcare information technology and financial services industries.

The results of the acquired businesses have been included in the Company’s consolidated financial statements from the dates of acquisition. The pro forma financial information for these acquisitions is not presented as these acquisitions, both individually and in the aggregate, are not material to CSC’s consolidated results.

The purchase prices were allocated to net assets acquired based on estimates of fair values at the dates of acquisition as: $8 million to current assets, $2 million to property and equipment, $7 million to intangible assets, $6 million to liabilities and $17 million to goodwill. Identified intangible assets consist primarily of customer related intangibles with useful lives of 4-10 years. Of the $17 million goodwill, $14 million is associated with the NPS segment and $3 million with the BSS segment. The $14 million goodwill associated with the NPS segment is expected to be tax deductible.

During fiscal 2011, CSC acquired four privately-held companies for $156 million. Two of the acquisitions were related to CSC's NPS segment and enhance the Company's cyber security, intelligence and analysis capabilities that support the national security and intelligence communities. Two of the acquisitions were related to CSC's BSS segment and augment the Company's healthcare business process outsourcing, software design and development, and our consulting practice within the chemical, energy and natural resources markets. The purchase consideration for the acquisitions was allocated to the assets acquired and liabilities assumed, based on their respective fair values at the date of acquisition. The total purchase consideration was allocated as $17 million to current assets, $5 million to property and equipment and other long term assets, $22 million to customer-related intangible assets, $19 million to other intangible assets, $20 million to liabilities assumed, and $113 million to goodwill. Identified other intangible assets include software, noncompetition agreements, trade names and in-process research and development. The weighted average amortization period for the customer-related intangible assets ranges from seven to ten years, and for other intangible assets it ranges from three to eight years. Of the total goodwill, $72 million is associated with CSC’s NPS segment and $41 million with the BSS segment; $69 million of the total goodwill was tax deductible. The aggregate amount of acquisition costs for the transactions amounted to $1 million and was expensed as incurred.

Pro forma financial information is not presented as the impact of these acquisitions was immaterial to CSC’s consolidated results.

XML

Receivables

12 Months Ended

Mar. 29, 2013

Receivables [Abstract]

Receivables

Receivables

Receivables consist of the following:

(Amounts in millions)	March 29, 2013		March 30, 2012
Billed trade accounts	$	1,627	$	1,794
Unbilled recoverable amounts under contracts in progress	1,176		1,300
Other receivables	396		163
Total	$	3,199	$	3,257

Unbilled recoverable amounts under contracts in-progress generally become billable upon completion of a specified contract, negotiation of contract modifications, completion of U.S. federal government audit activities, achievement of project milestones or upon acceptance by the customer.

Unbilled recoverable amounts under contracts in progress resulting from sales, primarily to the U.S. and other governments, which are expected to be collected after fiscal year 2014 totaled $48 million.

XML

Foreign Currency Derivative Instruments

12 Months Ended

Mar. 29, 2013

Foreign Currency Derivative Instruments [Abstract]

Foreign Currency Derivative Instruments

Foreign Currency Derivative Instruments

As a large global organization, the Company faces exposure to adverse movements in foreign currency exchange rates. During the ordinary course of business, the Company enters into certain contracts denominated in foreign currency. Potential foreign currency exposures arising from these contracts are analyzed during the contract bidding process. The Company generally manages these transactions by incurring costs to service contracts in the same currency in which revenue is received. Short-term contract financing requirements are met by borrowing in the same currency. By generally matching revenues, costs and borrowings to the same currency, the Company has been able to substantially mitigate foreign currency risk to earnings. However, as business practices evolve, the Company is increasing its use of offshore support and is therefore becoming more exposed to currency fluctuations.

The Company established policies and procedures to manage the exposure to fluctuations in foreign currency by using short-term foreign currency forward and option contracts to hedge certain foreign currency assets and liabilities, including intercompany loans, and certain revenues denominated in non-functional currencies. The Company uses these instruments as economic hedges and not for speculative or trading purposes. For accounting purposes, these foreign currency contracts are not designated as hedges, as defined under ASC 815, “Derivatives and Hedging” and all changes in fair value are reported as part of other (income) expense.

The notional amount of the foreign currency forward contracts outstanding as of March 29, 2013 and March 30, 2012 was $993 million and $2,138 million, respectively. The notional amount of option contracts outstanding as of March 29, 2013 and March 30, 2012 was $744 million and $785 million, respectively.

The estimated fair values of the foreign currency derivative assets and liabilities were $5 million and $11 million, respectively, as of March 29, 2013, and $12 million and $14 million, respectively, as of March 30, 2012 (see Note 6).

As a result of the use of derivative instruments, the Company is subject to counterparty credit risks. To mitigate this risk, the Company enters into forward and option contracts with several financial institutions and regularly reviews its credit exposure and the creditworthiness of the counterparties. As of March 29, 2013, there were four counterparties with concentration of credit risk. The maximum amount of loss for the four counterparties, based on gross fair value of the foreign currency derivative instruments, that the Company could incur, is $5 million.

XML

Fair Value Financial Instruments (Details) (USD $) In Millions, unless otherwise specified	Mar. 29, 2013	Mar. 30, 2012
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, net of current maturities	$ 2,498	$ 1,486
Accounts receivable with customers involved in bankruptcy proceedings	16
Allowance for doubtful accounts with customers involved in bankruptcy proceedings	11
Other assets with customers in bankruptcy proceedings	1
Carrying amount [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, net of current maturities	2,119	1,073
Fair value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, net of current maturities	$ 2,324	$ 1,190

XML

Segment and Geographic Information Geographic revenue and property and equipment, net (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Segment Reporting Information [Line Items]
Revenue	$ 14,993	$ 15,364	$ 15,582
Property and Equipment, Net	2,184	2,441	2,496
Total Assets	11,251	11,189	16,120
Capital Expenditures	568	829	972
Percentage of revenues derived from the US federal government (in hundredths)	34.00%	36.00%	37.00%
Percentage of accounts receivable due from the US federal government (in hundredths)	30.00%	33.00%
Maximum percentage of revenues from transactions with a single commercial customer (in hundredths)	10.00%	10.00%	10.00%
United States [Member]
Segment Reporting Information [Line Items]
Revenue	9,345	9,475	9,923
Property and Equipment, Net	1,273	1,406	1,396
Total Assets	6,454	6,198	6,855
Capital Expenditures	290	444	577
United Kingdom [Member]
Segment Reporting Information [Line Items]
Revenue	1,729	1,576	1,869
Property and Equipment, Net	320	367	403
Total Assets	1,389	1,329	2,998
Capital Expenditures	70	77	116
Other Europe [Member]
Segment Reporting Information [Line Items]
Revenue	2,217	2,446	2,276
Property and Equipment, Net	217	237	291
Total Assets	1,487	1,115	3,884
Capital Expenditures	80	90	100
Other International [Member]
Segment Reporting Information [Line Items]
Revenue	1,702	1,867	1,514
Property and Equipment, Net	374	431	406
Total Assets	1,921	2,547	2,383
Capital Expenditures	$ 128	$ 218	$ 179

XML

Intangible Assets (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Summary of amortizable intangible assets [Abstract]
Gross Carrying Value	$ 4,119	$ 4,531
Accumulated Amortization	2,772	3,027
Net Carrying Value	1,347	1,504
Amortization expense	414	442	444
Amortization of outsourcing contract cost premium	40	53	63
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]
Fiscal 2014	351
Fiscal 2015	292
Fiscal 2016	211
Fiscal 2017	158
Fiscal 2018	112
Impairment of Intangible Assets		(75)
Purchased software [Member]
Summary of amortizable intangible assets [Abstract]
Net Carrying Value	297	353
Internally developed commerical software
Summary of amortizable intangible assets [Abstract]
Net Carrying Value	304	293
Internally developed internal-use software
Summary of amortizable intangible assets [Abstract]
Net Carrying Value	10	3
Outsourcing contract costs [Member]
Summary of amortizable intangible assets [Abstract]
Gross Carrying Value	1,473	1,802
Accumulated Amortization	968	1,240
Net Carrying Value	505	562
Software [Member]
Summary of amortizable intangible assets [Abstract]
Gross Carrying Value	2,134	2,130
Accumulated Amortization	1,523	1,481
Net Carrying Value	611	649
Software [Member] | Purchased software [Member]
Summary of amortizable intangible assets [Abstract]
Amortization expense	143	149	135
Software [Member] | Internally developed commerical software
Summary of amortizable intangible assets [Abstract]
Amortization expense	53	47	34
Software [Member] | Internally developed internal-use software
Summary of amortizable intangible assets [Abstract]
Amortization expense	2	4	6
Customer and other intangible assets [Member]
Summary of amortizable intangible assets [Abstract]
Gross Carrying Value	512	599
Accumulated Amortization	281	306
Net Carrying Value	$ 231	$ 293

XML

Fair Value (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Liabilities:
Goodwill, Impairment charge	$ 0	$ (2,745)	$ 0
Impairment of Tangible and Intangible Assets		(156)
Fair Value, Measurements, Recurring [Member] | Fair value [Member]
Assets:
Money market funds	464	299
Time deposits	393	102
Short term investments	6	6
Derivative assets	5	12
Total assets	868	419
Liabilities:
Derivative liabilities	11	14
Total liabilities	11	14
Fair Value, Measurements, Recurring [Member] | Level 1 [Member]
Assets:
Money market funds	464	299
Time deposits	393	102
Short term investments	6	6
Derivative assets	0	0
Total assets	863	407
Liabilities:
Derivative liabilities	0	0
Total liabilities	0	0
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]
Assets:
Money market funds	0	0
Time deposits	0	0
Short term investments	0	0
Derivative assets	5	12
Total assets	5	12
Liabilities:
Derivative liabilities	11	14
Total liabilities	11	14
Fair Value, Measurements, Recurring [Member] | Level 3 [Member]
Assets:
Money market funds	0	0
Time deposits	0	0
Short term investments	0	0
Derivative assets	0	0
Total assets	0	0
Liabilities:
Derivative liabilities	0	0
Total liabilities	$ 0	$ 0

XML

Subsequent Events (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended			0 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	May 13, 2013 Subsequent Event [Member] Flood-Insurance-Related Business Process Outsourcing Practice [Member]	May 15, 2013 Subsequent Event [Member] Pending Litigation [Member] United States District Court, Eastern District of Virginia [Member]
Subsequent Event [Line Items]
Litigation settlement amount					$ 97.5
Amount of cash consideration received				46
Gain on disposition, before taxes	$ 769	$ (2)	$ 59	$ 31

XML

Investigations and Out of Period Adjustments (Tables)

12 Months Ended

Mar. 29, 2013

Out of period adjustments [Abstract]

Investigations and out of period adjustments

The impact of the adjustments on income (loss) from continuing operations before taxes is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2008 & Prior (unaudited)			Fiscal 2009 (unaudited)			Fiscal 2010			Fiscal 2011			Total
Intentional irregularities	$	10		$	(7	)	$	(4	)	$	1		$	—
Other Errors	(7		)	(16		)	3			(3		)	(23		)
	$	3		$	(23	)	$	(1	)	$	(2	)	$	(23	)

The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2013, but had no net impact on the full year fiscal 2013 results:

	Fiscal 2013
	Quarter Ended
(Amounts in millions)	June 29, 2012			September 28, 2012			December 28, 2012			March 29, 2013			Total
NHS adjustments	$	—		$	(9	)	$	—		$	—		$	(9	)
Other adjustments	3			12			4			(4		)	15
Effect on income from continuing operations before taxes	3			3			4			(4		)	6
Taxes on income	(2		)	(1		)	(4		)	(1		)	(8		)
Other income tax adjustments	(2		)	—			(2		)	(1		)	(5		)
Effect on income from discontinued operations, net of taxes	—			—			(28		)	28			—
Effect on net income attributable to CSC common shareholders	$	(1	)	$	2		$	(30	)	$	22		$	(7	)

The following table summarizes the cumulative effect on the fiscal 2011 net income attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2011, 2012 and 2013. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2011, but had no net impact on the full year fiscal 2011 results:

	Fiscal 2011
	Quarter Ended
(Amounts in millions)	July 2, 2010			October 1, 2010			December 31, 2010			April 1, 2011			Total
Operating costs inappropriately capitalized	$	15		$	38		$	8		$	6		$	67
Misapplication of US GAAP	4			3			6			(1		)	12
Miscellaneous errors	1			(1		)	9			(2		)	7
Total Nordic adjustments	20			40			23			3			86
Operating costs inappropriately capitalized	—			(1		)	(1		)	—			(2		)
Misapplication of US GAAP	—			1			3			(1		)	3
Miscellaneous errors	(4		)	5			(2		)	(3		)	(4		)
Total Australia adjustments	(4		)	5			—			(4		)	(3		)
NHS adjustments	(10		)	(2		)	(5		)	(5		)	(22		)
NPS adjustments	4			2			(10		)	(7		)	(11		)
Other adjustments	(9		)	(8		)	(18		)	(14		)	(49		)
Effect on income from continuing operations before taxes	1			37			(10		)	(27		)	1
Taxes on income	4			1			9			10			24
Other income tax adjustments	(1		)	(13		)	(6		)	18			(2		)
Effect on net income attributable to CSC common shareholders	$	4		$	25		$	(7	)	$	1		$	23

The rollover impact on income (loss) from continuing operations before taxes of the recorded out of period adjustments in fiscal 2013, 2012 and 2011 is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2011 Adjustments			Fiscal 2012 Adjustments			Fiscal 2013 Adjustments			Total Adjustments
Fiscal 2013	$	—		$	—		$	6		$	6
Fiscal 2012	—			79			7			86
Fiscal 2011	52			(29		)	(22		)	1
Fiscal 2010	(48		)	(9		)	14			(43		)
Prior fiscal years (unaudited)	(4		)	(41		)	(4		)	(49		)

Out of period adjustments recorded during fiscal 2011, 2012 and 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended April 1, 2011 under the rollover method:

	Twelve Months Ended April 1, 2011
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,582		$	1		$	15,583
Costs of services (excludes depreciation and amortization)	12,578			(4		)	12,574
Selling, general and administrative	949			1			950
Depreciation and amortization	1,068			3			1,071
Interest expense	167			—			167
Other (income) expense	(21		)	—			(21		)
Income from continuing operations before taxes	878			1			879
Taxes on income	202			(22		)	180
Income from continuing operations	676			23			699
Income from discontinued operations, net of taxes	83			—			83
Net income attributable to CSC common shareholders	740			23			763
EPS – Diluted
Continuing operations	$	4.20		$	0.15		$	4.35
Discontinued operations	0.53			—			0.53
Total	$	4.73		$	0.15		$	4.88

The impact on income (loss) from continuing operations before taxes of the out of period adjustments identified in fiscal 2013 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2013 Adjustments
Fiscal 2013	$	(9	)
Fiscal 2012	10
Fiscal 2011	(15		)
Fiscal 2010	18
Prior fiscal years (unaudited)	(4		)

The impact on income (loss) from continuing operations before taxes of the $25 million of out of period adjustments identified in fiscal 2012 related to the Company's NHS contract is attributable to the following prior fiscal years:

	Increase/(Decrease)
(Amounts in millions)	Fiscal 2012 Adjustments
Fiscal 2012	$	25
Fiscal 2011	(7		)
Fiscal 2010	(4		)
Prior fiscal years (unaudited)	(14		)

Out of period adjustments recorded in fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 29, 2013 under the rollover method:

	Twelve Months Ended March 29, 2013
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	14,993		14			$	15,007
Costs of services (excludes depreciation and amortization and restructuring costs)	11,851			6			11,857
Selling, general and administrative (excluding restructuring costs)	1,195			(1		)	1,194
Depreciation and amortization	1,076			(2		)	1,074
Restructuring costs	264			5			269
Interest expense	183			—			183
Other (income) expense	(34		)	—			(34		)
Income from continuing operations before taxes	480			6			486
Taxes on income	(35		)	13			(22		)
Income from continuing operations	515			(7		)	508
Income from discontinued operations, net of taxes	464			—			464
Net income attributable to CSC common shareholders	961			(7		)	954
EPS – Diluted
Continuing operations	$	3.20		$	(0.04	)	$	3.16
Discontinued operations	2.98			—			2.98
Total	$	6.18		$	(0.04	)	$	6.14

The following table summarizes the cumulative effect on the fiscal 2012 net loss attributable to CSC common shareholders of the consolidated out of period adjustments recorded during fiscal 2012 and fiscal 2013 under the rollover method. The amounts noted below also include certain adjustments that only impacted quarters (unaudited) within fiscal 2012, but had no net impact on the full year fiscal 2012 results:

	Fiscal 2012
	Quarter Ended
(Amounts in millions)	July 1, 2011			September 30, 2011			December 30, 2011			March 30, 2012			Total
Operating costs inappropriately capitalized	$	1		$	—		$	—		$	—		$	1
Misapplication of US GAAP	1			(1		)	2			(1		)	1
Miscellaneous errors	2			7			—			2			11
Total Nordic adjustments	4			6			2			1			13
Operating costs inappropriately capitalized	—			11			—			—			11
Misapplication of US GAAP	—			8			—			1			9
Miscellaneous errors	—			2			2			(1		)	3
Total Australia adjustments	—			21			2			—			23
NHS adjustments	(2		)	(2		)	46			(7		)	35
NPS adjustments	3			1			(5		)	11			10
Other adjustments	2			(11		)	5			9			5
Effect on income (loss) from continuing operations before taxes	7			15			50			14			86
Taxes on income	(2		)	(3		)	(2		)	(4		)	(11		)
Other income tax adjustments	1			14			(10		)	(5		)	—
Effect on net income (loss) attributable to CSC common shareholders	$	6		$	26		$	38		$	5		$	75

Out of period adjustments recorded during fiscal 2012 and fiscal 2013 had the following impact on select line items of the Consolidated Statements of Operations for the twelve months ended March 30, 2012 under the rollover method:

	Twelve Months Ended March 30, 2012
(Amounts in millions, except per-share amounts)	As Reported			Adjustments Increase/ (Decrease)			Amount Adjusted for Removal of Errors
Revenues	$	15,364		$	56		$	15,420
Costs of services (excludes depreciation and amortization, specified contract charge, settlement charge and restructuring costs)	13,019			(27		)	12,992
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	1,281			3			1,284
Selling, general and administrative (excludes restructuring costs)	1,128			2			1,130
Depreciation and amortization	1,147			(2		)	1,145
Restructuring costs	140			(5		)	135
Interest expense	175			(3		)	172
Other (income) expense	(6		)	2			(4		)
Loss from continuing operations before taxes	(4,454		)	86			(4,368		)
Taxes on income	(84		)	11			(73		)
Loss from continuing operations	(4,370		)	75			(4,295		)
Income from discontinued operations, net of taxes	145			—			145
Net loss attributable to CSC common shareholders	(4,242		)	75			(4,167		)
EPS – Diluted
Continuing operations	$	(28.31	)	$	0.48		$	(27.83	)
Discontinued operations	0.94						0.94
Total	$	(27.37	)	$	0.48		$	(26.89	)

XML

Summary of Significant Accounting Policies (Details) (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Revenue Recognition [Abstract]
Maximum percentage of the Company's revenues recognized under the percentage-of-completion method (in hundredths)	17.90%
Cash payments for interest and income taxes [Abstract]
Interest	$ 186	$ 177	$ 173
Taxes on income, net of refunds	214	139	219
Non-cash investing activities [Abstract]
Capital expenditures in accounts payable and accrued expenses	32	47	122
Capital expenditures through capital lease obligations	181	270	289
Assets acquired under long-term financing	26	32	115
Common share dividends declared but not yet paid	30	31
Foreign Currency [Abstract]
Other comprehensive income	(83)	(124)	261
Tax effect of foreign currency translation adjustment included in AOCI	12	1	3
Net income attributable to CSC common shareholders [Abstract]
Income from continuing operations, net of tax	497	(4,387)	657
From discontinued operations	464	145	83
Net income (loss) attributable to CSC common stockholders	$ 961	$ (4,242)	$ 740
Common share information [Abstract]
Weighted average common shares outstanding for basic EPS (in shares)	154,590,000.000	155,012,000.000	154,488,000.000
Dilutive effect of stock options and equity awards (in shares)	967,000.000	0.000	2,117,000.000
Shares for diluted earngns (loss) per share (in shares)	155,557,000.000	155,012,000.000	156,605,000.000
Basic EPS:
Continuing operations (in dollars per share)	$ 3.22	$ (28.31)	$ 4.25
Discontinued operations (in dollars per share)	$ 3.00	$ 0.94	$ 0.54
Total	$ 6.22	$ (27.37)	$ 4.79
Diluted EPS:
From continuing operations - diluted EPS (in dollars per share)	$ 3.20	$ (28.31)	$ 4.20
From discontinued operations - diluted EPS (in dollars per share)	$ 2.98	$ 0.94	$ 0.53
Total	$ 6.18	$ (27.37)	$ 4.73
Antidilutive stock options not included in the computation of earning per share (in shares)	14,755,024	17,592,316	9,431,834
Stock Options [Member]
Diluted EPS:
Antidilutive stock options not included in the computation of earning per share (in shares)	442,228
Restricted Stock Units (RSUs) [Member]
Diluted EPS:
Antidilutive stock options not included in the computation of earning per share (in shares)			1,064,959

XML

Pension and Other Benefit Plans

12 Months Ended

Mar. 29, 2013

Pension And Other Benefit Plans [Abstract]

Pension and other benefit plans

Pension and Other Benefit Plans

The Company and its subsidiaries offer a number of pension and postretirement benefits, life insurance benefits, deferred compensation, and other plans, as described below. All plans are accounted for using the guidance of ASC 710 "Compensation - General" and ASC 715 “Compensation—Retirement Benefits” and are measured as of the end of the fiscal year.

Contributory, defined benefit pension plans have been generally available to U.S. and U.K. employees. However, the largest U.S. and U.K. defined benefit plans were frozen for most participants in prior years. Certain non-U.S. employees are enrolled in defined benefit pension plans in the country of domicile. In addition, the Company has two supplemental executive retirement plans (SERP), which are non-qualified, noncontributory pension plans. The Company provides subsidized healthcare and life insurance retirement benefits for certain U.S. employees and retirees, generally for those employed prior to August 1992, as well as healthcare, dental and life insurance benefits for certain non-U.S. employees. A significant number of employees outside the U.S. are covered by government sponsored programs at no direct cost to the Company other than related payroll taxes.

CSC utilizes actuarial methods to recognize the expense for pension and other postretirement benefit plans. Inherent in the application of these actuarial methods are key assumptions, including, but not limited to, discount rates and expected long-term rates of return on plan assets. Changes in the related pension and other postretirement benefit costs may occur in the future due to changes in the underlying assumptions, changes in the number and composition of plan participants and changes in the level of benefits provided.

As discussed in Note 17, the Company initiated restructuring activities in both fiscal 2013 and 2012. The Fiscal 2012 Plan restructuring resulted in contractual termination benefit charges for some employees participating in a certain U.K. pension plan. During fiscal 2012, the Company recognized $20 million in expected contractual termination benefits which are reflected in the projected benefit obligation at the end of fiscal 2012 and recognized as expense in net periodic pension cost during fiscal 2012. During fiscal 2013, the projected benefit obligation and the net periodic pension cost reflect adjustments to the original estimates for actual contractual termination benefits paid in relation to the Fiscal 2012 Plan in the amount of $(3) million. Additionally, the Fiscal 2013 Plan restructuring resulted in expected contractual termination benefits for some employees participating in this same U.K. pension plan. During fiscal 2013, the Company recognized $23 million in expected contractual termination benefits which are reflected in the projected benefit obligation at the end of fiscal 2013 and recognized as expense in net periodic pension cost during fiscal 2013.

Effective July 1, 2012 a certain Norway pension plan was amended to change the index used to benchmark pension payment increases. The plan was remeasured at July 1, 2012 resulting in a reduction to the projected benefit obligation of $28 million, improving the plan's funded status. The plan's fiscal 2013 expense was also remeasured for the remaining 9 months of the fiscal year using a discount rate of 4%.

On December 31, 2012, the Company made a discretionary cash contribution of $400 million to its largest U.S. pension plan resulting in a remeasurement of the plan. The effects of this remeasurement were recorded during the fourth quarter of fiscal 2013 and resulted in a reduction of net periodic pension cost of $7.6 million for fiscal 2013 and additional plan liabilities of $379 million using a new discount rate of 4%.

On March 26, 2013, the Company and its Canadian subsidiary made additional discretionary cash contributions of $80 million and $20 million, respectively, to its various U.S. pension plans and to its largest Canadian pension plan.

Effective December 31, 2012, a second U.S. pension plan was remeasured as a result of a plan amendment which ceased benefit accruals on or after January 5, 2013. The effects of this remeasurement were recorded during the fourth quarter of fiscal 2013 and resulted in a reduction of net periodic pension cost of $1.1 million for fiscal 2013 and additional plan liabilities of $3 million using a new discount rate of 4.2%

On April 7, 2010, the Company announced an action to discontinue the accrual of future benefits for certain U.K. pension plans, effective July 1, 2010. As a result of this plan amendment, the Company recognized a curtailment loss of $0.4 million in the fourth quarter of fiscal 2010. In addition, the Company remeasured the amended U.K. plans’ pension expense for fiscal 2011 to reflect (a) a new discount rate of 5.6%, (b) the year-to-date increase in plan assets, and (c) the change in amortization basis to the expected average remaining life of plan participants. The U.K. plans’ discount rate was derived from a published rate: Markit iBoxx GBP Corporates AA 15+ Years Index. This remeasurement resulted in a $75 million reduction to the pension benefit obligation.

In response to the passage of the Patient Protection and Affordable Care Act of 2010 (PPACA), a number of changes were made to the underlying healthcare coverage offered to certain US retirees. In conjunction with those changes, the Company established limits on the level of employer subsidy it will provide to some retirees. The plans were amended and the impact of these changes is first reflected on April 1, 2011. In addition, although many administrative provisions of PPACA have not yet been promulgated by regulatory agencies, CSC included its best estimate of their financial impact into the benefit obligation for its U.S. postretirement benefit plans as of March 30, 2012, and the impact on fiscal 2012’s net periodic benefit cost was immaterial. In 2012, the retiree medical plans were further amended to allow Medicare Part D subsidies from 2012 and beyond to be collected by the healthcare provider. This subsequent change is reflected as of March 30, 2012 and the impact on fiscal 2012's net periodic benefit cost was immaterial.

Pension Plans

The following tables provide reconciliations of the changes in the plans’ projected benefit obligations and assets, and a statement of their funded status:

Reconciliation of Projected Benefit Obligation	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Projected benefit obligation at beginning of year	$	3,284		$	2,921		$	2,732		$	2,470
Service cost	10			10			25			33
Interest cost	153			164			123			128
Plan participants’ contributions	3			3			7			8
Amendments	—			—			(28		)	(11		)
Business/contract acquisitions/divestitures	—			—			(9		)	61
Contractual termination benefits	—			—			19			20
Settlement/curtailment	(5		)	—			(37		)	(36		)
Actuarial loss (gain)	194			314			400			151
Benefits paid	(133		)	(128		)	(79		)	(70		)
Foreign currency exchange rate changes	—			—			(141		)	(22		)
Projected benefit obligation at end of year	$	3,506		$	3,284		$	3,012		$	2,732

Reconciliation of Fair Value of Plan Assets	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Fair value of plan assets at beginning of year	$	2,419		$	2,276		$	2,295		$	2,083
Actual return on plan assets	245			140			314			148
Employer contribution	591			128			157			121
Plan participants’ contributions	3			3			7			8
Benefits paid	(133		)	(128		)	(79		)	(70		)
Business/contract acquisitions/divestitures	—			—			5			47
Plan settlement	—			—			(30		)	(31		)
Foreign currency exchange rate changes	—			—			(119		)	(11		)
Fair value of plan assets at end of year	$	3,125		$	2,419		$	2,550		$	2,295
Funded status at end of year	$	(381	)	$	(865	)	$	(462	)	$	(437	)

The following table provides the amounts recorded in the Company’s consolidated balance sheet:

	U.S. Plans						Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			March 29, 2013			March 30, 2012
Non-current assets	$	—		$	—		$	23		$	13
Current liabilities - Accrued expenses and other current liabilities	(7		)	(8		)	(3		)	(9		)
Non-current liabilities - Other long-term liabilities	(374		)	(857		)	(482		)	(441		)
Net amount recorded	$	(381	)	$	(865	)	$	(462	)	$	(437	)

The following is a summary of amounts in accumulated other comprehensive loss, before tax effects, as of March 29, 2013 and March 30, 2012 that have not been recognized in the consolidated statements of operations as components of net periodic pension cost:

	U.S. Plans				Non-U.S. Plans
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013			March 30, 2012
Net transition obligation	$	—	$	—	$	3		$	5
Prior service cost	5		7		(24		)	2
Net actuarial loss	1,140		1,077		895			712
Accumulated other comprehensive loss	$	1,145	$	1,084	$	874		$	719

The following table summarizes the weighted average assumptions used in the determination of the Company’s pension plans’ benefit obligations as of March 29, 2013 and March 30, 2012:

	U.S. Plans				Non-U.S. Plans
	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Discount rate	4.4	%	4.8	%	4.1	%	4.7	%
Rates of increase in compensation levels (1)	4.1	%	4.1	%	3.5	%	4.1	%

(1) The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average rate for all pension plans, including frozen plans, is 0.6% and 0.7%, respectively, for U.S. Plans, and 0.6% and 0.9%, respectively, for Non-U.S. Plans.

The following table lists selected information for the pension plans as of March 29, 2013 and March 30, 2012:

	U.S. Plans				Non-U.S. Plans
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Projected benefit obligation	$	3,506	$	3,284	$	3,012	$	2,732
Accumulated benefit obligation	3,487		3,259		2,969		2,655
Fair value of plan assets	3,125		2,419		2,550		2,295

	Plans with Projected Benefit Obligation In Excess of Plan Assets (U.S. and Non-U.S.)				Plans with Accumulated Benefit Obligation in Excess of Plan Assets (U.S. and Non-U.S.)
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Projected benefit obligation	$	6,270	$	5,845	$	6,132	$	5,844
Accumulated benefit obligation	6,217		5,770		6,100		5,770
Fair value of plan assets	5,405		4,531		5,276		4,530

The net periodic pension cost for U.S. and non-U.S. pension plans included the following components:

	U.S. Plans									Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011			March 29, 2013			March 30, 2012			April 1, 2011
Service cost	$	10		$	10		$	9		$	25		$	33		$	32
Interest cost	153			164			164			123			128			122
Expected return on assets	(160		)	(146		)	(157		)	(124		)	(129		)	(128		)
Amortization of transition obligation	—			—			—			1			1			1
Amortization of prior service costs	2			2			2			(1		)	1			1
Amortization of unrecognized net loss	42			32			23			20			13			18
Contractual termination benefit	—			—			—			20			20			—
Settlement/curtailment	—			—			—			—			2			—
Net periodic pension cost	$	47		$	62		$	41		$	64		$	69		$	46

Other before tax changes in plan assets and benefit obligations recognized in other comprehensive income during fiscal years 2013, 2012 and 2011 included the following components:

	U.S. Plans									Non-U.S. Plans
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011			March 29, 2013			March 30, 2012			April 1, 2011
Net actuarial (gain) / loss	$	105		$	319		$	83		$	201		$	133		$	(118	)
Prior service (credit) / cost	—			—			—			(27		)	(11		)	—
Amortization of:
Transition (asset) /obligation	—			—			—			(1		)	(1		)	(1		)
Prior service (credit) / cost	(2		)	(2		)	(2		)	1			(1		)	(1		)
Net actuarial (gain) / loss	(42		)	(32		)	(23		)	(25		)	(20		)	(24		)
Foreign currency exchange rate changes	—			—			—			6			(4		)	—
Total recognized in other comprehensive income	$	61		$	285		$	58		$	155		$	96		$	(144	)

Other comprehensive (gain) loss related to unamortized pension costs for the years ended March 29, 2013, March 30, 2012, and April 1, 2011 was $210 million (net of taxes of $6 million), $257 million (net of taxes of $124 million), and $(62) million (net of taxes of $20 million), respectively.

The estimated net transitional obligation, prior service cost and actuarial loss for defined benefit plans that will be amortized from accumulated other comprehensive income into net periodic pension cost over the next fiscal year are $1 million, $(1) million and $66 million, respectively.

The weighted-averages of the assumptions used to determine net periodic pension cost were:

	U.S. Plans						Non-U.S. Plans
	March 29, 2013		March 30, 2012		April 1, 2011		March 29, 2013		March 30, 2012		April 1, 2011
Discount or settlement rates	4.6	%	5.7	%	6.2	%	4.7	%	5.2	%	5.3	%
Expected long-term rates of return on assets	6.8	%	7.5	%	8.3	%	5.4	%	6.1	%	6.7	%
Rates of increase in compensation levels (1)	4.1	%	4.3	%	4.3	%	4.1	%	4.1	%	4.1	%

(1) The weighted average calculation is computed using rates of increase for active plans where participants are accruing future benefits. For fiscal 2013 and 2012, the weighted average for all pension plans, including frozen plans, is 0.7% and 0.7%, respectively, for U.S. Plans, and 0.9% and 1.0%, respectively, for Non-U.S. Plans.

U.S. pension assets are held in a trust that includes both separate accounts and commingled funds. Non-U.S. assets are subject to country specific regulations and invest primarily in commingled funds. The U.S. pension trust and the U.K. pension plans account for 90% of the total pension plan assets.

Information about the expected cash flows for pension plans as of March 29, 2013, is as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Employer contributions:
2014 (expected)	$	8	$	115
Expected Benefit Payments:
2014	$	151	$	84
2015	152		83
2016	165		86
2017	176		94
2018	188		99
2019-2023	1,069		595

No plan assets are expected to be returned to the Company in the next fiscal year.

Other Postretirement Benefit Plans

The following tables provide reconciliations of the changes in postretirement plans’ benefit obligations and assets and a statement of their funded status:

Reconciliation of Accumulated Postretirement Benefit Obligation
(Amounts in millions)	March 29, 2013			March 30, 2012
Accumulated benefit obligation at beginning of year	$	253		$	214
Service cost	4			3
Interest cost	11			11
Plan participants’ contributions	—			—
Business/contract acquisitions/divestitures	—			—
Amendments	—			21
Actuarial loss (gain)	(6		)	20
Benefits paid	(10		)	(16		)
Retiree drug subsidy reimbursement	1			1
Foreign currency exchange rate changes	—			(1		)
Accumulated benefit obligation at end of year	$	253		$	253
Reconciliation of Fair Value of Plan Assets
(Amounts in millions)	March 29, 2013			March 30, 2012
Fair value of plan assets at beginning of year	$	81		$	79
Actual return on plan assets	7			5
Employer contribution	6			13
Plan participants’ contributions	—			—
Benefits paid	(10		)	(16		)
Fair value of plan assets at end of year	$	84		$	81
Funded status at end of year	$	(169	)	$	(172	)

The following table provides the amounts recorded in the Company’s consolidated balance sheets:

(Amounts in millions)	March 29, 2013			March 30, 2012
Current liabilities - Accrued expenses and other current liabilities	$	(5	)	$	(5	)
Non-current liabilities - Other long-term liabilities	(164		)	(167		)
Net amount recorded	$	(169	)	$	(172	)

The following is a summary of amounts in accumulated other comprehensive loss as of March 29, 2013 and March 30, 2012 that have not been recognized in the consolidated statements of operations as components of net periodic benefit cost:

(Amounts in millions)	March 29, 2013			March 30, 2012
Net transition obligation	$	—		$	—
Prior service (gain) cost	(17		)	(19		)
Net actuarial loss	99			123
Accumulated other comprehensive loss	$	82		$	104

The following table lists selected information for other postretirement benefit plans as of March 29, 2013 and March 30, 2012:

					Plans with Accumulated Postretirement Benefit Obligation in Excess of the Fair Value of Plan Assets
(Amounts in millions)	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Accumulated postretirement benefit obligation	$	253	$	253	$	253	$	253
Fair value of plan assets	84		81		84		81

As of March 29, 2013 and March 30, 2012, the Company had no postretirement healthcare plan assets outside the U.S. Benefits paid include amounts paid directly from plan assets and amounts paid by the Company.    

The following table summarizes the weighted average assumptions used in the determination of the Company’s postretirement benefit obligations as of March 29, 2013 and March 30, 2012:

	March 29, 2013		March 30, 2012
Discount rate	4.1	%	4.5	%

The assumed healthcare cost trend rate used in measuring the accumulated postretirement benefit obligation was 4.5% for fiscal 2013, declining to 2.3% for 2026 and subsequent years for retirees whose age is less than 65. For retirees whose age is 65 or older, the assumed healthcare cost trend used in measuring accumulated postretirement benefit obligation was 3.6% for fiscal 2013, declining to 2.3% for 2026 and subsequent years. Assumed healthcare cost trend rates have a significant effect on the amounts reported for the healthcare plans. A one-percentage point change in the assumed healthcare cost trend rates would have had the following effect:

	One Percentage Point
(Amounts in millions)	Increase		Decrease
Effect on accumulated postretirement benefit obligation as of March 29, 2013	$	14	$	(12	)
Effect on net periodic postretirement benefit cost for fiscal 2013	1		(1		)

The net periodic benefit cost for other postretirement benefit plans included the following components:

(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Service cost	$	4		$	3		$	4
Interest cost	11			11			14
Expected return on assets	(5		)	(6		)	(6		)
Amortization of transition obligation	—			1			2
Amortization of prior service costs	(2		)	(6		)	—
Recognized actuarial loss	16			13			10
Net provision for postretirement benefits	$	24		$	16		$	24

Other before tax changes in plan assets and benefit obligations recognized in other comprehensive income during fiscal years 2013, 2012 and 2011 included the following components:

(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Net actuarial (gain) / loss	$	(8	)	$	21		$	(1	)
Prior service (credit) / cost	—			21			(50		)
Amortization of:
Transition (asset) /obligation	—			(1		)	(3		)
Prior service (credit) / cost	2			6			—
Actuarial (gain) / loss	(16		)	(13		)	(10		)
Foreign currency exchange rate changes	—			—			—
Total recognized in other comprehensive income	$	(22	)	$	34		$	(64	)

Other comprehensive (gain) loss related to unamortized postretirement benefit plan costs for the years ended March 29, 2013, March 30, 2012, and April 1, 2011 was $(13) million (net of taxes of $9 million), $22 million (net of taxes of $12 million), and $(39) million (net of taxes of $21 million), respectively.

The estimated net transitional obligation, prior service gain and actuarial loss for other postretirement benefit plans that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year are $0 million, $(2) million and $13 million, respectively.

The weighted-averages of the assumptions used to determine net periodic benefit cost were as follows. See the above discussion of Pension Plans for how the assumptions are developed.

Fiscal Year End	2013		2012		2011
Discount or settlement rates	4.5	%	5.3	%	6.1	%
Expected long-term rates of return on assets(1)	6.5	%	7.2	%	8.3	%

⁽¹⁾ The Company had no other postretirement benefit plan assets outside the U.S.

Information about the expected cash flows for other postretirement benefit plans follows. No significant cash flow is expected for other postretirement benefit plans outside the U.S.

(Amounts in millions)	Employer Contributions
2014 (expected)	$	9
Expected Benefit Payments
2014	$	13
2015	15
2016	16
2017	17
2018	18
2019-2023	94

No plan assets are expected to be returned to the Company in the next fiscal year.

Retirement Plan Asset Strategy

The Company’s investment goals and risk management strategy for plan assets takes into account a number of factors, including the time horizon of the pension plans’ obligations. Plan assets are invested in various asset classes that are expected to produce a sufficient level of diversification and a reasonable amount of investment return over the long term. Sufficient liquidity is maintained to meet benefit obligations as they become due. Third party investment managers are employed to invest assets in both passively-indexed and actively-managed strategies. Equities are primarily invested broadly in domestic and foreign companies across market capitalizations and industries. Fixed income securities are invested broadly, primarily in government treasury, corporate credit, mortgage backed and asset backed investments.

Risks include, but are not limited to, longevity risk, inflation risk, and the risk of other changes in market conditions that reduce the value of plan assets. Also, a decline in the yield of high quality corporate bonds may adversely affect discount rates resulting in an increase in the pension and other post retirement obligations. These risks, among others, could cause the plans’ funded status to deteriorate, increasing reliance on Company contributions. Generally, derivatives are permitted although their current use is limited. They are primarily used in the U.S. pension trust fixed income portfolios for duration and interest rate risk management and equity portfolios to gain market exposure, and are expected to be used in the U.K. pension schemes for inflation risk management. The Company also has investments in insurance contracts to pay plan benefits in certain countries.

For the U.S. pension trust, an allocation range by asset class is developed. The allocation had a significant weighting to equity investments in part due to the relatively long duration of the plans’ obligations. For the majority of the fiscal year, the allocation range for the U.S. pension trust was 49% – 66% equities, 34% – 44% fixed income securities and 0% – 10% cash and other investments. Asset allocations are monitored closely and investment reviews are conducted regularly. The Company consults with internal and external advisors regarding asset strategy and on March 21, 2013 adopted an allocation range for the U.S. pension trust of 37% - 66% equities, 29% - 44% fixed income securities, 0% - 25% alternative investments, and 0% - 10% cash and other investments. The alternative investments allocation may include, but is not limited to, hedge funds, real estate, commodities, private equity and infrastructure investments.

For the U.K. pension schemes, the Company's second largest pension plans by assets and projected liabilities, a target allocation by asset class is developed. The allocation had a significant weighting to equity investments in part due to the relatively long duration of the plans' obligations. For the majority of the fiscal year the allocation targets for the U.K. pension schemes were 40% equities, 31% fixed income securities, and 29% indexed-Gilts. Asset allocations are monitored closely by the schemes' trustees and investment reviews are conducted regularly.

Retirement Plan Asset Valuation Techniques

Cash equivalents are primarily short term money market commingled funds that are categorized as Level 2, except for funds that have quoted prices in active markets, which are classified as Level 1. They are valued at cost plus accrued interest which approximates fair value.

Fixed income separate accounts are categorized as Level 2. These investments are generally priced using model-based pricing methods that use observable market data as inputs. Broker dealer bids or quotes of securities with similar characteristics may also be used.

Domestic and global equity separate accounts are categorized as Level 1 if the securities trade on national or international exchanges and are valued at their last reported closing price.

Insurance contracts purchased to cover benefits payable to retirees are valued using the assumptions used to value the projected benefit obligation. Most of the plans' insurance contracts are categorized as level 2 while one plan has a level 3 insurance contract.

The fair value of our pension plan assets and postretirement benefit plans by investment category and the corresponding level within the fair value hierarchy as of March 29, 2013 are as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Fair value of pension plan assets	$	3,125	$	2,550
Fair value of other postretirement benefit plan assets	84		—
Total fair value of retirement plan assets as of March 29, 2013	$	3,209	$	2,550

U.S. Pension and Other Postretirement Benefit Plans
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	Global/International	$	31	$	38	$	—	$	69
	U.S. Domestic Stocks	51		—		—		51
	Domestic Equity commingled funds	5		1,325		—		1,330
	Global Equity commingled funds	—		380		—		380
	Global Equity mutual funds	83		—		—		83
Fixed Income:
	U.S. Treasuries	—		87		—		87
	U.S. Government Agencies	—		11		—		11
	Non U.S. Government	—		5		—		5
	Mortgage and asset backed securities	—		131		—		131
	Corporate(b)	—		74		—		74
	Fixed income commingled funds	3		959		—		962
Cash equivalents		8		117		—		125
Total		$	181	$	3,127	$	—	$	3,308
Unsettled Trade Receivable and Accrued Income								79
Unsettled Trade Payable and Accrued Expenses								(178		)
Fair value of assets for U.S. pension and postretirement medical plans as of March 29, 2013								$	3,209

Non-U.S. Pension Plan Assets
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	U.S./North American Equity commingled funds	$	—	$	54	$	—	$	54
	Global/International Equity commingled funds	—		915		—		915
	Global equity mutual funds	—		—		—		—
Fixed Income:
	Fixed income commingled funds	—		1,311		—		1,311
Insurance contracts		—		157		6		163
Cash equivalents		—		25		—		25
Other		—		83		—		83
Total		$	—	$	2,545	$	6	$	2,551
Unsettled Trades								(1		)
Fair value of non-U.S. pension assets as of March 29, 2013								$	2,550

(a) The majority of retirement plan assets are invested in a variety of commingled funds and fixed income. This results in a high amount of Level 2 investments.

(b) Primarily investment grade.

Below is a reconciliation of the assets valued using significant unobservable inputs (Level 3):

	Non-U.S. Plans Insurance Contracts
(Amounts in millions)
Beginning balance as of March 30, 2012	$	5
Actual return on plan assets relating to assets still held at the reporting date	1
Actual return on plan assets relating to assets sold during the period	—
Purchases, sales, and settlements	—
Transfers in and / or out of Level 3	—
Changes due to exchange rates	—
Ending balance as of March 29, 2013	$	6

The fair value of our pension plan assets and postretirement benefit plans by investment category and the corresponding level within the fair value hierarchy as of March 30, 2012, are as follows:

(Amounts in millions)	U.S. Plans		Non-U.S. Plans
Fair value of pension plan assets	$	2,419	$	2,295
Fair value of other postretirement benefit plan assets	81		—
Total fair value of retirement plan assets as of March 30, 2012	$	2,500	$	2,295

U.S. Pension and Other Postretirement Benefit Plans
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	Global/International	$	25	$	34	$	—	$	59
	U.S. Domestic Stocks	40		—		—		40
	Domestic Equity commingled funds	5		1,040		—		1,045
	Global Equity commingled funds	—		250		—		250
	Global Equity mutual funds	93		—		—		93
Fixed Income:
	U.S. Treasuries	—		72		—		72
	U.S. Government Agencies	—		10		—		10
	Non U.S. Government	—		2		—		2
	Mortgage and asset backed securities	—		118		—		118
	Corporate(b)	—		82		—		82
	Fixed income commingled funds	3		689		—		692
Cash equivalents		8		58		—		66
Total		$	174	$	2,355	$	—	$	2,529
Unsettled Trade Receivable and Accrued Income								84
Unsettled Trade Payable and Accrued Expenses								(113		)
Fair value of assets for U.S. pension and postretirement medical plans as of March 30, 2012								$	2,500

NON-U.S. PENSION PLAN ASSETS
(Amounts in millions)		Level 1		Level 2 (a)		Level 3		Total
Equity:
	U.S./North American Equity commingled funds	$	—	$	40	$	—	$	40
	Global/International Equity commingled funds	—		757		—		757
	Global equity mutual funds	78		—		—		78
Fixed Income:
	Fixed income commingled funds	115		1,104		—		1,219
Insurance contracts		—		141		5		146
Cash equivalents		—		13		—		13
Other		—		42		—		42
Total		$	193	$	2,097	$	5	$	2,295
Unsettled Trades								—
Fair value of non-U.S. pension assets as of March 30, 2012								$	2,295

(a) The majority of retirement plan assets are invested in a variety of commingled funds and fixed income. This results in a high amount of Level 2 investments.

(b) Primarily investment grade.

Below is a reconciliation of the assets valued using significant unobservable inputs (Level 3):

	Non-U.S. Plans Insurance Contracts
(Amounts in millions)
Beginning balance as of April 1, 2011	$	—
Asset acquired in purchase of iSOFT	3
Actual return on plan assets relating to assets still held at the reporting date	—
Actual return on plan assets relating to assets sold during the period	—
Purchases, sales, and settlements	2
Transfers in and / or out of Level 3	—
Changes due to exchange rates	—
Ending balance as of March 30, 2012	$	5

The asset allocation of pension plans at March 29, 2013 and March 30, 2012, respectively, is as follows:

	U.S. Plans				Non-U.S. Plans
Asset Category	March 29, 2013		March 30, 2012		March 29, 2013		March 30, 2012
Equity securities	58	%	59	%	38	%	38	%
Debt securities	38	%	39	%	51	%	53	%
Cash and other	4	%	2	%	11	%	9	%
Total	100	%	100	%	100	%	100	%

The asset allocation for U.S. other postretirement benefit plans at March 29, 2013 and March 30, 2012, respectively, is as follows:

	Percentage of Plan Assets at Year End
Asset Category	March 29, 2013		March 30, 2012
Equity securities	29	%	30	%
Debt securities	19	%	20	%
Cash and other	52	%	50	%
Total	100	%	100	%

Return on Assets

In the U.S., the Company uses a “building block” approach to compute the expected long-term rate of return using major asset classes expected in the plan. Starting with long run projected bond yields, an equity risk premium is added to estimate the equity long-term rate of return. Consideration is also given to the extent active management is employed in each asset class. A single expected long-term rate of return on plan assets is then calculated by weighting each asset class. Historical returns and peer data were also reviewed

Retirement Plan Discount Rate

The U.S. discount rate assumption is prepared with a two step process; the first step discounts the stream of expected annual benefit payments using high-quality corporate bond yields. In step two, the sum of each year’s discounted benefit payments are used to determine a single equivalent discount rate. In fiscal 2013, the discount rates for the U.S. pension and other postretirement plans were developed using a single yield curve, the Aon Hewitt AA Only Above Median Curve. This yield curve is a hypothetical AA or greater yield curve represented by a series of annualized individual spot discount rates going out 99 years. This curve provides a more transparent view to the underlying bonds and is available daily which provides for a discount rate to be calculated specific to the Company's fiscal year end. For years prior to fiscal 2013, the U.S. discount rates were determined using an average of two nationally recognized independent third party yield curves.

In fiscal 2012 the UK pension plans began using the AA Corporate Bond Mercer Pension Discount Yield Curve to set the discount rate. This yield curve approach determines a single equivalent discount rate from a curve based on market data using sample scheme cash flow data as a proxy to scheme specific liability cash flows. The benefits of the Mercer Pension Discount Yield Curve over the iBoxx GBP Corporates AA +15 index is that it provides the flexibility to use cash flow data over the average duration of the pension scheme's liabilities rather than over a set time period of 15 years. For years prior to fiscal 2012, the U.K. discount rate assumption was set by reference to the yield on the iBoxx GBP AA rated +15 years corporate bond index with an appropriate adjustment for duration if necessary after considering yield curve models and conditions in credit markets.

Other Benefit Plans

The Company sponsors several defined contribution plans for substantially all U.S. employees and certain foreign employees. The plans allow employees to contribute a portion of their earnings in accordance with specified guidelines. At March 29, 2013, plan assets included 10,730,413 shares of the Company’s common stock. During fiscal 2013, fiscal 2012, and fiscal 2011, the Company contributed $213 million, $223 million, and $207 million, respectively.

Pursuant to collective bargaining agreements, the Company makes contributions, generally at a stated hourly rate, to various multi-employer pension funds on behalf of its union-represented employees. All of these plans are within the Company's NPS segment. None of the contributions by the Company are individually significant to the multi-employer plans nor do they have a material impact on the Company's financial statements. The risks of participating in these multi-employer plans are different from single-employer plans. If a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers. The Company's contributions for fiscal years 2013, 2012, and 2011 were $11 million, $11 million, and $10 million, respectively.

Effective August 14, 1995, the Company adopted the Computer Sciences Corporation Deferred Compensation Plan (the Plan). The Plan consists of two separate plans, one for the benefit of key executives and one for the benefit of non-employee directors. Pursuant to the Plan, certain management and highly compensated employees are eligible to defer all or a portion of their regular salary that exceeds the limitation set forth in Internal Revenue Section 401(a)(17) and all or a portion of their incentive compensation, and non-employee directors are eligible to defer up to 100% of their compensation. Each plan participant is fully vested in all deferred compensation and earnings credited to his or her account. The liability, which is included in “Other long-term liabilities” under the Plan, amounted to $125 million as of March 29, 2013 and $129 million as of March 30, 2012. The Company’s expense under the Plan totaled $8 million, $8 million, and $8 million, for fiscal 2013, fiscal 2012, and fiscal 2011, respectively.

XML

Restructuring Costs

12 Months Ended

Mar. 29, 2013

Restructuring Costs [Abstract]

Restructuring and Related Activities Disclosure

Restructuring Costs

The Company recorded restructuring costs of $264 million and $140 million for fiscal years 2013 and 2012, respectively, as described below. There were no restructuring costs for fiscal 2011.

Fiscal 2013 Plan

In September 2012, the Company initiated restructuring actions (the Fiscal 2013 Plan) across its business segments. The objectives of the Fiscal 2013 Plan are to (i) further increase the use of lower cost off-shore resources, and (ii) reduce headcount in order to align resources to support business needs, including the assessment of management span of control and layers. Actions under the Fiscal 2013 Plan commenced in September 2012 and are expected to continue through fiscal 2014.

Total restructuring costs for the Fiscal 2013 Plan recorded during fiscal 2013 were $233 million, including pension benefit augmentations of $21 million, that are owed to certain employees in accordance with legal or contractual obligations, and which will be paid out over several years as part of normal pension distributions. The total restructuring costs also included $17 million of professional fees incurred for restructuring related consultancy.

The composition of the restructuring liability for the Fiscal 2013 Plan as of March 29, 2013 is as follows:

(Amounts in millions)	Restructuring liability as of March 30, 2012		Costs expensed in fiscal 2013		Less: costs not affecting restructuring liability (1)			Cash paid			Other(3)			Restructuring liability as of March 29, 2013
Workforce reductions	$	—	$	206	$	(22	)	$	(27	)	$	(2	)	$	155
Facilities costs	—		10		—			—			—			10
Other(2)	—		17		—			(6		)	—			11
	$	—	$	233	$	(22	)	$	(33	)	$	(2	)	$	176

⁽¹⁾  Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾  Other direct costs associated with the restructuring program.

⁽³⁾  Foreign currency translation adjustments.

Fiscal 2012 Plan

In March 2012, the Company initiated restructuring actions (the Fiscal 2012 plan) primarily impacting its MSS segment. The objectives of the Fiscal 2012 plan were to (i) align the Company's workforce across various geographies with business needs, (ii) increase use of lower cost off-shore resources, and (iii) optimize utilization of facilities. Actions under the Fiscal 2012 plan commenced in March 2012 and were carried out through fiscal 2013.

The restructuring costs for the Fiscal 2012 plan recorded during the year ended March 29, 2013 and March 30, 2012 were $31 million and $140 million, respectively, and were associated primarily with employee terminations. The net restructuring costs include pension benefit augmentations of $1 million and $20 million for fiscal 2013 and fiscal 2012, respectively, that were due to certain employees in accordance with legal or contractual obligations, which will paid out over several years as part of normal pension distributions.

The composition of the restructuring liability for the Fiscal 2012 plan as of March 29, 2013 is as follows:

(Amounts in millions)	Restructuring liability as of March 30, 2012		Costs expensed in fiscal 2013		Less: costs not affecting restructuring liability (1)			Cash paid			Other (2)			Restructuring liability as of March 29, 2013
Workforce reductions	$	110	$	31	$	(1	)	$	(129	)	$	(2	)	$	9
Facilities costs	9		—		—			(4		)	—			5
Total	$	119	$	31	$	(1	)	$	(133	)	$	(2	)	$	14

⁽¹⁾ Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾ Foreign currency translation adjustments

The composition of the restructuring liability for the Fiscal 2012 plan as of March 30, 2012 is as follows:

(Amounts in millions)	Restructuring liability as of April 1, 2011		Costs expensed in fiscal 2012		Less: costs not affecting restructuring liability (1)			Cash paid		Other (2)			Restructuring liability as of March 30, 2012
Workforce reductions	$	—	$	131	$	(20	)	$	—	$	(1	)	$	110
Facilities costs	—		9		—			—		—			9
Total	$	—	$	140	$	(20	)	$	—	$	(1	)	$	119

⁽¹⁾ Charges primarily consist of pension benefit augmentations and are recorded as a pension liability.

⁽²⁾ Foreign currency translation adjustments

The composition of restructuring costs, by segment, for fiscal 2013 and 2012 is as follows:

	Twelve Months Ended March 29, 2013
(Amounts in millions)	Fiscal 2013 Plan		Fiscal 2012 Plan		Total
NPS	$	13	$	—	$	13
MSS	181		9		190
BSS	17		22		39
Corporate	22		—		22
Total	$	233	$	31	$	264

	Twelve Months Ended March 30, 2012
(Amounts in millions)	Fiscal 2012 Plan
NPS	$	1
MSS	108
BSS	31
Corporate	—
Total	$	140

Of the total $190 million restructuring liability as of March 29, 2013, $186 million is included in accrued expenses and other current liabilities and $4 million is included in other long-term liabilities. Of the total $119 million restructuring liability as of March 30, 2012, $112 million was included in accrued expenses and other current liabilities and $7 million was included in other long-term liabilities.

XML

Commitments and Contingencies (Tables)

12 Months Ended

Mar. 29, 2013

Commitments and Contingencies [Abstract]

Future minimum operating lease payments

Minimum fixed rentals required for the next five years and thereafter under operating leases in effect at March 29, 2013, are as follows:

Fiscal Year
(Amounts in millions)	Real Estate		Equipment
2014	$	211	$	39
2015	152		26
2016	112		9
2017	82		2
2018	51		—
Thereafter	68		—
	$	676	$	76

Expiration of financial guarantees

The following table summarizes the expiration of the Company’s financial guarantees and stand-by letters of credit outstanding as of March 29, 2013:

(Amounts in millions)	Fiscal 2014		Fiscal 2015		Fiscal 2016 and thereafter		Total
Surety bonds	$	29	$	1	$	—	$	30
Letters of credit	58		1		33		92
Stand-by letters of credit	37		132		14		183
Total	$	124	$	134	$	47	$	305

XML

Income Taxes (Tables)

12 Months Ended

Mar. 29, 2013

Income Taxes [Abstract]

Sources of income before income taxes classified between domestic and foreign entities

The sources of (loss) income from continuing operations, before income taxes, classified between domestic entities and those entities domiciled outside of the United States, are as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Domestic entities	$	(25	)	$	(1,807	)	$	489
Entities outside the United States	505			(2,647		)	389
Total	$	480		$	(4,454	)	$	878

Components of the income tax provision

The income tax (benefit) expense on (loss) income from continuing operations is comprised of:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Current:
Federal	$	(307	)	$	(72	)	$	(13	)
State	(3		)	11			18
Foreign	174			94			96
	(136		)	33			101
Deferred:
Federal	84			(140		)	89
State	(16		)	(22		)	7
Foreign	33			45			5
	101			(117		)	101
Total income tax expense (benefit)	$	(35	)	$	(84	)	$	202

Federal statutory tax rate to effective tax rate reconciliation

The major elements contributing to the difference between the U.S. federal statutory tax rate of 35% and the effective tax rate (ETR) for continuing operations are as follows:

	Twelve Months Ended
	March 29, 2013		March 30, 2012		April 1, 2011
Statutory rate	35.0	%	(35.0	)%	35.0	%
State income tax, net of federal tax	(0.6	)	(0.3	)	1.3
Change in uncertain tax positions	1.2		0.6		(2.8	)
Foreign tax rate differential	(66.8	)	(0.8	)	(5.4	)
Income tax credits	(0.4	)	(1.0	)	(9.6	)
Valuation allowance	77.1		18.1		2.5
Change in entity tax status	(0.3	)	(0.7	)	—
Loss on sale of securities	(51.8	)	—		—
Tax audit settlements	—		(2.5	)	—
Goodwill impairment	—		18.8		—
Other items, net	(0.7	)	0.9		2.0
Effective tax rate	(7.3	)%	(1.9	)%	23.0	%

Components of deferred tax assets and liabilities

The deferred tax assets (liabilities) are as follows:

(Amounts in millions)	March 29, 2013			March 30, 2012
Deferred Tax Assets
Employee benefits	$	558		$	705
Tax loss/credit carryforwards	1,110			899
Accrued interest	47			52
State taxes	13			13
Cumulative foreign exchange gain/loss	14			6
Other assets	111			92
Total Deferred Tax Assets	1,853			1,767
Valuation allowance	(1,298		)	(951		)
Net Deferred Tax Assets	555			816
Deferred Tax Liabilities
Depreciation and amortization	(322		)	(387		)
Contract accounting	(53		)	(90		)
Investment basis differences	(128		)	(128		)
Other liabilities	(75		)	(65		)
Total Deferred Tax Liabilities	(578		)	(670		)
Total Deferred Tax Assets (Liabilities)	$	(23	)	$	146

Balance of uncertain tax positions (excluding interest and penalties and related tax carryforwards)

The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes):

	Twelve Months Ended
(Amounts in millions)	March 29, 2013			March 30, 2012			April 1, 2011
Balance at Beginning of Fiscal Year	$	287		$	426		$	442
Gross increases related to prior year tax positions	7			27			22
Gross decreases related to prior year tax positions	(40		)	(134		)	(41		)
Gross increases related to current year tax positions	8			29			14
Settlements and statute of limitation expirations	(18		)	(115		)	(15		)
Current year acquisitions	—			56			—
Foreign exchange and others	(3		)	(2		)	4
Balance at End of Fiscal Year	$	241		$	287		$	426

Tax Examination Status

The Company is currently under examination in several tax jurisdictions. A summary of the tax years that remain subject to examination in certain of the Company’s major tax jurisdictions are:

Jurisdiction:	Tax Years that Remain Subject to Examination (Fiscal Year Ending):
United States – Federal	2008 and forward
United States – Various States	2001 and forward
Australia	2009 and forward
Canada	2006 and forward
Denmark	2007 and forward
France	2009 and forward
Germany	2006 and forward
India	2007 and forward
United Kingdom	2010 and forward

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012
Consolidated Condensed Statements of Income Parentheticals [Abstract]
Cost of services (depreciation and amortization, contract charge, settlement charge and restructuring costs)	$ 238	$ 137
Specified contract charge (amount charged to revenue)	0	204
Settlement charge (amount charged to revenue)	0	42
Restructuring costs	$ 26	$ 3

XML

Settlement of Claims with U.S. Government (Details) (USD $)	3 Months Ended	12 Months Ended
	Sep. 30, 2011	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011	Jul. 01, 2011 Claims
Settlement of Claims with U.S. Government [Abstract]
Cash received under definitive settlement agreement with the U.S. Government in its contract claims asserted under the Contract Disputes Act of 1978	$ 277,000,000
Contract extension received under definitive settlement agreement with the U.S. Government in its contract claims asserted under the Contract Disputes Act of 1978 (in years)		5 years
Contract extension received under definitive settlement agreement with the U.S. Government in its contract claims asserted under the Contract Disputes Act of 1978, base years (in years)		4 years
Contract extension received under definitive settlement agreement with the U.S. Government in its contract claims asserted under the Contract Disputes Act of 1978, optional year (in years)		1 year
Estimated value of contract extension	1,000,000,000
Total pre-tax charge to write down claim related assets	269,000,000
Amount unbilled of accounts receivable related to claims filed	379,000,000
Amount of deferred costs related to claims filed	227,000,000
Estimated fair value of the contract extension	45,000,000
Previously unapplied payments on claim related assets	15,000,000
Pre-tax charge to write down claim related assets recorded as a reduction of revenue	42,000,000
Pre-tax charge to write down claim related assets recorded as a separately itemized charge to cost of services	227,000,000	0	227,000,000	0
Fair value of the contract extension, amortization period (in years)		4 years
Term of original contract awarded (in years)		10 years
Extension granted to term of original contract awarded (in years)		2 years
Number of claims outstanding against Federal Government (in claims)					14
Original amount of claims filed, against US Federal Government					858,000,000
Amended claim amount of reduction gross					35,000,000
Number of claims asserted against the U.S. Federal Government under a single contract pending before the Armed Services Board of Contracts Appeals					14
Total amount of claims outstanding, excluding unknown, against US Federal Government					$ 675,000,000

XML

Summary of Significant Accounting Policies

12 Months Ended

Mar. 29, 2013

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

The accompanying consolidated financial statements and notes are those of Computer Sciences Corporation, its subsidiaries, and those business entities in which the Company maintains a controlling interest, hereafter collectively referred to as “CSC” or “the Company.” Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are accounted for by the cost method. All intercompany transactions and balances have been eliminated.

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The Consolidated Statements of Operations, Consolidated Statements of Comprehensive Income, and related notes, for the fiscal years ended March 30, 2012 and April 1, 2011 have been recast from those presented in previously filed Forms 10-K and Form S-3 to reflect discontinued operations of three businesses sold in fiscal 2013 (see Note 3).

The Consolidated Balance Sheet for the year ended March 30, 2012 has not been recast to reflect the assets and liabilities divested as a result of sale of the three businesses. The Consolidated Statements of Cash Flows for all the fiscal years presented include both continuing and the discontinued operations.

For classification of certain assets and liabilities of our U.S. federal government contracts as current or long-term, we use the duration of the related contract as our operating cycle, which is generally longer than one year.

Use of Estimates

GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. These estimates are based on management’s best knowledge of historical experience, current events, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates. Amounts subject to significant judgment and estimates include, but are not limited to, contracts accounted for using the percentage-of-completion method, cash flows used in the evaluation of impairment of goodwill and other long-lived assets, intangible assets, certain deferred costs, collectability of receivables, reserves for uncertain tax benefits, valuation allowances on deferred tax assets, loss accruals for litigation, pension related liabilities, inputs used for computing stock-based compensation and the fair value of derivative instruments.

The Company's income (loss) from continuing operations, before taxes and noncontrolling interests, and diluted earnings per share (EPS) from continuing operations included the following adjustments due to changes in in estimated profitability on fixed price contracts accounted for under the percentage-of-completion method for the fiscal years presented:

	Twelve Months Ended
(Amounts in millions), except per share data	March 29, 2013			March 30, 2012			April 1, 2011
Gross favorable	$	143		$	58		$	53
Gross unfavorable (1)	(122		)	(289		)	(130		)
Total net adjustments, before taxes and noncontrolling interests (2)	$	21		$	(231	)	$	(77	)
Impact on diluted EPS from continuing operations	$	(0.10	)	$	(1.30	)	$	(0.42	)

⁽¹⁾ Fiscal 2012 does not include the contract charge related to the Company’s contract with the NHS of $1,485 million (see Note 18).

⁽²⁾  Quarterly changes in estimated profitability on the same fixed price contract are disclosed gross as either favorable or unfavorable.

Revenue Recognition

The Company's primary service offerings are information technology (IT) outsourcing, and both IT and other professional services. Revenues are recognized when persuasive evidence of an arrangement exists, services or products have been provided to the client, the sales price is fixed or determinable, and collectability is reasonably assured. For non-software arrangements that include multiple-elements, revenue recognition involves the identification of separate units of accounting after consideration of combining and/or segmenting contracts and allocation of the arrangement consideration to the units of accounting on the basis of their relative selling price. Revenue under such contracts is recognized based upon the levels of services delivered in the periods in which they are provided. Upfront fees for the contract set-up activities are deferred and recognized ratably over the period of performance. Costs are expensed as incurred except for direct and incremental set-up costs that are capitalized and amortized over the life of the agreement (see Outsourcing Contract Costs below). See the section below regarding software transactions that include multiple elements.

The Company provides these services under time and materials, cost-reimbursable, unit-price and fixed-price contracts, the revenue for which is recognized in the following manner:

Time and materials contracts - Revenue is recorded at agreed-upon billing rates at the time services are provided.

Cost-reimbursable contracts - Revenue is recorded at the time costs are incurred and associated fees are recognized when probable and estimable by applying an estimated factor to costs as incurred, such factor being determined by the contract provisions and prior experience.

Unit-price contracts - Revenue is recognized on unit-price contracts based on unit metrics multiplied by the agreed upon contract unit price or when services are delivered.

Fixed-price contracts - For certain fixed-price contracts, revenue is recognized under the percentage-of-completion method as described below; these include certain software development projects, all long-term construction-type contracts, and certain fixed-price arrangements with the U.S. federal government. For other fixed-price contracts, revenue is recognized based on the proportion of the services delivered to date as a percentage of the total services to deliver over the contract term. If output or input measures are not available or cannot be reasonably estimated, revenues are recognized ratably over the contract term.

Under the percentage-of-completion method, progress towards completion is measured based on either achievement of specified contract milestones, costs incurred as a proportion of estimated total costs, or other measures of progress when available. Profit in a given period is reported at the estimated profit margin to be achieved on the overall contract. This method can result in the recognition of unbilled receivables, the deferral of costs as work in process, or deferral of profit on these contracts. Contracts that require estimates at completion using the percentage-of-completion method accounted for approximately 17.9% of the Company's revenues for fiscal 2013. Management regularly reviews project profitability and underlying estimates. Revisions to the estimates at completion are reflected in results of operations as a change in accounting estimate in the period in which the facts that give rise to the revision become known by management. Provisions for estimated losses at completion, if any, are recognized in the period in which the loss becomes evident. The provision includes estimated costs in excess of estimated revenue and any profit margin previously recognized.

Multiple-element software sales - For multiple-element arrangements that involve the sale of CSC proprietary software, post contract customer support, and other software-related services, vendor-specific objective evidence (VSOE) of fair value is required to allocate and recognize revenue for each element. VSOE of fair value is determined based on the price charged where each deliverable is sold separately. In situations where VSOE of fair value exists for all undelivered elements but not a delivered element (typically the software license element), the residual method is used to allocate revenue to the undelivered elements equal to their VSOE value with the remainder allocated to the delivered element. If significant customization is required, and VSOE is available to support accounting for the software as a separate unit of account, software revenue is recognized as the related software customization services are performed in accordance with the percentage-of-completion method described above. In situations where VSOE of fair value does not exist for all of the undelivered software-related elements, revenue is deferred until only one undelivered element remains and then recognized following the pattern of delivery of the final undelivered element.

Depreciation and Amortization

The Company’s depreciation and amortization policies are as follows:

Property and Equipment:
Buildings	Up to 40 years
Computers and related equipment	3 to 5 years
Furniture and other equipment	2 to 15 years
Leasehold improvements	Shorter of lease term or useful life
Software	2 to 10 years
Outsourcing contract costs	Contract life, excluding option years
Customer related intangibles	Expected customer service life
Acquired contract related intangibles	Contract life and first contract renewal, where applicable

The cost of property and equipment, less applicable residual values, is depreciated using predominately the straight-line method. Depreciation commences when the specific asset is complete, installed and ready for normal use. Depreciation expense for fiscal years 2013, 2012, and 2011 was $715 million, $759 million, and $688 million, respectively.

Software and outsourcing contract costs are amortized using predominately the straight-line method. Acquired contract related and customer related intangible assets are amortized in proportion to the estimated undiscounted cash flows projected over the estimated life of the asset or on a straight-line basis if such cash flows cannot be reliably estimated.

Software Development Costs

The Company capitalizes costs incurred to develop commercial software products after technological feasibility has been established. Costs incurred to establish technological feasibility are charged to expense as incurred. Enhancements to software products are capitalized where such enhancements extend the life or significantly expand the marketability of the products. Amortization of capitalized software development costs is determined separately for each software product. Annual amortization expense is calculated based on the greater of (a) the ratio of current gross revenues for each product to the total of current anticipated future gross revenues for the product or (b) the straight-line method over the estimated economic life of the product.

Unamortized capitalized software costs associated with commercial software products are regularly evaluated for impairment on a product-by-product basis by a comparison of the unamortized balance to the product’s net realizable value. The net realizable value is the estimated future gross revenues from that product reduced by the related estimated future costs. When the unamortized balance exceeds the net realizable value, the unamortized balance is written down to the net realizable value and an impairment charge is recorded.

The Company capitalizes costs incurred to develop internal-use computer software. Internal and external costs incurred in connection with development of upgrades or enhancements that result in additional functionality are also capitalized. These capitalized costs are amortized on a straight-line basis over the estimated useful life of the software. Purchased software is capitalized and amortized over the estimated useful life of the software.

Outsourcing Contract Costs

Costs on outsourcing contracts, including costs incurred for bid and proposal activities, are generally expensed as incurred. However, certain costs incurred upon initiation of an outsourcing contract are deferred and expensed over the contract life. These costs represent incremental external costs or certain specific internal costs that are directly related to the contract acquisition or transition activities. Such capitalized costs can be separated into two principal categories: contract acquisition costs and transition/set-up costs. The primary types of costs that may be capitalized include labor and related fringe benefits, subcontractor costs, travel costs, and premiums on asset purchases.

Premiums are amounts paid to customers in excess of the fair market value of assets acquired. Fixed assets acquired in connection with outsourcing transactions are capitalized at fair value and depreciated consistent with the fixed asset policies described above. Premiums paid are capitalized as outsourcing contract costs and amortized over the contract life. The amortization of outsourcing contract cost premiums is accounted for as a reduction in revenue. The second principal category of capitalized outsourcing costs is transition/set-up costs. Such costs are primarily associated with the installation of systems and processes and are amortized over the contract life.

In the event indications exist that an outsourcing contract cost balance related to a particular contract may be impaired, undiscounted estimated cash flows of the contract are projected over its remaining term and compared to the associated long-lived asset group including the unamortized outsourcing contract cost balance. If the projected cash flows are not adequate to recover the unamortized cost balance of the asset group, the balance would be adjusted based on the fair value of the long-lived assets group in the period such a determination is made. The primary indicator used to determine when impairment testing should be performed is when a contract is materially underperforming, or is expected to materially underperform in the future, as compared to the original bid model or subsequent annual budgets.

Terminations of outsourcing contracts, including transfer of assets either back to the customer or to another IT provider, prior to the end of their committed contract terms, are infrequent due to the complex transition of personnel, assets, methodologies, and processes involved with outsourcing transactions. In the event of an early termination, the Company and the customer, pursuant to certain contractual provisions, engage in discussions to determine the recovery of unamortized contract costs, lost profits, transfer of personnel, rights to implemented systems and processes, as well as other matters.

Stock-Based Compensation

The Company provides different forms of stock-based compensation to its employees and nonemployee directors. For awards settled in shares, the Company recognizes compensation expense based on the grant-date fair value net of estimated forfeitures. For awards settled in cash, the Company recognizes compensation expense based on the fair value at each reporting date net of estimated forfeitures. The Company recognized stock-based compensation expense for fiscal 2013, fiscal 2012, and fiscal 2011 as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Cost of services	$	22	$	15	$	12
Selling, general and administrative	27		21		44
Total	$	49	$	36	$	56
Total, net of tax	$	31	$	23	$	35

The Company’s overall stock-based compensation granting practice has not changed year-over-year,except that with fiscal 2012's long-term incentive program, service-based restricted stock units (RSUs) and performance-based RSUs represent a larger portion of total stock-based compensation awards than in the past.

The increase in fiscal 2013 stock-based compensation expense was primarily due to performance-based RSUs granted in fiscal 2013 that increased the expense by $15 million. This increase was partially offset by a $3 million reduction of expense as a result of adjustments for expected achievement of the specified performance criteria for performance-based RSUs granted in previous fiscal years. Fiscal 2012 stock-based compensation expense included a $12 million reduction to expense for expected achievement of the specified performance criteria for performance-based RSUs granted in previous fiscal years. There were no such adjustments in fiscal 2011.

The Company periodically evaluates its significant assumptions used in the fair value calculation. Beginning in fiscal 2011, the Company modified certain underlying assumptions in the fair value calculations, which did not have a material impact on the fair value calculations, as described below.

The Company uses the Black-Scholes-Merton model in determining the fair value of options granted. The expected term is calculated based on the Company’s historical experience with respect to its stock plan activity in combination with an estimate of when vested and unexercised option shares will be exercised. The Company uses separate assumptions for the expected term of options granted based on two separate job tier classifications which had distinct historical exercise behavior. This resulted in separate fair value calculations by job tier. The risk-free interest rate is based on the zero coupon interest rate of U.S. government issued Treasury strips with a period commensurate with the expected term of the options. In determining the overall risk-free interest rate for fiscal 2013, a range of interest rates from 0.82% to 1.44% was applied depending on the expected life of the grant. The Company continued to base expected volatility on a blended approach using an equal weighting of implied volatility and historical volatility. However, beginning with the first quarter of fiscal 2011, the historical volatility calculation was based on the Company’s six-year and seven-year historical daily closing price, rather than the ten-year historical used in prior periods, in order to bring this factor more closely into alignment with the expected terms of the stock options. The range of volatility used for fiscal 2013 was 32% to 38%. The dividend yield assumption was added concurrent with the introduction of a cash dividend in fiscal 2011 and is based on the respective fiscal year dividend payouts. Forfeitures are estimated based on historical experience and adjustments are made annually to reflect actual forfeiture experience.

The weighted average grant date fair values of stock options granted during fiscal 2013, fiscal 2012, and fiscal 2011 were $7.37, $10.17, and $12.95 per share, respectively. In calculating the compensation expense for its stock incentive plans, the Company used the following weighted average assumptions:

	Fiscal Year
	2013		2012		2011
Risk-free interest rate	1.15	%	1.80	%	2.37	%
Expected volatility	36	%	31	%	28	%
Expected term (in years)	6.59		6.11		5.85
Dividend yield	2.86	%	1.79	%	1.17	%

During fiscal 2013, fiscal 2012, and fiscal 2011, the Company's actual tax benefit realized for tax deductions from exercising stock options was of $9 million, $7 million, and $11 million, respectively, and an excess tax benefit of $3 million, $2 million, and $6 million, respectively, related to all of its stock incentive plans.

Acquisition Accounting and Goodwill

Under acquisition accounting, the purchase price is allocated to the underlying tangible and intangible assets acquired and liabilities assumed based upon their respective fair market values, with the excess recorded as goodwill. Acquisition-related costs are expensed in the periods in which the costs are incurred, and the results of operations of acquired businesses are included in the Consolidated Financial Statements from the acquisition date.

The Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if circumstances change, of if an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount. A significant amount of judgment is involved in determining whether an event indicating impairment has occurred between annual testing dates. Such indicators may include: a significant decline in expected future cash flows; a significant adverse change in legal factors or in the business climate; unanticipated competition; the disposal of a significant component of a reporting unit; and the testing for recoverability of a significant asset group within a reporting unit.

The goodwill impairment test initially involves the assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is not more likely than not, then the subsequent two-step process is not required, although the Company has the option to bypass this initial qualitative assessment and proceed directly to step one of the two-step process. If the Company determines that it is more likely than not, then it proceeds with the subsequent two-step goodwill impairment testing process. The first step is to compare each reporting unit’s fair value to its carrying value. If the reporting unit’s fair value exceeds its carrying value, no further procedures are required. However, if a reporting unit’s fair value is less than its carrying value, an impairment of goodwill may exist, requiring a second step to measure the amount of impairment loss. In the second step, the reporting unit’s fair value is allocated to all of the assets and liabilities of the reporting unit, including any unrecognized intangible assets, in a hypothetical analysis to calculate the implied fair value of goodwill in the same manner as if the reporting unit was being acquired in a business acquisition. If the implied fair value of goodwill is less than the recorded goodwill, an impairment charge is recorded in operations for the difference.

The Company estimates the fair value of each reporting unit using a combination of the income approach and the market approach. The income approach incorporates the use of a discounted cash flow method in which the estimated future cash flows and terminal values for each reporting unit are discounted to a present value using a discount rate. Cash flow projections are based on management's estimates of economic and market conditions, which drive key assumptions of revenue growth rates, operating margins, capital expenditures and working capital requirements. The discount rate in turn is based on the specific risk characteristics of each reporting unit, the weighted-average cost of capital and its underlying forecasts. The market approach estimates fair value by applying performance-metric multiples to the reporting unit's prior and expected operating performance. The multiples are derived from comparable publicly traded companies that have operating and investment characteristics similar to the reporting unit. If the fair value of the reporting unit derived using the income approach is significantly different from the fair value estimate using the market approach, the Company reevaluates its assumptions used in the two models. The fair values determined by the market approach and income approach, as described above, are weighted to determine the fair value for each reporting unit. The weighted values assigned to each reporting unit are driven by two primary factors: 1) the number of comparable publicly traded companies used in the market approach, and 2) the similarity of the operating and investment characteristics of the reporting units to the comparable publicly traded companies used in the market approach.

In order to assess the reasonableness of the calculated reporting unit fair values, the Company also compares the sum of all of its reporting units’ fair values to the Company's market capitalization (per-share stock price multiplied by the number of shares outstanding) and calculates an implied control premium (the excess of the sum of the reporting units’ fair values over the market capitalization). The Company evaluates the reasonableness of the control premium by comparing it to control premiums of recent comparable transactions. If the implied control premium is not reasonable in light of these recent transactions, the Company reevaluates its fair value estimates of the reporting units by adjusting the discount rates and/or other assumptions. As a result, when CSC’s stock price is low, this reevaluation can result in lower estimated fair values of the reporting units.

Fair Value

The Company uses the fair value measurement guidance to value certain of its assets and liabilities. Under this guidance, assets and liabilities are required to be valued based on assumptions used by a market participant, consistent with the following hierarchy of inputs:

Level 1—	Quoted prices unadjusted for identical assets or liabilities in an active market.
Level 2—	Inputs other than quoted prices that are observable, either directly or indirectly, for similar assets or liabilities.
Level 3—	Unobservable inputs that reflect the entity’s own assumptions which market participants would use in pricing the asset or liability.

The assets and liabilities which are valued using the fair value measurement guidance, on a recurring basis, include the Company’s money market funds and money market deposits, time deposits, short-term investments, pension assets, and foreign currency derivatives comprised of forward and option contracts. The fair value of the forward contracts is based on quoted prices for similar but not identical derivative financial instruments; as such, the inputs are considered Level 2 inputs. Option contracts are valued using inputs which are based on quoted pricing intervals from external valuation models, which do not involve management judgment and as such, these inputs are considered Level 2 inputs. Certain pension assets are valued using model based pricing methods that use observable market data; as such these inputs are considered Level 2 inputs. There were no significant assets or liabilities measured at fair value on a recurring basis using significant unobservable (Level 3) inputs.

Certain assets and liabilities are measured at fair value on a non-recurring basis. These include acquired assets and liabilities in a business combination, equity method investments, asset retirement obligations, long-lived assets and goodwill, which are recognized at fair value to the extent that they are deemed to be impaired or are classified as long-lived assets held to be disposed of by sale. The fair value in these instances is determined using Level 3 inputs.

Receivables

Receivables consist of amounts billed and currently due from customers, amounts earned but unbilled (including contracts measured under the percentage-of-completion method of accounting), amounts retained by the customer until the completion of a specified contract, completion of U.S. federal government audit activities audit activities, negotiation of contract modification, and claims.

Allowances for uncollectible billed trade receivables are estimated based on a combination of write-off history, aging analysis and any specific known collectability issues. Unbilled amounts under contracts in progress that are recoverable do not have an allowance for credit losses. Adjustments to unbilled amounts under contracts in progress related to credit quality, should they occur, would be recorded as a reduction of revenue.

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or group of assets may not be recoverable. Recoverability of long-lived assets or groups of assets is assessed based on a comparison of the carrying amount to the estimated future net cash flows. If estimated future undiscounted net cash flows are less than the carrying amount, an expense is recorded in the amount, if any, required to reduce the carrying amount to fair value. Fair value is determined based on a discounted cash flow approach or, when available and appropriate, to comparable market values. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell.

Income Taxes

Accounting for income taxes requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities. The Company maintains valuation allowances when, based on the weight of available evidence, it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company takes into account such factors as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of realization of a deferred tax asset.

The Company recognizes uncertain tax positions in the financial statements when it is more likely than not that the tax position will be sustained upon examination. Uncertain tax positions are measured based on the probabilities that the uncertain tax position will be realized upon final settlement (see Note 10).

Cash and Cash Equivalents

The Company considers investments with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of time deposits, money market funds and money market deposit accounts with a number of institutions that have high credit ratings.

Cash Flows

Cash payments for interest on indebtedness and cash payments for taxes on income are as follows:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Interest	$	186	$	177	$	173
Taxes on income, net of refunds	214		139		219

Non-cash investing activities include the following:

	Twelve Months Ended
(Amounts in millions)	March 29, 2013		March 30, 2012		April 1, 2011
Capital expenditures in accounts payable and accrued expenses	$	32	$	47	$	122
Capital expenditures through capital lease obligations	181		270		289
Assets acquired under long-term financing	26		32		115

Non-cash financing activities include common stock dividends of $30 million which are declared but not yet paid as of March 29, 2013.

Foreign Currency

The Company has determined that, generally, the local currency of its foreign affiliates is their functional currency. Accordingly, the assets and liabilities of the foreign affiliates are translated from their respective functional currency to U.S. dollars using year-end exchange rates, income and expense accounts are translated at the average rates in effect during the year, and equity accounts are translated at historical rates. The resulting translation adjustment is reported in the Statement of Other Comprehensive Income and recorded as part of accumulated other comprehensive income (AOCI). The amount of currency translation adjustment included in AOCI, for the years ended March 29, 2013, March 30, 2012 and April 1, 2011, was $(83) million(net of taxes of $12 million),$(124) million (net of taxes of $1 million) and $261 million (net of taxes of $3 million), respectively.

To manage the exposure to movements in foreign currency exchange rates, the Company uses foreign currency forward contracts and option contracts (see Note 7). The use of these derivative instruments is intended to offset, to the extent possible, the gains and losses from remeasurement of the Company’s foreign currency denominated monetary assets and liabilities. Gains and losses from remeasurement of the Company’s foreign currency denominated assets and liabilities, and remeasurement and settlement of the related foreign currency derivatives are recorded in Other (income) expense.

Earnings (Loss) Per Share

Basic earnings (loss) per common share (EPS) are computed using the weighted average number of common shares outstanding during the period. Diluted EPS reflect the incremental shares issuable upon the assumed exercise of stock options and equity awards.

	Twelve Months Ended
(Amounts in millions, except per-share data)	March 29, 2013		March 30, 2012			April 1, 2011
Net income (loss) attributable to CSC common shareholders:
From continuing operations	$	497	$	(4,387	)	$	657
From discontinued operations	464		145			83
	$	961	$	(4,242	)	$	740
Common share information:
Weighted average common shares outstanding for basic EPS	$	154.590	$	155.012		$	154.488
Dilutive effect of stock options and equity awards	0.967		—			2.117
Shares for diluted earnings (loss) per share	$	155.557	$	155.012		$	156.605
Earnings (loss) per share – basic and diluted:
Basic EPS:
Continuing operations	$	3.22	$	(28.31	)	$	4.25
Discontinued operations	3.00		0.94			0.54
Total	$	6.22	$	(27.37	)	$	4.79
Diluted EPS:
Continuing operations	$	3.20	$	(28.31	)	$	4.20
Discontinued operations	2.98		0.94			0.53
Total	$	6.18	$	(27.37	)	$	4.73

The computation of diluted EPS does not include stock options which are antidilutive, as their exercise price exceeded the average market price of the Company’s common stock. The number of shares related to such stock options were 14,755,024, 17,592,316, and 9,431,834, for the years ended March 29, 2013, March 30, 2012, and April 1, 2011, respectively. In addition, the computation of diluted EPS for the year ended March 30, 2012, excluded options to purchase 442,228 shares of common stock and 1,064,959 RSUs whose effect, if included, would have been anti-dilutive due to the Company’s net loss.

New Accounting Standards

During fiscal year 2013, the Company adopted the following recent Accounting Standard Updates (ASUs):

On June 16, 2011, the FASB issued ASU 2011-05, “Presentation of Comprehensive Income,” which revises the manner in which entities present comprehensive income in their financial statements. The new guidance removes the presentation options in ASC 220 "Comprehensive Income" and requires entities to report components of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements. The Company adopted the amendments in this update effective at the beginning of fiscal 2013 using the two-statement approach.

On September 15, 2011, the FASB issued ASU 2011-08, “Testing Goodwill for Impairment,” which revises guidance on testing goodwill for impairment. The amendments in the ASU allow an entity the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines that it is not more likely than not, then performing the two-step impairment is unnecessary. However, if the entity concludes that fair value is more likely than not less than carrying value, then it is required to perform the first step of the two-step impairment test and calculate the fair value of the reporting unit to compare with the carrying value of the reporting unit as described in ASC 350-20-35-4. The entity may bypass the initial qualitative assessment for any reporting unit in any period and proceed directly to the first step of the two-step impairment test. The entity may resume performing the qualitative assessment in any subsequent period. The Company adopted the amendments in the update effective at the beginning of fiscal 2013 on a prospective basis, and they did not have a material effect on CSC's Consolidated Financial Statements.

Standards Issued But Not Yet Effective

The following ASUs were recently issued but have not yet been adopted by CSC:

On December 16, 2011, the FASB issued ASU 2011-11, “Disclosures about Offsetting Assets and Liabilities,” which was subsequently amended on January 31, 2013 when the FASB issued ASU 2013-01 “Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities”. Together these Updates provide guidance on disclosure of information pertaining to the offsetting (netting) of assets and liabilities in the financial statements. The amendments in these ASUs affect all entities that have financial instruments and derivative instruments that are either (1) offset in accordance with either ASC 210-20-45 or ASC 815-10-45, or (2) subject to an enforceable master netting arrangement or similar agreement. ASU 2011-11 amends the existing disclosure requirements on offsetting in ASC 210-20-50 by requiring disclosures relating to gross amounts of recognized assets and liabilities, the amounts that are offset, net amounts presented in the balance sheet, and amounts subject to an enforceable master netting arrangement or similar agreement. The amendments in these updates become effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The adoption of the amendments of these updates is not expected to have a material effect on CSC's Consolidated Financial Statements.

On February6, 2013, the FASB issued ASU 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income”, which requires entities to report the effect of significant reclassifications out of AOCI on the respective line items in net income unless the amounts are not reclassified in their entirety to net income. For amounts that are not required to be reclassified in their entirety to net income in the same reporting period, entities are required to cross-reference other disclosures that provide additional detail about those amounts. The amendments are effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2012. The Company is currently evaluating the impact of the adoption of these amendments.

In February 2013, the FASB issued ASU No.2013-04, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date” which requires an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors. The guidance in this ASU also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December15, 2013. CSC will be required to adopt the amendments in this ASU beginning in fiscal 2015. We are currently evaluating the impact that the adoption may have on CSC's Consolidated Financial Statements.

In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830): “Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” which resolves the diversity in practice about whether Subtopic 810-10, Consolidation - Overall, or Subtopic 830-30, Foreign Currency Matters - Translation of Financial Statements, applies to the release of the cumulative translation adjustment into net income when a parent either sells a part of or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. In addition, the amendments resolve the diversity in practice for the treatment of business combinations achieved in stages (i.e. step acquisitions) involving a foreign entity. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December15, 2013. CSC will be required to adopt the amendments in this ASU beginning in fiscal 2015. The adoption of the amendments of these updates is not expected to have a material effect on CSC's Consolidated Financial Statements.

XML

Investigations and Out of Period Adjustments (Impact on Consolidated Statement of Operations) (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Revenues	$ 14,993	$ 15,364	$ 15,582
Costs of services (excludes depreciation and amortization)	11,851	13,019	12,578
Cost of services – specified contract charge (excludes amount charged to revenue of $204)	0	1,281	0
Selling, general and administrative (excludes restructuring costs of $26 (2013) and $3 (2012))	1,195	1,128	949
Depreciation and amortization	1,076	1,147	1,068
Restructuring costs	264	140	0
Interest expense	183	175	167
Other expense (income), net	(34)	(6)	(21)
Income (loss) from continuing operations before taxes	480	(4,454)	878
Taxes on income	(35)	(84)	202
Income from continuing operations, net of tax	515	(4,370)	676
Income from discontinued operations, net of taxes	464	145	83
Net income (loss)	961	(4,242)	740
Earnings Per Share, Diluted [Abstract]
Continuing operations (in dollars per share)	$ 3.20	$ (28.31)	$ 4.20
Discontinued operations (in dollars per share)	$ 2.98	$ 0.94	$ 0.53
Diluted EPS (in dollars per share)	$ 6.18	$ (27.37)	$ 4.73
Adjustment Increase/(Decrease) [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Revenues	14	56	1
Costs of services (excludes depreciation and amortization)	6	(27)	(4)
Cost of services – specified contract charge (excludes amount charged to revenue of $204)		3
Selling, general and administrative (excludes restructuring costs of $26 (2013) and $3 (2012))	(1)	2	1
Depreciation and amortization	(2)	(2)	3
Restructuring costs	5	(5)
Interest expense	0	(3)	0
Other expense (income), net	0	2	0
Income (loss) from continuing operations before taxes	6	86	1
Taxes on income	13	11	(22)
Income from continuing operations, net of tax	(7)	75	23
Income from discontinued operations, net of taxes	0	0	0
Net income (loss)	(7)	75	23
Earnings Per Share, Diluted [Abstract]
Continuing operations (in dollars per share)	$ (0.04)	$ 0.48	$ 0.15
Discontinued operations (in dollars per share)	$ 0.00		$ 0.00
Diluted EPS (in dollars per share)	$ (0.04)	$ 0.48	$ 0.15
Amount Adjusted for Removal of Errors [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Revenues	15,007	15,420	15,583
Costs of services (excludes depreciation and amortization)	11,857	12,992	12,574
Cost of services – specified contract charge (excludes amount charged to revenue of $204)		1,284
Selling, general and administrative (excludes restructuring costs of $26 (2013) and $3 (2012))	1,194	1,130	950
Depreciation and amortization	1,074	1,145	1,071
Restructuring costs	269	135
Interest expense	183	172	167
Other expense (income), net	(34)	(4)	(21)
Income (loss) from continuing operations before taxes	486	(4,368)	879
Taxes on income	(22)	(73)	180
Income from continuing operations, net of tax	508	(4,295)	699
Income from discontinued operations, net of taxes	464	145	83
Net income (loss)	$ 954	$ (4,167)	$ 763
Earnings Per Share, Diluted [Abstract]
Continuing operations (in dollars per share)	$ 3.16	$ (27.83)	$ 4.35
Discontinued operations (in dollars per share)	$ 2.98	$ 0.94	$ 0.53
Diluted EPS (in dollars per share)	$ 6.14	$ (26.89)	$ 4.88

XML

Stock Incentive Plans Schedule of share based compensation shares authorized under stock option plans by exercise price range table (Details) (USD $)	12 Months Ended
	Mar. 29, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options outstanding (in shares)	15,140,567
Number of exercisable options (in shares)	10,694,088
$23.06-$39.04 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Option Exercise Price, Minimum	$ 23.06
Range of Option Exercise Price, Maximum	$ 39.04
Number of options outstanding (in shares)	5,269,835
Weighted average exercise price (in dollars per share)	$ 31.56
Weighted average remaining contractual life (in years)	7 years 9 months 15 days
Number of exercisable options (in shares)	1,392,011
Weighted average exercise price of exercisable options (in dollars per share)	$ 36.87
$39.11-$48.61 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Option Exercise Price, Minimum	$ 39.11
Range of Option Exercise Price, Maximum	$ 48.61
Number of options outstanding (in shares)	6,075,780
Weighted average exercise price (in dollars per share)	$ 45.73
Weighted average remaining contractual life (in years)	4 years 9 months 7 days
Number of exercisable options (in shares)	5,531,586
Weighted average exercise price of exercisable options (in dollars per share)	$ 45.82
$48.65-$60.25 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Option Exercise Price, Minimum	$ 48.65
Range of Option Exercise Price, Maximum	$ 60.25
Number of options outstanding (in shares)	3,794,952
Weighted average exercise price (in dollars per share)	$ 55.06
Weighted average remaining contractual life (in years)	3 years 3 months 7 days
Number of exercisable options (in shares)	3,770,491
Weighted average exercise price of exercisable options (in dollars per share)	$ 55.08

XML

Income Taxes Operating Loss Carryforwards (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012
Foreign Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Finite amount of NOL carryforwards subject to expiration	$ 122
Net operating loss (NOL) carryforwards	3,661	3,272
Last year in which NOLs will expire	2021
Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss (NOL) carryforwards	5	14
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss (NOL) carryforwards	782	467
Tax Credit Carryforward, Amount	67	69
Deferred Tax Assets, Capital Loss Carryforwards	$ 411	$ 0
Last year in which NOLs will expire	2033

XML

Contract with the U.K. National Health Service

12 Months Ended

Mar. 29, 2013

Cost of Services [Abstract]

Cost of Services - Specified Contract Charge

Contract with the U.K. National Health Service

Interim Agreement Contract Change Note

On August 31, 2012, the Company and the NHS entered into a binding interim agreement which has been approved by all required U.K. government officials ("interim agreement contract change note" or "IACCN"). The IACCN, which is described in greater detail below, amended the terms of the parties' then current contract under which the Company has developed and deployed an integrated patient records system using the Company's Lorenzo Regional Care software product. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain financial terms of the IACCN. The IACCN, and such letter agreement, forms the basis on which the parties will subsequently finalize a full restatement of the contract through a revised project agreement. The revised project agreement will consolidate the three regional contracts which comprise the Company's NHS contract into a single agreement. CSC and the NHS are in the process of negotiating the revised project agreement.

Under the IACCN, the parties redefined the scope of the Lorenzo products and established deployment and ongoing service pricing. CSC will deliver additional Lorenzo implementations based on demand from individual NHS trusts. A more flexible arrangement than under the contract terms existing prior to the IACCN has been established for these trusts to combine additional clinical modules with the core care management functionality of the Lorenzo solution to meet their specific requirements. CSC and the NHS also agreed to a process for trusts which wish to take the Lorenzo products within the NHS-designated North, Midlands and East regions of England (NME) to obtain central funding from the U.K. Department of Health for implementation of the Lorenzo products. Separately, CSC may offer the Lorenzo solution throughout the rest of England where trusts select CSC's solutions through separate competitive processes. Under the IACCN, the NHS is no longer subject to trust volume commitments and CSC has agreed to non-exclusive deployment rights in its designated regions. New trusts taking deployments of the Lorenzo product will receive ongoing managed services from CSC for a period of five years from the date of Lorenzo deployment by such trust, provided deployment is complete or substantially complete by July 2016. Beyond its Lorenzo offerings, CSC continues to provide a wide range of other solutions and services to the NHS, including general practitioner, ambulance and community systems, digital imaging and other related services.

Pursuant to the letter agreement signed on March 28, 2013, the parties agreed to modify a small number of financial terms of the IACCN and the NHS confirmed it would make a change compensation payment in accordance with the terms of the IACCN. The NHS paid the change compensation payment of £10 million ($15 million) net of value added tax to CSC on March 28, 2013 in full and final satisfaction of all costs and claims by CSC arising from changes to the Lorenzo software product that CSC delivered up to a certain version of the product, in addition to a small number of other changes.

Historical Background Concerning NHS Contract

The Company and the NHS are parties to a contract (originally having a value of £2.9 billion or approximately $5.4 billion at originally announced exchange rates) under which the Company has developed and deployed an integrated electronic patient records system. The NHS contract was amended in April 2009 and the parties entered into variation agreements subsequent to the 2009 amendment agreeing to various operational terms and conditions. The 2009 amendment included mutual releases of all claims existing at the time of the amendment.

In 2010, as part of the U.K. government's austerity program and to address delays in development and deployments, the Company and the NHS discussed modification of the contract scope in order to reduce the total contract value by £500 million. During the fourth quarter of fiscal year 2011, additional scope modification and total contract value reduction were discussed, bringing the combined total contract value reductions to £764 million, which would have reduced the total contract value to approximately £2.1 billion or $3.2 billion (at the March 29, 2013 exchange rate). Terms related to this scope modification and contract value reduction were included in a negotiated but unsigned non-binding memorandum of understanding (MOU), which MOU included a legally binding standstill agreement which provided that, while the parties were negotiating a contract amendment to implement the terms of the MOU, neither party would pursue any claims against the other party.Negotiation of the terms of the MOU was confirmed by the NHS to be substantially completed in May 2011, but CSC was subsequently informed by the NHS in December 2011 that neither the MOU nor the related contract amendment then under discussion would be approved by the U.K. government.

Based on subsequent discussions between CSC and the NHS regarding proposals advanced by both parties reflecting significant scope modifications, a reduced commitment by the NHS for deployment of the Lorenzo software product, revised delivery and payment terms, payments by the NHS for CSC-incurred costs and commitment and contract value reductions that differed materially from those contemplated by the MOU, on March 2, 2012, CSC and the NHS entered into a non-binding letter of intent that included the statement of principles that would serve as the basis for an interim agreement between the parties. The letter of intent contemplated that under the interim agreement, the NHS would provide a commitment of a certain number of trusts to receive the Lorenzo software product, and the Lorenzo product was redefined into deployment units categorized as "Base Product" and "Additional Product" (in each case, as described below) for pricing purposes. The letter of intent also included a standstill agreement related to the Lorenzo product. While the parties originally intended to conclude a binding interim agreement byJune 29, 2012, no agreement was reached by that date. On May 31, 2012, the standstill agreement was extended to August 31, 2012. On August 31, 2012, the parties entered into the IACCN. On March 28, 2013, the Company and the NHS signed a letter agreement that modified certain financial terms of the IACCN.

Principal Components of IACCN

The IACCN sets the terms relating to the delivery of the Lorenzo product and associated services as described below.

The key terms introduced by the IACCN are as follows:

1. Under contract terms existing prior to the IACCN, the NHS was committed to purchase the Lorenzo product for multiple trusts. In addition, the Company was the exclusive supplier of such software products and related services to two out of the three regions of the U.K. covered by the existing contract. Under the IACCN, the NHS is no longer subject to any trust volume commitment for the Lorenzo product (there were no changes in quantities for non-Lorenzo deployments), and the Company agreed to non-exclusive deployment rights for all products and services in those regions in which it previously enjoyed exclusivity. As a result, the individual trusts can choose third-party software vendors other than CSC to provide a software solution. CSC and the NHS have also agreed to a process for trusts which wish to take the Lorenzo products within the NME regions to obtain central funding from the U.K. Department of Health for implementation of the Lorenzo products. In addition, CSC may offer the Lorenzo solution throughout the rest of England where trusts select CSC's solutions through a separate competitive process.

2. The IACCN creates pricing and payment terms for the Lorenzo product and new terms under which trusts in the contract's NME region that choose the Lorenzo product can access central funds for its deployment, subject to business case justification. While the funding is provided by the NHS, there is a far greater degree of interaction with the trusts under the IACCN, as the Company works with each individual trust to build a business case and seek NHS approval and central funding to proceed.

3. The IACCN has not materially altered the terms relating to non-Lorenzo products. The Company will continue to provide non-Lorenzo deployment, hosting and maintenance services in accordance with contract terms in existence prior to the IACCN. The deployment of the non-Lorenzo products is expected to be completed or substantially completed by fiscal 2015.

4. Under the IACCN, the Lorenzo product is redefined for pricing purposes, with Lorenzo Regional Care comprising the "Base Product," consisting of seven deployment units (or modules) and the "Additional Product," consisting of three other modules. The parties agreed that six of the Base Product's modules had completed the necessary NHS assurances and were ready to deploy to further trusts as of August 31, 2012. The remaining module of the Base Product was similarly accepted by the NHS as complete and ready to deploy to further trusts in early September 2012. The Additional Product's three modules are expected to complete NHS assurance during 2013. Although the NHS assurance of the Base Product's seven modules is complete and the Company and the NHS are committed to complete the assurance of the Additional Product modules, neither the NHS nor any trust is obligated to purchase or deploy any of those modules.

5. New trusts taking deployments of the Lorenzo product will receive ongoing managed services from the Company for a period of five years from the date such deployment is complete, provided deployment is complete or substantially complete by July 7, 2016. The services include hosting of the software and trust data at the Company's data center as well as support and maintenance, including regulatory updates and other changes over the term of the contract. Under contract terms existing prior to the IACCN, all services were to expire upon the end of the contract term of July 7, 2016, subject to an optional one year extension and an exit transition period.

Accounting

Prior to the IACCN, the NHS contract has been accounted for using the percentage-of-completion method based on management's best estimates of total contract revenue and costs.Based on then existing circumstances, CSC revised its estimate of revenues and costs at completion during the third quarter of fiscal 2012 to include only those revenues reasonably assured of collection. As a result of that change, the Company recorded a $1.5 billion contract charge in that quarter, resulting in no material remaining net assets.

The terms of the IACCN represent a significant modification to the prior agreement, including a significant reduction in additional product development and elimination of any commitment by the NHS to future Lorenzo deployments and the Company's exclusivity rights in two of the three contract regions. The Company concluded that it will account for the IACCN as a new contract and will recognize revenue as a services arrangement. Revenue recognition for each trust deployment will begin at the start of the trust's hosting period. Payments from the NHS for deployment of systems will be deferred and recognized over the service period. Direct costs incurred for deployment activities will be deferred and amortized to expense over the service period as well. The total up-front consideration of £78 million ($126 million), including the £68 million ($110 million) net settlement payment and a £10 million ($16 million) escrow release, is primarily attributed to future Lorenzo deployments and will be deferred and recognized as revenue ratably over the term of the contract ending July 2016.

The £10 million ($15 million) payment received on March 28, 2013, as well as future consideration not noted above, when and if earned, will be deferred and amortized over the longer of the term of the contract or the estimated performance period.

XML

Short-term Debt (Details) (USD $) In Millions, unless otherwise specified					1 Months Ended
	Mar. 29, 2013 Commercial Paper [Member]	Mar. 30, 2012 Commercial Paper [Member] Parent Company [Member]	Mar. 29, 2013 Line of Credit Foreign Bank [Member] Guarantor Subsidiaries [Member]	Mar. 30, 2012 Line of Credit Foreign Bank [Member] Guarantor Subsidiaries [Member]	Mar. 29, 2013 Minimum [Member] Commercial Paper [Member]	Mar. 29, 2013 Maximum [Member] Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term Debt, Term					1 month	3 months
Commercial paper outstanding	$ 0	$ 0	$ 0	$ 43

XML

Fair Value (Tables)

12 Months Ended

Mar. 29, 2013

Fair Value [Abstract]

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table presents the Company’s assets and liabilities, excluding pension assets (see Note 12), that are measured at fair value on a recurring basis as of March 29, 2013 and March 30, 2012:

	March 29, 2013
			Fair Value Hierarchy
(Amounts in millions)	Fair Value		Level 1		Level 2		Level 3
Assets:
Money market funds and money market deposit accounts	$	464	$	464	$	—	$	—
Time deposits	393		393		—		—
Short term investments	6		6		—		—
Derivative assets	5		—		5		—
Total assets	$	868	$	863	$	5	$	—
Liabilities:
Derivative liabilities	$	11	$	—	$	11	$	—
Total liabilities	$	11	$	—	$	11	$	—
	March 30, 2012
			Fair Value Hierarchy
(Amounts in millions)	Fair Value		Level 1		Level 2		Level 3
Assets:
Money market funds and money market deposit accounts	$	299	$	299	$	—	$	—
Time deposits	102		102		—		—
Short term investments	6		6		—		—
Derivative assets	12		—		12		—
Total assets	$	419	$	407	$	12	$	—
Liabilities:
Derivative liabilities	$	14	$	—	$	14	$	—
Total liabilities	$	14	$	—	$	14	$	—

XML

Debt

12 Months Ended

Mar. 29, 2013

Debt Instruments [Abstract]

Debt

Debt

The following is a summary of the Company's debt as of March 29, 2013 and March 30, 2012:

(Amounts in millions)	March 29, 2013		March 30, 2012
4.45% term notes, due September 2022	$	349	$	—
6.50% term notes, due March 2018	998		997
2.50% term notes, due September 2015	350		—
5.50% term notes, due March 2013	—		699
5.00% term notes, due February 2013	—		300
Four-year term loan credit facility	250		—
Mandatorily redeemable preferred stock outstanding	59		—
Note payable of consolidated subsidiary	62		—
Capitalized lease liabilities	561		574
Borrowings for assets acquired under long-term financing	98		84
Other borrowings	5		86
Total debt	2,732		2,740
Less: short term debt and current maturities of long term debt	234		1,254
Total long-term debt	$	2,498	$	1,486

Term notes and term loan credit facility

On September 18, 2012, the Company issued $700 million of senior unsecured and unsubordinated notes (new term notes) comprised of $350 million of 2.50% Senior Notes due September 15, 2015 and $350 million of 4.45% Senior Notes due September 15, 2022. The new term notes were recorded net of debt discount of $1 million. The Company also incurred deferred debt issuance costs of $5 million, which along with the debt discount will be amortized over the respective terms of the new term notes using the effective interest method. The new term notes are senior unsecured and unsubordinated obligations and rank equally with all other existing and future senior unsecured and unsubordinated indebtedness, including any borrowings under the existing $1.5 billion Credit Facility (discussed below), and senior to all future subordinated debt. Interest is payable semi-annually on September 15 and March 15 beginning March 15, 2013. The proceeds from the new term notes were used to redeem a portion of the 5.50% term notes due March 2013 and the 5.00% term notes due February 2013, as described below.

In addition, on September 18, 2012, the Company entered into a four-year, unsecured, delayed-draw $250 million term loan credit facility (term loan) maturing on September 18, 2016. Under the term loan, the Company has an option to request an increase in the commitment up to a maximum amount of $350 million. Interest on borrowings under the new facility is based on prime rate or LIBOR plus a daily margin, and is payable quarterly. Quarterly principal repayments of 2.5% of borrowings commence December 31, 2013. Costs associated with establishing the term loan of $1 million have been deferred and will be amortized over the term of the agreement. On October 17, 2012, the Company borrowed $250 million under the term loan and used the proceeds to redeem a portion of the 5.50% and 5.00% term notes due in the fourth quarter of 2013, as described below.

On September 12, 2012, the Company delivered a notice of early redemption with respect to the Company’s outstanding $700 million 5.50% Senior Notes due March 2013 and $300 million 5.00% Senior Notes due February 2013. On October 19, 2012, the Company used the proceeds received from the issuance of new term notes and the $250 million drawn from the term loan credit facility to fund the early redemption of the 5.00% and 5.50% term notes due February 2013 and March 2013, respectively, resulting in the recognition of a $19 million loss recorded to interest expense.

Both the new term notes and the new term loan credit facility agreement contain representations, warranties, and covenants customary for arrangements of these types, as well as customary events of default, including a cross-default to payment defaults on principal payments aggregating $125 million or to other events if the effect is to accelerate or permit acceleration of such debt.

Both the term loan credit facility and the $1.5 billion Credit Facility (see below) require the Company to: (1) maintain a minimum interest coverage ratio of consolidated Earnings Before Interest, Taxes, Depreciation and Amortization adjusted for other non-cash charges as defined by the credit agreement (EBITDA), to consolidated interest expense for the period of four consecutive fiscal quarters ending on or immediately prior to such period not to be less than 3.00 to 1.00; and (2) not permit at the end of any quarterly financial reporting period the ratio of consolidated total debt to consolidated EBITDA for the period of four consecutive fiscal quarters ending on or immediately prior to such date, to exceed 3.00 to 1.00. The Company was in compliance with these financial covenants as of March 29, 2013 and March 30, 2012.

Mandatorily redeemable preferred stock and note payable of a consolidated subsidiary

Mandatorily redeemable preferred stock

In March 2013, CSC entered into a financing agreement with a bank involving the sale of the Company's interest in mandatorily redeemable preferred stock (the preferred stock) of one of its wholly-owned subsidiaries (the Subsidiary). Such preferred stock is mandatorily redeemable on the tenth anniversary of its issuance (in 2023) but can be optionally redeemed by the Subsidiary at any time after the fifth anniversary of issuance. Therefore, the preferred stock was accounted for as a liability and is presented as long-term debt within the consolidated balance sheet.

The preferred stock has a stated value of $63 million (the initial liquidation preference) and was recorded at its issue date fair value of $59 million. The difference between the initial fair value and the stated value will be accreted over the term of the preferred stock. The Company incurred debt issuance costs of $1 million associated with the issuance of the preferred stock. These costs have been deferred and will be amortized over ten years using the effective interest method.

The preferred stock requires payment of cumulative preferred dividends at 3.48% per annum for the first five years. In addition, the holder of the preferred stock has a remarketing option, exercisable by the holder after five years from initial issuance, that if exercised, requires the assistance of the Subsidiary to remarket the Series A preferred stock, which under certain circumstances, may result in changes to the thereafter dividend rate in order to successfully remarket the securities. Dividends are payable on a quarterly basis and any unpaid dividends are subject to an incremental interest rate margin of 2.50%. The preferred shares also participate at 3.80% in 1) dividends paid on the Subsidiary's common stock and in 2) any future appreciation (as defined in the agreement) of the Subsidiary's common stock equity value (variable redemption premium). The liquidation preference of the preferred stock is the sum of the stated value of the shares, accrued but unpaid dividends, and any unpaid variable redemption premium.

Note payable

Concurrent with the financing agreement mentioned above, the Company entered into a separate credit agreement with a bank to sell the Company's interest in a five-year note receivable due 2018 issued by the Subsidiary for cash consideration of £41 million ($62 million as of March 29, 2013). The Company incurred $1 million of debt issuance costs associated with the note payable. These costs have been deferred and will be amortized over five years using the effective interest method.

The note bears interest in British pounds at a variable rate based on LIBOR and is payable on a quarterly basis. Although the note is due in five years, the Subsidiary has the option to repay the principal amount of the note plus any unpaid accrued interest beginning upon its third anniversary from issuance. As part of the sale of the note to the bank, the Company became a guarantor of the Subsidiary's note payable. The financing agreement and the credit agreement require the Subsidiary to retain a minimum amount of assets. The Company and the Subsidiary were in compliance with all financial covenants at March 29, 2013.

Capital lease liabilities

Capitalized lease liabilities represent obligations due under capital leases for the use of computers and other equipment. The gross amount of assets recorded under capital leases was $1,095 million with accumulated amortization of $465 million, as of March 29, 2013, and $940 million with accumulated amortization of $341 million, as of March 30, 2012.

Borrowings for assets acquired under long-term financing

Certain asset purchases under outsourcing contracts were financed by borrowings from customers. These borrowings carry a rate of interest from 0.0% to 4.9% and will mature over the next five years. Gross amounts of assets purchased under long-term financings included $69 million and $44 million in property and equipment, $54 million and $45 million in software, $90 million and $86 million in outsourcing contract costs and $10 million and $10 million in other intangible assets as of March 29, 2013 and March 30, 2012, respectively.

Other borrowings

Several foreign subsidiaries of the Company had no borrowings outstanding, as of March 29, 2013, and $43 million of borrowings outstanding, as of March 30, 2012, under uncommitted lines of credit with certain foreign banks. CSC has provided parent guarantees for these short-term lines of credit which carry no commitment fees or significant covenants. In addition, the Company had $5 million and $43 million of other borrowings outstanding as of March 29, 2013 and March 30, 2012, respectively, consisting of other interest bearing debt and notes payable.

Commercial paper

The Company typically issues commercial paper with average maturities of one to three months. The commercial paper is backed by the $1.5 billion Credit Facility discussed below. As of both March 29, 2013 and March 30, 2012, the Company had no borrowings outstanding against commercial paper.

Credit facility

On March 18, 2011, the Company entered into a committed, unsecured line of credit for $1.5 billion (Credit Facility) that expires on March 18, 2015. The Credit Facility bears a variable rate of interest. The Company can elect to borrow at a prime rate, as published by the Bank of America, plus a margin or at a one, two, three, or six month LIBOR plus a margin. The margin varies with the credit ratings of the Company. As of both March 29, 2013 and March 30, 2012, the Company had no amounts outstanding under this Credit Facility.

Expected maturities of long-term debt, including borrowings for asset financing but excluding future minimum capital lease payments, for years subsequent to March 29, 2013, are as follows:

Fiscal Year	Amount (in millions)
2014	$	52
2015	71
2016	381
2017	194
2018	1,064
Thereafter	409
Total	$	2,171

The future minimum lease payments required to be made under the capital leases as of March 29, 2013, are as follows:

Fiscal Year	Amount (in millions)
2014	$	221
2015	195
2016	115
2017	73
2018	38
Thereafter	97
Total minimum lease payments	739
Less: Amount representing interest	178
Present value of net minimum lease payments	561
Less: Current maturities of capital lease obligations	182
Long-term capitalized lease liabilities	$	379